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The primary focus of this dissertation is the metabolic enzyme pyruvate carboxylase 
(PC). The structure and function of this fascinating enzyme has been studies and characterized 
by many laboratories over many decades. This extensive background is reviewed in Chapter 1, 
with an overview of the biotin-dependent carboxylase family and a particular focus on PC.  In 
this dissertation, we primarily use X-ray crystallography to study PC at a structural level.  
This dissertation is divided into two overarching sections, with the first section (Chapters 
2-5) focusing on the bacterial second messenger cyclic-di-AMP (c-di-AMP). This project was 
initiated by our collaborators in the laboratory of Josh Woodward at the University of 
Washington, who performed the first screen to identify c-di-AMP binding proteins in the 
bacterium Listeria monocytogenes. In Chapters 2 and 3, the regulation of PC by c-di-AMP in L. 
monocytogenes as well as the bacterium Lactococcus lactis is discussed. Crystal structures of the 
PC from each of these species in complex with cyclic-di-AMP reveal the binding site and give 
insights into the molecular mechanisms of this regulation. In Chapters 4 and 5, structural studies 
of other c-di-AMP binding proteins identified in the screen are discussed.  
The second section (Chapters 6) focuses on a second class of PC enzymes called the two-
subunit PCs, which are found in a subset of Gram-negative bacteria. In Chapter 6, the first 
crystal structure of a two-subunit PC from the bacterium Methylobacillus flagellatus is 
determined. In collaboration with the Lars Dietrich laboratory at Columbia University, we 
  
investigate the physiological function of the two-subunit PC in the pathogen Pseudomonas 
aeruginosa.  
A theme which emerges from these studies is that PC is an incredibly diverse enzyme 
which has been adapted for the peculiar physiological needs of each organism it inhabits. 
Because PC is found throughout nature in every kingdom of life, further studies of its unique 
properties and role in each organism are sure to provide more surprising insights in the years to 





















Table of Contents 
 
List of Figures and Tables ........................................................................................................... vi 
Acknowledgements ................................................................................................................... xvii 
Dedication ............................................................................................................................................ xviii 
 
Chapter 1 
Introduction to the biotin-dependent carboxylase family and pyruvate carboxylase 
1.1 Introduction to biotin-dependent carboxylases ......................................................................... 1 
1.2 Function of pyruvate carboxylase ............................................................................................. 4 
1.3 Structures of the individual components of pyruvate carboxylase ........................................... 7 
1.3.1 Biotin carboxylase (BC) ..................................................................................................... 7 
1.3.2 Carboxyltransferase (CT) ................................................................................................... 9 
1.3.3. Biotin carboxyl carrier protein (BCCP) .......................................................................... 11 
1.4 Structure of the pyruvate carboxylase holoenzyme ................................................................ 12 
1.4.1 The PC tetramerization (PT) domain ............................................................................... 14 
1.4.2 Mechanism of catalysis .................................................................................................... 15 
1.5 The allosteric activator acetyl-CoA ........................................................................................ 17 
1.6 Conclusions ............................................................................................................................. 21 
1.7 References ............................................................................................................................... 22 
 
Chapter 2 
The bacterial second messenger cyclic-di-AMP and its regulation of pyruvate carboxylase 
2.1 Introduction ............................................................................................................................. 25 
ii 
 
2.1.1 Cyclic-di-AMP is a widespread and essential bacterial second messenger ..................... 25 
2.1.2 Listeria monocytogenes as a model organism .................................................................. 28 
2.2 Experimental procedures ........................................................................................................ 29 
2.3 Identification of c-di-AMP-binding proteins in L. monocytogenes ........................................ 31 
2.4 Biochemical analysis of LmPC and its regulation by c-di-AMP............................................ 32 
2.5 Crystal structure of LmPC in complex with c-di-AMP .......................................................... 33 
2.5.1 Analysis of c-di-AMP binding to LmPC.......................................................................... 35 
2.5.2 A citrate is bound in the acetyl-CoA binding pocket ....................................................... 37 
2.5.3 Detailed interactions between LmPC and c-di-AMP ....................................................... 38 
2.5.4 Mutational analysis of the LmPC c-di-AMP binding pocket ........................................... 40 
2.6 Crystal structure of apo LmPC ............................................................................................... 42 
2.7 Insights into the mechanism of c-di-AMP inhibition ............................................................. 44 
2.8 Functional studies of c-di-AMP regulation of PC in Listeria monocytogenes ....................... 45 
2.9 References ............................................................................................................................... 48 
 
Chapter 3 
Regulation of pyruvate carboxylase by c-di-AMP in Lactococcus lactis 
3.1 Introduction ............................................................................................................................. 51 
3.2 Experimental Procedures ........................................................................................................ 54 
3.3 Biochemical Analysis of LlPC and its regulation by c-di-AMP ............................................ 56 
3.4 Crystal structure of LlPC in complex with c-di-AMP ............................................................ 58 
3.4.1 BCCP assignments in the LlPC-c-di-AMP structure and implications for PC catalysis . 59 
3.4.2 Comparisons of the c-di-AMP complex structures of LlPC and LmPC .......................... 61 
3.4.3 Analysis of c-di-AMP binding to LlPC............................................................................ 63 
3.4.4 Mutational analysis of the LlPC c-di-AMP binding pocket ............................................. 65 
iii 
 
3.5 Crystal structure of apo LlPC ................................................................................................. 67 
3.5.1 Binding of c-di-AMP causes a conformational change in the CT dimer ......................... 70 
3.6 Investigating the molecular basis for LlPC insensitivity to acetyl-CoA activation ................ 72 
3.7 Function of c-di-AMP regulation of PC in Lactococcus lactis .............................................. 74 
3.8 Conclusion and future directions ............................................................................................ 75 
3.9 References ............................................................................................................................... 77 
 
Chapter 4 
Structural studies of the c-di-AMP binding protein PstA 
4.1 Introduction ............................................................................................................................. 79 
4.2 Experimental Procedures ........................................................................................................ 80 
4.3 Crystal structure of LmPstA and comparison with PII proteins .............................................. 82 
4.4 The LmPstA c-di-AMP binding pocket .................................................................................. 85 
4.5 Structural changes in LmPstA upon c-di-AMP binding ......................................................... 89 
4.6 Sequence conservation in PstA of c-di-AMP binding residues .............................................. 91 
4.7 Insights into the evolutionary origins of the PstA family ....................................................... 92 
4.8 References ............................................................................................................................... 94 
 
Chapter 5 
Structural studies of the c-di-AMP-binding CBS domain proteins CbpA and OpuC  
5.1 Introduction ............................................................................................................................. 95 
5.2 Experimental Procedures ........................................................................................................ 96 
5.3 Crystal Structure of LmCbpA in complex with c-di-AMP..................................................... 98 
5.4 Crystal Structure of apo LmCbpA and comparisons with the c-di-AMP complex .............. 101 
iv 
 
5.5 Possible functions of CbpA in bacteria ................................................................................. 103 
5.6 Identification of OpuCA as a c-di-AMP binding protein ..................................................... 104 
5.7 Crystal structure of LmOpuCA in complex with c-di-AMP ................................................ 106 
5.8 Comparisons of the CBS dimers of LmCbpA and LmOpuCA ............................................ 110 
5.9 Future directions for the studies of c-di-AMP signaling in bacteria ..................................... 112 
5.10 References ........................................................................................................................... 114 
 
Chapter 6 
Structural studies of the two-subunit pyruvate carboxylase 
6.1 Introduction ........................................................................................................................... 117 
6.2 Experimental Procedures ...................................................................................................... 118 
6.3 Crystallization of two-subunit PC ......................................................................................... 121 
6.4 Building the MfPC model ..................................................................................................... 125 
6.5 Evidence for the α2β4 stoichiometry of the MfPC complex ................................................. 126 
6.6 Crystal structure of the MfPC holoenzyme .......................................................................... 129 
6.6.1 A BT-like structure in two-subunit PC .......................................................................... 132 
6.6.2 An interface between the BT-like and BC domains ....................................................... 135 
6.6.3 Structure-based mutations in MfPC ............................................................................... 137 
6.6.4 Insights into catalytic mechanism of MfPC ................................................................... 140 
6.7 Implications for the evolution of pyruvate carboxylase enzymes ........................................ 142 
6.8 Functional Studies of the two-subunit PC in Pseudomonas aeruginosa .............................. 144 
6.9 Conclusions and future directions ......................................................................................... 146 




Appendix A: The cyclic-dinucleotide c-di-AMP is an allosteric regulator of metabolic enzyme 
function ....................................................................................................................................... 150 
Appendix B: Molecular basis for the recognition of cyclic-di-AMP by PstA, a PII-like signal 
transduction protein  ................................................................................................................... 164 
Appendix C: Cyclic di-AMP targets the cystathionine beta-synthase domain of the osmolyte 
transporter OpuC ......................................................................................................................... 179 



















List of Figures and Tables 
 
Chapter 1 
Figure 1. Catalysis in biotin-dependent carboxylases. The separate reactions in the BC and 
CT domains are illustrated, and BCCP must translocate between the distant active sites. Figure 
from (1) 
Figure 2. Domain architecture of biotin-dependent carboxylases. The BC domain is shown in 
red. The CT domain is shown in various colors for each sub-class, acyl-CoA carboxylases (cyan 
and yellow), pyruvate carboxylases (PC) (green), and urea carboxylases (UC) (purple, pink, and 
orange). The BCCP domain is shown in blue. The length of the protein in amino acid residues is 
indicated by the scale bar at the bottom. The unique BT domain in some acyl-CoA carboxylases 
and PT domain in PC are shown in orange. Figure from (1)  
Figure 3. Diverse substrates of biotin-dependent carboxylases. The chemical structures of the 
substrates utilized by each biotin-dependent carboxylase are shown. The red arrow highlights the 
atom to which the carboxyl group is added. Figure from (1) 
Figure 4. Metabolic functions of pyruvate carboxylase in mammalian tissues. Figure from 
(13) 
Figure 5. Structure of the biotin carboxylase (BC) domain from Escherichia coli acetyl-
CoA carboxylase. (A) The BC domain dimer, with the three sub-domains (A,B,C). The bound 
ADP, Mg
2+
, and biotin ligands are shown as sticks. (B) A close-up view of the BC active site. 
Residues important for catalysis are shown as sticks, and hydrogen-bonds are shown as dashed 
lines (red). Figure from (27) 
Figure 6. The carboxyltransferase domain from Staphylococcus aureus pyruvate 
carboxylase. (A) A CT dimer from S. aureus PC (34). The TIM barrel is seen in a top-down 
view in Monomer 1 (green), and in the side-view in Monomer 2 (yellow). The C-terminal 
extension outside the TIM barrel is colored orange in Monomer 2. The side-chains coordinating 
the metal-ion (M
2+
, gray sphere) are shown with stick representation. (B) The CT active site 
from S. aureus PC. The biotin attached to BCCP is shown in gray, and the various side chains of 
SaPC (cyan) which recognize the biotin are shown in sticks. Pyruvate is in black, and the metal 
ion is a red sphere.  Figure from (35) 
Figure 7. Crystal structure of the BCCP domain from Staphylococcus aureus pyruvate 
carboxylase (SaPC) Schematic drawing of the BCCP structure (34). The individual β-strands, 
along with the attached biotinyl group are indicated.   
Figure 8. Crystal structure of the full-length Staphylococcus aureus pyruvate carboxylase 
(SaPC). Schematic drawing of the SaPC structure. The individual domains (BC, CT, PT, and 
BCCP) are indicated. Monomer 1 is colored as in Figure 2, while the other three monomers are 
colored magenta, cyan, and yellow. The biotin, pyruvate, and ATP ligands are shown as sticks. 
The metal ion is shown as a red sphere. Figure from (34) 
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Figure 9. Difference in symmetry between RePC and SaPC structures. (A) An overlay of 
two monomers from the RePC structure, and one monomer from the SaPC structure. The SaPC 
monomer is colored per the individual domains (see Figure 2), while the RePC monomers are in 
black and gray. The monomers are overlaid by the CT domain, and the differences in the 
positioning of the BC domain are seen. (B) Overlay by the CT domain of the four monomers in 
the SaPC structure. The monomers are colored as in Fig. 7. The red arrow highlights a 
conformational change in the CT domain of the monomer with a BCCP in the active site.    
Figure 10. The PT domain from PC and the BT domain from PCC. (A) The PT domain from 
the structure of S. aureus PC (34). The connections to the rest of the protein are indicated. (B) 
The BT domain from propionyl-CoA carboxylase (39).   
Figure 11. Possible BCCP movement during PC catalysis. The PC tetramer is shown as a 
cartoon schematic. The view and color scheme is the same as in Figure 7. The black line 
extending from BCCP is the biotin moiety. In the left side of the panel, the BCCP is the CT 
active site of the other monomer. In the right side of the panel, the BCCP is in the BC active site 
of its own monomer. The distances between the active sites are indicated by the black arrow. 
Figure from (34)  
Figure 12. Acetyl-CoA activation of SaPC. A representative titration is shown for acetyl-CoA 
and other analogs measuring PC activity. Figure from (35) 
Figure 13. Crystal structure of SaPC bound to CoA. (A) Schematic drawing of the SaPC 
tetramer in complex with four CoA molecules (black spheres). One of the CoA molecules is 
highlighted inside the gray circle. The coloring scheme is the same as in Figure 7. (B) A close-up 
view of the SaPC CoA binding site showing detailed interactions between CoA and the BC (red) 
and PT (orange) domains of SaPC. The CoA is shown in stick representation (black). Figure 
from (35) 
Figure 14. Conformational changes in the SaPC BC dimer upon CoA binding. A BC dimer 
from SaPC in complex with CoA (Monomer 2 in magenta, Monomer 4 in yellow), is overlaid 
with a BC dimer from unbound SaPC (gray). Monomer 2 is overlaid and the changes in the 
dimer conformation (red arrow) are observed in the positioning of Monomer 4. Figure from (35) 
 
Chapter 2 
Figure 1. Chemical structure of cyclic-di-nucleotides. (A) cyclic-di-AMP (B) cyclic-di-GMP 
(C) cyclic-GMP-AMP 
Figure 2. L. monocytogenes proteins identified in c-di-AMP binding screen. List of proteins 
identified to bind c-di-AMP in L. monocytogenes. The name of the gene locus is in the left 
column, and the annotation of the protein is indicated. The FC indicates the degree of binding 
compared to control sepharose beads, and the FDR indicates the false discovery rate based on the 
FC.   
Figure 3. Enzymatic assays of LmPC with c-di-AMP. (A) Michaelis-Menten curves of LmPC 
with various c-di-AMP concentrations, as indicated. The reactions were done in the presence of 
viii 
 
100 uM acetyl-CoA. (B) LmPC inhibition assays with various nucleotide analogs, as indicated. 
The reactions were done with 20 mM pyruvate.  
Figure 4. L. monocytogenes pyruvate carboxylase in complex with c-di-AMP. Schematic 
drawing of the LmPC structure at 2.5 Å resolution in complex with 2 c-di-AMP molecules (cdA, 
black spheres). Monomer 1 is colored according to the key at the bottom, and the other 
monomers are colored magenta, cyan, and yellow. The metal ion (M
2+
) is shown as a gray 
sphere. The distance between the c-di-AMP and the metal ion in Monomer 1 is shown as a 
dashed line (red). The lysine residue on the BCCP domain to which biotin is attached is shown in 
stick representation.  
Figure 5. The c-di-AMP binding pocket in LmPC. (A) Omit Fo-Fc density for c-di-AMP 
bound to LmPC at 2.5 Å resolution, contoured at 3σ (B) Molecular surface of the LmPC binding 
site for c-di-AMP (black sticks). The surface is colored according to the electrostatic potential 
(blue is positive, red is negative, white is neutral) 
Figure 6. LmPC crystal packing. (A) Crystal form 1 with the bridging c-di-AMP (c-di-AMP) 
molecule. Two adjacent CT dimers from neighbouring LmPC tetramers are shown. The CT 
dimer from tetramer 1 is colored green and yellow, the CT dimer from tetramer 2 is colored 
magenta and cyan. (B) Crystal form 2 with no bridging c-di-AMP. The view and coloring 
scheme is identical to (A).  
Figure 7. Citrate binding to LmPC. (A) Omit Fo-Fc density for citrate bound to LmPC at 2.5 Å 
resolution, contoured at 3σ. (B) The LmPC citrate binding pocket at the interface of the BC and 
PT domains of one monomer. Hydrogen-bonding interactions with the protein are shown as 
dashed red lines.  
Figure 8. Detailed interactions between c-di-AMP and LmPC. (A) The c-di-AMP (black) and 
the side-chains which interact with c-di-AMP are shown in stick representation. Hydrogen-
bonding interactions are shown as red dashes. Water molecules are shown as red spheres. (B) 
Sequence alignment of the c-di-AMP binding pocket from selected PC homologues. The 
residues which interact with the c-di-AMP are highlighted in red. The numbering is according to 
LmPC.  
Figure 9. c-di-AMP binding and inhibition assays of LmPC mutants. (A) c-di-AMP binding 
to wild-type LmPC and various mutants measured using the DRaCALA assay. (B) Enzymatic 
activity of wild-type LmPC and various mutants. Figure from (33)    
Figure 10. Comparisons between the apo and c-di-AMP bound LmPC structures. (A) 
Overlay of the apo (gray) and c-di-AMP bound (colors) LmPC tetramer. Monomer 1 was 
overlaid, to highlight the conformational changes in the other monomers.  The c-di-AMP bound 
tetramer is colored as in Figure 4, and the c-di-AMP (cdA) is shown as black spheres. (B) 
Overlay of the four monomers in the apo LmPC tetramer by the CT domain. The red arrow 
highlights the conformational differences of the BC domain. (C) Overlay of the four monomers 
in the c-di-AMP bound LmPC tetramer. The c-di-AMP (cdA) is shown as black spheres.   
Figure 11. Conformational changes of LmPC upon c-di-AMP binding. (A) Overlay of the 
CT dimer of the apo (gray) and c-di-AMP (colors) bound LmPC structures. The red arrows 
highlight the conformational changes upon c-di-AMP binding. The c-di-AMP (black) and the 
ix 
 
side-chains that interact with c-di-AMP are shown in stick representation. (B) Overlay of the CT 
domain of Monomer 4 between the apo (gray) and c-di-AMP bound (colors) LmPC structures. 
The change in position of Monomer 1 upon c-di-AMP binding is indicated by the red arrow. The 
c-di-AMP (cdA) is labeled and shown as black sticks.  
Figure 12. Functional studies in L. monocytogenes on the metabolic regulation of LmPC by 
c-di-AMP. (A) Schematic of L. monocytogenes pyruvate metabolism and the synthesis of the 
amino acids from alanine, aspartate, and glutamate from metabolic precursors. (B) 
13
C 
enrichment into the amino acids alanine, aspartate, and glutmate/glutamine measured in mid-
exponential L. monocytogenes strains. (C) The bacterial burden measured in colony forming 
units (CFU) in the spleen and the liver in various L. monocytogenes strains measured 48 hours 
post-infection. Figure from (33) 
Table 1. Crystallographic data and refinement statistics 
 
Chapter 3 
Figure 1. Sequence conservation in the c-di-AMP binding pocket of pyruvate carboxylase 
(A) Sequence alignment of PC enzymes from Listeria monocytogenes (LmPC), Staphylococcus 
aureus (SaPC), and Enterococcus faecalis (EfPC). Residues that interact with c-di-AMP are 
highlighted in red. The numbering is according to LmPC. (B) Molecular surface of the c-di-AMP 
binding pocket in the CT dimer of LmPC. The two CT monomers are colored in green and 
yellow. (C) The same CT dimer interface in SaPC as in (B). The c-di-AMP molecule is modelled 
into the SaPC structure, showing that the binding pocket is occluded. (D) The LmPC c-di-AMP 
binding pocket with residues substituted as in EfPC, to show a hypothetical EfPC c-di-AMP 
binding pocket.  
Figure 2. Enzymatic assays of LlPC with c-di-AMP. (A) Michaelis-Menten curve of LlPC. 
The Km and kcat are indicated. (B) LmPC inhibition assays with c-di-AMP and c-di-GMP. The 
reactions were performed with 20 mM pyruvate.  
Figure 3. LlPC is not sensitive to activation by acetyl-CoA. (A) Titration of LmPC with 
various concentrations acetyl-CoA. The pyruvate concentration, which is the Km for LmPC (10). 
The activation constant (Ka) and Hill coefficient (n) are indicated. (B) LlPC enzymatic assays 
comparing the effect of no acetyl-CoA or 250 uM acetyl-CoA. The reactions were performed 
with or without 25 uM c-di-AMP (cdA). The pyruvate concentration was 3 mM, which is the Km 
for LlPC. The error bars represent the standard deviation for 3 independent reactions.    
Figure 4. L. lactis pyruvate carboxylase in complex with c-di-AMP. Schematic drawing of the 
LlPC structure at 2.3 Å resolution in complex with 2 c-di-AMP molecules (black spheres). 
Monomer 1 is colored according to the key at the bottom, the other three monomers are colored 
magenta, cyan, and yellow. The metal ion (M
2+
) is shown as a gray sphere. The ADP molecules 
are shown as black sticks. The lysine residue (K1103) on the BCCP domain, to which biotin is 
attached, is shown in stick representation. The biotin is disordered.  
Figure 5. LlPC BCCP assignments (A) Omit Fo-Fc density for the LlPC PT-BCCP linker 
(residues 1050-1061) at 2.3 Å resolution, contoured at 3σ. (B) Close-up view of the PT-BCCP 
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linkers for Monomer1 and Monomer 2. (C) Close-up view of the BC domain of Monomer 1 and 
the BCCP domain of Monomer 3. The asterisk (*) indicates the location of the BC active site.   
Figure 6. Possible movements of the BCCP domain during PC catalysis (A) Cartoon 
schematic of PC catalysis in which the BCCP visits the BC active site of the opposite monomer, 
and then moves (gray arrow) to the CT active site of the its own monomer. The color scheme is 
the same as in Figure 4. The PT domains form dimers, as in the free SaPC and LlPC structures 
(see Section 3.6). (B) Cartoon schematic of PC catalysis in which the BCCP visits the BC active 
site of its own monomer, and then moves (gray arrow) to the CT active site of the opposite 
monomer. 
Figure 7. Comparison of the LlPC and LmPC structures in complex with c-di-AMP. (A) 
Overlay of the LlPC-c-di-AMP complex (colored the same as Figure 4), and the LmPC-c-di-
AMP complex (gray). The CT dimer of Monomer 1 and Monomer 4 is overlaid, to see the 
conformational differences in the other domains. (B) An overlay by the CT domain of one 
monomer from the LlPC-c-di-AMP complex (colored the same as Monomer 1 in Fig. 4) and 
LmPC-c-di-AMP complex (gray). Because the connectivity of the BCCP domain is ambiguous 
in the LmPC structure, both possible connections are shown.  
Figure 8. The c-di-AMP binding pocket in LlPC. (A) Omit Fo-Fc density for one of the c-di-
AMP molecules bound to LlPC at 2.3 Å resolution, contoured at 3σ. Two views are shown. (B) 
Detailed interactions between c-di-AMP (cdA) and LlPC. Hydrogen-bonding interactions are 
shown as red dashes. Water molecules are shown as red spheres.  
Figure 9. Comparison of the LlPC and LmPC c-di-AMP binding pocket. (A) An overlay of 
the CT dimer between the LlPC (colors) and LmPC (gray) c-di-AMP complex structures. The c-
di-AMP bound to LlPC is shown in black, while the c-di-AMP bound to LmPC is shown in gray. 
The non-carbon atoms in the LlPC structure have bright colors while they have faded colors in 
the LmPC structure. The residues for Monomer 1 only are labeled with the LlPC residue on top 
(black), and the LmPC residue on the bottom (gray). Hydrogen-bonding interactions are shown 
with a dashed red line. (B) Sequence alignment of the c-di-AMP binding pocket from selected 
PC homologues. The residues which interact with the c-di-AMP are highlighted in red. The 
numbering is according to LmPC.  
Figure 10. Enzymatic assays for LlPC mutants. (A) Enzymatic activity for wild-type LlPC 
and the Y715T and G746A mutants with and without 100 μM c-di-AMP. The reactions were 
performed with 20 mM pyruvate. The error bars represent the standard deviation from three 
independent reactions. (B) The percentage inhibition by c-di-AMP calculated from (A).   
Figure 11. The LlPC G746A mutant c-di-AMP binding. Overlay of wild-type LlPC-c-di-
AMP (colors) and the G746A mutant bound to c-di-AMP (gray). The G746A mutation is labeled 
in red. The other side-chains in the binding pocket which interact with c-di-AMP are also shown   
Figure 12. Comparisons of the apo LlPC tetramer. (A) Overlay of the LlPC-c-di-AMP 
complex (colors) and apo LlPC (gray). The BC dimer of Monomer 1 and 3 was overlaid. The 
BCCP domains for LlPC-c-di-AMP have been removed for clarity. (B) Overlay of apo LlPC 




Figure 13. Comparing the four monomers composing the tetramer. (A) Overlay of the four 
monomers in the c-di-AMP bound LlPC tetramer. The CT domains are overlaid, in order to see 
the differences in the positions of the other domains. The c-di-AMP (cdA) is shown as black 
spheres. (B) Overlay by the CT domain of the four monomers in the apo LlPC tetramer.  
Figure 14. Conformational changes in the CT dimer upon c-di-AMP binding (A) Overlay of 
the CT dimer from LlPC-c-di-AMP (colors) and LmPC-c-di-AMP (gray). Only Monomer 1 is 
overlaid, in order to see the difference in conformation of Monomer 4 (red arrow). (B) Overlay 
of the CT dimer from LlPC-c-di-AMP (colors) and apo LlPC (gray). Only Monomer 1 is 
overlaid, in order to see the difference in conformation of Monomer 4 (red arrow).  
Figure 15. Local changes in the c-di-AMP binding pocket. (A) Overlay of one CT dimer from 
LlPC-c-di-AMP (colors) and apo LlPC (gray). The entire CT dimer is overlaid. Residues that 
interact with c-di-AMP are shown as sticks. (B) Molecular surface view of the c-di-AMP binding 
pocket in LlPC. (C) Molecular surface of apo LlPC with the c-di-AMP modelled in. The binding 
pocket is occluded prior to c-di-AMP binding.  
Figure 16. The BC-PT interface is affected by CoA binding (A) Overlay of the BC domain 
(Mon 3) from apo LlPC (cyan), apo SaPC (black), and SaPC-CoA (gray). The shift in the 
position of the PT domain (Mon 3) of the apo SaPC structure is shown (red arrows) relative to 
the PT domains of SaPC-CoA and apo LlPC (orange). The position of the bound CoA (gray) is 
shown.  (B) The surface area burial was calculated for the BC-PT interface for each of the four 
monomers in the tetramer (error bars represent the standard deviation). The surface area burial 
was determined by the PISA server (18).  
Figure 17. Sequence variants at the BC-PT interface in LlPC are responsible for its 
insensitivity to acetyl-CoA. (A) Sequence alignment from various PC homologues with residues 
at the BC-PT interface. The residues identified which are unique to LlPC are highlighted in cyan 
for LlPC, and yellow for other homologues. (B) Interactions at the BC-PT interface in the apo 
LlPC structure. Residues in red were targeted for mutagenesis. (C) Acetyl-CoA titration for the 
LlPC quadruple mutant (E36K, Y37S, K1006T, S1018I). Ka indicates the activation constant, n 
indicates the Hill coefficient.  
Table 1. Crystallographic data and refinement statistics 
 
Chapter 4 
Figure 1. Conservation of PstA proteins in a collection of bacterial species. Sequence 
alignment of PstA from L. monocytogenes (Lm), Staphylococcus aureus (Sa), Halobacillus 
halophilus (Hh), Bacillus subtilis (Bs), Enterococcus faecalis (Ef), Lactobacillus brevis (Lb), 
Clostridium botulinum (Cb), and Thermoanaerobacterium thermosaccharolyticum (Tt). The 
secondary structure elements are indicated at the top of the alignment. Conserved residues are 
indicated in red. Residues that interact with c-di-AMP are colored cyan (monomer 1) or yellow 
(monomer 2). The T-loop is indicated by the orange bar. The B-loop is indicated by the green 
bar. Figure made with ESPript (7).  
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Figure 2. Crystal Structure of LmPstA in complex with c-di-AMP at 1.6 Å resolution. 
Schematic drawing of the LmPstA homotrimer in complex with three c-di-AMP molecules. The 
three monomers are colored separately and the c-di-AMP molecules are labeled.  
Figure 3. Comparing the LmPstA monomer with the Mtb PII monomer. (A) Structure of a 
LmPstA monomer (cyan) in complex with c-di-AMP (black). The secondary structure elements 
and loops are labeled. The B-loops from the two other monomers are shown in yellow and 
magenta. (B) Structure of a PII monomer from Mycobacterium tuberculosis (green) in complex 
with ATP (black). 
Figure 4. Electron density for c-di-AMP bound to LmPstA. (A) Omit Fo–Fc electron density 
for c-di-AMP at 1.6 Å resolution, contoured at 3σ. The first and second nucleotides are labeled. 
The second nucleotide is in the syn conformation. (B) Omit Fo–Fc electron density for c-di-AMP 
at 1.6 Å resolution, contoured at 3σ. The second nucleotide is in the anti conformation. 
 
Figure 5. Binding region for c-di-AMP in LmPstA and comparison to Mtb PII binding 
mode of ATP. (A) The overall organization of the LmPstA c-di-AMP binding pocket at the 
interface of Monomer 1 and Monomer 2. The first and second nucleotide of c-di-AMP are 
labeled. The loops and secondary structure elements are indicated. (B) The overall organization 
of the Mtb PII ATP binding pocket. 
Figure 6. Binding mode of c-di-AMP to LmPstA. Detailed interactions between LmPstA and 
c-di-AMP. Hydrogen-bonding interactions are indicated with dashed lines (in black). Water 
molecules are shown as red spheres. 
 
Figure 7. Binding assays for LmPstA mutants. DRaCALA binding titration of c-di-AMP 
using 
32
P-c-di-AMP for wild-type LmPstA and mutants to disrupt c-di-AMP binding.  
 
Figure 8. Conformational changes of LmPstA upon c-di-AMP binding. (A) Overlay of c-di-
AMP bound and apo forms of the LmPstA trimer. (B) Overlay of an LmPstA monomer with c-
di-AMP bound (cyan) and in the apo (gray) form. The red arrow highlights the conformational 
changes of the B-loop upon c-di-AMP binding. (C) Overlay of an LmPstA monomer with c-di-
AMP bound (cyan) and a monomer of the apo form of P. pentosaceus PstA (gray).  
Figure 9. Sequence conservation of LmPstA overall and in the c-di-AMP binding site. (A) 
Molecular surface view of the sequence conservation of the LmPstA c-di-AMP binding site, 
generated based on an alignment of 150 sequences by the program ConSurf (14). Purple 
indicates conserved residues, cyan indicates variable residues, and white indicates average 
conservation. The c-di-AMP molecule and Phe36 residues are labeled. (B) Top view of the 
LmPstA trimer showing sequence conservation. (C) Bottom view of the LmPstA trimer showing 
sequence conservation. 
 






Figure 1. Crystal structure of LmCbpA in complex with c-di-AMP. (A) Domain organization 
of LmCbpA. (B) Schematic drawing of the LmCbpA dimer, bound to two c-di-AMP (cdA) 
molecules. The CBS and ACT domains are labeled.   
Figure 2. The LmCbpA c-di-AMP binding site. Detailed interactions between LmCbpA and c-
di-AMP. The first and second nucleotides of c-di-AMP are labeled. Hydrogen-bonding 
interactions are shown as a dashed line (red). Water molecules are shown as spheres (red).    
Figure 3: Conformational changes induced by c-di-AMP binding. (A) The Bateman domain 
of Monomer 2 between the apo and c-di-AMP bound LmCbpA is overlaid, in order to visualize 
the changes in the position of the other Bateman domain in the CBS dimer, as well as the change 
in the position of the ACT domain. This view is from the front. (B) Same overlay as Fig. 3A, but 
viewed from the side. The conformational changes in the CBS domain of Monomer 1 and the 
ACT domain of Monomer 2 are shown by the red arrow 
Figure 4. The Arg35-Glu96 salt bridge in LmCbpA. (A) The interaction between Arg35 and 
Glu96. Monomer 1 is colored in cyan, while Monomer 2 is colored yellow. The side-chains are 
shown in stick representation. (B) Overlay of the apo LmCbpA structure (colors) and the apo 
LmCbpA R35A structure (gray). The Arg35-Glu96 salt bridge in the wild-type structure is 
shown.  
Figure 5. The effect of c-di-AMP levels on osmotic stress tolerance in L. monocytogenes. (A) 
The wild-type, cΔdacA, and ΔpdeA ΔpgpH L. monocytogenes strains were tested for growth in 
BHI broth with increasing concentrations of NaCl. Growth at 0% NaCl is set at 100. (B) The 
same strains were tested for growth with increased concentrations of sorbitol.  
Figure 6. LmOpuCA is a c-di-AMP binding protein. (A) Domain arrangement of LmOpuCA. 
(B) DRaCALA binding assay for LmOpuCA with c-di-AMP. (C) DrACALA binding assay for 
the isolated CBS domain from LmOpuCA with c-di-AMP. (D) Thermal shift assay for the 
isolated CBS domain from LmOpuCA with c-di-AMP.   
Figure 7. Crystal structure of LmOpuCA in complex with c-di-AMP. (A) Schematic of the 
LmOpuCA dimer in complex with c-di-AMP. The CBS1 and CBS2 sub-domains, along with the 
N and C-termini are labeled. (B) Omit Fo-Fc density map for c-di-AMP bound to LmOpuCA, 
contoured at 3σ.    
Figure 8. The LmOpuCA c-di-AMP binding pocket. Detailed interactions LmOpuCA and the 
c-di-AMP. Hydrogen-bonding interactions are shown with red dashes.   
Figure 9. Sequence conservation of the OpuCA c-di-AMP binding pocket. The LmOpuCA c-
di-AMP binding site is shown in molecular surface representation. Purple indicates highly 
conserved residues, cyan indicates weakly conserved residues, and white indicates intermediate 
conservation. The figure was produced using the Consurf server (16).  
Figure 10. Comparison between LmOpuCA and LmCbpA. (A) Front view of the overlay of 
Monomer 1 of the CBS domain of LmOpuCA (colors) and LmCbpA (gray). The differences in 
the position of Monomer 2 are seen. The ACT domain of LmCbpA has been omitted for clarity. 
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The c-di-AMP bound to LmOpuCA (black) and one of the c-di-AMP bound to LmCbpA (gray) 
are shown as sticks. (B) Same as (A) but from the side view, in order to better see the positional 
changes in Monomer 2. (C) Close-up view of the c-di-AMP binding region in (A).  
Table 1. Crystallographic data and refinement statistics 
 
Chapter 6 
Figure 1. Domain Organization of PC enzymes. (A) Domain organization of Staphylococcus 
aureus PC, a single-chain, homo-tetrameric PC (α4). (B) Domain organization of 
Methylobacillus flagellatus PC, a two-subunit PC, thought to have an α4β4 composition.  
Figure 2. Purification of two-subunit PCs. (A) Gel filtration profiles of MfPC, PaPC, PfPC, 
and TdPC. The gel filtration profile for SaPC is also shown for comparison. (B) SDS-PAGE gel 
of MfPC. Lanes were run with and without streptavidin added. A clear gel shift of the β subunit, 
which contains a biotinyl group, is observed upon inclusion of the streptavidin. The α and β 
subunits are indicated on the right. 
Figure 3. Wild-type MfPC crystals. (A) MfPC crystals. (B) Diffraction image for the wild-type 
MfPC crystals. The diffraction does not go beyond ~8 Å.  
Figure 4. The B-domain deletion of MfPC. (A) The BC domain from the structure of the 
Aquifex aeolicus PC BC dimer (PDB ID 1ULZ) (4). The flexible B-domain is indicated. (B) 
Crystals of the B-domain deletion mutant of MfPC. (C) Crystals of the B-domain deletion MfPC 
mutant with surface entropy mutations.   
Figure 5. Experiments to confirm the α2β4 stoichiometry of MfPC. (A) Known quantities of 
separately purified α and β subunits were run alone or after mixing on an SDS-PAGE gel. These 
were run alongside the purified MfPC and PaPC complexes, demonstrating that the 1:2 ratio of α 
to β subunits is genuine and not a staining artifact. The separately purified β subunit contains a 
His-tag, while the β subunit in the purified complex does not, which accounts for the slight 
difference in molecular weight. (B) Known quantities of separately purified α and β subunits 
were mixed in different ratios and run on an SP-12 gel filtration column. The dashed line 
indicates the elution volume of the complex formed upon mixing. (C) Fractions were collected 
from the dashed line in (B) from two mixing experiments (1:0.5 and 1:2 ratios of α to β 
subunits), and run on a Coomassie-stained SDS-PAGE gel. (D) Analytical ultracentrifugation 
experiments showing the size distribution of PCs at 0.5 mg/ml in solution. The various two-
subunit PCs show a similar major species with a sedimentation coefficient (S) of 11.5, while 
SaPC has an S=14.8.      
Figure 6. Structures of M. flagellatus PC holoenzyme. (A) Schematic drawing of the mutant 
MfPC α2β4 holoenzyme structure, having the shape of the letter U in this view. The domains are 
colored per the scheme in Figure 1B, with the exception of the α2 BC domain colored in light 
pink for clarity (B) Structure of the mutant MfPC holoenzyme viewed down the BC domain 
dimer, rotated 90° from (A) (C) Structure of wild-type MfPC holoenzyme, with a characteristic 
butterfly shape (D) Structure of the wild-type MfPC holoenzyme viewed down the BC domain 
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dimer, rotated 90° from (C). The differences in the relative orientation of the CT dimers in 
comparison to the mutant structure in (B) are clearly visible.   
Figure 7. Relative positioning of the BC and CT dimers in MfPC and SaPC. (A) Overlay of 
the two BC monomers between mutant and wild-type MfPC, showing the difference (red arrow) 
in the orientation of the two CT dimers. The BC monomer is linked to the CT dimer by the PT or 
BT-like (BT-L) domain. (B) Overlay of the BC domains of mutant MfPC and SaPC-CoA 
complex, showing the difference (red arrow) in the orientation of the CT dimer. The binding 
location of CoA at the interface between the BC and PT domains of SaPC is indicated.  
Figure 8. A BT-like domain in MfPC. (A) Schematic drawing of the BT-like domain in MfPC. 
The α-helix comes from the α1 subunit (red), and the two β-sheets come from the β1 (green) and 
β2 (yellow) subunits. Each of these subunits is colored differently to highlight the origins of each 
component of the BT-like domain. (B) Overlay of the BT-like domain (orange) with the SaPC 
PT domain (gray). (C) Overlay of the BT-like domain (orange) with the BT domain from 
propionyl-CoA carboxylase (gray) (13). 
Figure 9. Sequence comparisons between the BT-like and PT domains. (A) Sequence 
alignment of the PT domain α-helix from selected single-chain PCs. The residues are colored 
with hydrophilic residues in light blue, and hydrophobic residues in purple. The sequence 
numbering is in accordance with S. aureus PC. (B) The PT domain from S. aureus PC viewed 
down the central α-helix. The α-helix is amphipathic, with one half composed of hydrophobic 
residues (purple) and packed against the β-sheet, while the other half is hydrophilic (blue) and 
exposed to solvent. (C) Sequence alignment of the BT-like domain α-helix from selected two-
subunit PCs. The residues are colored as in (A). The residues are numbered in accordance with 
MfPC. (D) The BT-like domain from MfPC viewed down the central α-helix. The α-helix is 
hydrophobic, and surrounded by the β-barrel. The residues are colored as in (B). 
Figure 10. An important interface in MfPC mimics CoA binding. (A) Interactions between 
the BT-like domain (colored as in Figure 8A), and the BC dimer. Important residues at this 
interface are shown as sticks. (B) Overlay of the BC dimer between MfPC (colors) and the SaPC 
(gray) in complex with CoA (gray for carbon atoms). The change in the position of the PT 
domain in relation to the BT-like domain is indicated by the red arrow.   
Figure 11. Comparing the MfPC BC dimer with SaPC. (A) Overlay of the BC dimer between 
MfPC (colors) and SaPC (gray). The bottom BC monomer is overlaid, in order to compare the 
relative positions of the top BC monomer (red arrow) (B) Overlay of the BC dimer between 
MfPC (colors) and SaPC (gray) in complex with CoA (black for carbon atoms). The bottom BC 
monomer is overlaid, in order to compare the relative positions of the top BC monomer.  
Figure 12. Mutational studies of MfPC. (A) The Q452stop mutation deletes the C-terminal α-
helix of the α-subunit. Various fractions were run on an SDS-PAGE gel including the 
supernatant (S), pellet (P), flow-through after Ni-binding (F), and elution with imidazole (E). 
Excess β-subunit is observed before elution, but only α-subunit is pulled down by the Ni-beads. 
(B) The A465R mutation in the α subunit. The same fractions were run as in (A). (C) The 
H476A/E478A/D502A/E507A quadruple mutant in the β-subunit. The same fractions were run 
as in (A). (D) Catalytic activity of wild-type and mutant MfPC. The reactions were performed 
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with saturating pyruvate concentrations (20 mM). The error bars represent the standard deviation 
from three independent reactions. NA indicates no activity observed.  
Figure 13. Distances between the BC and CT active sites in the wild-type MfPC structure. 
A schematic drawing of the wild-type MfPC structure is shown, with one of the CT dimers 
removed for clarity. The BC active site is indicated (*) along with ADP and biotin molecules 
which are modelled based on a previously solved BC structure (21). The CT active site is 
indicated (*), along with the metal ion (gray sphere) and pyruvate, as was observed in the mutant 
MfPC structure. The distances between one of the BC active sites (pink, α2) and each of the two 
CT active sites (β1, β2) is shown with a red and black arrow, respectively. A BCCP is modelled 
into each of the CT active sites, showing that the distal (β2) CT active site is accessible, while 
the proximal (β1) CT active site is not due to clashes between the BCCP and the α2 BC 
monomer. Interactions between the B-domain of the α2 BC and the β1 CT is shown with the 
gray arrow.   
Figure 14. PaPC is required for growth on selected carbon sources. Shaken liquid-culture 
growth of wild-type P. aeruginosa PA14, the PaPC deletion strain (ΔPC), the PC-complemented 
strain (ΔPC::PC) and various site-specific mutants. The strains were grown in a defined medium 
containing 20 mM succinate, pyruvate, or glucose as the sole carbon source. Each growth curve 
represents the average of three biological replicates, and the error bars indicate the standard 
deviation.  
Figure 15. Dysfunction of PaPC leads to altered colony morphology. Colony morphology of 
wild-type P. aeruginosa PA14, the PaPC deletion strain (ΔPC), the PC-complemented strain 
(ΔPC::PC) and the K572A mutant assessed over five days. The strains were grown on 1% 
tryptone, and 1% agar supplemented with Congo red and Coomassie blue for visualization.   
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Introduction to the biotin-dependent carboxylase family and pyruvate 
carboxylase 
1.1 Introduction to biotin-dependent carboxylases 
Biotin-dependent carboxylases are a large family of enzymes that are conserved in all forms of 
life. All members of this family utilize the cofactor biotin, also called Vitamin B7, in order to 
carry out their enzymatic reaction. Biotin-dependent carboxylases populate all branches of the 
metabolic network, and have crucial roles in the metabolism of amino acids, carbohydrates, and 
fatty acids (1). Defects in these enzymes lead to severe human diseases, including hereditary 
disorders (2), and acquired disorders such as obesity, type 2 diabetes, and cancer (3, 4). 
Microorganisms utilize these enzymes for diverse functions such as CO2 fixation and ammonia 
oxidation which have important impacts on the environment (5). Targeting the function of biotin-
dependent carboxylases is an important strategy for developing antibiotics against microbial 
pathogens (6) and for use as herbicides in agricultural use (7, 8).   
 
Figure 1. Catalysis in biotin-dependent carboxylases. The separate reactions in the BC and CT 
domains are illustrated, and BCCP must translocate between the distant active sites. Figure from (1) 
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Biotin-dependent carboxylases carry out their chemical reaction in two distinct enzymatic 
reactions (Fig. 1). The biotin carboxyl carrier protein (BCCP) has a strictly conserved lysine 
residue to which a biotin cofactor is covalently linked to the ε-amino group. This attachment of 
biotin is carried out by the enzyme holocarboxylase synthetase in eukaryotes, and the enzyme 
biotin ligase in bacteria (9, 10). All biotin-dependent carboxylases carry out the same first 
reaction, in which the biotin is carboxylated in an Mg-ATP dependent reaction by the biotin 
carboxylase (BC) component. The BC component is shared and highly conserved among all 
biotin-dependent carboxylases. The second reaction occurs in the carboxyltransferase (CT) 
component, in which the carboxyl group carried by biotin is transferred to the substrate. Unlike 
the BC component, the CT component varies considerably both in sequence and structure 
between members of the biotin-dependent carboxylase family, depending on the nature of the 
individual substrate. The distance between BC and CT active sites is greater than 50 Å in most 
biotin-dependent carboxylases, and thus BCCP must translocate between the BC and CT domain 





Figure 2. Domain architecture of biotin-dependent carboxylases. The BC domain is shown in red. The 
CT domain is shown in various colors for each sub-class, acyl-CoA carboxylases (cyan and yellow), 
pyruvate carboxylases (PC) (green), and urea carboxylases (UC) (purple, pink, and orange). The BCCP 
domain is shown in blue. The length of the protein in amino acid residues is indicated by the scale bar at 
the bottom. The unique BT domain in some acyl-CoA carboxylases and PT domain in PC are shown in 
orange. Figure from (1)  
The largest class of biotin-dependent enzymes are the acyl-CoA carboxylases, which all have a 
substrate containing a coenzyme A ester group (Fig. 2). The acyl-CoA carboxylases utilize a 
distinct carboxyltransferase domain, and different members of the class carboxylate various 
substrates including acetyl-CoA (Fig. 3), propionyl-CoA, 3-methyl-crotonyl CoA, and geranyl-
CoA. The acyl-CoA carboxylases have diverse subunit configurations, in which some have all 




Figure 3. Diverse substrates of biotin-dependent carboxylases. The chemical structures of the 
substrates utilized by each biotin-dependent carboxylase are shown. The red arrow highlights the atom to 
which the carboxyl group is added. Figure from (1)  
The next class of biotin-dependent carboxylases is pyruvate carboxylase (PC), which uses 
pyruvate as a substrate (Fig. 3). Due to the different chemical nature of the substrate, PC has a 
distinct carboxyltransferase domain from the acyl-CoA carboxylases. There are two-classes of 
PC enzymes: the single-chain class in which all domains reside on a single polypeptide chain, 
and the two-subunit class in which the protein is divided into two separate subunits (Fig. 2). The 
former class is predominant and is found in bacteria and eukaryotes, while the latter class is 
found in a subset of bacteria as well as archaea. The PC enzymes are the focus of this 
dissertation.  
Urea carboxylases comprise the last class of biotin-dependent carboxylases, and have a 
carboxyltransferase component distinct from both acyl-CoA carboxylases and PCs. They are 
found in some bacteria, fungi, and algae, and catalyze the conversion of urea to allophanate (1). 
This enzyme is important for these organisms to utilize urea as a nitrogen source. 
1.2 Function of pyruvate carboxylase 
PC performs several crucial functions in mammals (Fig. 4). In the cell, PC is localized to the 
mitochondrial matrix, where it performs an anaplerotic function in replenishing the tricarboxylic 
acid (TCA) cycle intermediate oxaloacetate. TCA cycle intermediates are withdrawn for the 
biosynthesis of various important molecules. PC is expressed in a tissue-specific manner, with 
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the highest levels of expression found in the liver and kidney, adipose tissue, and the pancreas, 
while lower levels of expression are found in the brain, heart and adrenal glands (11). In the liver 
and kidney, PC catalyzes the first committed reaction in the gluconeogenesis pathway, with 
oxaloacetate subsequently converted to phosphoenolpyruvate (PEP) by phosphoenolpyruvate 
carboxykinase (PEPCK). In adipocytes, oxaloacetate generated from PC is needed for the 
production of citrate, which is transported to the cytoplasm where it is converted back to 
oxaloacetate and acetyl-CoA, the latter of which is used for the de novo synthesis of long-chain 
fatty acids (12).  
 
Figure 4. Metabolic functions of pyruvate carboxylase in mammalian tissues. Figure from (13) 
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In astrocytes, PC activity is important for the production of the excitatory neurotransmitter 
glutamate, which is synthesized from the TCA cycle intermediate 2-oxoglutarate (α-
ketoglutarate) (14). In rat β-pancreatic islet cells, glucose-induced insulin secretion has been 
found to be dependent on PC activity which causes an increase in levels of NADPH (15).  
Deficiency of pyruvate carboxylase is a rare autosomal recessive disease in humans which has 
three different clinical manifestations (16). The B form of pyruvate carboxylase deficiency is the 
most severe, with lactic acidosis, hyperammonemia, hypercitrullinemia appearing soon after 
birth, and death occurring within the first months of life. Forms A and C have similar but milder 
symptoms of lactic acidosis and neurological symptoms such as hypotonia, spasticity and 
seizures (17).  
Impaired regulation of PC activity has been linked to several human diseases, including type 2 
diabetes and cancer. In human β-pancreatic islet cells, PC activity is necessary for glucose-
induced insulin secretion and PC expression levels are regulated by the p53-MDM2 axis. 
Dysfunction of PC regulation is linked to the development of type 2 diabetes, and correction of 
PC activity can ameliorate the disease (18). Another study has shown that dysregulation of PC 
activity in the liver can also contribute to the development of type 2 diabetes (19). White adipose 
tissue lipolysis due to inflammation leads to increased acetyl-CoA levels in the liver, driving 
aberrantly high PC activity. This leads to impaired insulin-mediated suppression of hepatic 
gluconeogenesis, playing a major role in the pathogenesis of type 2 diabetes. 
Cancer cells depend on replenishing the intermediates of the TCA cycle to support biomass 
production, either through the conversion of glutamine to α-ketoglutarate or the production of 
oxaloacetate from pyruvate through PC activity. Different cancer types have a reliance on one 
pathway or the other (20). PC has been found to be required for the glutamine-independent 
growth of glioblastoma tumor cells (21).  Elevated PC expression levels and activity have been 
found in non-small-cell lung cancer (22), and breast cancer (20, 23). RNAi-mediated knockdown 
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of PC activity decreases tumor proliferation and survival, implicating PC as a crucial oncogenic 
protein. Recent studies have shown that PC is essential for the growth of tumor cells with a loss-
of-function mutation in the tumor suppressor protein succinate dehydrogenase (SDH), which is 
part of the TCA cycle (24, 25). Loss of SDH activity leads to a truncated TCA cycle, causing 
glucose-derived carbons to be diverted through PC activity into aspartate, which is derived from 
oxaloacetate through aspartate aminotransferase. Aspartate biosynthesis through the PC pathway 
is essential for the growth of these SDH-deficient tumor cells.   
1.3 Structures of the individual components of pyruvate carboxylase 
1.3.1 Biotin carboxylase (BC)  
The biotin carboxylase component is shared among all biotin-dependent carboxylase enzymes. 
The sequence and structural homology for the BC subunit is high even among the diverse 
members of the biotin-dependent carboxylase family. BC catalyzes the ATP-dependent 
carboxylation of biotin using bicarbonate as the carboxylate donor. The BC subunit has been 
extensively characterized biochemically and structurally. The first structural information of the 
BC subunit was provided in 1994 with the crystal structure of the Escherichia coli acetyl-CoA 





Figure 5. Structure of the biotin carboxylase (BC) domain from Escherichia coli acetyl-CoA 
carboxylase. (A) The BC domain dimer, with the three sub-domains (A,B,C). The bound ADP, Mg
2+
, 
and biotin ligands are shown as sticks. (B) A close-up view of the BC active site. Residues important for 
catalysis are shown as sticks, and hydrogen-bonds are shown as dashed lines (red). Figure from (27) 
The BC domain consists of 3 subdomains (A, B, C), from the N to C-terminus. The A and C-
domains form the main body, and provide the ATP-binding site. The B-domain consists of two 
α-helices packed against a 3-stranded β-sheet, and extends out from the main body formed by the 
A and C-sub-domains.  The B-domain is connected to the main body through a flexible hinge, 
such that the B-domain can adopt “closed” or “open” conformations. When in the “closed” state, 
the B-domain encloses the ATP ligand and the active site is formed at the interface of the B-
domain with the other two sub-domains (28). A crystal structure of a fully catalytically 
competent E. coli BC in complex with ATP, Mg
2+
, bicarbonate and biotin was solved in 2009 
(27). 
The E. coli BC structure was observed to form a dimer in this crystal structure and also exists as 
a stable dimer in solution. A subsequent crystal structure of the BC domain of a PC from Aquifex 
aeolicus also showed that its BC forms a similar dimer (29). However, the crystal structure of the 
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BC domain from yeast ACC was in a monomeric form (30). It was initially believed that EcBC 
is only active as a dimer, but subsequent studies showed that it retained almost full catalytic 
activity as a monomer as well (31).  
1.3.2 Carboxyltransferase (CT)  
Unlike the BC domain, the CT domain is not shared between pyruvate carboxylase and other 
biotin-dependent carboxylases. This is due to the fact that most biotin-dependent carboxylases 
use CoA esters as a substrate, while PC uses the much smaller pyruvate as its substrate. The first 
CT domain from the acyl-CoA carboxylases was solved in 2003 from yeast ACC. This CT 
domain has a crotonase fold, and forms either a dimer in ACC enzymes, or a hexamer in MCC, 
PCC, and GCC. The CT active site is located at the interface of the dimer, thus CT can only be 
active in the dimeric form.  
On the other hand, the CT domain of PC enzymes is similar to that of the 5S subunit of 
transcarboxylase (32) and the CT domain of oxaloacetate decarboxylase (33). This CT domain 
consists of a triosephosphate isomerase (TIM) barrel, 8 α-helices alternating with 8 β-strands 
with the 8-stranded β-barrel in the interior and the α-helices on the exterior. The CT domain also 
has a long C-terminal extension consisting solely of α-helices. Like the CT domain of the acyl-
CoA carboxylases, the CT domain of PC also forms a dimer, but the active site is located solely 





Figure 6. The carboxyltransferase domain from Staphylococcus aureus pyruvate carboxylase. (A) A 
CT dimer from S. aureus PC (34). The TIM barrel is seen in a top-down view in Monomer 1 (green), and 
in the side-view in Monomer 2 (yellow). The C-terminal extension outside the TIM barrel is colored 
orange in Monomer 2. The side-chains coordinating the metal-ion (M
2+
, gray sphere) are shown with stick 
representation. (B) The CT active site from S. aureus PC. The biotin attached to BCCP is shown in gray, 
and the various side chains of SaPC (cyan) which recognize the biotin are shown in sticks. Pyruvate is in 
black, and the metal ion is a red sphere.  Figure from (35) 
The active site consists of central metal ion coordinated by conserved residues including two 
histidines, one aspartate, and a carbamylated lysine side-chain. Residues involved in 
coordinating the metal ion or binding pyruvate are absolutely conserved across all PC 
homologues and are essential for activity. A structure of a PC enzyme from Staphylococcus 
aureus revealed pyruvate and BCCP-biotin bound at the CT active site in a catalytically 
competent conformation. Mutagenesis of residues involved in recognition of the biotin-moiety 







1.3.3. Biotin carboxyl carrier protein (BCCP) 
The first structure of an isolated BCCP domain was determined in 1995 from E. coli acetyl-CoA 
carboxylase (36). Several more structures of BCCP domains in the intact holoenzyme context 
have subsequently been determined. The BCCP structure is well-conserved between all biotin-
dependent carboxylases, consisting of two separate four-stranded anti-parallel β-sheets. The β-
sheets come together to form a pseudo-symmetrical, capped β-sandwich structure with a 
hydrophobic interior. There is also a characteristic “thumb-like” hairpin protrusion on one half of 
the BCCP domain formed from the turn between strands β2 and β3. The biotin is attached to a 
lysine residue which sits on a hairpin turn between strands β4 and β5 at one end of the structure.  
 
 
Figure 7. Crystal structure of the BCCP domain from Staphylococcus aureus pyruvate carboxylase 
(SaPC) Schematic drawing of the BCCP structure (34). The individual β-strands, along with the 







1.4 Structure of the pyruvate carboxylase holoenzyme 
The first crystal structure of a full-length pyruvate carboxylase was solved in 2007 from the 
Gram-negative bacterium Rhizobium etli (37). This report was quickly followed by a crystal 
structure of a full-length PC from Staphylococcus aureus (Fig. 8), along with a human PC crystal 
structure which is lacking the BC domain (34).  
 
Figure 8. Crystal structure of the full-length Staphylococcus aureus pyruvate carboxylase (SaPC). 
Schematic drawing of the SaPC structure. The individual domains (BC, CT, PT, and BCCP) are 
indicated. Monomer 1 is colored as in Figure 2, while the other three monomers are colored magenta, 
cyan, and yellow. The biotin, pyruvate, and ATP ligands are shown as sticks. The metal ion is shown as a 
red sphere. Figure from (34) 
These structures provided a tremendous wealth of insight into the structures of PC enzymes 
along with the mechanisms by which they carry out catalysis. RePC and SaPC form ~500 kDa 
homotetramers, which are arranged in top and bottom layers, with two monomers in each layer. 
The structures revealed that the two monomers in each layer have few contacts between them. 
Instead, each monomer forms a BC dimer and CT dimer with the two monomers in the other 
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layer. These BC and CT dimers form the primary interfaces which function to stabilize the 
tetramer. The BC dimer conformation is similar to that of the previously determined structures of 
E. coli BC (27), and A. aeolicus BC (29), while the CT dimer conformation is similar to that of 
the 5S transcarboxylase (32). The overall structure is that of a diamond-shaped tetramer, with BC 
and CT dimers at the four corners of the diamond.  
 
Figure 9. Difference in symmetry between RePC and SaPC structures. (A) An overlay of two 
monomers from the RePC structure, and one monomer from the SaPC structure. The SaPC monomer is 
colored per the individual domains (see Figure 2), while the RePC monomers are in black and gray. The 
monomers are overlaid by the CT domain, and the differences in the positioning of the BC domain are 
seen. (B) Overlay by the CT domain of the four monomers in the SaPC structure. The monomers are 
colored as in Fig. 7. The red arrow highlights a conformational change in the CT domain of the monomer 
with a BCCP in the active site.    
A remarkable finding from the RePC and SaPC structures is the degree to which the tetramers 
diverge in structure from one another. The RePC tetramer is strikingly asymmetric, in which the 
two monomers in one layer have a completely different conformation than in the other layer (Fig. 
9A). On the other hand, the SaPC structure is more symmetric, with all four monomers in the 
tetramer assuming a generally similar conformation (Fig. 9B). It was at first speculated that this 
divergence was due to the binding of an acetyl-CoA mimic, ethyl-CoA, to two of the RePC 
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monomers (in the same layer), while the other two monomers were not bound. However, a 
subsequent structure of SaPC in complex with CoA revealed a tetramer with an even higher 
degree of symmetry than the original structure (35). Moreover, a structure of RePC determined 
without ethyl-CoA retained the same asymmetric arrangement (38). Thus, it appears that RePC 
and SaPC have strikingly different tetramer arrangements, even with a high degree of sequence 
similarity. It remains to be seen whether PC enzymes from other species will also have unique 
architectures, or if they will be similar to either the RePC or SaPC structures.  
1.4.1 The PC tetramerization (PT) domain 
 
Figure 10. The PT domain from PC and the BT domain from PCC. (A) The PT domain from the 
structure of S. aureus PC (34). The connections to the rest of the protein are indicated. (B) The BT 
domain from propionyl-CoA carboxylase (39).   
A great surprise in these PC crystal structures was the presence of a previously unrecognized 
domain, which was termed the allosteric domain in RePC, and the PC tetramerization (PT) 
domain in SaPC and HsPC. This domain is formed from two discontinuous segments of the 
protein: an α-helical linker between the BC and CT domains, and a twisted 4-stranded anti-
parallel β-sheet formed from the linker between the CT and BCCP domains. The β-sheet 
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partially wraps around the central α-helix, while the other half of the α-helix is exposed to 
solvent. In the RePC structure, the allosteric domain along with BC domain forms the binding 
site for the acetyl-CoA analog, ethyl-CoA. A subsequent structure of SaPC in complex with CoA 
confirmed that this site is also the acetyl-CoA binding site in SaPC (35). In the SaPC structure, 
several residues mediate the dimerization of two PT dimers from adjacent monomers, with 
Phe1077 and Leu1084 providing the largest contributions to this interface. A mutation of 
Phe1077 to alanine or glutamic acid results in dimeric and catalytically inactive PC in solution, 
confirming the importance of the PT domain for maintaining the tetramer structure (34). 
Interestingly, adding acetyl-CoA to the reaction rescued PC activity, suggesting that acetyl-CoA 
may also play a role in stabilizing the tetramer structure.  
The crystal structure of a bacterial propionyl-CoA carboxylase (PCC) holoenzyme revealed the 
presence of a previously unrecognized BT (BC-CT interaction) domain (39). Subsequent 
structures of 3-methyl-crotonyl-CoA carboxylase (MCC) and acetyl-CoA carboxylase (ACC) 
would also have this BT domain (40, 41). The BT domain consists of a long central α-helix, 
surrounded by an 8-stranded anti-parallel β-barrel. The α-helix and β-barrel are directly 
connected in the sequence by a long “hook”. Remarkably, the PT domain from PC and the BT 
domain from these acyl-CoA carboxylases appear to have some structural similarity, with the PT 
domain lacking half of the strands compared to the β-barrel structure of the BT domain. The PT 
domain also has a much shorter α-helix, and lacks the “hook” feature found in the BT domain.   
1.4.2 Mechanism of catalysis 
In the RePC structure, two BCCP domains were observed in one layer of the tetramer, positioned 
between BC and CT active sites. In the SaPC structure, three BCCP domains were observed. One 
BCCP is located in the CT active site with the biotin clearly observed and in a catalytically 
competent position. The other two BCCPs are located with their biotin found in a previously 
unrecognized site at the interface of the PT and CT domains, termed the exo site. This exo site 
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may represent a “resting” position for the BCCP while it is not undergoing catalysis. The BCCP 
of one monomer is found in the exo site of the opposite monomer in the layer. Based on the 
position of the BCCP domains within the tetramers, both St. Maurice et al. and Xiang et al. 
hypothesized that the BCCP visits the BC active site in the same monomer, while then transiting 
to the CT active site of the other monomer (Fig. 11).  
 
Figure 11. Possible BCCP movement during PC catalysis. The PC tetramer is shown as a cartoon 
schematic. The view and color scheme is the same as in Figure 7. The black line extending from BCCP is 
the biotin moiety. In the left side of the panel, the BCCP is the CT active site of the other monomer. In the 
right side of the panel, the BCCP is in the BC active site of its own monomer. The distances between the 
active sites are indicated by the black arrow. Figure from (34)  
This swap of BCCP domains between monomers provides the basis for the tetramerization 
requirement for PC catalysis, as the BCCP would be unable to perform both reactions within its 
own monomer. In addition, a PC monomer would not have a stable structure in solution. A 
subsequent structure was solved of RePC with a T882A mutation to hinder BCCP binding to CT 
(38). This structure has the BCCP interacting with the BC of its own monomer, although it is not 
in a catalytically competent conformation. This RePC T882A structure provided further evidence 
for the catalytic scheme shown in Figure 11.      
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A major finding from the RePC and SaPC structures was that the distance between the BC and 
CT active sites was ~75 Å, a much longer distance than previously anticipated. The prevailing 
model for catalysis in biotin-dependent enzymes was the “swinging-arm” model, in which the 
biotin arm (biotin + lysine side-chain) with a length of ~16 Å would swing between the two 
active sites, while the domains would remain relatively stationary (42). However, the distance of 
~75 Å between the active sites demonstrates that the biotin arm itself is not sufficient to reach 
both active sites, but that the BCCP domain itself would have to shuttle between the active sites 
to complete a catalytic cycle. The ~15 residue linker between the PT domain and the BCCP is 
flexible, reflected by it being unobserved in several PC monomers in both RePC and SaPC 
structures, and thus may serve to swing the BCCP domain between the active sites. Subsequent 
crystal structures of propionyl-CoA carboxylase (39), methyl-crotonyl CoA carboxylase (40), 
geranyl-CoA carboxylase (43), and acetyl-CoA carboxylase (41) also have active sites separated 
by >50 Å, demonstrating that the swinging-domain model may be shared among all of the biotin-
dependent carboxylases.  
1.5 The allosteric activator acetyl-CoA 
 
Figure 12. Acetyl-CoA activation of SaPC. A representative titration is shown for acetyl-CoA and other 
analogs measuring PC activity. Figure from (35) 
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Pyruvate carboxylase is allosterically activated by acetyl-CoA (Fig. 12). The only other member 
of the biotin-carboxylase family which is similarly regulated is acetyl-CoA carboxylase, which is 
allosterically activated by citrate (44). The regulation of PC by acetyl-CoA serves a crucial 
metabolic function, as increased acetyl-CoA levels signal an increased need for oxaloacetate, so 
that acetyl-CoA and oxaloacetate can be converted to citrate by citrate synthase and enter the 
TCA cycle. One layer of the RePC tetramer was bound to a non-hydrolysable acetyl-CoA 
analog, ethyl-CoA, which can also activate enzyme activity but to a lesser degree than acetyl-
CoA (Fig. 12). However, the electron density was only strong for the nucleotide portion of this 
analog, precluding a full-view of the acetyl-CoA binding mode.  
 
 
Figure 13. Crystal structure of SaPC bound to CoA. (A) Schematic drawing of the SaPC tetramer in 
complex with four CoA molecules (black spheres). One of the CoA molecules is highlighted inside the 
gray circle. The coloring scheme is the same as in Figure 7. (B) A close-up view of the SaPC CoA 
binding site showing detailed interactions between CoA and the BC (red) and PT (orange) domains of 
SaPC. The CoA is shown in stick representation (black). Figure from (35) 
A subsequent crystal structure of SaPC in complex with CoA allowed for a more detailed 
analysis of ligand recognition (35). The binding site for CoA in the SaPC structure is in the same 
region at the PT-BT interface as the RePC structure. Although acetyl-CoA was used for 
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crystallization, the acetyl group was not observed in the density and may have been hydrolyzed. 
Nevertheless, this structure allowed for a detailed analysis of the acetyl-CoA binding pocket and 
the residues that are necessary for binding.  
A cluster of four arginine residues, Arg398, Arg451, Arg453, Arg1085 help to recognize the 3’ 
phosphate of CoA. These arginine residues are strongly conserved among PC enzymes, and 
R451C is a disease-causing mutation in humans (13). The equivalent residues when mutated in 
SaPC or RePC result in an increase in the activation constant (KA) of acetyl-CoA, confirming 
their functional importance in mediating the allosteric activation (34, 45). The adenine base is 
sandwiched between Tyr78 and Lys1056, and the N6 atom makes a hydrogen bond with the 
main-chain carbonyl oxygen of Ala80. The rest of the CoA molecule makes primarily van der 
Waals interactions with the protein.  
Previous studies have reported that the activation of PC by acetyl-CoA is at the BC reaction site, 
while the CT reaction is unaffected (46). It was observed in the RePC structure that in the layer 
of the enzyme which was bound to ethyl-CoA, the distances between the active sites were 15 Å 
closer than the in unbound layer. St. Maurice et al. speculated that acetyl-CoA binding may 
change the tetramer conformation such that the BC and CT active sites come closer together, 
allowing for increased catalytic activity. However, the crystal structure of SaPC in complex with 
CoA (35) did not affect the distance between the active sites, making this an unlikely mechanism 




Figure 14. Conformational changes in the SaPC BC dimer upon CoA binding. A BC dimer from 
SaPC in complex with CoA (Monomer 2 in magenta, Monomer 4 in yellow), is overlaid with a BC dimer 
from unbound SaPC (gray). Monomer 2 is overlaid and the changes in the dimer conformation (red 
arrow) are observed in the positioning of Monomer 4. Figure from (35) 
The SaPC-CoA complex structure did show that CoA binding caused a marked change in the 
conformation of the BC dimer, in which one of the BC monomers is rotated ~14° relative to the 
other BC monomer (Fig. 14). On the other hand, the CT dimer conformation was unaffected. 
This is consistent with the binding of CoA at the interface of the BC dimer, far from the CT 
domains. Yu et al. then speculated that acetyl-CoA binding may stabilize a BC dimer 
conformation that is more catalytically competent. Previous studies with E. coli BC showed that 
mutations at the dimer interface which changed the dimer conformation also affected BC 
catalytic activity.  However, the BC active sites are located far from one another and the precise 
molecular mechanisms for how the dimer conformation affects activity is not resolved. It is 
possible that there is a long-range communication between the active sites, but further studies 




This chapter presents a structural overview of the biotin-dependent carboxylase family, with a 
particular focus on pyruvate carboxylase. In addition to PC, there is now structural information 
on the holoenzyme architectures of almost every member of the family, including acetyl-CoA 
carboxylase (41), propionyl-CoA carboxylase (39), 3-methyl-crotonyl-CoA carboxylase (40), 
geranyl-CoA carboxylase (43), long-chain acyl-CoA carboxylase (47), and urea carboxylase 
(48). Although these enzymes all share BC, CT and BCCP components, these domains are 
arranged in strikingly different ways in the various holoenzyme structures, underlying their long 
evolutionary history and the diversity in their functional roles. This theme will be expanded in 
the next two chapters, as we will show that pyruvate carboxylase has been adapted for regulation 
by the bacterial second messenger cyclic-di-AMP in a subset of bacterial species. As studies of 
biotin-dependent carboxylases continue to expand, we are sure to find more examples of their 













1.  L. Tong, Structure and function of biotin-dependent carboxylases. Cell. Mol. life Sci. 70, 
863–91 (2013). 
2.  B. Wolf, G. L. Feldman, The biotin-dependent carboxylase deficiencies. Am. J. Hum. 
Genet. 34, 699–716 (1982). 
3.  L. Tong, Acetyl-coenzyme A carboxylase: Crucial metabolic enzyme and attractive target 
for drug discovery. Cell. Mol. Life Sci. 62, 1784–1803 (2005). 
4.  L. Galluzzi, O. Kepp, M. G. Heiden, G. Kroemer, Metabolic targets for cancer therapy. 
Nat. Rev. Drug Discov. 12, 829–846 (2013). 
5.  J. Pratscher, M. G. Dumont, R. Conrad, Ammonia oxidation coupled to CO(2) fixation by 
archaea and bacteria in an agricultural soil. Proc. Natl. Acad. Sci. U. S. A. 108, 4170–4175 
(2011). 
6.  J. R. Miller et al., A class of selective antibacterials derived from a protein kinase 
inhibitor pharmacophore. Proc. Natl Acad. Sci. USA. 106, 1737–1742 (2009). 
7.  L. P. C. Yu, Y. S. Kim, L. Tong, Mechanism for the inhibition of the carboxyltransferase 
domain of acetyl-coenzyme A carboxylase by pinoxaden. Proc. Natl. Acad. Sci. U. S. A. 
107, 22072–7 (2010). 
8.  S. Xiang, M. M. Callaghan, K. G. Watson, L. Tong, A different mechanism for the 
inhibition of the carboxyltransferase domain of acetyl-coenzyme A carboxylase by 
tepraloxydim. Proc. Natl. Acad. Sci. 106, 20723–20727 (2009). 
9.  A. Chapman-Smith, J. E. Cronan, Molecular biology of biotin attachment to proteins. J. 
Nutr. 129, 477S–484S (1999). 
10.  J. Zempleni, S. S. K. Wijeratne, Y. I. Hassan, Biotin. BioFactors. 35, 36–46 (2009). 
11.  S. Jitrapakdee, J. C. Wallace, Structure, function and regulation of pyruvate carboxylase. 
Biochem. J. 340, 1–16 (1999). 
12.  F. J. Ballard, R. W. Hanson, The citrate cleavage pathway and lipogenesis in rat adipose 
tissue: replenishment of oxaloacetate. J Lipid Res. 8, 73–79 (1967). 
13.  S. Jitrapakdee et al., Structure, mechanism and regulation of pyruvate carboxylase. 
Biochem. J. 413, 369–87 (2008). 
14.  L. Hertz, L. Peng, G. a Dienel, Energy metabolism in astrocytes: high rate of oxidative 
metabolism and spatiotemporal dependence on glycolysis/glycogenolysis. J. Cereb. Blood 
Flow Metab. 27, 219–249 (2007). 
15.  M. J. Macdonald, J. H. Kaysen, S. M. Moran, E. Pomije, Pyruvate Dehydrogenase and 
Pyruvate Carboxylase. J. Biol. Chem. 266, 22392–22397 (1991). 
16.  B. H. Robinson, Lactic acidemia and mitochondrial disease. Mol. Genet. Metab. 89, 3–13 
(2006). 
17.  A. García-Cazorla et al., Pyruvate carboxylase deficiency: Metabolic characteristics and 
new neurological aspects. Ann. Neurol. 59, 121–127 (2006). 
18.  X. Li et al., The MDM2–p53–pyruvate carboxylase signalling axis couples mitochondrial 
23 
 
metabolism to glucose-stimulated insulin secretion in pancreatic β-cells. Nat. Commun. 7, 
11740 (2016). 
19.  R. J. Perry et al., Hepatic Acetyl CoA Links Adipose Tissue Inflammation to Hepatic 
Insulin Resistance and Type 2 Diabetes. Cell. 160, 745–758 (2015). 
20.  S. Christen et al., Breast Cancer-Derived Lung Metastases Show Increased Pyruvate 
Carboxylase-Dependent Anaplerosis. Cell Rep. 17, 837–848 (2016). 
21.  T. Cheng et al., Pyruvate carboxylase is required for glutamine-independent growth of 
tumor cells. Proc. Natl. Acad. Sci. 108, 8674–8679 (2011). 
22.  K. Sellers et al., Pyruvate carboxylase is critical for non – small-cell lung cancer 
proliferation. J. Clin. Invest. 125, 687–698 (2015). 
23.  P. Phannasil et al., Pyruvate carboxylase is up-regulated in breast cancer and essential to 
support growth and invasion of MDA-MB-231 cells. PLoS One. 10, 1–20 (2015). 
24.  C. Lussey-Lepoutre et al., Loss of succinate dehydrogenase activity results in dependency 
on pyruvate carboxylation for cellular anabolism. Nat. Commun. 6, 8784 (2015). 
25.  S. Cardaci et al., Pyruvate carboxylation enables growth of SDH-deficient cells by 
supporting aspartate biosynthesis. Nat. Cell Biol. 17, 1–6 (2015). 
26.  G. L. Waldrop, I. Rayment, H. M. Holden, Three-dimensional structure of the biotin 
carboxylase subunit of acetyl-CoA carboxylase. Biochemistry. 33, 10249–10256 (1994). 
27.  C.-Y. Chou, L. P. C. Yu, L. Tong, Crystal structure of biotin carboxylase in complex with 
substrates and implications for its catalytic mechanism. J. Biol. Chem. 284, 11690–7 
(2009). 
28.  J. B. Thoden, C. Z. Blanchard, H. M. Holden, G. L. Waldrop, Movement of the biotin 
carboxylase B-domain as a result of ATP binding. J. Biol. Chem. 275, 16183–16190 
(2000). 
29.  S. Kondo et al., Structure of the biotin carboxylase subunit of pyruvate carboxylase from 
Aquifex aeolicus at 2.2 A resolution. Acta Crystallogr. D. Biol. Crystallogr. 60, 486–92 
(2004). 
30.  Y. Shen, S. L. Volrath, S. C. Weatherly, T. D. Elich, L. Tong, A mechanism for the potent 
inhibition of eukaryotic acetyl-coenzyme A carboxylase by soraphen A, a macrocyclic 
polyketide natural product. Mol. Cell. 16, 881–891 (2004). 
31.  Y. Shen, C.-Y. Chou, G.-G. Chang, L. Tong, Is dimerization required for the catalytic 
activity of bacterial biotin carboxylase? Mol. Cell. 22, 807–18 (2006). 
32.  P. R. Hall et al., Transcarboxylase 5S structures: assembly and catalytic mechanism of a 
multienzyme complex subunit. EMBO J. 23, 3621–3631 (2004). 
33.  R. Studer et al., Crystal Structure of the Carboxyltransferase Domain of the Oxaloacetate 
Decarboxylase Na+ Pump from Vibrio cholerae. J. Mol. Biol. 367, 547–557 (2007). 
34.  S. Xiang, L. Tong, Crystal structures of human and Staphylococcus aureus pyruvate 
carboxylase and molecular insights into the carboxyltransfer reaction. Nat. Struct. Mol. 
Biol. 15, 295–302 (2008). 
35.  L. P. C. Yu et al., A symmetrical tetramer for S. aureus pyruvate carboxylase in complex 
24 
 
with coenzyme A. Structure. 17, 823–32 (2009). 
36.  F. K. Athappilly, W. A. Hendrickson, Structure of the biotinyl domain of acetyl-coenzyme 
A carboxylase determined by MAD phasing. Structure. 3, 1407–1419 (1995). 
37.  M. St Maurice et al., Domain architecture of pyruvate carboxylase, a biotin-dependent 
multifunctional enzyme. Science. 317, 1076–9 (2007). 
38.  A. D. Lietzan et al., Interaction between the biotin carboxyl carrier domain and the biotin 
carboxylase domain in pyruvate carboxylase from rhizobium etli. Biochemistry. 50, 9708–
9723 (2011). 
39.  C. S. Huang et al., Crystal structure of the α6β6 holoenzyme of propionyl-coenzyme A 
carboxylase. Nature. 466, 1001–1005 (2010). 
40.  C. S. Huang, P. Ge, Z. H. Zhou, L. Tong, An unanticipated architecture of the 750-kDa 
α6β6 holoenzyme of 3-methylcrotonyl-CoA carboxylase. Nature. 481, 219–223 (2012). 
41.  J. Wei, L. Tong, Crystal structure of the 500-kDa yeast acetyl-CoA carboxylase 
holoenzyme dimer. Nature. 526, 723–7 (2015). 
42.  J. R. Knowles, The mechanism of biotin-dependent enzymes. Annu. Rev. Biochem. 58, 
195–221 (1989). 
43.  A. R. Jurado, C. S. Huang, X. Zhang, Z. H. Zhou, L. Tong, Structure and substrate 
selectivity of the 750-kDa α6β6 holoenzyme of geranyl-CoA carboxylase. Nat. Commun. 
6, 8986 (2015). 
44.  A. K. Kleinschmidt, J. Moss, M. D. Lane, Acetyl Coenzyme A Carboxylase : Filamentous 
Nature of the Animal Enzymes 500 A. Science. 166, 0–3 (1966). 
45.  A. Adina-Zada et al., Roles of Arg427 and Arg472 in the binding and allosteric effects of 
acetyl CoA in pyruvate carboxylase. Biochemistry. 51, 8208–8217 (2012). 
46.  A. Adina-Zada, T. N. Zeczycki, P. V Attwood, Regulation of the structure and activity of 
pyruvate carboxylase by acetyl CoA. Arch. Biochem. Biophys. 519, 118–30 (2012). 
47.  T. H. Tran et al., Structure and function of a single-chain, multi-domain long-chain acyl-
CoA carboxylase. Nature. 518, 120–4 (2015). 
48.  C. Fan, C. Y. Chou, L. Tong, S. Xiang, Crystal structure of urea carboxylase provides 





The bacterial second messenger cyclic-di-AMP and its regulation of pyruvate 
carboxylase 
2.1 Introduction 
2.1.1 Cyclic-di-AMP is a widespread and essential bacterial second messenger 
Cellular processes in all forms of life require complex signaling networks to regulate their 
activities. The cyclic-di-nucleotides are a family of signaling molecules that have emerged 
recently as important second messengers in both bacteria and eukaryotes.  
 
Figure 1. Chemical structure of cyclic-di-nucleotides. (A) cyclic-di-AMP (B) cyclic-di-GMP (C) 
cyclic-GMP-AMP 
Cyclic-di-AMP (c-di-AMP) (Fig. 1A) is a bacterial second messenger which was first discovered 
in 2010 to be produced in vivo in the bacterium Listeria monocytogenes (1)
 
, and has since been 
found to be nearly ubiquitous in the bacterial kingdom. Cyclic-di-GMP (c-di-GMP) (Fig. 1B) is 
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the best characterized cyclic-di-nucleotide second messenger and was first discovered in 1987 
(2). Cyclic-di-GMP is widespread in bacteria and has been implicated in a number of 
physiological processes such as production of extracellular matrix, transition from a sessile to 
biofilm state, and virulence (3). Cyclic-GMP-AMP (cGAMP) (Fig. 1C) is found in metazoa, 
including humans, and is involved in the STING-dependent type I interferon immune response 
(4).  
The mechanism for the synthesis and degradation of c-di-AMP has been well-characterized. 
Cyclic-di-AMP is synthesized from two molecules of ATP by DisA-N domain containing 
proteins, termed diadenylyl cyclases (DACs), of which there are two major classes (5). The first 
and most common class, termed the DacA proteins, has a DAC linked to an N-terminal 
transmembrane domain. The DacA proteins likely synthesize c-di-AMP in response to 
extracellular cues, although the precise mechanisms have yet to be elucidated. The second class, 
termed the DisA proteins, have a domain organization in which a DAC is linked to a DNA-
binding domain. This class is known to be responsive to DNA damage signals, and is primarily 
found in Gram-positive, spore-forming bacteria such as Bacillus and Clostridium. DAC proteins 
of both classes are widespread in bacteria, particularly in Gram-positive organisms including the 
pathogens Staphylococci, Streptococci, Mycobacteria, Listeria, and Mycoplasma spp. (1). DAC 
proteins are also present in some Gram-negative bacteria. The DAC domain possesses no 
sequence or structural similarity to the GGDEF proteins responsible for c-di-GMP synthesis, 
although both c-di-GMP and c-di-AMP signaling networks are present together in many bacterial 
species. 
Cyclic-di-AMP is degraded by phosphodiesterases to AMP or pApA (6). There are two major 
classes of phophodiesterases, the DHH-DHHA1 domain-containing GdpP proteins, and the HD 
domain-containing PgpH proteins. Both of these classes have sensory domains which regulate c-
di-AMP hydrolysis to modulate c-di-AMP levels in the cell (7). In Listeria monocytogenes, and 
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other bacteria, c-di-AMP can also be secreted from the cell through multidrug resistance 
transporters (1).  
Subsequent functional studies in L. monocytogenes showed that c-di-AMP plays a fundamental 
role in many bacterial physiological processes including cell wall homeostasis (8, 9), biofilm 
formation (10, 11), and potassium transport (12). In various pathogenic bacteria, c-di-AMP is 
essential for mediating host-pathogen interactions and promoting virulence (8, 13–16). Depletion 
of c-di-AMP causes an increased susceptibility to β-lactam antibiotics in L. monocytogenes (8), 
as well as Staphylococcus aureus (17), and Bacillus subtilis (18). In addition, depletion of c-di-
AMP hampered growth of L. monocytogenes and its ability to infect bone-marrow derived 
macrophages in vitro or in a mouse model (8).  
The identification of several c-di-AMP binding proteins in recent years has provided some clues 
as to how it carries out its physiological functions in the cell. Cyclic-di-AMP has been found to 
bind proteins important for growth in low potassium conditions in S. aureus (19), and 
Streptococcus pneumoniae (12). In Mycobacterium smegmatis, it binds the transcription factor 
DarR, which regulates genes involved in metabolism (20). Cyclic-di-AMP was also found to 
bind to the YdaO riboswitch family
 
(21–23). Although these findings shed some light on the c-
di-AMP signaling network, the major physiological changes induced by c-di-AMP disruption in 
L. monocytogenes and other bacteria suggests that there are more effector proteins than those 
known. In addition, there were no crystal structures of c-di-AMP in complex with effector 
proteins, so the mechanisms by which c-di-AMP binds and modulates its targets are also unclear. 
The main goal of this project was to expand our knowledge of c-di-AMP signaling and function 
in cells, identify novel binding partners and define the molecular mechanisms of how they 





2.1.2 Listeria monocytogenes as a model organism 
L. monocytogenes is an ideal bacterium to use for our research proposal, as recent studies have 
shown that many essential physiological processes in this organism are regulated by c-di-AMP
 
(8, 17). In addition, L. monocytogenes is a public health concern as a common cause of 
foodborne illness in the United States. Thus, our findings may unveil new strategies for 
combating L. monocytogenes as well as the wide array of other bacterial pathogens which utilize 
c-di-AMP signaling. L. monocytogenes is a Gram-positive, facultative anaerobic, rod-shaped 
bacterium and induces infection as an intracellular pathogen. L. monocytogenes causes the 
disease listeriosis, with an estimated 1600 cases annually in the United States resulting in 400-
500 deaths (24). Listeriosis is most common among the elderly, the immunocompromised, 
newborns, and pregnant women. Clinical manifestations of listeriosis include meningitis, 
encephalitis, septicemia, and spontaneous abortion (24). Despite timely intervention with 
antibiotic therapy, listeriosis is fatal in 30% of cases and there are reports of increasing antibiotic 




The pathogenesis of L. monocytogenes has been extensively studied over the past several 
decades, but the metabolism of the bacterium in intracellular and extracellular environments is 
less well understood. Recent studies have shown that L. monocytogenes has several remarkable 
features in its metabolism in comparison to other bacterial species. Oxaloacetate is one of the 
central players in carbon metabolism as a component of the citric acid cycle and as a precursor to 
the amino acids aspartate, glutamate, and glutamine. While most species have multiple pathways 
of producing oxaloacetate, L. monocytogenes lacks the α-ketoglutarate dehydrogenase complex 
and thus possesses a fractured citric acid cycle that is unable to produce oxaloacetate. Therefore, 
L. monocytogenes can only synthesize oxaloacetate through pyruvate carboxylase activity
 
(26). 
When pyruvate carboxylase is knocked-out in L. monocytogenes, the bacterium is unable to grow 
in minimal medium or intracellularly in mammalian cells and thus has severely mitigated 
virulence
 
(26). Based on these results, it is clear that pyruvate carboxylase plays a significant role 
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in L. monocytogenes metabolism, growth and virulence. Despite this importance, there have been 
few studies characterizing L. monocytogenes pyruvate carboxylase, and its precise role in the 
physiology of L. monocytogenes is unknown. In the results presented in this chapter, we identify 
the PC enzyme in L. monocytogenes as a target of c-di-AMP-mediated regulation, and show that 
this regulation plays a crucial functional role in the bacterium.  
2.2 Experimental procedures 
Protein expression and purification. The full-length gene for L. monocytogenes pyruvate 
carboxylase (LmPC) was sub-cloned into the pET28a vector (Novagen). This construct was then 
co-transformed into BL21 Star (DE3) cells along with a plasmid which encodes a bacterial biotin 
ligase (BirA) gene. The cells were cultured in LB medium with 35 mg/ml kanamycin and 35 
mg/ml chloramphenicol and were induced for 14 hours with 1 mM IPTG at 20 °C. Prior to 
induction, 20 mg/l biotin and 10 mM MnCl2 was added to the medium. The protein was purified 
through nickel-agarose affinity chromatography followed by gel filtration chromatography (S-
300, GE Healthcare). The purified protein was concentrated to 15 mg/ml in a buffer containing 
20 mM Tris (pH 8.0), 150 mM NaCl, 5% (v/v) glycerol, and 5 mM DTT, flash-frozen in liquid 
nitrogen and stored at –80°C. The protein was confirmed to be fully biotinylated by an avidin 
gel-shift assay. The N-terminal His-tag was not removed for crystallization. 
Mutagenesis and kinetic studies. Mutants were made using the QuikChange kit (Stratagene) 
and confirmed by sequencing. They were expressed and purified using the same protocol as the 
wild-type protein. The catalytic activity of wild-type and mutant proteins was assessed based on 
a published protocol (27) which couples oxaloacetate production to the oxidation of NADH by 
malate dehydrogenase, followed spectrophotometrically by the decrease in absorbance at 340 
nm. The activity was measured at room temperature in a reaction mixture containing 100 mM 
Tris (pH 7.5), 200 mM NaCl, 5 mM MgCl2, 50 mM sodium bicarbonate, 50 mM ammonium 
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sulfate, 10 units of malate dehydrogenase, 0.3-0.7 µM LmPC (based on monomer), and varying 
concentrations of pyruvate. 
Protein crystallization. Crystals were grown by the sitting-drop vapor diffusion method at 20 
°C. For the c-di-AMP complex, the protein was incubated with 2.5 mM c-di-AMP and 2.5 mM 
ATP for 30 min at 4 °C before setup. The reservoir solution contained 19% (w/v) PEG3350 and 
0.2 M ammonium citrate (pH 7.0). The crystals appeared within 1-2 weeks and grew to full-size 
after a few additional days. The crystals were cryo-protected in the reservoir solution 
supplemented with 10% (v/v) PEG200 and were flash-frozen in liquid nitrogen for data 
collection at 100 K. For the apo structure, the protein at 5 mg/ml was incubated with 2.5 mM 
ATP and 2.5 mM pyruvate for 30 min at 4 °C before setup. The reservoir solution contained 16% 
(w/v) PEG3350, 0.1 M Bis-Tris (pH 6.5), and 1% (w/v) tacsimate (pH 7.0, Hampton). The 
crystals appeared within 1 week and grew to full-size within a few more days. They were cryo-
protected in the reservoir solution supplemented with 15% (v/v) ethylene glycol and flash-frozen 
in liquid nitrogen. 
Data collection and structure determination. All X-ray diffraction data were collected at the 
X29 or X25 beamline at the National Synchrotron Light Source (NSLS) at Brookhaven National 
Laboratory. The diffraction images were processed using HKL2000 (28). The structures were 
solved using the molecular replacement method with the program Phaser (29), with the S. aureus 
PC structure (30) as the search model. Manual rebuilding was carried out in Coot (31) and 
refinement was done with the program Refmac (32). Data collection and refinement statistics are 













Space Group P21 C2 P1 
Cell dimensions 
a, b, c (Å) 
α, β, γ (°) 
 
96.8, 153.3, 221.2 
90, 101.6, 90 
 
227.0, 146.9, 96.1 
90, 103.5, 90 
 
91.4, 132.6, 257.5 
86.6, 79.8, 70.1 
Resolution
1
 50-2.5 (2.6-2.5) 50-2.7 (2.8-2.7) 50-3.3 (3.4-3.3) 
Rmerge (%) 7.2 (38.0) 5.9 (48.8) 5.6 (43.5) 
I/σI 15.9 (3.3) 16.0 (1.9) 11.3 (1.6) 
Redundancy 3.9 (3.4) 3.0 (2.9) 1.8 (1.7) 
Completeness 97 (88) 97 (97) 89 (71) 
Rwork (%) 19.5 (29.5) 19.8 (32.5) 23.8 (33.9) 


















bond lengths (Å) 
0.015 0.013 0.009 
R.m.s deviation 
bond angles (°) 
1.7 1.6 1.4 
PDB Accession 
Code 
4QSH 4QSK 4QSL 
  1Values in parentheses refers to the highest resolution shell 
2.3 Identification of c-di-AMP-binding proteins in L. monocytogenes
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To identify c-di-AMP interacting proteins in Listeria monocytogenes, our collaborators at the 
Woodward Lab (University of Washington) performed a pull-down assay using c-di-AMP-linked 
beads and L. monocytogenes lysates (33). Through mass spectrometry, they identified the 
bacterial proteins that were pulled down by the c-di-AMP-linked beads. Among the proteins 
identified was the central metabolic enzyme pyruvate carboxylase. This was a striking finding 
because c-di-AMP had not previously been recognized as a regulator of metabolic processes. 
Other proteins of note identified in the screen included the CBS domain protein lmo0553 
(discussed in Chapter 5), and a PII-like protein lmo2692 (discussed in Chapter 4).  
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Figure 2. L. monocytogenes proteins identified in c-di-AMP binding screen. List of proteins identified 
to bind c-di-AMP in L. monocytogenes. The name of the gene locus is in the left column, and the 
annotation of the protein is indicated. The FC indicates the degree of binding compared to control 
sepharose beads, and the FDR indicates the false discovery rate based on the FC. See Appendix A for 
methods.   
2.4 Biochemical analysis of LmPC and its regulation by c-di-AMP 
Biochemical studies performed by the Woodward lab confirmed that c-di-AMP binds directly to 
L. monocytogenes PC (LmPC), and that c-di-AMP is an inhibitor of its enzymatic activity. The 
inhibition could not be overcome by increasing the amount of the pyruvate substrate, an 
indication that the inhibition is non-competitive with respect to pyruvate. The Woodward lab 
also tested various other cyclic-di-nucleotides, including cyclic-di-GMP, and bacterial cGAMP, 
neither of which affected LmPC activity. These findings demonstrate that the inhibition is 
specific for c-di-AMP. Remarkably, c-di-AMP showed no inhibitory effect towards PC enzymes 
from other species such as Staphylococcus aureus (SaPC) or human PC. This suggested that the 
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regulation of PC by c-di-AMP is not a general mechanism but may be more limited to a subset of 
bacterial PC enzymes.  
 
Figure 3. Enzymatic assays of LmPC with c-di-AMP. (A) Michaelis-Menten curves of LmPC with 
various c-di-AMP concentrations, as indicated. The reactions were done in the presence of 100 uM 
acetyl-CoA. (B) LmPC inhibition assays with various nucleotide analogs, as indicated. The reactions were 
done with 20 mM pyruvate.  
 
2.5 Crystal structure of LmPC in complex with c-di-AMP 
Our lab had previously solved several crystal structures of PC enzymes, so we started a 
collaboration with the Woodward lab to solve the crystal structure of L. monocytogenes PC 
(LmPC) in complex with c-di-AMP. There were several questions we wished to answer by 
solving the structure of the complex. First, we wished to determine the location of the c-di-AMP 
binding pocket. The most well studied allosteric ligand for pyruvate carboxylase is acetyl-CoA, 
which is an activator of its enzymatic activity. The acetyl-CoA binding pocket is strongly 
conserved and has been well-characterized in both Rhizobium etli PC and in Staphylococcus 
aureus PC (34, 35). The Woodward lab had observed that high levels of acetyl-CoA could 
overcome the inhibitory effect of c-di-AMP, raising the possibility that the two ligands may 
share the same binding pocket. We also wished to explain the specificity that LmPC exhibited 
for c-di-AMP over other cyclic-di-nucleotides and why c-di-AMP only inhibits LmPC out of the 
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many PC enzymes that were also tested. In addition, by identifying the c-di-AMP binding 
pocket, this could allow for the identification of PC enzymes from other species which are also 
inhibited by c-di-AMP.  Finally, the structure could provide insights into the molecular 
mechanisms by which c-di-AMP inhibits LmPC activity.  
The crystal structure of LmPC in complex with c-di-AMP was determined at 2.5 Å resolution 
(Fig. 4). LmPC forms a tetramer in the crystal structure, consistent with the gel filtration 
analysis, and similar to previously determined structures of human PC, SaPC (30), and RePC 
(35) (described in Chapter 1). In the LmPC tetramer, the PT domains of adjacent monomers do 
not make contacts, in contrast to the SaPC tetramer in which the PT domains dimerize. All four 
BCCP domains are well-ordered in the crystal structure, and are found near the exo site which 
was previously identified in the SaPC structure (30). The biotinyl group is disordered and could 
not be modelled. In addition, linkers connecting the BCCP to the PT domain are disordered, so 
each BCCP could not be reliably assigned to a monomer. Thus, the BCCPs were assigned in 
accordance with the SaPC structure, in which the BCCP from one monomer would visit the CT 
active site of the opposing monomer, while going to the BC active site of the same monomer. 
This assignment cannot be confirmed by the crystallographic data.  Although ATP was added to 
the protein before crystallization, no density for ATP was found in the BC active site, and the B-




Figure 4. L. monocytogenes pyruvate carboxylase in complex with c-di-AMP. Schematic drawing of 
the LmPC structure at 2.5 Å resolution in complex with 2 c-di-AMP molecules (cdA, black spheres). 
Monomer 1 is colored according to the key at the bottom, and the other monomers are colored magenta, 
cyan, and yellow. The metal ion (M
2+
) is shown as a gray sphere. The distance between the c-di-AMP and 
the metal ion in Monomer 1 is shown as a dashed line (red). The lysine residue on the BCCP domain to 
which biotin is attached is shown in stick representation.  
 
2.5.1 Analysis of c-di-AMP binding to LmPC 
There was clear density for the c-di-AMP ligand based on the crystallographic analysis (Fig. 
5A). The c-di-AMP binding site is found in a solvent-exposed region at the dimer interface of 
two CT monomers (Fig. 5B). Accordingly, there are two c-di-AMP molecules bound to the 
tetramer, at equivalent CT dimer interface sites. This region of the CT dimer has previously not 
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been recognized as having any structural or regulatory significance. The c-di-AMP is bound 25 
Å away from the CT active site (Fig. 4), suggesting that the inhibition is not through direct 
competition with the substrate, but through an allosteric mechanism.  
 
Figure 5. The c-di-AMP binding pocket in LmPC. (A) Omit Fo-Fc density for c-di-AMP bound to 
LmPC at 2.5 Å resolution, contoured at 3σ (B) Molecular surface of the LmPC binding site for c-di-AMP 
(black sticks). The surface is colored according to the electrostatic potential (blue is positive, red is 
negative, white is neutral) 
There is a third c-di-AMP molecule which inserts an adenine base in between the adenine bases 
of each bound c-di-AMP, forming π-stacking interactions with the c-di-AMP but making no 
direct contacts with the protein (Fig. 6A). This third c-di-AMP makes identical contacts with 
another bound c-di-AMP in a neighboring LmPC tetramer in the crystal, thus “bridging” the two 
adjacent LmPC tetramers. The bridging c-di-AMP raised concerns that the binding mode of c-di-
AMP observed in this crystal form may be a crystal artifact. To confirm this finding, an attempt 
was made to find a different crystal form in which the bridging c-di-AMP molecule is not 
present. To this end, a second crystal form was obtained which forms in the same crystallization 
condition as the original crystal, and the structure was determined at 2.7 Å. This new crystal 
form is in the C2 space group, while the original crystal form was in the P21 space group. In the 
C2 crystal form, the neighboring LmPC tetramers move closer to one another, and the bridging 
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c-di-AMP molecule is absent (Fig. 6B). The overall conformation of the LmPC tetramer, as well 
as the binding mode of c-di-AMP, are almost identical to the first crystal structure, confirming 
the relevant findings.  
 
 
Figure 6. LmPC crystal packing. (A) Crystal form 1 with the bridging c-di-AMP (c-di-AMP) molecule. 
Two adjacent CT dimers from neighbouring LmPC tetramers are shown. The CT dimer from tetramer 1 is 
colored green and yellow, the CT dimer from tetramer 2 is colored magenta and cyan. (B) Crystal form 2 
with no bridging c-di-AMP. The view and coloring scheme is identical to (A).  
 
2.5.2 A citrate is bound in the acetyl-CoA binding pocket 
A surprise in the crystal structure was the presence of a citrate molecule, with good electron 
density (Fig. 7A), located at the BC-PT interface, at the same site as the putative acetyl-CoA 
binding pocket of LmPC (Fig. 7B). There are four citrate molecules symmetrically bound to the 
tetramer, in the four acetyl-CoA binding sites. The citrate is present in both LmPC-c-di-AMP 
crystal forms. The citrate likely comes from the crystallization condition which includes 0.2 M 
ammonium citrate. The citrate forms several hydrogen bonds with arginine residues which are 
also responsible for interacting with acetyl-CoA. These residues are well-conserved across 
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various PC homologues. PC enzymes are known to be inhibited by aspartate and glutamate, 
which have similar chemical structures to citrate and thus may bind at the same site (36). 
However, citrate did not affect LmPC activity, even at millimolar concentration, so its presence 
in the crystal structure may be an artifact and not possess any biochemical significance. It cannot 
be ruled out, however, that citrate may affect the conformation of the LmPC tetramer observed in 
the crystal structure. Attempts were made to find a crystallization condition which did not 
include citrate, but these were unsuccessful.  
 
 
Figure 7. Citrate binding to LmPC. (A) Omit Fo-Fc density for citrate bound to LmPC at 2.5 Å 
resolution, contoured at 3σ. (B) The LmPC citrate binding pocket at the interface of the BC and PT 
domains of one monomer. Hydrogen-bonding interactions with the protein are shown as dashed red lines.  
 
2.5.3 Detailed interactions between LmPC and c-di-AMP 
The crystal structure allowed for a detailed examination of the binding pocket for c-di-AMP and 
its interactions with LmPC. The c-di-AMP adopts a symmetrical conformation, and is bound at 
the two-fold symmetry axis of the CT dimer, such that the c-di-AMP makes identical interactions 
with each CT monomer (Fig. 8A). The c-di-AMP adopts a U-shaped conformation, which is 
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similar to the conformation adopted by cyclic-di-GMP bound to several crystal structures such as 
the bacterial PilZ domain (37) and the human immune regulator STING (38).  
 
Figure 8. Detailed interactions between c-di-AMP and LmPC. (A) The c-di-AMP (black) and the 
side-chains which interact with c-di-AMP are shown in stick representation. Hydrogen-bonding 
interactions are shown as red dashes. Water molecules are shown as red spheres. (B) Sequence alignment 
of the c-di-AMP binding pocket from selected PC homologues. The residues which interact with the c-di-
AMP are highlighted in red. The numbering is according to LmPC.  
The c-di-AMP molecule is recognized by the protein through several hydrophobic and 
hydrophilic interactions. Each adenine base of the c-di-AMP makes direct face-to-face π-
stacking interactions with the side chain of Tyr722. The adenine base is not recognized 
specifically by the protein, so the preference for c-di-AMP inhibition over c-di-GMP (Fig. 3B) is 
not well-explained by the structure. The side chain of Tyr749 forms the base of the binding 
pocket, and additionally contributes a hydrogen bond to the terminal oxygen of the c-di-AMP 
phosphate group. The other terminal oxygen makes a water-mediated hydrogen bond with the 
40 
 
side chain of Ser756. The residues Ala752 and Ala753 are located near the ribose group of c-di-
AMP, and these small side-chains provide the necessary space for the ligand to bind. The 
residues that interact with c-di-AMP are not well-conserved among PC homologues (Fig. 8B), 
providing an explanation for why only LmPC was inhibited by c-di-AMP among the PC 
enzymes tested (discussed further in Chapter 3).  
 
2.5.4 Mutational analysis of the LmPC c-di-AMP binding pocket 
To confirm that the binding site identified in the LmPC crystal structure is correct, several 
mutants were made and tested for their c-di-AMP binding affinity. An aromatic residue forming 
π-stacking interactions with the adenine or guanine base of a cyclic-di-nucleotide is a common 
structural motif among several cyclic-di-nucleotide binding proteins, including the STING-c-di-
GMP complex (38). To test the importance of this interaction, the Tyr722 residue was mutated to 
a threonine, equivalent to the residue found in the human PC protein (Fig. 8B). A Y722F mutant 
was also made, to test the necessity of the hydroxyl group of tyrosine for c-di-AMP binding.  A 
comparison of the LmPC c-di-AMP binding site with the equivalent region in SaPC revealed 
several major differences, which eliminates the binding pocket in the latter enzyme. The most 
consequential of these differences is that the LmPC Ala752 and Ala753 residues are replaced by 
a lysine and glutamine residue (Fig. 8B), respectively, which closes the binding pocket and 
precludes c-di-AMP binding. In addition, the Tyr749 residue of LmPC is replaced by leucine in 
SaPC, losing the hydrogen bond to the phosphate group. To test the importance of these residues 
for c-di-AMP binding in LmPC, these sequence comparisons to SaPC were used to guide the 




Figure 9. c-di-AMP binding and inhibition assays of LmPC mutants. (A) c-di-AMP binding to wild-
type LmPC and various mutants measured using the DRaCALA assay. (B) Enzymatic activity of wild-
type LmPC and various mutants. Figure from (33)    
The LmPC mutants were expressed in E. coli and purified using the same protocol as the wild-
type protein. Binding assays performed by the Woodward lab using the DRaCALA assay (39) 
confirmed that the LmPC mutants no longer bound to c-di-AMP (Fig. 9A). Excepting the Y749L 
mutant, all the mutants were catalytically active. However, the mutants had varying degrees of 
activity in comparison to the wild-type protein (Fig. 9B). For example, the A753Q mutant was 
far more active than wild-type, while the Y722T mutant had 3-fold lower catalytic activity. The 
reason for these observations is not clear, but we can speculate that the c-di-AMP binding pocket 
has a significant functional role in LmPC catalytic activity, and that c-di-AMP binding may be 
modulating this effect. As expected, all the mutants except Y722F were no longer inhibited by c-
di-AMP, confirming the binding site in solution. The Y722F mutant bound c-di-AMP and was 
still inhibited, demonstrating that a tyrosine residue is not essential at this position, and that other 
aromatic residues can be substituted without disrupting c-di-AMP binding. In addition, the 
Y722F still exhibited no inhibition by c-di-GMP, demonstrating that this residue is not 






2.6 Crystal structure of apo LmPC 
To understand the mechanisms of c-di-AMP inhibition, the apo structure of LmPC in the absence 
of c-di-AMP was also solved at 3.3 Å resolution (Table 1). There were two tetramers in the 
asymmetric unit which are essentially identical (0.1 Å r.m.s distance among Cα atoms), thus only 
one of these tetramers was used for analysis. Unlike the c-di-AMP complex structure, all four 
BCCP domains in the apo structure were disordered and could not be modelled.  
 
 
Figure 10. Comparisons between the apo and c-di-AMP bound LmPC structures. (A) Overlay of the 
apo (gray) and c-di-AMP bound (colors) LmPC tetramer. Monomer 1 was overlaid, to highlight the 
conformational changes in the other monomers.  The c-di-AMP bound tetramer is colored as in Figure 4, 
and the c-di-AMP (cdA) is shown as black spheres. (B) Overlay of the four monomers in the apo LmPC 
tetramer by the CT domain. The red arrow highlights the conformational differences of the BC domain. 
(C) Overlay of the four monomers in the c-di-AMP bound LmPC tetramer. The c-di-AMP (cdA) is shown 
as black spheres.   
 
Overlaying the apo and c-di-AMP LmPC tetramers revealed dramatic conformational changes 
between them due to c-di-AMP binding (Fig. 10A). These differences are best illustrated by 
comparing the four individual monomers in each tetramer. When the four monomers of the apo 
LmPC structure are overlaid by their CT domain, the BC domain has major conformational 
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differences relative to the CT domain (Fig. 10B). On the other hand, the four monomers of the c-
di-AMP complex LmPC structure overlay almost perfectly (Fig. 10C). Thus, the apo LmPC has 
a high degree of asymmetry within the tetramer, while the c-di-AMP bound complex is almost 
perfectly symmetric. In fact, the c-di-AMP-bound structure is the most symmetric of all PC 
structures determined to date, even more so than the previously determined SaPC structure which 
also had a high degree of symmetry.  The apo LmPC structure is more reminiscent of the RePC 
structure, which was also asymmetric (35).  
 
Figure 11. Conformational changes of LmPC upon c-di-AMP binding. (A) Overlay of the CT dimer 
of the apo (gray) and c-di-AMP (colors) bound LmPC structures. The red arrows highlight the 
conformational changes upon c-di-AMP binding. The c-di-AMP (black) and the side-chains that interact 
with c-di-AMP are shown in stick representation. (B) Overlay of the CT domain of Monomer 4 between 
the apo (gray) and c-di-AMP bound (colors) LmPC structures. The change in position of Monomer 1 
upon c-di-AMP binding is indicated by the red arrow. The c-di-AMP (cdA) is labeled and shown as black 
sticks.  
We then compared the individual BC and CT dimers between the apo and c-di-AMP-bound 
structures. There are significant changes in the c-di-AMP binding pocket of the CT dimer upon 
ligand binding (Fig. 11A). Each CT monomer rotates ~5° in order to accommodate the c-di-
AMP. These local changes result in a global conformational rearrangement of the CT dimer. This 
is best illustrated by overlaying one of the CT monomers between the apo and c-di-AMP bound 
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structures, which reveals that the second CT monomer is rotated ~10° between the two structures 
(Fig. 11B).  On the other hand, the BC dimers are essentially identical between the two apo and 
c-di-AMP bound tetramers, which is consistent with the fact that the c-di-AMP binding site is far 
from the BC domains.  
2.7 Insights into the mechanism of c-di-AMP inhibition 
These crystal structures provided insights into recognition of c-di-AMP by LmPC, but the 
precise molecular mechanism by which c-di-AMP leads to inhibition of PC activity is not well 
understood. It is clear from the distance between the c-di-AMP binding site and the BC active 
site that the BC reaction is unlikely to be affected by c-di-AMP binding. This leaves the two 
possibilities that c-di-AMP inhibits the carboxyltransferase reaction, or that c-di-AMP binding 
somehow restricts or slows the movement of the BCCP domain between the BC and CT active 
site. In favor of the latter model is the unusual degree of symmetry present in the c-di-AMP 
complex structure. Previous cryo-EM studies have demonstrated that the SaPC tetramer 
undergoes dramatic conformational changes in order to complete the catalytic cycle (40, 41). The 
binding of c-di-AMP could restrict these movements and “freeze” the tetramer in a conformation 
that is unfavorable for catalysis.  
The other possibility that was considered is that c-di-AMP inhibits the carboxyltransferase 
reaction. Close examination of the CT active site does not show any noticeable changes upon c-
di-AMP binding. However, there is a large change in the CT dimer conformation induced by c-
di-AMP binding. This is similar to the case of the allosteric activator acetyl-CoA, which binds at 
the BC dimer interface, and also induces a large conformational change in the BC dimer (34). 
Acetyl-CoA has been recognized as mainly affecting the BC reaction (42). This raised the 
possibility that acetyl-CoA binding may act to stabilize a particular conformation of the BC 
dimer which is more catalytically competent.  Previous studies had demonstrated that mutation at 
the BC interface can affect catalysis, even though the active site is far from the interface (43, 44). 
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This suggests that there may be a long-range communication between the active sites, although 
the details of the mechanism have not been studied further. Such a mechanism could also be true 
in the case of the CT dimer and c-di-AMP, although further investigations would be needed to 
support this hypothesis.       
2.8 Functional studies of c-di-AMP regulation of PC in Listeria monocytogenes 
Our collaborators at the Woodward Lab performed functional studies in L. monocytogenes in 
order to understand the effects of c-di-AMP regulation of LmPC on the metabolism of the 
bacterium (Fig. 12A). In L. monocytogenes, the oxaloacetate that is generated from PC activity 
can be converted to aspartate through aspartate aminotransferase, or be used to produce citrate 
through citrate synthase. Because L. monocytogenes has a truncated TCA cycle, the downstream 
product of citrate is glutamate. Additionally, the de novo production of glutamate in L. 




Figure 12. Functional studies in L. monocytogenes on the metabolic regulation of LmPC by c-di-
AMP. (A) Schematic of L. monocytogenes pyruvate metabolism and the synthesis of the amino acids 
from alanine, aspartate, and glutamate from metabolic precursors. (B) 
13
C enrichment into the amino acids 
alanine, aspartate, and glutmate/glutamine measured in mid-exponential L. monocytogenes strains. (C) 
The bacterial burden measured in colony forming units (CFU) in the spleen and the liver in various L. 
monocytogenes strains measured 48 hours post-infection. Figure from (33). See Appendix A for methods.  
The Woodward lab produced a conditional strain of L. monocytogenes (cΔdacA), in which c-di-
AMP levels are lower in the cell, and tested the incorporation of U-
13
C-glucose into the amino 
acids alanine, glutamate, or aspartate (Fig. 12B). They found that the cΔdacA strain had 
significantly higher intracellular levels of glutamate compared to the wild-type, while the levels 
of alanine and aspartate remained unchanged. This suggests that the metabolic flux through 
LmPC is higher in the absence of c-di-AMP, consistent with the biochemical data, and that 
higher LmPC activity leads to increased production of glutamate. When the downstream citrate 
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synthase gene was deleted as well (cΔdacA ΔcitZ), the incorporation of U-
13
C-glucose into 
glutamate was abolished, confirming that elevated glutamate biosynthesis is a direct result of 
increased LmPC activity.  
In order to analyze the physiological consequences of this glutamate imbalance, the Woodward 
lab tested the growth of the various L. monocytogenes strains in a murine model of acute 
listeriosis (Fig. 12C). The cΔdacA strain exhibited a severe growth defect compared to the wild-
type in the liver and spleen, which is consistent with the results from an earlier study (8). 
However, the cΔdacA ΔcitZ strain rescued growth to approximately the same levels as the wild-
type. These results directly implicate the c-di-AMP regulation of PC as being important for L. 
monocytogenes to establish infection in host cells. The metabolic imbalance created by a 
disruption in this regulation appears to mitigate the virulence of the bacterium.  
The precise mechanism by which metabolic regulation promotes virulence of L. monocytogenes 
is still unclear. Previous studies have shown that c-di-AMP has effects on cell wall homeostasis 
(8). In addition, the glmM gene which encodes a phosphoglucosamine mutase, is often located 
within the cdaA operon in bacteria, including in L. monocytogenes. GlmM converts 
glucosamine-6-phosphate to glucosamine-1-phosphate, and is an important component of the 
peptidoglycan synthesis pathway. GlmM has also been found to be a regulator of CdaA activity 
(9), further linking c-di-AMP to cell wall homeostasis. It is possible that increased PC activity 
may deplete the pool of acetyl-CoA needed for synthesis of branched-chain fatty acids, which 
are an important component of the cell wall, leading to the toxic effects on bacterial growth and 
survival. Further studies will be needed to understand in more depth the functional implications 
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Regulation of pyruvate carboxylase by c-di-AMP in Lactococcus lactis 
3.1 Introduction 
The identification of the binding pocket for c-di-AMP in Listeria monocytogenes in Chapter 2 
led us to the search for additional bacterial PC enzymes which may be regulated by c-di-AMP in 
a similar manner. One of the major findings from the LmPC structure was that the c-di-AMP 
binding pocket is not well-conserved, even among Gram-positive bacterial species that utilize c-
di-AMP signaling (Fig. 1A).    
 
Figure 1. Sequence conservation in the c-di-AMP binding pocket of pyruvate carboxylase (A) 
Sequence alignment of PC enzymes from Listeria monocytogenes (LmPC), Staphylococcus aureus 
(SaPC), and Enterococcus faecalis (EfPC). Residues that interact with c-di-AMP are highlighted in red. 
The numbering is according to LmPC. (B) Molecular surface of the c-di-AMP binding pocket in the CT 
dimer of LmPC. The two CT monomers are colored in green and yellow. (C) The same CT dimer 
interface in SaPC as in (B). The c-di-AMP molecule is modelled into the SaPC structure, showing that the 
binding pocket is occluded. (D) The LmPC c-di-AMP binding pocket with residues substituted as in 
EfPC, to show a hypothetical EfPC c-di-AMP binding pocket.  
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For example, the c-di-AMP binding pocket (Fig. 1B) does not exist in the PC enzyme from 
Staphylococcus aureus (SaPC) due to several substitutions in the primary sequence. The most 
consequential of these is the change from Ala752 and Ala753 in LmPC, to more bulky lysine and 
glutamine residues in SaPC. These side chains close off the binding pocket such that c-di-AMP 
binding is precluded (Fig. 1C). However, a search through the sequence database revealed 
several PC enzymes that had small side chains at these positions, raising the possibility that these 
enzymes may bind c-di-AMP. Among these candidates is the PC enzyme from Enterococcus 
faecalis (EfPC), which is in the clade of lactic acid bacteria. E. faecalis inhabits the 
gastrointestinal tracts of humans and other animals, and is an opportunistic human pathogen 
which commonly causes life-threatening infections in nosocomial settings due to its intrinsic 
resistance to many antibiotics (1). EfPC contains the crucial tyrosine residue in the c-di-AMP 
binding pocket which π-stacks with the adenine base, and has serine and alanine residues at the 
base of the pocket (Fig. 1A), giving space for c-di-AMP binding. Modelling the c-di-AMP into a 
hypothetical EfPC binding region showed that the ligand can fit well into the pocket (Fig. 1D). 
However, EfPC also has several differences in this region compared to LmPC. The Tyr749 
residue of LmPC which makes a hydrogen bond with terminal oxygen of the phosphate group of 
c-di-AMP is replaced by an isoleucine residue in EfPC. In addition, the Ser756 residue in LmPC 
which makes a water-mediated hydrogen-bond with the c-di-AMP, is replaced by a lysine 
residue in EfPC. Based on these sequence differences, c-di-AMP may bind EfPC differently than 
LmPC. 
EfPC had previously been studied in our lab, so the protein was expressed and purified according 
to established protocols. The enzyme could be purified to homogeneity and was fully active 
catalytically. Surprisingly, EfPC showed ~35% inhibition by c-di-AMP only in the presence of 
the allosteric activator acetyl-CoA. If acetyl-CoA is not present in the reaction, EfPC only 
exhibited weak inhibition by c-di-AMP. However, our collaborators in the Woodward lab 
confirmed that EfPC does bind c-di-AMP in a specific manner. In addition, a mutation of the 
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Tyr715 residue, which forms aromatic interactions with the adenine base of c-di-AMP in the 
binding pocket, eliminated the inhibition. These experiments confirmed that EfPC binds c-di-
AMP in the same region of the protein as LmPC, but due to the major differences in the 
composition of the respective binding pockets, the structural details of c-di-AMP recognition by 
EfPC were still not clear.   
We then set out to determine the crystal structure of EfPC in complex with c-di-AMP. The EfPC 
protein was incubated with c-di-AMP and crystallization trays were setup, from which thin 
needle-like crystals were obtained. However, these crystals diffracted very poorly at a 
synchrotron source to only ~6 Å, and the diffraction could not be improved after extensive 
optimization. Prior to the EfPC studies, crystals from a two-subunit PC (MfPC, detailed in 
Chapter 6), could be improved through an internal deletion of the B-subdomain of the BC 
domain. This strategy was also attempted with EfPC. However, upon expression the protein was 
aggregated in solution and could not be purified. It is not clear why the two-subunit PC remained 
soluble after the deletion of its B-subdomain while EfPC became aggregated. Additionally, it is 
also uncertain if other single-chain PC enzymes would also become insoluble in this manner.  
Due to the failure to produce EfPC crystals of sufficient quality, we turned to other PC 
homologues that are closely related to EfPC and may behave better in crystallization trials. The 
PC enzyme from the bacterium Lactococcus lactis (LlPC) has high overall sequence identity to 
EfPC (72%) and has an almost identical composition in the c-di-AMP binding pocket. Based on 
these sequence comparisons, it is expected that c-di-AMP will bind similarly to both EfPC and 
LlPC. Lactococcus lactis is also a member of the lactic acid clade of bacteria and is used in the 
industrial production of various dairy products (2). Other members of this genus such as 
Lactococcus garviae, which is a rarely encountered human pathogen, have PC enzymes with 




3.2 Experimental Procedures 
Protein expression and purification. The Lactococcus lactis strain was obtained from the US 
Department of Agriculture ARS Culture Collection from which the genomic DNA was purified. 
The pyruvate carboxylase gene for Lactococcus lactis was amplified from genomic DNA and 
sub-cloned into the pET28a vector with an N-terminal hexa-histidine tag (Novagen). This 
expression construct was then co-transformed into BL21 Star (DE3) cells along with a plasmid 
encoding the E. coli biotin ligase (BirA) gene.  
The cells were cultured in LB medium with 35 mg/ml kanamycin and 35 mg/ml chloramphenicol 
and were induced for 14 hours with 1 mM IPTG at 20 °C. Prior to induction, 20 mg/l biotin and 
10 mM MnCl2 were supplemented to the culture medium. The protein was purified through 
nickel-agarose affinity chromatography (Qiagen) followed by gel filtration chromatography 
(Sephacryl S-300, GE Healthcare). The purified protein was concentrated to 15 mg/ml in a buffer 
containing 20 mM Tris (pH 8.0), 150 mM NaCl, 5% (v/v) glycerol, and 5 mM DTT, flash-frozen 
in liquid nitrogen and stored at –80 °C. The protein was confirmed to be fully biotinylated by a 
streptavidin gel-shift assay. The N-terminal hexa-histidine tag was not removed for 
crystallization. 
Mutagenesis and kinetic studies. Mutants were made using the QuikChange kit (Stratagene) 
and confirmed by sequencing. They were expressed and purified using the same protocol as 
described for the wild-type enzyme. The catalytic activity was determined based on a published 
protocol (3), which couples oxaloacetate production to the oxidation of NADH by malate 
dehydrogenase, followed spectrophotometrically by the decrease in absorbance at 340 nm. The 
activity was measured at room temperature in a reaction mixture containing 20 mM Tris (pH 
7.5), 200 mM NaCl, 5 mM MgCl2, 50 mM sodium bicarbonate, 50 mM ammonium sulfate, 5 
units of malate dehydrogenase (Sigma), 158 nM LlPC (by the monomer), and varying 
concentrations of pyruvate. 
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Protein crystallization. Crystals of L. lactis PC (LlPC) were grown by the sitting-drop vapor 
diffusion method at 20 °C. For the c-di-AMP complex, the protein at 5 mg/ml was incubated 
with 2.5 mM c-di-AMP and 2.5 mM ATP for 30 min at 4 °C before crystallization setup. The 
reservoir solution contained 20% (w/v) PEG3350, and 0.2 M ammonium formate. Crystals 
appeared within a few days and grew to full-size within one week. The crystals were cryo-
protected in the reservoir solution supplemented with 18% (v/v) ethylene glycol and were flash-
frozen in liquid nitrogen for data collection at 100 K.  
For the apo LlPC enzyme, the protein at 5 mg/ml was incubated with 4 mM ATP for 30 min at 4 
°C before crystallization setup. The reservoir solution contained 15% (w/v) PEG 3350 and 0.2 M 
ammonium tartrate. Crystals appeared after 2 days and grew to full-size within a week. They 
were cryo-protected in the reservoir solution supplemented with 25% (v/v) ethylene glycol and 
flash-frozen in liquid nitrogen for data collection at 100 K  
Data collection and structure determination. X-ray diffraction data were collected at the 
Advanced Photon Source beamline NE-CAT 24-ID-C using a Pilatus-6MF detector. The 
diffraction images for the c-di-AMP complex were processed using HKL2000 (4). The 
diffraction images for the free enzyme were processed using XDS (5), and scaled with the 
program Aimless in the CCP4 package (6).  
The structures were solved by the molecular replacement method with the program Phaser (7), 
using the BC, CT and BCCP domains of the Listeria monocytogenes PC structure as the search 
models. Manual rebuilding was carried out with Coot (8) and refinement with the program 
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0.015 0.013 0.013 
R.m.s deviation bond 
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1.7 1.6 1.6 
PDB Accession Code – – – 
  1Values in parentheses refers to the highest resolution shell 
3.3 Biochemical Analysis of LlPC and its regulation by c-di-AMP 
LlPC was expressed and purified in a fully biotinylated and catalytically active form. A 
Michaelis-Menten plot for LlPC gives a Km value of 3.1 mM toward the pyruvate substrate and a 
kcat value of 192 s
-1 
(Fig. 2A). The Km value is higher than LmPC (0.5 mM) (10), but similar to 
the Km value of SaPC (5 mM) (11). Kinetic assays performed with c-di-AMP confirmed 
inhibition of LlPC activity by ~60%, to a similar degree as LmPC (Fig. 2B), with an approximate 




Figure 2. Enzymatic assays of LlPC with c-di-AMP. (A) Michaelis-Menten curve of LlPC. The Km and 
kcat are indicated. (B) LmPC inhibition assays with c-di-AMP and c-di-GMP. The reactions were 
performed with 20 mM pyruvate.  
LmPC is activated by acetyl-CoA, with a Ka of 78 μM and a Hill coefficient (n) of 1.8 (Fig. 3A). 
However, when testing LlPC we were surprised to find that it is insensitive to activation, even up 
to 250 μM of acetyl-CoA (Fig. 3B). LlPC has a conserved acetyl-CoA binding site so the 
molecular basis for this decreased sensitivity to acetyl-CoA is unclear. All single-chain PC 
enzymes studied to date can be activated by acetyl-CoA to some degree (12). 
 
Figure 3. LlPC is not sensitive to activation by acetyl-CoA. (A) Titration of LmPC with various 
concentrations acetyl-CoA. The pyruvate concentration, which is the Km for LmPC (10). The activation 
constant (Ka) and Hill coefficient (n) are indicated. (B) LlPC enzymatic assays comparing the effect of no 
acetyl-CoA or 250 uM acetyl-CoA. The reactions were performed with or without 25 uM c-di-AMP 
(cdA). The pyruvate concentration was 3 mM, which is the Km for LlPC. The error bars represent the 
standard deviation for 3 independent reactions.    
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However, in the presence of saturating c-di-AMP inhibition, LlPC is activated by acetyl-CoA by 
~30%. Thus, acetyl-CoA appears to be able to activate the c-di-AMP-bound form of LlPC, 
which is consistent with the fact that the acetyl-CoA binding residues are conserved. However, 
this level of activation is still well below what is observed for other PC enzymes. For example, 
LmPC is activated ~4-fold by acetyl-CoA (Fig. 3A), while SaPC is activated ~6-fold (13). LlPC 
has a kcat of 192 s
-1 
(Fig. 2A), which is significantly higher than most PC enzymes studied to 
date. For example, SaPC has a kcat of 20 s
-1 
(11), but the kcat increases ~6-fold with acetyl-CoA in 
the reaction to become comparable with the LlPC kcat value. Thus, LlPC appears to be in 
constitutively activated state, even without the presence of acetyl-CoA. 
3.4 Crystal structure of LlPC in complex with c-di-AMP  
Next, the crystal structure LlPC in complex with c-di-AMP at was determined at 2.3 Å resolution 
(Fig. 4A). There is one LlPC tetramer in the asymmetric unit of the crystal, consistent with the 
gel filtration analysis of LlPC and with previously determined PC crystal structures of R. etli PC 
(RePC) (14), S. aureus PC (SaPC) (13), and LmPC (10). The c-di-AMP ligand is bound at the 
expected solvent-exposed region at the CT dimer interface, confirming that c-di-AMP binds to 
LlPC in the same location as LmPC. There are two c-di-AMP molecules identically bound to 
both CT dimers in the LlPC tetramer (Fig. 4B). Unlike the LmPC-c-di-AMP structure which had 
a citrate molecule bound in the acetyl-CoA binding pocket, the acetyl-CoA binding pocket is 
empty in the LlPC structure. The B-domains of three of the BC domains are ordered in the 
crystal structure and in a closed conformation. An ADP molecule coordinating an Mg
2+
 ion is 
found in each of the four BC active sites. The LlPC tetramer is similar in overall structure to 
other PC enzymes, with two monomers in top and bottom layers of the tetramer. Contacts 
between monomers are mediated primarily by the BC and CT dimers, which are located at 
opposite corners of the square-shaped tetramer. All four BCCP domains are well-ordered in the 




Figure 4. L. lactis pyruvate carboxylase in complex with c-di-AMP. Schematic drawing of the LlPC 
structure at 2.3 Å resolution in complex with 2 c-di-AMP molecules (black spheres). Monomer 1 is 
colored according to the key at the bottom, the other three monomers are colored magenta, cyan, and 
yellow. The metal ion (M
2+
) is shown as a gray sphere. The ADP molecules are shown as black sticks. 
The lysine residue (K1103) on the BCCP domain, to which biotin is attached, is shown in stick 
representation. The biotin is disordered.  
 
3.4.1 BCCP assignments in the LlPC-c-di-AMP structure and implications for PC catalysis  
In contrast to the LmPC structure, the LlPC PT-BCCP linkers are clearly visible (Fig. 5A), 




Figure 5. LlPC BCCP assignments (A) Omit Fo-Fc density for the LlPC PT-BCCP linker (residues 
1050-1061) at 2.3 Å resolution, contoured at 3σ. (B) Close-up view of the PT-BCCP linkers for 
Monomer1 and Monomer 2. (C) Close-up view of the BC domain of Monomer 1 and the BCCP domain 
of Monomer 3. The asterisk (*) indicates the location of the BC active site.   
The BCCP domains are swapped between monomers in the same layer of the tetramer, with each 
BCCP making extensive contacts with the PT domain of the opposite monomer. This BCCP-PT 
interface has previously not been observed in PC crystal structures, although the BCCP has been 
found in a similar location in SaPC cryo-EM structures (15, 16). The BCCP domain comes into 
close proximity with the BC domain of the opposite monomer (BCCP from Monomer 2 to the 
BC of Monomer 1), and the BCCP K1103 residue to which the biotin is attached is located 20 Å 
from the BC active site, suggesting that it is primed to enter the BC active site (Fig. 5C). The 
biotin moiety itself is projected into solution and is disordered in this structure. This mechanism 
in which the BCCP visits the BC active site of the opposing monomer and then visits the CT 
active site of its own monomer (Fig. 6A), is opposite from that deduced from the structures of 
RePC and SaPC (Fig. 6B) (13, 14). 
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The unusual location of the BCCP domain in the LlPC-c-di-AMP structure prompted a 
reevaluation of the BCCP assignments in the LmPC-c-di-AMP complex structure. In that 
structure, the BCCP was assigned per the accepted view of PC catalysis in which the BCCP 
visits the BC of its own monomer, and then visits the CT of the opposite monomer. However, if 
the BCCP in the LmPC-c-di-AMP structure was assigned differently, the BCCP would then be 
near the CT active site of its own monomer. This would be consistent with the scheme shown in 
Figure 6A. If the original LmPC-c-di-AMP BCCP assignments were correct, however, a scheme 
in which the BCCP undergoes both BC and CT reactions in the opposite monomer is also 
consistent with the structural evidence.  
 
 
Figure 6. Possible movements of the BCCP domain during PC catalysis (A) Cartoon schematic of PC 
catalysis in which the BCCP visits the BC active site of the opposite monomer, and then moves (gray 
arrow) to the CT active site of the its own monomer. The color scheme is the same as in Figure 4. The PT 
domains form dimers, as in the free SaPC and LlPC structures (see Section 3.6). (B) Cartoon schematic of 
PC catalysis in which the BCCP visits the BC active site of its own monomer, and then moves (gray 
arrow) to the CT active site of the opposite monomer. 
3.4.2 Comparisons of the c-di-AMP complex structures of LlPC and LmPC  
A comparison of the LlPC-c-di-AMP complex and the LmPC-c-di-AMP complex structures 
reveal large changes in the overall tetramer conformation (Fig. 7A). When a CT dimer for each 
tetramer is overlaid, the other domains do not align well. In particular, the LlPC-c-di-AMP 
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tetramer has CT dimers that are further apart, such that the overall dimensions of the tetramer are 
slightly larger than LmPC-c-di-AMP.  
 
Figure 7. Comparison of the LlPC and LmPC structures in complex with c-di-AMP. (A) Overlay of 
the LlPC-c-di-AMP complex (colored the same as Figure 4), and the LmPC-c-di-AMP complex (gray). 
The CT dimer of Monomer 1 and Monomer 4 is overlaid, to see the conformational differences in the 
other domains. (B) An overlay by the CT domain of one monomer from the LlPC-c-di-AMP complex 
(colored the same as Monomer 1 in Fig. 4) and LmPC-c-di-AMP complex (gray). Because the 
connectivity of the BCCP domain is ambiguous in the LmPC structure, both possible connections are 
shown.  
There is also conformational difference between individual monomers from each structure (r.m.s. 
distance of 1.5 Å between equivalent Cα atoms). When the CT domain from an LlPC and LmPC 
monomer are overlaid, there is a significant difference in the position of the BC domain (Fig. 
7B). This change in the conformation of the monomer contributes to the large differences 
observed in the overall tetramer structures. The largest difference between the LlPC and LmPC 
monomers are in the position of the BCCP domain. Both possible BCCP connectivities are 
displayed for the LmPC monomer. One possibility is that the different positions in the BCCP 
domain represent different stages in the catalytic cycle. The differences in the overall tetramer 
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conformation may also reflect the dynamics of the tetramer during different stages of catalysis. It 
is also possible that the structure of the LmPC and LlPC enzymes are intrinsically different. This 
interpretation may be supported by the fact that LmPC is activated by acetyl-CoA while LlPC is 
insensitive. In addition, there is a citrate molecule bound in the acetyl-CoA binding region of 
LmPC, which could also affect the structure, while this region is empty in the LlPC tetramer. 
3.4.3 Analysis of c-di-AMP binding to LlPC  
There is clear electron density for two c-di-AMP molecules bound to the LlPC tetramer (Fig. 
8A). As in LmPC, the two-fold axis of the c-di-AMP molecule aligns with that of the LlPC CT 
dimer, and two alpha-helices from each of the CT monomers form the binding pocket (Fig. 8B). 
 
 
Figure 8. The c-di-AMP binding pocket in LlPC. (A) Omit Fo-Fc density for one of the c-di-AMP 
molecules bound to LlPC at 2.3 Å resolution, contoured at 3σ. Two views are shown. (B) Detailed 
interactions between c-di-AMP (cdA) and LlPC. Hydrogen-bonding interactions are shown as red dashes. 




However, the recognition of c-di-AMP is significantly different between LmPC and LlPC, due to 
the extensive substitutions in the binding pocket (Fig. 9A, 9B). Similar to LmPC, the side chain 
of the Tyr715 residue in LlPC (LmPC Y722) makes face-to-face π-stacking interactions with the 
adenine base. The LmPC Tyr749 residue, which makes a hydrogen bond with the terminal 
oxygen of the c-di-AMP phosphate group, is replaced in LlPC by an Ile742 residue, which loses 
this hydrogen bond but still forms the base of the binding pocket. The hydrogen bond to the c-di-
AMP phosphate group is instead contributed by the Ser745 residue (LmPC A752) of the opposite 
CT monomer. An additional hydrogen bond to the c-di-AMP phosphate group is contributed by 
Gln749 (LmPC Ser756). The different conformations of the c-di-AMP molecules in LmPC and 
LlPC may be due to the terminal oxygen of the phosphate group interacting with opposite 
monomers. C-di-AMP bound to LlPC is also buried deeper into the binding pocket (Fig. 9A), 
due to the extra space provided by the Tyr749 -> Ile742 and Ala753 -> Gly746 substitutions 
compared to LmPC.  
The LlPC and LmPC structures indicate that c-di-AMP can be recognized even without strict 
conservation of the binding pocket. The divergent amino acids interacting with c-di-AMP result 
in distinct conformations of the compound to fit the particular shape of the binding pocket. Like 
in LmPC, the adenine does not appear to be recognized specifically by LlPC, so how the 
specificity for c-di-AMP over c-di-GMP is achieved remains unclear. These structures suggest 
that the minimum requirements for c-di-AMP binding to PC include an aromatic residue to π-
stack with the adenine, and small residues (serine, alanine, glycine) at positions 745-746 (752-
753 in LmPC) in order for c-di-AMP to gain access to the pocket. These rules can be used to 
identify other bacterial PCs which are regulated by c-di-AMP. The LmPC and LlPC structures 
demonstrate that even divergent residues in the binding pocket can recognize c-di-AMP, and 





Figure 9. Comparison of the LlPC and LmPC c-di-AMP binding pocket. (A) An overlay of the CT 
dimer between the LlPC (colors) and LmPC (gray) c-di-AMP complex structures. The c-di-AMP bound 
to LlPC is shown in black, while the c-di-AMP bound to LmPC is shown in gray. The non-carbon atoms 
in the LlPC structure have bright colors while they have faded colors in the LmPC structure. The residues 
for Monomer 1 only are labeled with the LlPC residue on top (black), and the LmPC residue on the 
bottom (gray). Hydrogen-bonding interactions are shown with a dashed red line. (B) Sequence alignment 
of the c-di-AMP binding pocket from selected PC homologues. The residues which interact with the c-di-
AMP are highlighted in red. The numbering is according to LmPC.  
In contrast to c-di-AMP bound to LmPC, which adopts a U-shaped conformation where the 
adenines are in neither a syn nor anti conformation, the c-di-AMP bound to LlPC is found in a 
more extended conformation, in which the adenines adopt a more anti orientation (Fig. 9A).  
3.4.4 Mutational analysis of the LlPC c-di-AMP binding pocket 
To confirm the functional importance of this binding site, we made a Y715T mutation (in 
accordance with human PC). This mutant was expressed and purified using the same protocol as 
66 
 
the wild-type protein. In LmPC, the equivalent mutation (Y722T) resulted in a more than 50% 
loss in baseline catalytic activity. However, the LlPC Y715T mutant had the same baseline 
catalytic activity as the wild-type enzyme (Fig. 10A). As expected, the Y715T mutation 
abolished inhibition by c-di-AMP, confirming the functional importance of the c-di-AMP 
binding site identified in the crystal structure (Fig. 10B). 
 
 
Figure 10. Enzymatic assays for LlPC mutants. (A) Enzymatic activity for wild-type LlPC and the 
Y715T and G746A mutants with and without 100 μM c-di-AMP. The reactions were performed with 20 
mM pyruvate. The error bars represent the standard deviation from three independent reactions. (B) The 
percentage inhibition by c-di-AMP calculated from (A).   
 
We also made a G746A mutation (in accordance with EfPC), as the alanine side-chain would 
clash with the c-di-AMP ribose in the structure (2.2 Å distance). This mutant also had 
approximately the same baseline catalytic activity as wild-type. However, the inhibition by c-di-
AMP is 37%, significantly less than the 63% inhibition of the wild-type enzyme (Fig. 10A, 10B). 
To further understand the effect of this mutation, we determined the crystal structure of the 
LlPC-G746A mutant in complex with c-di-AMP at 2.0 Å resolution. The overall tetrameric 
structure of the G746A mutant is essentially identical to the wild-type protein. There are only 
minor perturbations of the c-di-AMP in order to avoid steric clashes with the Ala746 side-chain 
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(Fig. 11). This LlPC G746A mutant may closely approximate the binding mode of c-di-AMP to 
EfPC, as the only difference is that Gln756 in LlPC is replaced by lysine in EfPC.     
 
Figure 11. The LlPC G746A mutant c-di-AMP binding. Overlay of wild-type LlPC-c-di-AMP (colors) 
and the G746A mutant bound to c-di-AMP (gray). The G746A mutation is labeled in red. The other side-
chains in the binding pocket which interact with c-di-AMP are also shown   
 
3.5 Crystal structure of apo LlPC 
We then determined the apo LlPC structure in the absence of c-di-AMP at 3.1 Å resolution. All 
four BCCP domains were disordered in this structure, although one ordered biotin is observed in 
the exo site, as identified in the SaPC structure (13). Three of the BC B-domains are disordered, 
while one B-domain is in an open configuration with an empty active site. Remarkably, the 
overall structure of apo LlPC is quite different than the c-di-AMP complex (Fig. 12A). The BC 
dimers are farther apart in the apo tetramer, while the CT dimers move closer, such that the apo 




Figure 12. Comparisons of the apo LlPC tetramer. (A) Overlay of the LlPC-c-di-AMP complex 
(colors) and apo LlPC (gray). The BC dimer of Monomer 1 and 3 was overlaid. The BCCP domains for 
LlPC-c-di-AMP have been removed for clarity. (B) Overlay of apo LlPC (colors) and SaPC in complex 
with CoA (gray). The BC dimer of Monomer 1 and 3 was overlaid.  
The most apparent consequence of these conformational changes is that the PT domains in the 
apo LlPC structure dimerize, as in the SaPC structure. The dimerization interface is composed 
primarily by hydrophobic interactions between two F1036 residues. The corresponding residue 
in SaPC and HsPC has previously been found to be critical for maintaining the tetramer in 
solution (13). On the other hand, the PT domains do not interact in the LlPC c-di-AMP complex 
structure. In the RePC or LmPC structures, the PT domains also do not dimerize, suggesting 
there could be two distinct subsets of PC enzymes. 
After comparing the apo LlPC tetramer to all of the available PC crystal structures, the most 
similar structure was found to be the SaPC structure in complex with CoA (Fig. 12B) (17). The 
apo LlPC is more similar overall to the SaPC-CoA complex structure than the apo SaPC 
structure. Moreover, the BC dimer in the apo LlPC structure is more similar to the BC dimer in 
the SaPC-CoA structure (0.86 Å r.m.s.d over Cα atoms), than to the SaPC-apo structure (1.57 Å 
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r.m.s.d over Cα atoms). Thus, the LlPC BC dimer adopts a conformation as if acetyl-CoA was 
bound, even without the presence of the acetyl-CoA ligand. The BC dimer for the apo and c-di-
AMP LlPC structures are similar (0.55 Å r.m.s.d over Cα atoms), indicating that c-di-AMP does 
not affect the BC dimer conformation. This was also the case for the apo and c-di-AMP bound 
LmPC structures.    
As is the case for LmPC-c-di-AMP, the four monomers of LlPC-c-di-AMP are highly 
symmetrical when compared by overlaying the CT domains (Fig. 13A). However, LlPC-c-di-
AMP is slightly more asymmetrical than LmPC-c-di-AMP, particularly in respect to the BCCP 
domains. In contrast to apo LmPC, which is highly asymmetrical, apo LlPC is more symmetrical 
in line with the SaPC structures with and without CoA bound (Fig. 13B). This indicates that PCs 
with widely divergent apo structures can recognize and bind c-di-AMP.       
 
 
Figure 13. Comparing the four monomers composing the tetramer. (A) Overlay of the four 
monomers in the c-di-AMP bound LlPC tetramer. The CT domains are overlaid, in order to see the 
differences in the positions of the other domains. The c-di-AMP (cdA) is shown as black spheres. (B) 
Overlay by the CT domain of the four monomers in the apo LlPC tetramer.  
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3.5.1 Binding of c-di-AMP causes a conformational change in the CT dimer 
A major conformational change of the CT dimer is observed between the apo LlPC and c-di-
AMP structures. In fact, the CT dimer from the LlPC-c-di-AMP structure is more similar to the 
CT dimer from LmPC-c-di-AMP (0.89 Å r.m.s.d over Cα atoms when the entire dimer is 
overlaid) (Fig. 14A) than the CT dimer from the apo LlPC structure (1.47 Å r.m.s.d over Cα 
atoms when the entire dimer is overlaid) (Fig. 14B). This indicates that c-di-AMP binding results 
in a distinct CT dimer conformation. These conformational changes could contribute to the 
inhibition by c-di-AMP. It has been suggested that changes in the BC dimer conformation 
resulting from acetyl-CoA binding may affect the BC reaction rate, possibly through long-range 
communication between active sites in the BC dimer (17). Such a mechanism could also be 
possible in the case of c-di-AMP inhibition of the CT reaction rate.   
 
Figure 14. Conformational changes in the CT dimer upon c-di-AMP binding (A) Overlay of the CT 
dimer from LlPC-c-di-AMP (colors) and LmPC-c-di-AMP (gray). Only Monomer 1 is overlaid, in order 
to see the difference in conformation of Monomer 4 (red arrow). (B) Overlay of the CT dimer from LlPC-
c-di-AMP (colors) and apo LlPC (gray). Only Monomer 1 is overlaid, in order to see the difference in 
conformation of Monomer 4 (red arrow).  
In addition to the general conformational changes in the CT dimer, there is a significant change 
in the shape of the the c-di-AMP binding pocket between the apo and c-di-AMP bound structures 
(Fig. 15A). In particular, the side chains of Q749 and Q712 occlude the binding pocket in the apo 




Figure 15. Local changes in the c-di-AMP binding pocket. (A) Overlay of one CT dimer from LlPC-c-
di-AMP (colors) and apo LlPC (gray). The entire CT dimer is overlaid. Residues that interact with c-di-
AMP are shown as sticks. (B) Molecular surface view of the c-di-AMP binding pocket in LlPC. (C) 
Molecular surface of apo LlPC with the c-di-AMP modelled in. The binding pocket is occluded prior to c-
di-AMP binding.  
Even with the differences in how LmPC and LlPC recognize c-di-AMP, in both cases the c-di-
AMP appears to act as a sort of molecular wedge, in which the CT monomers are pushed apart to 
adopt a particular “c-di-AMP-bound” CT dimer conformation. This change in the shape of the 
CT dimer extends to a dramatic change in the overall tetramer conformation in both LmPC and 
LlPC. Either the local change in the CT dimer conformation, or the global change in the tetramer 
could contribute to the inhibitory effect upon c-di-AMP binding. It has been proposed that 
acetyl-CoA activates PC activity by changing the BC dimer to a more active conformation. 
Although the BC active sites are far apart, there may be long-range communication between 
them in the BC dimer (17). Such an allosteric mechanism could also be possible in the case of 
the “c-di-AMP-bound” CT conformation, although how this structural change would result in the 
72 
 
inhibition of the CT active site is not clear. The other possibility is that the overall tetramer 
conformation induced by c-di-AMP may restrict movement of the BCCP between the active 
sites, or its access to the active sites.  
3.6 Investigating the molecular basis for LlPC insensitivity to acetyl-CoA activation 
LlPC appears to be unique among single-chain PC enzymes as it is completely insensitive to 
activation by acetyl-CoA (Fig. 3B). The similarity of the free LlPC structure to the SaPC-CoA 
complex (Fig. 12B) gave rise to the possibility that there are specific sequence variants in LlPC 
that cause it to adopt this activated tetramer conformation. Comparing the SaPC-CoA complex to 
the free SaPC structure, it was observed that CoA binding causes an increase in the interface 
formed between the BC domain and the PT domain of the monomer in the other layer (Fig. 16A, 
16B).  
 
Figure 16. The BC-PT interface is affected by CoA binding (A) Overlay of the BC domain (Mon 3) 
from apo LlPC (cyan), apo SaPC (black), and SaPC-CoA (gray). The shift in the position of the PT 
domain (Mon 3) of the apo SaPC structure is shown (red arrows) relative to the PT domains of SaPC-
CoA and apo LlPC (orange). The position of the bound CoA (gray) is shown.  (B) The surface area burial 
was calculated for the BC-PT interface for each of the four monomers in the tetramer (error bars represent 
the standard deviation). The surface area burial was determined by the PISA server (18).  
This interface between the BC and PT domains is also the location of acetyl-CoA binding (Fig. 
16A). The PT domain of free SaPC would clash with acetyl-CoA, thus these conformational 
differences between free and CoA-bound SaPC are caused directly by acetyl-CoA binding. In the 
free LlPC structure, this BC-PT interface also shows increased surface area burial, as compared 
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to free SaPC or LmPC (Fig. 16B). Sequence analysis among various PC homologues in this 
interface revealed several residues in both the BC and PT domains that appear to be unique to 
LlPC (Fig. 17A), and which help to form contacts between the domains in the structure (Fig. 
17B). Two residues in the PT domain (K1006, S1018) are unique to LlPC among the sequences 
analyzed, while the two residues in the BC domain (E36, Y37) are also found in EfPC. 
 
Figure 17. Sequence variants at the BC-PT interface in LlPC are responsible for its insensitivity to 
acetyl-CoA. (A) Sequence alignment from various PC homologues with residues at the BC-PT interface. 
The residues identified which are unique to LlPC are highlighted in cyan for LlPC, and yellow for other 
homologues. (B) Interactions at the BC-PT interface in the apo LlPC structure. Residues in red were 
targeted for mutagenesis. (C) Acetyl-CoA titration for the LlPC quadruple mutant (E36K, Y37S, 
K1006T, S1018I). Ka indicates the activation constant, n indicates the Hill coefficient.  
By comparison, the residues at the BC dimer interface are well-conserved between LlPC and 
other PC homologues. A quadruple mutant LlPC protein was designed to disrupt the BC-PT 
interface, in which these four residues were mutated to their equivalent residue in SaPC (E36K, 
Y37S, K1006T, S1018I). This mutant LlPC exhibited a four-fold decrease in the kcat compared to 
wild-type, suggesting that the mutations have disrupted the BC-PT interface and forced LlPC 
74 
 
into a less active conformation. Moreover, the mutant LlPC is now activated by acetyl-CoA by 
~2-fold, with a Ka of ~ 10 µM (Fig. 17C). In comparison, SaPC is activated ~6-fold by acetyl-
CoA, with a Ka of 2 µM. Thus, these mutations cause the enzyme to become sensitive to acetyl-
CoA, implicating this BC-PT interface as an important regulatory site for enzymatic activity and 
allosteric activation by acetyl-CoA.   
This BC-PT interface may be important in forming a particular BC dimer conformation, 
affecting the BC reaction rate. Alternatively, this interface may be important in the proper 
positioning of the BC domain for optimal access by the BCCP domain. Regulation by c-di-AMP 
appears to be the main control mechanism for LlPC activity, but LlPC still has an intact acetyl-
CoA binding pocket and is activated by acetyl-CoA to a small degree when it is in an inhibited 
state bound to c-di-AMP. Thus, LlPC appears to be regulated in opposing directions by both c-
di-AMP and acetyl-CoA, similar to what was found for LmPC.  
3.7 Function of c-di-AMP regulation of PC in Lactococcus lactis 
Similar to L. monocytogenes, L. lactis lacks an α-ketoglutarate dehydrogenase and has a 
truncated TCA cycle. The oxaloacetate generated by PC can be diverted into three pathways, 1) 
the oxidative pathway leading to α-ketoglutarate, 2) the reductive pathway leading to succinate, 
and 3) the biosynthesis of aspartate through aspartate aminotransferase (19). However, unlike L. 
monocytogenes, L. lactis lacks the glutamate dehydrogenase enzyme to convert α-ketoglutarate 
to glutamate, and glutamate cannot be produced de novo. In addition, the upstream enzyme 
isocitrate dehydrogenase which converts isocitrate to α-ketoglutarate has been found to be non-
functional (20), although its activity has been detected in other L. lactis strains(19). Thus, 
compared to L. monocytogenes in which production of glutamate is one of the main functions of 
PC activity, this oxidative pathway appears to be less important in L. lactis.  
Instead, the primary function of PC activity in L. lactis appears to be aspartate biosynthesis, 
which is a precursor for several other amino acids, as well as purine and pyrimidine biosynthesis. 
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A slow milk coagulation phenotype (Fmc
-
) in L. lactis was found to be caused by a deficiency in 
PC, and this defect could be rescued by supplementing the growth medium with aspartate-
containing peptides (21). In addition, the single aspartate aminotransferase in L. lactis, which 
converts oxaloacetate to aspartate, is essential for growth in minimal media (22).  
These characteristics of L. lactis suggest that the unique biochemical properties of LlPC have 
been adapted for the particular growth requirements of the bacterium. Acetyl-CoA regulation of 
PC functions to couple the levels of acetyl-CoA in the cell and the production of oxaloacetate by 
PC, such that citrate synthase can efficiently convert acetyl-CoA and oxaloacetate to citrate. This 
metabolic pathway appears to be less important in L. lactis, while the conversion of oxaloacetate 
to aspartate is prioritized. Thus, the regulation of LlPC by acetyl-CoA may no longer be needed 
in the L. lactis metabolic network. In addition, LlPC has a much higher kcat value than previously 
studied PC enzymes, suggesting that very high levels of PC activity are needed to sustain 
bacterial growth. Regulation by c-di-AMP appears to be the main control for LlPC activity, but 
the precise functional consequences of a loss in this regulation have yet to be elucidated.    
3.8 Conclusion and future directions 
After the initial identification of PC regulation by c-di-AMP in Listeria monocytogenes, we have 
extended this mode of regulation to two additional bacterial species: Enterococcus faecalis and 
Lactococcus lactis. The crystal structure of LlPC in complex with c-di-AMP confirmed the 
binding site found in L. monocytogenes PC (LmPC), while also revealing a strikingly different 
binding mode due to the low sequence conservation in the binding pocket. Both LlPC and LmPC 
have large conformational changes upon c-di-AMP binding, particularly in the CT dimer 
conformation. The similarity between LlPC and LmPC in the conformation of the c-di-AMP-
bound CT dimer provides insights into the mechanism of inhibition. Further structural studies, 
possibly utilizing other techniques such as cryo-EM, may provide additional insights into how c-
di-AMP binding affects the conformation and dynamics of these PC enzymes.  
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A remaining open question is how the specificity for c-di-AMP over c-di-GMP is determined. In 
both structures, the adenine base of c-di-AMP is not specifically recognized by the protein. In 
addition, the c-di-AMP binding pocket is occluded in the apo enzymes, and must open to 
accommodate c-di-AMP binding. Further studies using molecular dynamics simulation may 
provide more insights into the specificity of cyclic-di-nucleotide recognition, along with the 
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Structural studies of the c-di-AMP binding protein PstA 
4.1 Introduction 
The screen for c-di-AMP binding proteins in Listeria monocytogenes performed by the 
Woodward Lab identified the previously uncharacterized protein lmo2692. Lmo2692 contains a 
DUF970 domain, which is predicted to be structurally homologous to the PII proteins. Thus, 
lmo2692 was named PstA (PII-like signal transduction protein A). The PII proteins are 
widespread in bacteria and are often involved in nitrogen regulation (1). Although PstA is 
predicted to have a similar structure to the PII proteins, LmPstA only has 16% and 20% sequence 
identity with the Escherichia coli PII proteins GlnK and GlnB, respectively. A search of the 
sequence database revealed that PstA proteins are found only in the Gram-positive Firmicutes 
phylum, while it is absent in the Actinobacteria and Gram-negative bacterial species. Among the 
Firmicutes, PstA proteins are widely distributed and highly conserved (Fig. 1). C-di-AMP 
signaling is particularly prevalent and well-studied in the Firmicutes, further suggesting that c-di-
AMP signaling through PstA may be of functional importance   
PII proteins are able to bind and sense levels of ATP, ADP and 2-oxoglutarate levels in the cell, 
and in response bind various regulatory targets such as the ammonium channel AmtB (2). Many 
crystal structures of PII proteins have been determined, and the binding pocket for ADP/ATP has 
been particularly well-characterized (3–5). Unlike the PII proteins, PstA binds specifically to c-
di-AMP and cannot bind to ATP or ADP (6). Because the overall structure of PstA is predicted 
to be highly similar to the PII proteins, the molecular basis for this selectivity is unknown. 
Therefore, we wished to determine the structure of LmPstA in complex with c-di-AMP, in order 
to understand this specificity, and provide clues into the function of LmPstA in the cell, which is 




Figure 1. Conservation of PstA proteins in a collection of bacterial species. Sequence alignment of 
PstA from L. monocytogenes (Lm), Staphylococcus aureus (Sa), Halobacillus halophilus (Hh), Bacillus 
subtilis (Bs), Enterococcus faecalis (Ef), Lactobacillus brevis (Lb), Clostridium botulinum (Cb), and 
Thermoanaerobacterium thermosaccharolyticum (Tt). The secondary structure elements are indicated at 
the top of the alignment. Conserved residues are indicated in red. Residues that interact with c-di-AMP 
are colored cyan (monomer 1) or yellow (monomer 2). The T-loop is indicated by the orange bar. The B-
loop is indicated by the green bar. Figure made with ESPript (7).  
4.2 Experimental Procedures 
Protein expression and purification. The PstA gene (lmo2692) in L. monocytogenes was sub-
cloned into a pET20b vector with a C-terminal His-tag (obtained from the Woodward Lab). This 
construct was transformed into BL21(DE3) Rosetta cells. The cells were cultured in LB medium 
with 35 mg/L kanamycin and 35 mg/L chloramphenicol and were induced for 14 hours with 1 
mM IPTG at 20°C. The protein was purified through nickel-agarose affinity chromatography 
followed by gel filtration chromatography (S-300, GE Healthcare). The purified protein was 
concentrated to 20 mg/mL in a buffer containing 20 mM Tris (pH 8.0), 150 mM NaCl, 5% (v/v) 
glycerol, and 5 mM DTT, flash-frozen in liquid nitrogen and stored at –80°C. The C-terminal 





Protein crystallization. LmPstA crystals were grown by the sitting-drop vapor diffusion method 
at 20°C. For the c-di-AMP complex, the protein at 20 mg/mL was incubated with 2.5 mM c-di-
AMP for 30 min at 4°C before setup. The reservoir solution contained 12% (w/v) PEG3350 and 
0.1 M sodium malonate (pH 4.0). The crystals appeared within 1–2 weeks. The crystals were 
cryoprotected in the reservoir solution supplemented with 15% (v/v) glycerol and were flash-
frozen in liquid nitrogen for data collection at 100 K. For the apo LmPstA structure, the protein 
at 10 mg/mL was mixed with a reservoir solution containing 20% (w/v) PEG3350, 0.1 M bis-
Tris (pH 5.5), and 0.1 M ammonium acetate. The crystals appeared within 1 week and grew to 
full size within a few more days. They were cryoprotected in the reservoir solution supplemented 
with 10% (v/v) glycerol and flash-frozen in liquid nitrogen. 
 
Data collection and structure determination. All X-ray diffraction data were collected at the 
X29 beamline at the National Synchrotron Light Source (NSLS) at Brookhaven National 
Laboratory. The diffraction images were processed using HKL2000 (8). The structures were 
solved using the molecular replacement method with the program Phaser (9), using a PstA 
homolog from Pediococcus pentosaceus (PDB code 3M05) as the search model. Manual 
rebuilding was carried out in Coot (10) and refinement was done with the program Refmac (11). 
















Space Group P1 P212121 
Cell dimensions 
a, b, c (Å) 







55.9, 61.6, 83.5 






Rmerge (%) 9.0 (41.6) 6.1 (51.3) 
I/σI 15.8 (3.1) 22.4 (3.3) 
Redundancy 3.9 (3.8) 4.7 (4.8) 
Completeness 97 (95) 99 (100) 
Rwork (%) 15.7 (24.6) 22.4 (33.1) 













R.m.s deviation bond 
lengths (Å) 
0.015 0.011 
R.m.s deviation bond 
angles (°) 
1.7 1.4 
PDB Accession Code 4RWW 4RWX 
1
Values in parentheses refers to the highest resolution shell 
 
4.3 Crystal structure of LmPstA and comparison with PII proteins
1
 
Binding studies performed by the Woodward lab confirmed that lmo2692 directly and 
specifically binds c-di-AMP with a Kd of 1.4 μM, determined through DRaCALA (differential 
radial capillary action of ligand assay). LmPstA was co-crystallized with c-di-AMP and the 
structure was determined at 1.6 Å resolution using the molecular replacement method (Fig. 2). In 
addition, an apo structure of LmPstA without c-di-AMP was determined at 2.9 Å resolution. 
There is a single trimer of LmPstA in the asymmetric unit of both crystal forms. LmPstA 
migrated as a trimer on gel filtration analysis. PII proteins also have a trimeric structure.   
                                                          
1




Figure 2. Crystal Structure of LmPstA in complex with c-di-AMP at 1.6 Å resolution. Schematic 
drawing of the LmPstA homotrimer in complex with three c-di-AMP molecules. The three monomers are 
colored separately and the c-di-AMP molecules are labeled.  
The structure of the LmPstA monomer is largely similar to that of a PII nitrogen regulatory 
protein from Mycobacterium tuberculosis (Mtb PII, PDB code 3LF0) (3). The structure of Mtb PII 
is representative of the canonical PII family, and will thus be used to compare with LmPstA. The 
LmPstA monomer is composed of a four-stranded anti-parallel β-sheet, packed against two α-
helices on one face of the β-sheet. A fifth β-strand is contributed by a neighboring monomer in 
the LmPstA trimer, forming a five-stranded β-sheet (Fig. 3A). The LmPstA monomer has a 






Figure 3. Comparing the LmPstA monomer with the Mtb PII monomer. (A) Structure of a LmPstA 
monomer (cyan) in complex with c-di-AMP (black). The secondary structure elements and loops are 
labeled. The B-loops from the two other monomers are shown in yellow and magenta. (B) Structure of a 
PII monomer from Mycobacterium tuberculosis (green) in complex with ATP (black). 
 
However, the LmPstA and Mtb PII monomers also have several loop regions which have notable 
differences between the two structures. These loop regions are of importance because they help 
form the binding pocket for the ATP or c-di-AMP ligand. For clarity, the naming convention of 
these loops will be kept consistent with that used for PII proteins. In Mtb PII, the T-loop (residues 
36-55) consists of a 20-residue flexible extension between strands β2 and β3 (Fig. 3B). The B-
loop (residues 82-87) is shorter and connects α2 and β4. Lastly, there is a C-loop at the C-
terminus of the monomer. In LmPstA, however, the B-loop and T-loop are swapped such that it 
is now the B-loop (residues 65-94) that has the longer 30-residue extension while the T-loop 
(residues 35-38) is much shorter (Fig. 3A). Moreover, LmPstA does not have a C-loop. The B-
loop forms a twisted two-stranded β-sheet (residues 67-71 and 89-93) connected by a long 
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looping turn (residues 72-88). The LmPstA B-loop is significantly longer in length than the Mtb 
PII T-loop. The Mtb PII T-loop extends out from the main body of the trimer, and has been found 
to be involved in mediating protein-protein interactions (2). The LmPstA B-loop could play a 
similar functional role.  
 
Upon examination of the LmPstA trimer, the three individual monomers are almost identical in 
structure (r.m.s distance of 0.3 Å for their Cα atoms). However, the long B-loop does have 
variations between the three monomers, suggesting that it is flexible in solution (Fig. 3A). The 
B-loops mediate most of the crystal contacts with neighboring trimers, which likely contribute to 
the observed conformations. Only one of the B-loops is fully ordered in the crystal structure, 
while the other two B-loops had some disordered regions.  
 
In the LmPstA trimer, the β-sheets from the three individual monomers form a compact 
hydrophobic core, while the α-helices are situated at the periphery (Fig. 2). The overall 
architecture of the LmPstA trimer is similar to that of Mtb PII, with an r.m.s. distance of 0.9 Å for 
their Cα atoms when the trimers are overlaid without the loop regions. 
 
4.4 The LmPstA c-di-AMP binding pocket 
 
Figure 4. Electron density for c-di-AMP bound to LmPstA. (A) Omit Fo–Fc electron density for c-di-
AMP at 1.6 Å resolution, contoured at 3σ. The first and second nucleotides are labeled. The second 
nucleotide is in the syn conformation. (B) Omit Fo–Fc electron density for c-di-AMP at 1.6 Å resolution, 




There is strong electron density for three c-di-AMP molecules bound to the LmPstA homotrimer 
(Fig. 4A, 4B). For clarity, each nucleotide of the c-di-AMP will be referred to as the first or 
second nucleotide (as shown in Fig. 4).  All three c-di-AMP molecules have the first adenine 
base in an anti conformation. Two of the c-di-AMP molecules have the second adenine base in a 
syn conformation (Fig. 4A), while the other c-di-AMP has the second adenine base in an anti 
conformation (Fig. 4B). The reason for these differences is not clear.  
 
. 
Figure 5. Binding region for c-di-AMP in LmPstA and comparison to Mtb PII binding mode of 
ATP. (A) The overall organization of the LmPstA c-di-AMP binding pocket at the interface of Monomer 
1 and Monomer 2. The first and second nucleotide of c-di-AMP are labeled. The loops and secondary 
structure elements are indicated. (B) The overall organization of the Mtb PII ATP binding pocket. 
 
The three c-di-AMP molecules are bound to symmetrically equivalent locations on the LmPstA 
homotrimer (Fig. 2), located in the inter-subunit cleft between β1-β4, and the T/B-loops of one 
monomer (Monomer 1 in Fig. 5A) and α1, β2-β3, and β5 of a neighboring monomer (Monomer 
2 in Fig. 5A). The binding region for c-di-AMP in LmPstA is equivalent to that for ATP in Mtb 
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PII (Fig. 5B), and the first nucleotide of c-di-AMP is recognized in an almost identical manner as 
ATP.  
 
Figure 6. Binding mode of c-di-AMP to LmPstA. Detailed interactions between LmPstA and c-di-
AMP. Hydrogen-bonding interactions are indicated with dashed lines (in black). Water molecules are 
shown as red spheres. 
 
The adenine base of the first nucleotide of c-di-AMP is recognized specifically by LmPstA, 
through hydrogen-bonds between its N1 and N6 atoms with the main-chain amide and carbonyl 
of Gly47 (β3 of Monomer 2) (Fig. 6). The adenine base is packed on one face with the side-chain 
of Phe99 (β4 of Monomer 1), and the Gly26-Ala27 amide bond of the β2 strand of Monomer 2. 
The side-chain of Thr28 makes a hydrogen-bond with the N3 atom of adenine, as well as a 
hydrogen-bond with the 2’ OH of the ribose. The side-chain of Asn41 (β3 of Monomer 1) also 
makes a hydrogen-bond with the ribose 2’ OH.  The phosphate group of the first c-di-AMP 
nucleotide is hydrogen-bonded to the side chain His108 (β5 of Monomer 2) and the main-chain 
amide of Gly94 (B-loop of Monomer 1). The phosphate group also forms a water-mediated 




In contrast, the recognition of the second nucleotide of the c-di-AMP molecule is mediated by 
unique structural features in LmPstA in comparison to Mtb PII, which are due primarily to the 
significant structural differences in the loop regions. The extended T-loop of Mtb PII would clash 
with the adenine of the second nucleotide of c-di-AMP, while the extended B-loop of LmPstA 
would clash with the β- and -phosphates of the ATP molecule. Instead, the T-loop in PstA 
forms a shorter, more structured loop with a conserved 34-GGFL-37 sequence in the turn (Fig. 1, 
Fig. 6). The main-chain amides of Gly35, Phe36 and Leu37 have hydrogen-bonding interactions 
with the phosphate group of this second nucleotide. The side chain of Phe36 is π-stacked against 
one face of the adenine, while its other face is exposed to the solvent. In contrast with the first 
adenine base, this second adenine base does not make any specific interactions with LmPstA. 
The structures of PstA from Staphylococcus aureus and Bacillus subtilis have also been 
determined by other groups (12, 13). In these PstA homologues, the second adenine is not 
exposed to solvent on one face, but is instead stacked against an arginine side-chain, forming a 
cation-π interaction. This Arg26 is present in most PstA homologues (Fig. 1), while in LmPstA it 
is instead substituted by a glycine residue, suggesting that it is not essential for c-di-AMP 
binding.  
 
In the Mtb PII structure, the B-loop and C-loop are important for anchoring the triphosphate 
moiety of ATP (Fig. 5B). The B-loop contains a highly conserved Walker A-like sequence motif 
(TGxxGDGKI) which interacts with the ATP triphosphate, and the C-loop also has several 
arginine residues which interacts with the ATP triphosphate (1). In sharp contrast, LmPstA lacks 
the C-loop entirely, and the longer B-loop does not contain the Walker A-like sequence motif 
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that is found in ATP-binding proteins. As a result, the PstA binding site cannot accommodate the 
β- and -phosphates of ATP, which explains the specificity for c-di-AMP binding over ATP.  
 
Figure 7. Binding assays for LmPstA mutants. DRaCALA binding titration of c-di-AMP using 
32
P-c-
di-AMP for wild-type LmPstA and mutants to disrupt c-di-AMP binding. See Appendix B for methods.  
 
 
In order to confirm the LmPstA c-di-AMP binding pocket, several mutations were made and 
tested by our collaborators in the Woodward Lab. Using a direct binding assay (DRaCALA), 
they found that the Phe36 residue when mutated to alanine significantly decreased binding 
affinity to c-di-AMP, increasing the Kd from 1.4 μM to 7 μM. The Asn41 when mutated to 
alanine abrogated binding to an even larger degree, such that little binding of c-di-AMP was 
observed. These binding experiments confirm that the c-di-AMP binding site observed in the 
crystal structure is the true binding site in solution.  
 
4.5 Structural changes in LmPstA upon c-di-AMP binding 
We solved the crystal structure of the apo form of LmPstA at 2.9 Å resolution. The core trimer 
structure of apo LmPstA is almost identical to the c-di-AMP bound structure, with an r.m.s 
distance of 0.6 A for their Cα atoms when they are overlaid (Fig. 8A). However, there is a 






Figure 8. Conformational changes of LmPstA upon c-di-AMP binding. (A) Overlay of c-di-AMP 
bound and apo forms of the LmPstA trimer. (B) Overlay of an LmPstA monomer with c-di-AMP bound 
(cyan) and in the apo (gray) form. The red arrow highlights the conformational changes of the B-loop 
upon c-di-AMP binding. (C) Overlay of an LmPstA monomer with c-di-AMP bound (cyan) and a 
monomer of the apo form of P. pentosaceus PstA (gray).  
 
In the apo LmPstA structure, the T-loop from residues 33-39 is largely disordered and could not 
be built into the model, indicating that the T-loop is flexible in the absence of c-di-AMP binding. 
This is in sharp contrast to the c-di-AMP complex structure, in which the T-loop is well-ordered 
and makes extensive contacts with the c-di-AMP ligand. The long B-loop undergoes an even 
more dramatic conformational change, in which it rotates 45° in to make contacts with c-di-AMP 
(Fig. 8B). The B-loop kinks at the flexible 94-GGA-96 position in order to make this 
conformation change. Several interactions between LmPstA and c-di-AMP mediate the 
movement of the B-loop upon ligand binding. The main chain nitrogen of Gly94 forms a 
hydrogen-bond with the phosphate of the first nucleotide of c-di-AMP, while the main chain 
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carbonyl of Gln92 forms a hydrogen-bond with the 2’ OH of the ribose of the second nucleotide 
(Fig. 6).  
 
The C-terminal His-tag of the apo PstA structure forms β-sheet interactions with the B-loop, 
possibly affecting its conformation. Thus, we also compared the c-di-AMP bound PstA with the 
apo form of a PstA homologue from P. pentosaceus which was crystallized with an N-terminal 
His-tag (PDB code 3M05). The same conformational change in the B-loop is seen between these 
structures (Fig. 8C), and because the B-loops are more ordered in the P. pentosaceus PstA 
structure, the conformational change that occurs upon c-di-AMP binding is better illustrated.    
 
4.6 Sequence conservation in PstA of c-di-AMP binding residues 
Sequence analysis with the ConSurf server (14) shows that the residues identified in LmPstA as 
being important for c-di-AMP recognition are highly conserved among the PstA protein family 
(Fig. 9A), while the rest of the PstA protein is less conserved (Fig. 9B). Significantly, the 34-
GGFL-37 sequence motif in the T-loop, which is critical for interactions with the second 
nucleotide of c-di-AMP, is highly conserved among PstA homologues. In addition, the 94-GGA-
96 sequence at the B-loop kink which allows for the loop to move towards c-di-AMP is also 
universally conserved. The bottom of the PstA trimer also has high sequence conservation, as 
this region likely plays a role in the structural integrity of the trimer (Fig. 9C). Notably, the 
extended B-loop in PstA has only weak sequence conservation. This is in contrast to the T-loop 
of PII proteins which has been found to be important for mediating protein-protein interactions. 
Notably, Tyr51 on the T-loop of PII proteins is strictly conserved and is known be modified by 
reversible uridylylation or adenylation in some bacterial species (1). The uridyl-modification of 
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Tyr51 has been shown to disrupt the T-loop mediated interaction of the PII protein GlnK with the 
ammonium channel AmtB (2). In contrast, two tyrosine residues are located on the B-loop of 
PstA but have only weak (~70%) sequence conservation among PstA homologues (Fig. 1A). 
Furthermore, L. monocytogenes does not contain a homolog of the E. coli uridylyl-transferase. 
Thus, it appears that the B-loop of PstA is not modified like the T-loop of PII proteins, although 
the overall role of the B-loop in possibly mediating protein-protein interactions is still unclear.   
 
Figure 9. Sequence conservation of LmPstA overall and in the c-di-AMP binding site. (A) Molecular 
surface view of the sequence conservation of the LmPstA c-di-AMP binding site, generated based on an 
alignment of 150 sequences by the program ConSurf (14). Purple indicates conserved residues, cyan 
indicates variable residues, and white indicates average conservation. The c-di-AMP molecule and Phe36 
residues are labeled. (B) Top view of the LmPstA trimer showing sequence conservation. (C) Bottom 
view of the LmPstA trimer showing sequence conservation. 
 
4.7 Insights into the evolutionary origins of the PstA family 
The core structure of PII and PstA are remarkably similar (r.m.s distance 0.9 Å for the Cα atoms) 
despite only ~15-20% sequence identity. In addition, the recognition of the equivalent adenine of 
c-di-AMP and ATP are almost identical in PstA and PII proteins. The structures differ in the loop 
regions which are less important for the overall structural integrity of the trimer but are critical 
for defining the ligand binding site. Thus, it is likely that PstA and PII arose from a common 
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protein ancestor, and diverged through evolutionary changes in these loop regions.  Based on 
these observations, we conclude that PstA is related to the larger PII protein superfamily, but has 
diverged through evolution to specifically recognize the bacterial second messenger c-di-AMP. 
Therefore, PstA is structurally and functionally distinct from the canonical PII proteins and 
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Structural studies of the c-di-AMP-binding CBS domain proteins CbpA and 
OpuC 
5.1 Introduction 
CBS domains are 60 residue tandem pair motifs that are conserved in all species from bacteria to 
humans (1). In humans, CBS domains are found in proteins with a diverse array of functions 
including cystathionine-β-synthase (from which CBS domains are named), inosine 5′-
monophosphate dehydrogenase, chloride channels, and AMP-activated protein kinase (AMPK) 
(2). CBS domains exhibit a remarkable degree of sequence heterogeneity, but the domain 
structure is strictly conserved. Each CBS domain consists of two α-helices packed against three 
β-strands, forming a βαββα secondary structure motif (3). CBS domains invariably are found as 
tandem repeats. Two tandem CBS domains form a tightly-packed dimeric structure called a 
Bateman domain, and two Bateman domains form a conserved disc-like CBS dimer, usually with 
a cavity or ligand binding pocket in the center of the disc at the dimer interface. The interface 
between CBS domain pairs forms a pocket which binds adenosine-containing nucleotides such as 
ATP and AMP (4). Crystal structures of CBS-domain containing proteins reveal the formation of 
both head-to-head and head-to-tail CBS dimer (4). Mutations in this binding pocket are 
responsible for the human diseases homocystinuria, retinitis pigmentosa, idiopathic generalized 
epilepsy, and Wolff-Parkinson-White syndrome (5). CBS domains in humans are usually 
associated with catalytic domains and play a regulatory role, such as in AMPK where they act as 
a metabolic sensor for AMP/ATP levels in the cell and modulate the activity of the kinase 
domain (6). The function of CBS domains found in prokaryotes is less clearly defined.  
In the chemical proteomics screen performed by the Woodward Lab, two proteins predicted to 
have CBS domains were identified in Listeria monocytogenes. These proteins were named CbpA 
and CbpB (CBS-domain binding protein A or B). CbpA and CbpB have little sequence identity 
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between them, and in fact the many proteins annotated as having CBS domains in L. 
monocytogenes have highly divergent sequences. CbpB is a 150 residue protein which is a stand-
alone CBS domain. This protein will not be discussed here further.  CbpA has a CBS domain at 
the N-terminus and an extra ~90 residue C-terminal region which is predicted to be an ACT 
domain, adopting a ferredoxin-like fold (7) (Fig. 1A). LmCbpA was confirmed by the 
Woodward Lab to directly and specifically bind c-di-AMP with a Kd of < 10 μM.  Structural 
investigations into CbpA, including how it recognizes and interacts with c-di-AMP, may reveal 
novel functions for this protein in bacterial physiology and may provide additional clues on the 
utilization of c-di-AMP signaling in the cell. 
5.2 Experimental Procedures 
Protein expression and purification. L. monocytogenes full-length CbpA (lmo0553) and 
OpuCA (lmo1428) residues 247-371 were subcloned into a pET28a vector with an N-terminal 
His-tag. The constructs were then transformed into BL21 Star (DE3) cells. The cells were 
cultured in LB medium with 35 mg/L kanamycin and were induced for 14 h at 20 °C with 1 mM 
IPTG. A selenomethionine-derivative of CbpA was expressed using a methionine-auxotroph E. 
coli BL21 strain, supplemented with selenomethionine in the medium.  The protein was purified 
through nickel-agarose affinity chromatography followed by gel filtration chromatography (S-
300, GE Healthcare). The purified protein was concentrated to 30 mg/mL in a buffer containing 
20 mM Tris (pH 8.0), 250 mM NaCl, 5% (v/v) glycerol, and 5 mM dithiothreitol, flash-frozen in 
liquid nitrogen and stored at −80 °C. The N-terminal hexa-histidine tag was not removed for 
crystallization.  
 
Protein crystallization. LmCbpA-c-di-AMP complex crystals were grown by the sitting-drop 
vapor diffusion method at 20°C. The protein at 15 mg/mL was first incubated with 2.5 mM c-di-
AMP for 30 minutes, and then mixed with reservoir solution containing 23% PEG 3350 (w/v), 
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0.2M Calcium acetate. The crystals were cryo-protected with 12% (v/v) glycerol and flash-
frozen in liquid nitrogen for data collection at 100 K.  
LmCbpA apo crystals were grown by the sitting-drop vapor diffusion method at 20°C. The 
protein at 16 mg/mL was mixed with reservoir solution containing 1.4 M ammonium sulfate, 
0.1M sodium citrate (pH 5). The crystals were cryo-protected with 20% (v/v) glycerol and flash-
frozen in liquid nitrogen for data collection at 100 K. 
LmOpuC-247-371 crystals were grown by the sitting-drop vapor diffusion method at 20°C. The 
protein at 3 mg/mL was mixed with reservoir solution containing 3% (w/v) PEG 20,000, 0.1M 
Bicine (pH 9.0), and 2% 1,4-dioxane (v/v). The crystals appeared within a few days. The crystals 
were then soaked overnight in the reservoir solution supplemented with 4 mM of c-di-AMP and 
25% (v/v) ethylene glycol. The crystals were then flash-frozen in liquid nitrogen for data 
collection at 100 K.  
Data collection and structure determination. X-ray diffraction data for LmCbpA was 
collected on the X29 beamline at the National Synchrotron Light Source. X-ray diffraction data 
for LmOpuCA was collected on a Saturn944HG CCD mounted on a Rigaku Micromax-003 X-
ray generator.  All diffraction images were processed using HKL2000 (8). The program 
Phenix.Xtriage was used to determine that there is pseudotranslational symmetry (Peak height 
64%) present in the LmOpuCA crystal (9). The structure of LmCbpA was solved using the 
single-wavelength anomalous dispersion (SAD) method with selenomethionine-derivatized 
crystals, using the program Phenix (9). The structure of LmOpuCA was solved using molecular 
replacement with Phaser (10), using the CBSX1 domain from Arabidopsis thaliana (PDB code 
4GQV) as the search model. Manual rebuilding was carried out in Coot (11) and refinement was 










Space Group P3121 P21 P21 
Cell dimensions 
  a, b, c (Å) 
  α, β, γ (°) 
 
87.8, 87.8, 107.2 
90, 90, 120 
 
37.2, 70.6, 88.7 
90, 99.8, 90 
 
52.3, 43.9, 68.8 








Rmerge (%) 5.5 (43.4) 9.7 (37.3) 11.5 (33.0) 
I/σI 32.9 (5.2) 10.3 (2.6) 8.1 (2.2) 
Redundancy 8.1 (8.1) 2.9 (2.7) 2.5 (2.0) 
Completeness 100 (100) 97 (97) 97 (89) 
Rwork (%) 16.7 (19.8) 24.1 (31.5) 26.6 (32.5) 
Rfree (%) 20.2 (24.7) 28.1 (38.6) 32.3 (37.1) 
Average B-factors 
  Protein 
  Ligand/ion 













R.m.s deviation bond 
lengths (Å) 
0.014 0.011 0.013 
R.m.s deviation bond 
angles (°) 
1.6 1.5 1.7 
PDB Accession Code – – 5KS7 
  1Values in parentheses refers to the highest resolution shell 
  
5.3 Crystal Structure of LmCbpA in complex with c-di-AMP 
The crystal structure of LmCbpA in complex with c-di-AMP was determined at 1.6 Å resolution 
(Fig. 1B) through the single-wavelength anomalous dispersion (SAD) method using 
selenomethionine-derivative crystals. The asymmetric unit contains one CbpA dimer. The 
Bateman domain (formed from CBS1 and CBS2 domains) from each monomer forms a head-to-
head disc-like dimer. This CBS domain dimer is similar to previously determined structures of 
CBS-domain containing proteins. There are two c-di-AMP molecules bound in the central cavity, 
at equivalent positions in the dimer. As predicted, the C-terminal ACT domain of LmCbpA 
adopts a ferredoxin fold (βαββαβ), and also forms a dimer, making a structure consisting of an 8-
stranded β-sheet packed against four α-helices. The CBS dimer sits atop the β-sheet of the ACT 
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dimer, forming an extensive interface. The CBS and ACT domains are diagonally swapped in the 
structure, such that the Bateman domain of Monomer 1 packs against the ACT domain of 
Monomer 2 (Fig. 1B).   
 
Figure 1. Crystal structure of LmCbpA in complex with c-di-AMP. (A) Domain organization of 
LmCbpA. (B) Schematic drawing of the LmCbpA dimer, bound to two c-di-AMP (cdA) molecules. The 
CBS and ACT domains are labeled.   
 
The c-di-AMP is bound in a solvent-exposed cavity at the dimer interface of the CBS domains 
(Fig. 2). The adenine of the first nucleotide (labeled as 1 in Fig. 2) is buried into the inter-subunit 
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cleft of the Bateman domain, between the CBS1 and CBS2 domains of a monomer. This adenine 
makes extensive interactions with the protein and is recognized specifically, while the adenine of 
the second nucleotide (labeled as 2 in Fig. 2) makes very few direct interactions with the protein 
although it comes into close proximity with an α-helix from the opposite monomer.  
 
 
Figure 2. The LmCbpA c-di-AMP binding site. Detailed interactions between LmCbpA and c-di-AMP. 
The first and second nucleotides of c-di-AMP are labeled. Hydrogen-bonding interactions are shown as a 
dashed line (red). Water molecules are shown as spheres (red).    
The N6 atom of the first adenine makes a hydrogen bond with the carbonyl oxygen of Asn12, 
and the N1 atom forms a hydrogen bond with the main-chain nitrogen of Thr14. The first 
adenine is stacked between the side-chains of Tyr34 on one face, and the side-chains of Ile8, 
Leu13, Tyr99, and Ile112 on the other face. The ribose 2’hydroxyl of the first nucleotide forms a 
hydrogen-bond with the main-chain carbonyl oxygen of Cys36. The phosphate group of the first 
nucleotide is recognized by a water-mediated hydrogen bond with Thr114, and through a 
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hydrogen bond with the main-chain nitrogen of G116. The phosphate group of the second 
nucleotide forms a hydrogen-bond with Arg35 and the main-chain nitrogen of Tyr34.  
The unusual binding mode of c-di-AMP in which only one of the adenines interacts with the 
protein gives rise to the possibility that c-di-AMP may not be the endogenous ligand for CbpA. 
However, the Woodward lab found that ATP or AMP are not able to compete off c-di-AMP 
from the binding site. In addition, c-di-AMP binds with high affinity to CbpA, with a Kd of 10 
μM, which is within the physiological concentration for c-di-AMP in bacteria. Thus, c-di-AMP 
is likely the endogenous ligand for CbpA, but other adenine-containing nucleotides cannot be 
excluded as possible ligands.  
5.4 Crystal Structure of apo LmCbpA and comparisons with the c-di-AMP complex 
The apo crystal structure of LmCbpA without c-di-AMP was determined at 2.5 Å resolution. 
This structure shows dramatic conformational differences from the c-di-AMP bound LmCbpA 
structure. When one monomer of the CBS dimer (Fig. 3A, Monomer 2) is overlaid, there is a 
rotation by 10° in the position of the second monomer (Fig. 3B, Monomer 1). In addition, the 





Figure 3: Conformational changes induced by c-di-AMP binding. (A) The Bateman domain of 
Monomer 2 between the apo and c-di-AMP bound LmCbpA is overlaid, in order to visualize the changes 
in the position of the other Bateman domain in the CBS dimer, as well as the change in the position of the 
ACT domain. This view is from the front. (B) Same overlay as Fig. 3A, but viewed from the side. The 
conformational changes in the CBS domain of Monomer 1 and the ACT domain of Monomer 2 are shown 
by the red arrow 
 
In the apo LmCbpA structure, the side-chain of Arg35 forms a salt bridge with the side-chain of 
Glu96 in the other monomer. In the c-di-AMP complex structure, Arg35 interacts with the 
phosphate group of c-di-AMP. This gave rise to the possibility that c-di-AMP binding breaks this 
salt bridge, giving rise to the conformation changes observed. Thus, we hypothesized that 
mutating the Arg35 residue would result in “c-di-AMP-bound” conformation of LmCbpA, even 
in the absence of c-di-AMP. In order to interrogate this hypothesis, a R35A mutation of 
LmCbpA was made, and the crystal structure without c-di-AMP bound was determined at 2.7 Å 
resolution. This R35A structure was essentially the same as the wild-type apo LmCbpA structure 
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(0.74 Å r.m.s distance over 393 Cα atoms) (Fig. 4). Thus, the Arg35-Glu96 salt-bridge does not 
appear to be involved in the conformation changes upon c-di-AMP binding.   
 
 
Figure 4. The Arg35-Glu96 salt bridge in LmCbpA. (A) The interaction between Arg35 and Glu96. 
Monomer 1 is colored in cyan, while Monomer 2 is colored yellow. The side-chains are shown in stick 
representation. (B) Overlay of the apo LmCbpA structure (colors) and the apo LmCbpA R35A structure 
(gray). The Arg35-Glu96 salt bridge in the wild-type structure is shown.  
The crystal structure of the R35A LmCbpA mutant in complex with c-di-AMP was also 
determined at 2.2 Å resolution. The c-di-AMP was bound identically to this mutant as to the 
wild-type structure, demonstrating that the Arg35 residue is dispensable for c-di-AMP binding.  
 
5.5 Possible functions of CbpA in bacteria 
CbpA is well-conserved among Gram-positive bacteria, but its function is not yet known. The 
ACT domain is often involved in DNA-binding and several ACT-domain containing proteins are 
transcription factors (7), so CbpA could be involved in a similar gene regulatory role. In 
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addition, CbpA could be involved in protein-protein interactions, through the CBS domain 
and/or ACT domains. There are dramatic conformational rearrangements both in the CBS dimer 
and the ACT dimer upon c-di-AMP binding, suggesting a possible link between c-di-AMP 
binding in the CBS domain and the DNA or protein binding capability of LmCbpA. Further 
investigations will be needed to define the role of CbpA in bacterial physiology.  




Figure 5. The effect of c-di-AMP levels on osmotic stress tolerance in L. monocytogenes. (A) The 
wild-type, cΔdacA, and ΔpdeA ΔpgpH L. monocytogenes strains were tested for growth in BHI broth 
with increasing concentrations of NaCl. Growth at 0% NaCl is set at 100. (B) The same strains were 
tested for growth with increased concentrations of sorbitol. See Appendix C for methods.  
In order to further understand the function of c-di-AMP in L. monocytogenes, our collaborators 
at the Woodward lab discovered that c-di-AMP levels in the cell are inversely correlated with 
resistance to osmotic stress. The cΔdacA strain, which is depleted of c-di-AMP levels, had 
increased survival with increasing salt stress. On the other hand, the ΔpdeA ΔpgpH strain 
(phosphodiesterase double knock-out), which has high levels of c-di-AMP had decreased 
resistance. Further experiments showed that the ΔpdeA ΔpgpH strain was impaired in carnitine 
transport, implicating c-di-AMP as an inhibitor of carnitine transport. 
 
                                                          
1




Figure 6. LmOpuCA is a c-di-AMP binding protein. (A) Domain arrangement of LmOpuCA. (B) 
DRaCALA binding assay for LmOpuCA with c-di-AMP. (C) DrACALA binding assay for the isolated 
CBS domain from LmOpuCA with c-di-AMP. (D) Thermal shift assay for the isolated CBS domain from 
LmOpuCA with c-di-AMP.   
The previous identification of CbpA and CbpB as c-di-AMP binding proteins in L. 
monocytogenes implicated the multi-component OpuC system, which includes a CBS domain, as 
a possible molecular target of c-di-AMP affecting carnitine transport. The OpuC system consists 
of four proteins: OpuCA, OpuCB, OpuCC and OpuCD. The subunits OpuCB and OpuCD make 
up the transmembrane permease, OpuCC is an extracellular substrate binding protein, and 
OpuCA is the cytoplasmic subunit (13). The domain arrangement of OpuCA consists of an N-
terminal ATP-binding cassette (ABC) linked to a C-terminal CBS domain (Fig. 6A). The 
Woodward lab used a DRaCALA assay to confirm c-di-AMP binding to OpuCA from L. 
monocytogenes (LmOpuCA), as well as to the isolated LmOpuCA CBS domain, which had 
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lower affinity than the full-length protein (Fig. 6B, 6C). The binding was specific to c-di-AMP 
over other nucleotides. LmOpuCA CBS domain binding to c-di-AMP was also confirmed 
through a thermal shift assay with an upshift in the Tm of ~10 °C (Fig. 6D).  
5.7 Crystal structure of LmOpuCA in complex with c-di-AMP 
The sequence identity between the CBS domains of LmOpuCA and LmCbpA is only 21 %, so 
the binding mode of c-di-AMP to LmOpuCA may be different than for LmCbpA. In addition, 
LmOpuCA was not identified in the original screen for c-di-AMP binding proteins in L. 
monocytogenes. In order to better understand the regulation of the OpuC system by c-di-AMP, 
we attempted to obtain the crystal structure of LmOpuCA in complex with c-di-AMP. However, 
the full-length LmOpuCA protein was not soluble when expressed in Escherichia coli. Next, the 
N-terminal ATP-binding cassette domain was removed, and only residues 247-397 containing 
the CBS domain was attempted. This fragment also failed to crystallize. An analysis of the 
LmOpuCA protein by the program Psipred showed that the last ~30 residues were predicted to 
not have any secondary structure. Thus, the next fragment to be attempted was from residues 
247-371, which only encapsulated the CBS domain. From this new fragment, very small crystals 
were obtained, but which diffracted very poorly. However, upon soaking these crystals with c-di-
AMP, the crystals showed better diffraction. The crystal exhibited pseudo-translational 
symmetry with a peak height of 64% relative to the Patterson origin peak. This resulted in 
somewhat higher R factors and some abnormalities in the density map, but the structure was able 




Figure 7. Crystal structure of LmOpuCA in complex with c-di-AMP. (A) Schematic of the 
LmOpuCA dimer in complex with c-di-AMP. The CBS1 and CBS2 sub-domains, along with the N and 
C-termini are labeled. (B) Omit Fo-Fc density map for c-di-AMP bound to LmOpuCA, contoured at 3σ.    
We solved the structure of LmOpuCA tandem CBS domains (residues 247-371, Fig. 7A) at 2.9 
Å resolution using the molecular replacement method with the CBSX1 protein structure from 
Arabidopsis thaliana as the search model (14) (PDB entry code: 4GQV, sequence identity 24%). 
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There is a dimer of LmOpuCA in the asymmetric unit. Like other CBS-domain protein, 
LmOpuCA forms a disc-like head-to-tail CBS domain dimer, with a large central cavity.  
Based on the crystallographic analysis, there was clear electron density for one c-di-AMP 
molecule bound to the LmOpuCA dimer (Fig. 7B). The c-di-AMP binding pocket is located in a 
solvent-exposed, electropositive pocket in the center of the dimer. The two-fold symmetry axis 
of the c-di-AMP is aligned with that of the dimer, such that each half of the c-di-AMP makes 
identical interactions with each monomer. This is similar to the binding mode of c-di-AMP to the 
CT dimer of LmPC (pyruvate carboxylase), in which the ligand is also aligned with the two-fold 
symmetry axis of that dimer (15).  The c-di-AMP binding mode to LmOpuCA is strikingly 
different than in LmCbpA, which has two c-di-AMP molecules bound to the dimer. Moreover, 
the c-di-AMP bound to LmCbpA adopts a U-shaped conformation, while the c-di-AMP bound to 
LmOpuCA adopts a flat, fully extended conformation, which appears to be unique among known 






Figure 8. The LmOpuCA c-di-AMP binding pocket. Detailed interactions LmOpuCA and the c-di-
AMP. Hydrogen-bonding interactions are shown with red dashes.   
The c-di-AMP compound bridges the two LmOpuCA monomers, and makes symmetrical 
interactions with each (Fig. 8). The adenine bases are buried deep into the binding pocket, 
packed between the side chains of Tyr342 and Ile355 on one face, and Val260 and Val280 on the 
other. The adenines are specifically recognized by the protein through hydrogen bonds between 
its N1 and N6 atoms to the main chain amide and carbonyl of Val280. In addition, the N7 atom 
of adenine makes a hydrogen bond with the side chain hydroxyl of Thr282. The phosphate group 
of c-di-AMP makes two hydrogen bonds to the main chain amide of Arg358 and Ala359, which 
are located at the N-terminal end of the last helix of the CBS domain. The residues in the c-di-
AMP binding pocket are well conserved among OpuCA homologues, suggesting that c-di-AMP 




Figure 9. Sequence conservation of the OpuCA c-di-AMP binding pocket. The LmOpuCA c-di-AMP 
binding site is shown in molecular surface representation. Purple indicates highly conserved residues, 
cyan indicates weakly conserved residues, and white indicates intermediate conservation. The figure was 
produced using the Consurf server (16).  
 
5.8 Comparisons of the CBS dimers of LmCbpA and LmOpuCA 
The CBS dimer conformation of LmOpuCA in complex with c-di-AMP is significantly different 
than that of LmCbpA-c-di-AMP. LmOpuCA forms a head-to-tail CBS dimer, while LmCbpA 
forms a head-to-head CBS dimer. Thus, the two-fold symmetry axis is absent in LmCbpA, and 
the c-di-AMP cannot “bridge” the two monomers as in the LmOpuCA complex. These structural 
differences become clear when Monomer 1 is overlaid between the two CBS dimers, giving rise 
to a significant difference in the position of Monomer 2 (Fig. 10A, 10B).  In addition, the 
recognition of c-di-AMP is different between the two proteins, with the N6 atom of the c-di-
AMP adenine bound to LmOpuCA pointing toward the interior of the pocket, while the c-di-
AMP adenine bound to LmCbpA is pointing towards solvent (Fig. 10C). These differences in the 
c-di-AMP recognition mode between these two structures likely reflect their low sequence 
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identity in the c-di-AMP binding region, as well as the large differences in the overall structure 
of the CBS dimer.  
 
  
Figure 10. Comparison between LmOpuCA and LmCbpA. (A) Front view of the overlay of Monomer 
1 of the CBS domain of LmOpuCA (colors) and LmCbpA (gray). The differences in the position of 
Monomer 2 are seen. The ACT domain of LmCbpA has been omitted for clarity. The c-di-AMP bound to 
LmOpuCA (black) and one of the c-di-AMP bound to LmCbpA (gray) are shown as sticks. (B) Same as 
(A) but from the side view, in order to better see the positional changes in Monomer 2. (C) Close-up view 




The OpuCA CBS domain crystal structure from Staphylococcus aureus has also been determined 
by a different group (17). The structure of SaOpuCA does not have c-di-AMP bound, and 
appears to be monomeric in the crystal. It is possible that c-di-AMP binding may promote dimer 
formation. Through mutational analysis of SaOpuCA, this group also concluded that c-di-AMP 
binds in the cleft identified in the LmOpuCA structure.  
5.9 Future directions for the studies of c-di-AMP signaling in bacteria 
In the studies described in Chapters 2-5, the Woodward lab has identified several proteins in the 
bacterium L. monocytogenes which bind c-di-AMP, and we have determined their structures in 
complex with the ligand. However, the functional roles of these proteins in L. monocytogenes, as 
well as in the many other bacteria which utilize c-di-AMP, are less well understood. The 
metabolic enzyme pyruvate carboxylase is broadly conserved in the bacterial kingdom, and its 
conservation overlaps well with the distribution of c-di-AMP signaling. However, in our studies, 
we discovered that the c-di-AMP regulation of PC is limited to only a subset of these bacterial 
species including L. monocytogenes, Lactococcus lactis, and Enterococcus faecalis. Further 
studies would almost certainly reveal the existence of this regulation in other bacterial species as 
well. More investigations will be needed to understand the physiological role of c-di-AMP 
regulation of PC, and if or how this function is fulfilled by other regulatory systems in the 
bacterial species that do not have this mode of regulation. 
The example of PC demonstrates that c-di-AMP may have unique protein targets in different 
bacterial species. Thus, proteomic screens to identify c-di-AMP binding proteins in other 
bacterial species are needed. In the original screen of L. monocytogenes performed by the 
Woodward lab, OpuC was not one of the proteins identified. The structure of OpuCA in complex 
with c-di-AMP reveals that both adenines of c-di-AMP are buried deep into the binding pocket 
of the protein. Because the original screen performed by the Woodward lab used sepharose beads 
covalently linked to c-di-AMP through the N6 atom, proteins to which c-di-AMP binds in which 
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neither adenine base of c-di-AMP is exposed to solvent, would not be pulled-down in this screen. 
All crystal structures of proteins identified in the original L. monocytogenes screen, including 
PC, PstA and CbpA, have one or both adenines of the c-di-AMP ligand exposed to solvent. The 
screen that was carried out in Staphylococcus aureus employed a similar protocol (18). Thus, the 
example of OpuC indicates that a different screening strategy, such as labeling the ribose 2’OH, 
will be needed to fully capture the c-di-AMP interactome in each bacterial species.  
Unlike PC, the c-di-AMP-mediated regulation of the proteins PstA, CbpA, and OpuC are broadly 
conserved in bacteria. While OpuC is known to be involved in osmoregulation, PstA and CbpA 
have poorly defined functions. However, due to their broad distribution among bacterial species, 
along with the specific conservation of their c-di-AMP binding sites, these proteins likely have 
important physiological roles. One of the main outstanding questions regarding c-di-AMP is why 
it is essential in many bacterial species. A better understanding of the functions of PstA, CbpA, 
and OpuC may provide insights into this question. In addition, many questions about the basic 
physiology of c-di-AMP, such as the environmental cues which signal for its synthesis and 
degradation, remain unanswered. A precise measurement of intracellular c-di-AMP levels in 
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Structural studies of the two-subunit pyruvate carboxylase 
6.1 Introduction 
Since the discovery of pyruvate carboxylase in the 1960s, it was appreciated that there exists two 
distinct classes of the enzyme, distinguished by their sensitivity to the allosteric activator acetyl-
CoA. The PC enzymes studied from chicken, sheep, and yeast were all activated by acetyl-CoA, 
by varying degrees. On the other hand, PC enzymes from the bacteria Pseudomonas citronellolis 
and Azotobacter vinelandii showed no activation by acetyl-CoA (1, 2). Further studies showed 
that these two classes were distinguished not only by their biochemical properties, but in their 
overall structures (1). The class of PCs activated by acetyl-CoA has all domains (BC, CT, and 
BCCP) residing on a single polypeptide chain, which assemble into a homo-tetramer in solution 
(Fig. 1A). This class is termed the single-chain, or α4 PCs (3). All eukaryotes, including humans, 
and most prokaryotes have a PC of this class. The second class of PCs, which are insensitive to 
acetyl-CoA, were found to consist of two separate polypeptide chains that form a complex in 
solution. This class is referred to as the two-subunit PCs, with the BC domain on the α subunit, 
and the CT and BCCP domains on the β subunit (Fig. 1B). The two-subunit PCs were generally 
accepted to have a composition of α4β4, such that they have the same number of BC, CT, and 
BCCP domains as the α4 PCs. The evidence for this composition came primarily from analysis of 
migration on a gel filtration column and analysis on SDS-PAGE gels (1). The two-subunit PCs 
are found in many Gram-negative bacteria, particularly in the phylum of gammaproteobacteria, 
along with all archaeal species.  
With the determination of the structures of several α4 PC structures in recent years, the atomic 
details of PC catalysis have been revealed in unprecedented detail. It has been assumed that the 
two-subunit PCs would have a similar architecture to that of the α4 PCs. To confirm this 




Figure 1. Domain Organization of PC enzymes. (A) Domain organization of Staphylococcus 
aureus PC, a single-chain, homo-tetrameric PC (α4). (B) Domain organization of 
Methylobacillus flagellatus PC, a two-subunit PC, thought to have an α4β4 composition.  
 
There have been few structural studies of two-subunit PCs. The BC domain dimer of the two-
subunit PC from Aquifex aeolicus (AaPC) has been determined at 2.0 Å resolution (4). This BC 
dimer adopts a conformation that is similar to previously determined PC structures. The C-
terminal end of the AaPC BC domain was disordered and was not modelled in the structure. In 
this study, the authors attempted to crystallize the full complex, but the complex appears to have 
dissociated during the crystallization procedure. Kondo et al. suggested that the crystallization 
conditions (20% PEG 8000 and pH 8) may have led to the dissociation of the α and β subunits, 
and that the complex may be weakly held together in solution.  
6.2 Experimental Procedures 
Protein expression and purification. The pyruvate carboxylase genes from various bacterial 
species were amplified from genomic DNA (ATCC) and sub-cloned into the pCDFduet vector 
(Novagen). All expression constructs were co-transformed into BL21 Star (DE3) cells along with 
a plasmid encoding the E. coli biotin ligase (BirA) gene. The cells were cultured in LB medium 
with 50 mg/ml streptomycin and 35 mg/ml chloramphenicol and were induced for 14 hours with 
1 mM IPTG at 20 °C. Prior to induction, 20 mg/L biotin and 10 mM MnCl2 were added to the 
growth medium. The protein was purified through nickel-agarose affinity chromatography 
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(Qiagen) followed by gel filtration chromatography (Sephacryl S-300, GE Healthcare). The 
purified protein was concentrated to 15 mg/ml in a buffer containing 20 mM Tris (pH 8.0), 150 
mM NaCl, 5% (v/v) glycerol, and 5 mM DTT, flash-frozen in liquid nitrogen and stored at –80 
°C. The protein was confirmed to be fully biotinylated by a streptavidin gel-shift assay. The N-
terminal His-tag was not removed before crystallization. 
Mutagenesis and kinetic studies. Mutants were made using the QuikChange kit (Stratagene) 
and confirmed by sequencing. They were expressed and purified using the same protocol as 
described for the wild-type enzyme. The catalytic activity was determined based on a published 
protocol (5), which couples oxaloacetate production to the oxidation of NADH by malate 
dehydrogenase, followed spectrophotometrically by the decrease in absorbance at 340 nm. The 
activity was measured at room temperature in a reaction mixture containing 20 mM Tris (pH 
7.5), 200 mM NaCl, 5 mM MgCl2, 50 mM sodium bicarbonate, 50 mM ammonium sulfate, 5 
units of malate dehydrogenase (Sigma), 2 mM ATP, 54 nM MfPC (based on the α2β4 complex), 
and varying concentrations of pyruvate. 
Protein crystallization. Crystals were grown by the sitting-drop vapor diffusion method at 20 
°C. For MfPC with the B-domain deletion and SER mutations, the protein was incubated with 
2.5 mM pyruvate for 30 min at 4 °C before crystallization setup. The reservoir solution contained 
19% (w/v) PEG3350, 2% tacsimate (pH 6.0) (Hampton), and 3% (v/v) ethanol. The crystals 
appeared within 1 week and grew to full-size after an additional week. The crystals were cryo-
protected in the reservoir solution supplemented with 10% (v/v) ethylene glycol and 5% (w/v) 
sucrose and were flash-frozen in liquid nitrogen for data collection at 100 K. For wild-type 
MfPC, the protein at 15 mg/ml was incubated with 2.5 mM ATP and 2.5 mM pyruvate for 30 
min at 4 °C before crystallization setup. The reservoir solution contained 1.3 M ammonium 
sulfate and 0.1 M sodium citrate (pH 6.0). The crystals appeared after 1 day and grew to full-size 
within a week. They were cryo-protected in the reservoir solution supplemented with 15% (v/v) 
ethylene glycol and flash-frozen in liquid nitrogen for data collection at 100 K.  
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Analytical ultracentrifugation. Analytical ultracentrifugation (AUC) was performed by the 
Chou Lab on an XL-A analytical ultracentrifuge (Beckman Coulter) using an An-50 Ti rotor. 
The sedimentation velocity experiments were carried out using a double-sector epon charcoal-
filled centerpiece at 20 
o
C with a rotor speed of 42,000 rpm. Protein solutions of 0.5 mg/ml (330 
μl) and reference (370 μl) solutions, both containing 20 mM Tris (pH 8.0) and 150 mM NaCl, 
were loaded into the centerpiece. The absorbance at 280 nm was monitored in a continuous mode 
with a time interval of 360 s and a step size of 0.003 cm. Multiple scans at different time 
intervals were then fitted to a continuous c(s) distribution model using the SEDFIT program (6). 
 
Table 1. Crystallographic data and refinement statistics 





Space Group R32 P3221 
Cell dimensions 
  a, b, c (Å) 
  α, β, γ (°) 
 
285.8, 285.8, 274.9 
90, 90, 120 
 
160.8, 160.8, 227.7 
90, 90, 120 
Resolution
1
 50-3.0 (3.1-3.0) 50-6.6 (6.83-6.6) 
Rmerge (%) 8.2 (60.8) 8.8 (>100) 
I/σI 11.0 (1.8) 14.9 (1.3) 
Redundancy 2.8 (2.7) 6.4 (6.3) 
Completeness 96 (96) 95 (96) 
Rwork (%) 22.5 27.4 
Rfree (%) 27.2 33.4 
Average B-factors 
  Protein 
  Ligand/ion 









R.m.s deviation bond 
lengths (Å) 
0.010 0.010 
R.m.s deviation bond 
angles (°) 
1.5 1.3 
PDB Accession Code 5KS8 – 
1




Data collection and structure determination. X-ray diffraction data for mutant MfPC was 
collected at Advanced Photon Source beamline NE-CAT 24-ID-E using an ADSC Q315r 
detector. X-ray diffraction data for wild-type MfPC was collected at the X25 beamline at the 
National Synchrotron Light Source (NSLS) at Brookhaven National Laboratory using a Pilatus 
6M detector. The diffraction images were processed using HKL2000 (7). The structures were 
solved by the molecular replacement method with the program Phaser (8), using the BC, CT and 
BCCP domains of the S. aureus PC structure (9) as the search models. Manual rebuilding was 
carried out with Coot (10) and refinement with the program Refmac (11). Data collection and 
refinement statistics are summarized in Table 1.   
6.3 Crystallization of two-subunit PC 
The first species targeted for structural studies of two-subunit PC was the gram-negative 
bacterium Pseudomonas aeruginosa (PaPC). In P. aeruginosa, the PC α and β genes are 
arranged in an operon. The entire operon was cloned into the pET28a vector, such that an N-
terminal His-tag would be placed onto the α subunit. The PaPC protein was then expressed in 
BL-21 (DE3) Star cells. However, this resulted in overproduction of the α subunit compared to 
the β subunit, with low yield of the complex. To improve the yield, the α and β subunits were 
individually cloned into separate multiple cloning sites on the pCDFduet vector, with an N-
terminal His-tag placed only on the α subunit. This strategy significantly improved the protein 
yield, providing enough protein to set-up crystallization trays.  
The two-subunit PC migrated significantly slower on size-exclusion chromatography than SaPC 
(Fig. 2A). However, even though the protein peak on the gel filtration profile indicated that the 
sample was homogenous, when analyzed on an SDS-PAGE gel, it was clear that the complex 
between α and β subunits was not in a 1:1 ratio, with the β subunit clearly in excess (Fig. 2B). 
The reason for this observation would not become clear until the crystal structure of the two-





Figure 2. Purification of two-subunit PCs. (A) Gel filtration profiles of MfPC, PaPC, PfPC, 
and TdPC. The gel filtration profile for SaPC is also shown for comparison. (B) SDS-PAGE gel 
of MfPC. Lanes were run with and without streptavidin added. A clear gel shift of the β subunit, 
which contains a biotinyl group, is observed upon inclusion of the streptavidin. The α and β 
subunits are indicated on the right. 
 
Unfortunately, no crystal hits were obtained for PaPC. We then expanded our search for two-
subunit PCs to several other Gram-negative species including Pseudomonas fluorescens (PfPC), 
Methylobacillus flagellatus (MfPC), and Thiobacillus denitrificans (TdPC), using the same 
expression and purification strategy with the pCDFduet vector as was used for PaPC. After 
screening through these three additional two-subunit PC enzymes, one crystal hit was obtained 
for MfPC grown in a condition containing 1.3 M ammonium sulfate and 0.1 M sodium citrate pH 
6.5 (Fig. 3A). These crystals were then optimized and could be grown to a very large size (500 x 
500 x 500 µM). However, the diffraction quality of these crystals was very poor, diffracting to 
no better than 8 Å at a synchrotron source (Fig. 3B). Several methods were employed to attempt 
to improve their diffraction quality (12). Since these crystals were grown in high salt, the 
cryoprotection strategy was optimized by testing several reagents such as ethylene glycol, 
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glycerol, Paratone-N, DMSO, low molecular weight PEGs, and high concentrations of salts such 
as lithium sulfate and ammonium sulfate. Through these trials, it was determined that ethylene 
glycol was the best cryoprotectant, but the diffraction quality of the crystals did not measurably 
improve.  
 
Figure 3. Wild-type MfPC crystals. (A) MfPC crystals. (B) Diffraction image for the wild-type MfPC 
crystals. The diffraction does not go beyond ~8 Å.  
 
The structure of propionyl-CoA carboxylase (PCC), which has an α6β6 composition, was 
determined with a hybrid complex, with the α and β subunits each coming from different 
bacterial species (13). This strategy was employed for the two-subunit PCs. Using the four 
different PC homologues that were available, several different hybrid two-subunit PCs were 
made. The α or β subunit from MfPC was expressed with the complementary subunit from PaPC, 
PfPC, or TdPC. MfPC was kept constant in these hybrids, as it exhibited the most promising 
crystallization behavior. As these PCs have high sequence identity with each other, it was 
expected that these hybrids should form stable complexes. As expected, all the hybrid two-
subunit PCs could be expressed and purified similarly to the wild-type enzymes, and retained 
catalytic activity. However, none of these hybrid two-subunit PCs yielded a crystal. 
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Surface entropy reduction is a strategy that has been used to improve the diffraction quality of 
crystals (14). Using the UCLA SerP server, several mutation strategies were obtained. A set of 
three point mutations, K419A/E421A/E422A, was chosen based on the location of the residues 
at the surface of the CT domain rather than close to the active site, and since these residues are 
not highly-conserved among PC homologues. This mutant (SER mutant) was purified similarly 
to the wild-type protein, and had the same catalytic activity. In addition, the SER mutant formed 
the same crystals as the wild-type protein. Although these crystals still had poor diffraction, the 
resolution improved slightly but noticeably to around 6 Å.  
 
Figure 4. The B-domain deletion of MfPC. (A) The BC domain from the structure of the Aquifex 
aeolicus PC BC dimer (PDB ID 1ULZ) (4). The flexible B-domain is indicated. (B) Crystals of the B-
domain deletion mutant of MfPC. (C) Crystals of the B-domain deletion MfPC mutant with surface 




The next strategy was to remove parts of the protein that may be flexible in solution and thus 
hinder crystallization. In particular, the ATP-grasp domain of the BC domain, also termed the B-
domain, was a good candidate for deletion (Fig. 4A). The B-domain is often disordered or has 
high temperature factors in previously determined PC structures, and is known to exist in 
multiple states in solution (15). As the B-domain is internal to the BC domain, we deleted it 
through overlapping PCR methods. In its place, a Gly-Ser-Ser-Gly linker was included. The B-
domain deletion mutant could be expressed and purified, and as expected, it was catalytically 
inactive. This mutant yielded a new crystal form which was grown in 18% PEG 3350, and 0.2M 
sodium malonate pH 6 (Fig. 4B). However, this crystal form also diffracted only to 8 Å. The B-
domain deletion was then combined with the previously attempted SER mutant 
(K419A/E421A/E422A). This new mutant yielded a different crystal form grown in 19% PEG 
3350, 2% tacsimate pH 6, and 3% ethanol (Fig. 4C). Remarkably, this crystal form had 
significantly better diffraction to 3 Å, and the structure for the two-subunit PC could be solved 
through molecular replacement with the individual domains of SaPC serving as the search 
model. 
6.4 Building the MfPC model
1
 
Using molecular replacement, one BC dimer and one CT dimer were located using molecular 
replacement. These dimers had a similar structure to previously determined PC structures, giving 
confidence that the solutions were correct. After refining this initial model, density for BCCP 
domains could be appreciated. However, instead of the expected two BCCP domains, there was 
density for a third BCCP domain as well. In addition, observation of the crystal packing revealed 
a large solvent cavity where densities for protein fragments were present. Due to the third BCCP 
domain, it became apparent that CT domains from additional β subunits must be present in the 
crystal. An additional round of molecular replacement found a second CT dimer, which had 
significantly weaker density and higher B factors than the first CT dimer. Thus, the 
                                                          
1
 These results have been published (27). See Appendix D 
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stoichiometry of the two-subunit MfPC was determined to be α2β4 rather than α4β4. This 
surprising finding explained the previous discrepancy in the SDS-PAGE gels which showed 
excess β subunit compared to the α subunit (Fig. 2B).  
After the placement of two BC, four CT, and three BCCP domains (the fourth BCCP domain is 
disordered), there was still unassigned electron density in the space between the BC and CT 
domains. This density was weaker, and the side-chains were not clearly visible. However, it was 
clear that it consisted of a central α-helix, surrounded by several β-strands. Thus, it appeared that 
this density corresponded to the PT domain present in the α4 PCs. However, the PT domain from 
SaPC did not fit into the density well, and using the PT domain as a search model did not yield a 
solution. The density could not be assigned until it became apparent that the domain consisted of 
two four-stranded β-sheets surrounding the central α-helix, each from a separate β subunit. Thus, 
this domain has a stoichiometry of α1β2, and likely is the primary determinant of the α2β4 
stoichiometry of the overall complex.  
In addition, several parts of the protein were disordered and could not be modelled including one 
BCCP domain, and the linkers between the CT and BT-like domains for one of the β dimers.  
6.5 Evidence for the α2β4 stoichiometry of the MfPC complex 
An immediate question was whether this α2β4 stoichiometry was an artifact of the deletion of the 
B-domain. To resolve this question, the weakly diffracting wild-type MfPC crystals were 
revisited. A molecular replacement solution for these crystals was found by using the newly 
determined individual BC and CT domains of MfPC as search models. One BC domain and two 
CT domains were located in the asymmetric unit of this MfPC crystal. The two CT domains 
form the expected dimer, and the BC domain sits on a crystallographic two-fold axis, forming a 
BC dimer. Because the molecular replacement procedure was able to find the appropriate BC 
and CT dimers, this strongly suggested that the solution was correct, despite the low resolution 
of the dataset. Thus, the wild-type enzyme also has α2β4 stoichiometry.  
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To provide further evidence for the α2β4 stoichiometry in solution, rather than as a crystal 
artifact, a series of solution experiments was performed to validate the structure. To rule out 
differential Coomassie-staining of the subunits, known amounts of individually purified α and β 
subunits were run on a SDS-PAGE gel (Fig. 5A). This experiment confirmed that the 1:2 
staining pattern observed for the purified complex was due to excess presence of the β subunit 
rather than stronger staining of the β subunit. Next, we considered the possibility that excess β 
subunit expression over the α subunit in E. coli promotes the formation of the α2β4 complex over 
the α4β4 complex. To rule out this possibility, separately purified α and β subunits were mixed in 
1:2, 1:1, or 2:1 molar ratios. Regardless of the mixing ratio, the resulting complex eluted at the 
same point on a gel filtration column (Fig. 5B) and showed excess β over α by a Coomassie-
stained SDS PAGE gel (Fig. 5C). These findings confirmed that the composition of the complex 
remained the same regardless of the mixing ratio. In addition, when α and β subunits were mixed 
in a 1:1 molar ratio, only half of the total α formed the complex and the rest migrated as free α on 
the gel filtration column. Only when α and β were mixed in a 1:2 molar ratio was all the α 
subunit incorporated into the complex. Lastly, our collaborator Prof. Chi-Yuan Chou at the 
National Yang-Ming University in Taiwan performed analytical ultracentrifugation experiments 
on the wild-type MfPC and PaPC, as well as the mutant MfPC, and the wild-type α4 SaPC (Fig. 
5D). All the two-subunit PC samples gave molecular masses of ~340 kDa (11.5 S), which is 
close to the estimated molecular weight of 370 kDa for an α2β4 complex. In comparison, SaPC 
gave a molecular mass of ~570 kDa (14.8 S), consistent with the homo-tetrameric α4 complex 
and similar to previously published data (16). Overall, these experiments confirmed the findings 




Figure 5. Experiments to confirm the α2β4 stoichiometry of MfPC. (A) Known quantities of 
separately purified α and β subunits were run alone or after mixing on an SDS-PAGE gel. These were run 
alongside the purified MfPC and PaPC complexes, demonstrating that the 1:2 ratio of α to β subunits is 
genuine and not a staining artifact. The separately purified β subunit contains a His-tag, while the β 
subunit in the purified complex does not, which accounts for the slight difference in molecular weight. 
(B) Known quantities of separately purified α and β subunits were mixed in different ratios and run on an 
SP-12 gel filtration column. The dashed line indicates the elution volume of the complex formed upon 
mixing. (C) Fractions were collected from the dashed line in (B) from two mixing experiments (1:0.5 and 
1:2 ratios of α to β subunits), and run on a Coomassie-stained SDS-PAGE gel. (D) Analytical 
ultracentrifugation experiments showing the size distribution of PCs at 0.5 mg/ml in solution. The various 
two-subunit PCs show a similar major species with a sedimentation coefficient (S) of 11.5, while SaPC 
has an S=14.8.      
This α2β4 complex for the bacterial two-subunit PC contradicts earlier reports of an α4β4 subunit 
composition (1, 17), so possible reasons for these discrepancies were examined. In a 2006 study 
on PaPC, Lai et al. found an apparent 1:1 ratio between α and β subunits for the complex after 
Ni-NTA purification. However, because this analysis was performed without a size-exclusion 
purification step, free α subunit (only the α subunit contained a His-tag) may have bound to the 
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Ni-NTA column along with the complex, which would hinder accurate analysis of the ratio 
between α and β subunits for the active enzyme. In addition, PaPC appears to have excess β 
subunit when expressed aerobically in P. aeruginosa based on this study. In a 1978 study, Cohen 
et al. examined the two-subunit PC from Pseudomonas citronellolis and concluded that the 
active enzyme exists as an α4β4 complex. Based on two different protocols for Coomassie-
staining of SDS gels, Cohen et al. found α:β subunit ratios of 1:1.7 and 1:1.18 for the complex, 
which is inconclusive between 1:1 and 1:2 ratio of subunits. Gel filtration analysis was then used 
to determine a molecular weight between 454-530 kDa. However, separate studies of two-
subunit PCs from Azotobacter vinelandii and Pseudomonas fluorescens reported molecular 
weights of ~300 kDa based on gel filtration, and these groups proposed an α2β2 subunit 
stoichiometry (2, 18). The wide-range of these estimates is likely due to the lack of precision 
when using gel filtration to determine molecular weights, particularly for large proteins with 
extended shapes.  
6.6 Crystal structure of the MfPC holoenzyme 
The 370 kDa α2β4 mutant MfPC holoenzyme has overall dimensions of 140  130  70 Å and 
adopts a shape like the letter U (Fig. 6). The BC dimer forms the bottom and a CT dimer is on 
each arm of the U shape, leaving a large cavity in the middle (Fig. 6A, 6B). The wild-type MfPC 
holoenzyme instead has an overall shape of a butterfly, with overall dimensions of 160  110  
120 Å, and no central cavity (Fig. 6C, 6D). This difference is due to a significant rotation of the 
CT dimer relative to the BC dimer, such that the CT dimers are now splayed away from each 
other, indicating that the contact between the BC and CT domains is flexible (Fig. 7A). This 
flexibility is partly afforded due to the lack of a second BC dimer, which constrains this rotation 
in the α4 PCs. Relative to the BC dimer, the CT dimers of MfPC are rotated nearly 90° in 
comparison to SaPC, highlighting the remarkable structural differences between the two classes 





Figure 6. Structures of M. flagellatus PC holoenzyme. (A) Schematic drawing of the mutant MfPC 
α2β4 holoenzyme structure, having the shape of the letter U in this view. The domains are colored per the 
scheme in Figure 1B, with the exception of the α2 BC domain colored in light pink for clarity (B) 
Structure of the mutant MfPC holoenzyme viewed down the BC domain dimer, rotated 90° from (A) (C) 
Structure of wild-type MfPC holoenzyme, with a characteristic butterfly shape (D) Structure of the wild-
type MfPC holoenzyme viewed down the BC domain dimer, rotated 90° from (C). The differences in the 






Figure 7. Relative positioning of the BC and CT dimers in MfPC and SaPC. (A) Overlay of the two 
BC monomers between mutant and wild-type MfPC, showing the difference (red arrow) in the orientation 
of the two CT dimers. The BC monomer is linked to the CT dimer by the PT or BT-like (BT-L) domain. 
(B) Overlay of the BC domains of mutant MfPC and SaPC-CoA complex, showing the difference (red 
arrow) in the orientation of the CT dimer. The binding location of CoA at the interface between the BC 
and PT domains of SaPC is indicated.  
 
In the mutant structure, the BC dimer possesses a two-fold axis of symmetry, with a r.m.s. 
distance of 0.1 Å for the equivalent Cα atoms of the two domains. However, the CT dimers are 
in different conformations, making the complex asymmetric. In the wild-type structure, the BC 
dimer sits on a crystallographic two-fold axis, making the complex symmetric.  
Three BCCP domains are observed in this mutant holoenzyme. Two are wedged between the BC 
and CT domains, at the bottom of the U-shaped structure, and may help to stabilize the overall 
structure (Fig. 6A, 6B). Although the linkers between the BT-like domain (see next section) and 
the BCCP domains are disordered, based on the distance of the gaps, we assigned these two 
BCCP domains with two β subunits (β2 and β4) that are distal from the BC dimer. The third 
BCCP domain is located near the active site of the distal β subunit (β2), with its biotin in a 
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catalytically competent position with good electron density.  This BCCP is assigned to the 
proximal β subunit (β1). Therefore, the BCCP domains are swapped between the β subunits in 
the holoenzyme. In the wild-type enzyme, weak density was present for a BCCP in the active site 
in the distal CT domain.  
6.6.1 A BT-like structure in two-subunit PC 
Previously determined structures of α4 PCs have been notable for having few direct contacts 
between the BC and CT domains. The two-subunit MfPC is similar in this respect, having few 
interactions between the BC and CT domains, and instead having interactions between the α and 
β subunits mediated primarily through a novel domain that we have named the BT-like domain. 
This BT-like domain consists of a helix at the C-terminal end of an α subunit (residues 454-472, 
outside of the BC domain) and a 4-stranded anti-parallel β-sheet (residues 470-512) in the CT-
BCCP linker of a β subunit (Fig. 8A). This is equivalent to the PT domain in the single-chain 
PCs. However, the PT and BT-like domains have significant differences in structure with r.m.s. 
distance of 3.7 Å for 56 equivalent Cα atoms between the MfPC and SaPC structures, and low 
sequence identity (<10%) (Fig. 8B).  
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Figure 8. A BT-like domain in MfPC. (A) Schematic drawing of the BT-like domain in MfPC. The α-
helix comes from the α1 subunit (red), and the two β-sheets come from the β1 (green) and β2 (yellow) 
subunits. Each of these subunits is colored differently to highlight the origins of each component of the 
BT-like domain. (B) Overlay of the BT-like domain (orange) with the SaPC PT domain (gray). (C) 
Overlay of the BT-like domain (orange) with the BT domain from propionyl-CoA carboxylase (gray) 
(13). 
 
The distinguishing feature of the BT-like domain is that the β-sheet from the second subunit of 
the CT dimer wraps around the other face of the α-helix, forming a domain with a central α-helix 
surrounded by an eight-stranded up-down β-barrel. This structural motif is remarkably similar to 
that of the BT (BC-CT interaction) domain found in the structures of propionyl-CoA carboxylase 
(PCC) (13),  3-methylcrotonyl-CoA carboxylase (MCC) (19), and acetyl-CoA carboxylase (20). 
In fact, the MfPC BT-like domain is in fact more similar to the PCC BT domain (r.m.s. distance 
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of 3.2 Å for 88 equivalent Cα atoms), than the SaPC PT domain (r.m.s. distance of 3.7 Å over 
equivalent Cα atoms). However, the PCC BT domain has a longer central helix and a ‘hook’ 
linking the helix and the first strand of the barrel that is important for interactions in the PCC 
holoenzyme.  
The stoichiometry of this BT-like domain is α1β2, and the formation of this domain is likely the 
primary determinant for the α2β4 stoichiometry of the MfPC holoenzyme. While the BT-like 
domain has essentially no sequence identity with the PT domain of single-chain PCs (Fig. 9A, 
9C), there is a high degree of sequence conservation of the BT-like domain among all bacterial 
two-subunit PCs, strongly suggesting that these enzymes share a common α2β4 subunit 
composition. 
An important difference between the two-subunit and single-chain PCs is that the α-helix in the 
PT domain of single-chain PCs is amphipathic (Fig. 9A, 9B), with the hydrophilic side of the α-
helix being open to solvent in the holoenzyme. In contrast, the central α-helix of the BT-like 
domain in two-subunit PCs is entirely hydrophobic, consisting primarily of alanine residues, and 
is shielded from solvent by the β-barrel structure (Fig. 9C, 9D). The α-helix in the BT domain of 




Figure 9. Sequence comparisons between the BT-like and PT domains. (A) Sequence alignment of 
the PT domain α-helix from selected single-chain PCs. The residues are colored with hydrophilic residues 
in light blue, and hydrophobic residues in purple. The sequence numbering is in accordance with S. 
aureus PC. (B) The PT domain from S. aureus PC viewed down the central α-helix. The α-helix is 
amphipathic, with one half composed of hydrophobic residues (purple) and packed against the β-sheet, 
while the other half is hydrophilic (blue) and exposed to solvent. (C) Sequence alignment of the BT-like 
domain α-helix from selected two-subunit PCs. The residues are colored as in (A). The residues are 
numbered in accordance with MfPC. (D) The BT-like domain from MfPC viewed down the central α-
helix. The α-helix is hydrophobic, and surrounded by the β-barrel. The residues are colored as in (B). 
 
6.6.2 An interface between the BT-like and BC domains  
A highly conserved 476-HGE-478 motif in a β-hairpin of the BT-like domain interacts with 
residues at the BC dimer interface (Fig. 10A). Additional conserved residues at this interface 
include Asp502 and Glu507 in the BT-like domain. However, these residues are not conserved in 
single-chain PCs. Instead, this region is equivalent to the binding site for the adenine diphosphate 
portion of acetyl-CoA in single-chain PCs (Fig. 10B). When comparing the MfPC structure with 
that of SaPC in complex with CoA, the side chain of His476 in MfPC occupies the same position 
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as the adenine base of CoA, and forms an equivalent hydrogen bond with the carbonyl of Ala45 
(Ala47 in SaPC). The Glu478 side chain is located near the 3 phosphate of CoA, and they both 
interact with residues in the opposite BC monomer.  
 
Figure 10. An important interface in MfPC mimics CoA binding. (A) Interactions between the BT-
like domain (colored as in Figure 8A), and the BC dimer. Important residues at this interface are shown as 
sticks. (B) Overlay of the BC dimer between MfPC (colors) and the SaPC (gray) in complex with CoA 
(gray for carbon atoms). The change in the position of the PT domain in relation to the BT-like domain is 
indicated by the red arrow.   
This is consistent with the fact that the BC dimer in MfPC is more similar to the CoA complex of 
SaPC rather than the free SaPC structure (Fig. 11A, 11B), even though there is a significant 
difference in the position of the BT-like domain relative to the PT domain of SaPC (Fig. 10B). 
The presence of the HGE motif occupying the acetyl-CoA binding pocket in the two-subunit PCs 






Figure 11. Comparing the MfPC BC dimer with SaPC. (A) Overlay of the BC dimer between MfPC 
(colors) and SaPC (gray). The bottom BC monomer is overlaid, in order to compare the relative positions 
of the top BC monomer (red arrow) (B) Overlay of the BC dimer between MfPC (colors) and SaPC (gray) 
in complex with CoA (black for carbon atoms). The bottom BC monomer is overlaid, in order to compare 
the relative positions of the top BC monomer.  
 
6.6.3 Structure-based mutations in MfPC 
Based on the structural observations, several mutations were made in the MfPC holoenzyme that 
were predicted to disrupt holoenzyme formation and/or catalysis. A Q452stop mutant, which 
would delete the α-helix in the center of the BT-like domain, abolished the formation of the 
holoenzyme, confirming the importance of the BT-like domain in forming the intact complex 
(Fig. 12A). In addition, mutating one of the alanine residues in the center of the BT-like domain 
α-helix to arginine (A465R), also disrupted formation of the holoenzyme, confirming that it is 
necessary for the α-helix to have small hydrophobic residues to form the intact BT-like domain 




Figure 12. Mutational studies of MfPC. (A) The Q452stop mutation deletes the C-terminal α-helix of 
the α-subunit. Various fractions were run on an SDS-PAGE gel including the supernatant (S), pellet (P), 
flow-through after Ni-binding (F), and elution with imidazole (E). Excess β-subunit is observed before 
elution, but only α-subunit is pulled down by the Ni-beads. (B) The A465R mutation in the α subunit. The 
same fractions were run as in (A). (C) The H476A/E478A/D502A/E507A quadruple mutant in the β-
subunit. The same fractions were run as in (A). (D) Catalytic activity of wild-type and mutant MfPC. The 
reactions were performed with saturating pyruvate concentrations (20 mM). The error bars represent the 
standard deviation from three independent reactions. NA indicates no activity observed.  
To assess whether the conserved residues at the interface between the BC and BT-like domains 
(Fig. 10A) are necessary for holoenzyme formation, the double mutants H476A/E478A and 
D502A/E507A were made. Surprisingly, both double mutants still formed a stable holoenzyme 
and the H476A/E478A mutant was fully active while the D502A/E507A double mutant retained 
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40% of wild-type activity (Fig. 12D). However, the H476A/E478A/D502A/E507A quadruple 
mutation completely abolished holoenzyme formation (Fig. 12C) and catalytic activity (Fig. 
12D). These results implicate this BT-like-BC interface as being important for complex 
formation.   
The MfPC BC dimer interface is similar to that observed in SaPC (Fig. 11) as well as the BC 
subunit of E. coli ACC (21). Mutational studies of SaPC demonstrated that a single point 
mutation (K442E) at the BC dimer interface is sufficient to disrupt tetramerization of the enzyme 
and abolish catalytic activity (16). The equivalent mutation (R401E) was introduced into the α 
subunit of MfPC. The R401E mutant still formed the complex and had only a ~50% reduction in 
catalytic activity compared to wild-type MfPC (Fig. 12D). Two additional E. coli BC dimer 
interface mutants, R19E and E23R, were also tested in MfPC. In SaPC, the equivalent R19E 
mutant forms a tetramer but does not have catalytic activity, while E23R formed aggregates. The 
R19E and E23R MfPC mutants were also able to form the holoenzyme and did not differ 
markedly from the wild-type enzyme in catalytic activity (Fig. 12D). Overall, these results 
indicate that the MfPC complex is more robust to mutations at the BC dimer interface compared 
to SaPC. The single-chain PC monomers are held together in the tetramer primarily by the BC 
and CT dimer interfaces. The additional inter-subunit interactions mediated by the BT-like 
domain in MfPC may allow for the complex to better tolerate these BC interface mutations and 
retain catalytic activity. The α subunit of MfPC alone is a monomer in solution (Fig. 5B), and the 
BC domain from SaPC alone is also a monomer and catalytically inactive (16), indicating that 
additional interactions within the holoenzyme are necessary to form a stable BC dimer in these 
PC enzymes.  
Several mutations were identified in SaPC which completely abolish catalytic activity (22). The 
A610T mutation in SaPC is located in the CT active site and the bulkier threonine side chain 
blocks the access of biotin into the active site. As expected, the equivalent A49T mutant in MfPC 
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had essentially no catalytic activity (Fig. 12D). In addition, blocking biotinylation of the enzyme 
by mutating the Lys581 residue in BCCP to Ala (K581A) also abolished catalysis (Fig. 12D).  
6.6.4 Insights into catalytic mechanism of MfPC 
Because of the unusual α2β4 stoichiometry of the MfPC complex, there is a 2:1 ratio between the 
number of CT/BCCP domains and BC domains. Thus, the catalytic mechanism of the two-
subunit PC must be substantially different than that of the α4 PCs. In the wild-type MfPC 
structure, a BCCP domain is found in the active site of the distal CT domain. In the mutant 
MfPC structure, only one of the two distal CT domains has a BCCP in the active site. The 
distance between the distal CT active site and the closest BC active site is ~ 70 Å (Fig. 13). This 
is within the range of the BC-CT distance found in other biotin-dependent carboxylase structures 
determined to date (9, 13, 19, 20). This distance indicates that the BCCP must translocate 
between the two active sites and supports a swinging-domain model of catalysis. The proximal 
CT active site is inaccessible in the wild-type structure, as the BCCP domain would clash with 
the BC domain (Fig. 13). However, in the mutant structure, the proximal CT active site is 
accessible due to a large rotation of the CT dimer in relation to the BC dimer.  
Based on these observations, there are two different models for how catalysis can proceed. In the 
first model, only the distal CT active site would be active, while the proximal CT domain would 
be inactive. Moreover, only one of the BCCP domains would be necessary to carry out catalysis. 
In this scenario, one β subunit would provide the active BCCP domain, while the other β subunit 
provides the active CT domain. The inactive BCCP domain may serve a structural function, such 
as in the mutant structure where it is wedged between the BC and CT dimers.   
In the second model, both CT active sites in a dimer would be active. In this scenario, the BCCP 
would be able to access the proximal CT active site through a conformational change in the 
enzyme, as observed in the mutant structure. It may be possible that the B-subdomain of the BC 
domain could play a role in this process, as there are contacts between the B-subdomain and the 
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CT domain in the wild-type structure (Fig. 13). However, this interaction is lost in the mutant 
structure, potentially causing the conformational differences that are observed. In this way, the 
closed or open state of the B-subdomain could be coordinated with the movement of the CT 
dimer “arm”, allowing for the BCCP to access the proximal CT active site when needed. The 
proximal CT active site is located ~40 Å from the nearest BC active site (Fig. 13). In this case, 
both BCCP domains would have to sequentially visit the same BC active site. It is not clear how 
the BCCP domains would coordinate as they access the BC active site. It may be possible that 
while one BCCP visits the CT active site, the other goes to the BC active site. 
 
Figure 13. Distances between the BC and CT active sites in the wild-type MfPC structure. A 
schematic drawing of the wild-type MfPC structure is shown, with one of the CT dimers removed for 
clarity. The BC active site is indicated (*) along with ADP and biotin molecules which are modelled 
based on a previously solved BC structure (21). The CT active site is indicated (*), along with the metal 
ion (gray sphere) and pyruvate, as was observed in the mutant MfPC structure. The distances between one 
of the BC active sites (pink, α2) and each of the two CT active sites (β1, β2) is shown with a red and 
black arrow, respectively. A BCCP is modelled into each of the CT active sites, showing that the distal 
(β2) CT active site is accessible, while the proximal (β1) CT active site is not due to clashes between the 
BCCP and the α2 BC monomer. Interactions between the B-domain of the α2 BC and the β1 CT is shown 
with the gray arrow.   
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6.7 Implications for the evolution of pyruvate carboxylase enzymes 
It has been hypothesized that the multifunctional biotin-dependent carboxylases arose through 
gene fusion events of single domain precursors. The structures of the α2β4 two-subunit PC and 
the homo-tetrameric α4 PC provide evidence for this theory. The PT domain, also termed the 
allosteric domain, found in the α4 PCs, is unusual in that it is formed from two discontinuous 
segments. The central α-helix comes from the linker between the BC and CT domains, while the 
4-stranded β-sheet is formed within the linker between the CT and BCCP domains. The presence 
of the BT-like domain in the MfPC structure provides evidence that the PT domain, and by 
extension the α4 PCs, were formed from a gene fusion event between the α and β subunits of the 
two-subunit PC. In most bacterial species, including M. flagellatus and P. aeruginosa, the genes 
for the α and β subunits are found in an operon, with the β subunit gene found directly 
downstream of the α subunit gene, and separated by ~30 base pairs. If the stop codon were to be 
mutated such that the gene would be continuously translated, this would give rise to a single-
chain PC with all domains residing on one polypeptide chain. The most important consequence 
of this type of gene fusion event would be the disruption of the α1β2 stoichiometry of the BT-like 
domain, which would force the removal of one of the 4-stranded β-sheets from the BT-like 
domain. This would essentially give rise to the PT domain which is found in the α4 PCs. In 
addition, the gene fusion would force a α4β4 stoichiometry onto the newly-formed protein, which 
would add an additional pair of BC domains into the new complex. This disruption in the α2β4 
complex likely would have precipitated the drastic conformational changes observed between the 
native α2β4 complex and the newly formed α4 tetramer. However, the structures of the individual 
CT and BC domains and the dimer conformations appear to be strongly conserved between the 
two PC classes, demonstrating that these structures are important for catalysis. The swinging-
domain model in which the BCCP translocates between distant BC and CT active site also 
appears to be shared between the two classes.  
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With the disruption of the BT-like domain, the newly formed PT domain acquires several new 
functions, such as tetramer stabilization through the dimerization of two neighboring PT 
domains. In addition, the PT domain forms part of the binding pocket for the activator acetyl-
CoA. An intriguing finding from these studies is that acetyl-CoA binds to SaPC in a 
conformation that appears to mimic a structurally important protein segment from the BT-like 
domain in MfPC (Fig. 6B). The PT domain also moves relative to the BC dimer in order to 
create the acetyl-CoA binding pocket. We can speculate that the acetyl-CoA regulation of the α4 
PCs may have arisen due to the structural rearrangements induced by the gene fusion event. 
Notably, acetyl-CoA binding of SaPC induces a structural change in the BC dimer conformation 
by binding to the BC dimer interface (22). The MfPC BC dimer conformation is more similar to 
the BC dimer of the “CoA-bound” SaPC structure than the apo SaPC structure. Thus, the MfPC 
HGE motif, by forming a bridge between the two BC monomers, appears to play a similar role as 
acetyl-CoA in helping to shape a particular BC dimer conformation.  
The PC enzymes from archaea are also separated into α and β subunits (23, 24), but they have 
several major differences from bacterial two-subunit PCs. The β subunit of archaeal PCs is ~570 
residues, significantly shorter than the 600-620 residues of bacterial two-subunit PCs. This is due 
to a large deletion in the region corresponding to the putative PT/BT-like domain, such that only 
two β strands are predicted. The α subunit of bacterial two-subunit PCs is generally ~471 
residues and terminates precisely at the end of the BT-like domain α helix. In comparison, the β 
subunit of archaeal PCs has ~500 residues due to a much longer C-terminal extension. In 
addition, while a stretch of small hydrophobic residues is present in the putative PT/BT-like 
domain helix, it is much shorter than that in bacterial two-subunit PCs. Because of these 
significant differences, it is unclear if archaeal two-subunit PCs share the subunit stoichiometry 
and holoenzyme architecture of bacterial two-subunit PCs. Thus, it may be better to classify the 




6.8 Functional Studies of the two-subunit PC in Pseudomonas aeruginosa 
Our collaborators in the Dietrich Lab created a marker-less deletion of the PC operon (ΔPC), to 
assess further the function of the two-subunit PC in P. aeruginosa (PaPC). They tested the 
growth of the ΔPC strain in liquid culture containing succinate, pyruvate, or glucose (Fig. 14). 
No effect in growth was observed with succinate, but a severe growth defect was seen with 
pyruvate or glucose. This growth deficiency could be rescued when the PC operon was placed 
back into the endogenous locus, confirming that loss of PC activitiy is the cause of the defect. 
They then tested several PaPC mutations based on observations from the MfPC crystal structure. 
A K572A mutation which would abolish biotinylation of the enzyme reproduced the defect seen 
with ΔPC. In addition, a K451stop mutation which would delete the α-helix of the BT-like 
domain and abolish formation of the α2β4 complex also shows the same growth defect. This 
result confirms the necessity of the BT-like domain for forming an active enzyme complex. An 
A55T mutant (Fig. 12D), which would block access of biotin to the CT active site, only had 
modest growth defects in glucose. The equivalent mutation in MfPC is essentially inactive, so 
the reason for this minimal growth defect is unclear.  
 
 
Figure 14. PaPC is required for growth on selected carbon sources. Shaken liquid-culture growth of 
wild-type P. aeruginosa PA14, the PC deletion strain (ΔPC), the PC-complemented strain (ΔPC::PC) and 
various site-specific mutants. The strains were grown in a defined medium containing 20 mM succinate, 
pyruvate, or glucose as the sole carbon source. Each growth curve represents the average of three 
biological replicates, and the error bars indicate the standard deviation. See Appendix D for methods. 
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To provide a more physiologically relevant assay, the Dietrich lab tested the ΔPC strain in a 
colony morphogenesis assay, in which colonies are grown on agar-solidified media with Congo 
red and Coomassie blue dyes (Fig. 15). These colonies form wrinkled structures in a well-
defined manner, and this wrinkling depends on the production of extracellular matrix. 
 
Figure 15. Dysfunction of PaPC leads to altered colony morphology. Colony morphology of wild-type 
P. aeruginosa PA14, the PaPC deletion strain (ΔPC), the PC-complemented strain (ΔPC::PC) and the 
K572A mutant assessed over five days. The strains were grown on 1% tryptone, and 1% agar 
supplemented with Congo red and Coomassie blue for visualization. See Appendix D for methods.  
In this assay, a striking difference in colony morphology was observed between the wild-type 
strain and the ΔPC strain. In contrast to the wild-type strain, the ΔPC strain wrinkles earlier, and 
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exhibits more exaggerated wrinkles in a “spoke” formation. The hyper-wrinkled phenotype is 
due to an increase in matrix production and has been observed before in electron acceptor 
limitation conditions and may be a response to cellular redox imbalance (25). The K572A 
mutation shows a similar phenotype to the ΔPC strain. The ΔPC morphology reverts back to 
wild-type when PC is complemented. These results suggest that anaplerosis by PC and the 
proper function of the TCA cycle may be important for redox homeostasis and the formation of 
multicellular communities like biofilms, which is a major driver of pathogenicity of P. 
aeruginosa in diseases like cystic fibrosis (26).  
6.9 Conclusions and future directions 
We have solved the first crystal structure of a two-subunit PC, and reveal that it has an α2β4 
stoichiometry, contrary to previous reports of an α4β4 stoichiometry. We then performed 
extensive solution studies, including analytical ultracentrifugation experiments performed by our 
collaborator Prof. Chi-Yuan Chou, to confirm our findings from the crystal structure. A novel 
α1β2 BT-like domain mediates complex formation in the structure. The similarity between the 
BT-like domain and the BT domain of acyl-CoA carboxylases and the PT domain of single-chain 
PCs, provides insights into the evolutionary history of the biotin-dependent carboxylase family. 
In particular, these structures demonstrate that the single-chain PCs are likely a product of a gene 
fusion event from a two-subunit PC. The structure of the archaeal two-subunit PC remains a 
mystery, due to the low sequence identity with the bacterial two-subunit PCs. A structure of the 
archaeal PC, along with a determination of its stoichiometry, would clarify its place in the 
evolutionary lineage of PC enzymes.  
The functional studies in P. aeruginosa performed by the Dietrich lab, along with previous 
studies (26), demonstrate that the two-subunit PC likely plays a critical role in many 
physiological processes in this organism, including in its pathogenesis and ability to colonize the 
lung in cystic fibrosis. Thus, the two-subunit PC represents a potential novel drug target for 
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developing antibiotics to combat P. aeruginosa. Due to the structural and biochemical 
differences between the two-subunit PC of P. aeruginosa, and the single-chain PC in humans, a 
drug could be developed to selectively inhibit the activity of the bacterial PC while having no 
effect on the host.  
However, for the two-subunit PC to become a viable drug target, further studies will be needed 
to understand in more detail its mechanism of catalysis. Unlike all biotin-dependent carboxylases 
studied to date, the two-subunit PC does not have a 1:1 ratio between the BC and CT domains. 
Thus, it is not certain if all the domains participate in catalysis, or if some may be catalytically 
inactive and play a structural role. It is clear from the structures, however, that the two-subunit 
PC is a very dynamic enzyme. Additional crystal or cryo-EM structures capturing more 
conformations of the enzyme, particularly the locations of the various BCCP domains, may 














1.  N. Cohen, J. Duc, B. H, M. Utter, Quaternary structure of pyruvate carboxylase from 
Pseudomonas citronellolis. J. Biol. Chem. 254, 9262–9269 (1979). 
2.  C. Scrutton, B. L. Taylor, Isolation and Characterization of Pyruvate Carboxylase from 
Azotobacter vinelandii OP. Arch. Biochem. Biophys. 654, 641–654 (1974). 
3.  L. Tong, Structure and function of biotin-dependent carboxylases. Cell. Mol. life Sci. 70, 
863–91 (2013). 
4.  S. Kondo et al., Structure of the biotin carboxylase subunit of pyruvate carboxylase from 
Aquifex aeolicus at 2.2 A resolution. Acta Crystallogr. D. Biol. Crystallogr. 60, 486–92 
(2004). 
5.  H. V. Modak, D. J. Kelly, Acetyl-CoA-dependent pyruvate carboxylase from the 
photosynthetic bacterium Rhodobacter capsulatus: Rapid and efficient purification using 
dye-ligand affinity chromatography. Microbiology. 141, 2619–2628 (1995). 
6.  P. Schuck, Size-distribution analysis of macromolecules by sedimentation velocity 
ultracentrifugation and lamm equation modeling. Biophys. J. 78, 1606–19 (2000). 
7.  W. Minor, M. Cymborowski, Z. Otwinowski, M. Chruszcz, HKL-3000: The integration of 
data reduction and structure solution - From diffraction images to an initial model in 
minutes. Acta Crystallogr. Sect. D Biol. Crystallogr. 62, 859–866 (2006). 
8.  A. J. McCoy et al., Phaser crystallographic software. J. Appl. Crystallogr. 40, 658–674 
(2007). 
9.  S. Xiang, L. Tong, Crystal structures of human and Staphylococcus aureus pyruvate 
carboxylase and molecular insights into the carboxyltransfer reaction. Nat. Struct. Mol. 
Biol. 15, 295–302 (2008). 
10.  P. Emsley, K. Cowtan, Coot: Model-building tools for molecular graphics. Acta 
Crystallogr. Sect. D Biol. Crystallogr. 60, 2126–2132 (2004). 
11.  G. N. Murshudov et al., REFMAC5 for the refinement of macromolecular crystal 
structures. Acta Crystallogr. Sect. D Biol. Crystallogr. 67, 355–367 (2011). 
12.  B. Heras, J. L. Martin, Post-crystallization treatments for improving diffraction quality of 
protein crystals. Acta Crystallogr. D. Biol. Crystallogr. 61, 1173–80 (2005). 
13.  C. S. Huang et al., Crystal structure of the α6β6 holoenzyme of propionyl-coenzyme A 
carboxylase. Nature. 466, 1001–1005 (2010). 
14.  L. Goldschmidt, D. R. Cooper, Z. S. Derewenda, Toward rational protein crystallization : 
A Web server for the design of crystallizable protein variants. Protein Sci. 16, 1569–1576 
(2007). 
15.  B. R. Novak, D. Moldovan, G. L. Waldrop, M. S. De Queiroz, Behavior of the ATP grasp 
domain of biotin carboxylase monomers and dimers studied using molecular dynamics 
simulations. Proteins. 79, 622–632 (2011). 
16.  L. P. C. Yu, C. Chou, P. H. Choi, L. Tong, Characterizing the Importance of the Biotin 
Carboxylase Domain Dimer for Staphylococcus aureus Pyruvate Carboxylase Catalysis. 
Biochemistry. 52, 488–496 (2013). 
149 
 
17.  H. Lai, J. L. Kraszewski, E. Purwantini, B. Mukhopadhyay, Identification of pyruvate 
carboxylase genes in Pseudomonas aeruginosa PAO1 and development of a P. aeruginosa-
based overexpression system for alpha4- and alpha4beta4-type pyruvate carboxylases. 
Appl. Environ. Microbiol. 72, 7785–92 (2006). 
18.  S. Milrad de Forchetti, J. Cazzulo, Some Properties of the Pyruvate Carboxylase from 
Pseudomonas fluorescens. J. Gen. Microbiol. 93, 75–81 (1976). 
19.  C. S. Huang, P. Ge, Z. H. Zhou, L. Tong, An unanticipated architecture of the 750-kDa 
α6β6 holoenzyme of 3-methylcrotonyl-CoA carboxylase. Nature. 481, 219–223 (2012). 
20.  J. Wei, L. Tong, Crystal structure of the 500-kDa yeast acetyl-CoA carboxylase 
holoenzyme dimer. Nature. 526, 723–7 (2015). 
21.  C.-Y. Chou, L. P. C. Yu, L. Tong, Crystal structure of biotin carboxylase in complex with 
substrates and implications for its catalytic mechanism. J. Biol. Chem. 284, 11690–7 
(2009). 
22.  L. P. C. Yu et al., A symmetrical tetramer for S. aureus pyruvate carboxylase in complex 
with coenzyme A. Structure. 17, 823–32 (2009). 
23.  B. Mukhopadhyay, V. J. Patel, R. S. Wolfe, A stable archaeal pyruvate carboxylase from 
the hyperthermophile Methanococcus jannaschii. Arch. Microbiol. 174, 406–414 (2000). 
24.  B. Mukhopadhyay, S. F. Stoddard, R. S. Wolfe, Purification, regulation, and molecular 
and biochemical characterization of pyruvate carboxylase from Methanobacterium 
thermoautotrophicum strain deltaH. J. Biol. Chem. 273, 5155–66 (1998). 
25.  L. E. P. Dietrich et al., Bacterial community morphogenesis is intimately linked to the 
intracellular redox state. J. Bacteriol. 195, 1371–1380 (2013). 
26.  I. Kukavica-Ibrulj et al., Functional genomics of PycR, a LysR family transcriptional 
regulator essential for maintenance of Pseudomonas aeruginosa in the rat lung. 
Microbiology. 154, 2106–18 (2008). 
27.  P. H. Choi et al., A distinct holoenzyme organization for two-subunit pyruvate 











Appendix A:  
The cyclic dinucleotide c-di-AMP is an allosteric  
regulator of metabolic enzyme function 
 
 150
The Cyclic Dinucleotide c-di-AMP
Is an Allosteric Regulator
of Metabolic Enzyme Function
Kamakshi Sureka,1,8 Philip H. Choi,2,8 Mimi Precit,1 Matthieu Delince,3,9 Daniel A. Pensinger,4 TuAnh Ngoc Huynh,1
Ashley R. Jurado,2 Young Ah Goo,5 Martin Sadilek,6 Anthony T. Iavarone,7 John-Demian Sauer,4 Liang Tong,2,*
and Joshua J. Woodward1,*
1Department of Microbiology, University of Washington, Seattle, WA 98195, USA
2Department of Biological Sciences, Columbia University, New York, NY 10027, USA
3Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720, USA
4Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, WI 53706, USA
5Department of Pharmaceutical Sciences, University of Maryland, Baltimore, MD 21201, USA
6Department of Chemistry, University of Washington, Seattle, WA 98195, USA
7QB3/Chemistry Mass Spectrometry Facility, University of California, Berkeley, CA 94720, USA
8Co-first author
9Present address: School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), Lausanne 1015, Switzerland
*Correspondence: ltong@columbia.edu (L.T.), jjwoodwa@uw.edu (J.J.W.)
http://dx.doi.org/10.1016/j.cell.2014.07.046
SUMMARY
Cyclic di-adenosine monophosphate (c-di-AMP) is a
broadly conserved second messenger required for
bacterial growth and infection. However, the mole-
cular mechanisms of c-di-AMP signaling are still
poorly understood. Using a chemical proteomics
screen for c-di-AMP-interacting proteins in the path-
ogen Listeria monocytogenes, we identified several
broadly conserved protein receptors, including the
central metabolic enzyme pyruvate carboxylase
(LmPC). Biochemical and crystallographic studies
of the LmPC-c-di-AMP interaction revealed a previ-
ously unrecognized allosteric regulatory site 25 Å
from the active site. Mutations in this site disrupted
c-di-AMP binding and affected catalytic activity of
LmPC as well as PC from pathogenic Enterococcus
faecalis. C-di-AMP depletion resulted in altered
metabolic activity in L. monocytogenes. Correction
of this metabolic imbalance rescued bacterial
growth, reduced bacterial lysis, and resulted in
enhanced bacterial burdens during infection. These
findings greatly expand the c-di-AMP signaling
repertoire and reveal a central metabolic regulatory
role for a cyclic dinucleotide.
INTRODUCTION
The colonization of diverse environmental and host niches by
bacteria depends on the ability to sense and respond to
external stimuli. Signal transduction pathways dependent
upon nucleotide-based second messengers are ubiquitous
among bacteria (Kalia et al., 2013) and mediate cellular devel-
opment, group behavior, and metabolism as a result of chang-
ing environmental conditions. Among such molecules, cyclic
di-adenosine monophosphate (c-di-AMP, cdA) has recently
emerged as a broadly conserved second messenger of fun-
damental importance for microbial growth and physiology,
with effects on stress responses, antibiotic resistance, cellular
morphology, bacterial growth, and virulence (Campos et al.,
2014; Corrigan et al., 2011; Corrigan et al., 2013; Luo and Hel-
mann, 2012; Mehne et al., 2013; Oppenheimer-Shaanan et al.,
2011; Pozzi et al., 2012; Smith et al., 2012; Witte et al., 2013;
Zhang and He, 2013). Moreover, c-di-AMP secreted by
L. monocytogenes, M. tuberculosis, and C. trachomatis during
infection results in an IFN-b-mediated host immune response
(Barker et al., 2013; Woodward et al., 2010; Yang et al.,
2014). Together, these reports have established c-di-AMP
as a crucial intracellular signaling molecule and an impor-
tant component of innate immune detection during infection.
Despite this central importance, the molecular mechanisms
of c-di-AMP-mediated signal transduction in bacteria are just
being elucidated.
Components of second messenger signaling systems in-
clude mechanisms to generate, degrade, and relay the signal.
C-di-AMP is synthesized from two molecules of ATP (Witte
et al., 2008), and in some cases ADP (Bai et al., 2012), through
the catalytic activity of di-adenylate cyclases (DACs). The
signal is subsequently degraded to pApA or AMP by DHH/
DHHA1 domain containing phosphodiesterases (Bai et al.,
2013; Rao et al., 2010). Second messengers initiate signal
transduction by binding to and altering protein and nucleic
acid function, resulting in transcriptional, translational, and
posttranslational alterations within a cell. Recent reports have
identified several mechanisms of c-di-AMP regulation within
these contexts, including riboswitches and protein receptors
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(Bai et al., 2014; Corrigan et al., 2013; Nelson et al., 2013;
Zhang et al., 2013). However, c-di-AMP riboswitches are ab-
sent in some organisms and protein receptor homologs are
not well conserved. Similarly, the functional roles of identified
protein receptors cannot explain the breadth of phenotypes
associated with altered c-di-AMP levels. Together these ob-
servations imply that additional c-di-AMP signaling pathways
likely exist.
Listeria monocytogenes is a gram-positive intracellular bacte-
rial pathogen that provides an attractive model to interrogate
the molecular details of protein-mediated c-di-AMP signaling.
C-di-AMP produced from a single DAC containing protein is a
central regulator of numerous fundamental processes within
this organism, including growth, cell wall homeostasis, stress
responses, and the establishment of infection (Witte et al.,
2013). In this study we developed a chemical proteomics
approach to identify the c-di-AMP-interacting proteins. We iden-
tified several c-di-AMP-binding proteins that are broadly
conserved in numerous bacterial species. Among these pro-
teins, we structurally and biochemically characterized the inter-
action with pyruvate carboxylase (PC) and characterized the
consequences of c-di-AMP regulation of central metabolic activ-
ity on L. monocytogenes survival within the host environment.
Our findings provide insight into the central biological function
of c-di-AMP among the diverse bacteria known to generate
this second messenger.
RESULTS
Chemical Proteomics to Define the c-di-AMP
Interactome of L. monocytogenes
We utilized a proteomics approach to identify the c-di-AMP
interactome of L. monocytogenes (Figure 1A). The nucleotide
was covalently conjugated to epoxy-activated sepharose
beads (Figure S1). Nucleotide-bound and control beads were
used in parallel for affinity purification of proteins from
L. monocytogenes 10403S. Initial binding results were visually
analyzed by SDS-PAGE (Figure 1B) and subsequently using
gel-free quantitative shotgun proteomics (Figure 1C). We iden-
tified 12 proteins that were statistically significant among rep-
licates (false discovery rate < 0.05) and enriched > 7-fold by
spectral count ratio (>2 SD) with c-di-AMP versus control se-
pharose (Figure 1D). The four proteins with highest enrichment
are of conserved hypothetical annotation, with homologs
found in a large number of bacteria. Among these, the homo-
log of Lmo2692 in S. aureus was recently identified as a c-di-
AMP-binding protein (Corrigan et al., 2013). In addition, the
known c-di-AMP phosphodiesterase PdeA (Lmo0052) is the
fifth protein on our list (Witte et al., 2013). The successful iden-
tification of known c-di-AMP-binding proteins validated our
approach.
To confirm these interactions, proteins were probed for direct
c-di-AMP-binding by differential radial capillary action of ligand
Figure 1. Identification of c-di-AMP-Inter-
acting Proteins from L. monocytogenes
(A) Schematic diagram of chemical proteomics
used to identify c-di-AMP-interacting proteins. 1
and 2 represent direct and indirect specific
binding proteins.
(B) Representative pull-down from bacterial ly-
sates with c-di-AMP (+) and control sepharose ().
The remaining lanes from the SDS-PAGE gel have
been removed for clarity.
(C) Quantitative shotgun proteomics of c-di-
AMP-binding proteins. Data are sorted based
upon fold change (FC) in spectral count ratio
(c-di-AMP sepharose/control sepharose). Data
points in red represent proteins with FC > 7
(horizontal black line) and a false discovery rate
(FDR) < 0.05.
(D) List of top hits identified by chemical
proteomics. Studies performed in L. mono-
cytogenes strain 10403S. Locus numbers based
on strain EGD-e (Accession number: NC_
003210.1).
(E and F) Proteins in bold confirmed for direct c-di-
AMP binding with (E) purified recombinant pro-
teins or (F) crude cell lysate for proteins identified
by chemical proteomics.
Data are mean ± SEM and are representative of
multiple independent experiments. *p < 0.05
(Students t test, two-tailed). See also Figure S1,
S2, and S3.
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assay (DRaCALA) (Roelofs et al., 2011). 32P-labeled c-di-AMP
was synthesized (Figure S2) and used to quantify binding.
Those proteins predicted to be soluble by in silico analysis
(Bernsel et al., 2009) were expressed and purified to homoge-
neity from E. coli. The three soluble proteins of conserved hypo-
thetical annotation (renamed here PstA, CbpA, and CbpB)
as well as PdeA and LmPC exhibited binding in purified form
(Figure 1E). No binding was observed for purified recombinant
ClpC, OppA, CtaP, or Lmo1634, which were likely identified
because they interact with a direct c-di-AMP-interacting protein
(labeled 2 in Figure 1A) or contain posttranslational modifica-
tions that facilitate c-di-AMP binding. NrdR exhibited significant
instability in purified form, while Lmo1466 and NADH dehy-
drogenase are predicted to be membrane anchored. As
such, these proteins were characterized in whole-cell lysates.
E. coli lysates containing either an empty vector or encoding
Lmo0553 were used as negative and positive controls, respec-
tively (Figure 1F). A significant level of binding was observed for
Lmo1466 and NrdR-expressing lysates, consistent with a direct
interaction with c-di-AMP. No interaction was observed for ly-
sates derived from E. coli expressing NADH dehydrogenase.
However, overexpression of NADH dehydrogenase was not
observed and the direct interaction with c-di-AMP was there-
fore inconclusive.
Figure 2. LmPC Specifically Binds and Is
Inhibited by c-di-AMP.
(A) Binding titration of c-di-AMP and LmPC using
32P-c-di-AMP.
(B) Enzymatic activity of LmPC in the presence of
Acetyl-CoA (100 mM), varied pyruvate, and c-di-
AMP concentrations as indicated.
(C) Rate constants of pyruvate turnover in the
presence of c-di-AMP.
(D) Enzymatic activity of LmPC in the presence of
pyruvate (20 mM), varied Acetyl-CoA (allosteric
activator) and c-di-AMP concentrations as indi-
cated.
(E) LmPC activity in the presence of nucleotide
analogs. Data reported as percent activity relative
to that without added nucleotide. All data reported
as the mean ± SEM and are representative of
multiple independent experiments. See also
Figure S4.
The top three proteins that displayed
positive binding and could be purified
were investigated in further detail.
CbpA, CbpB, and PstA demonstrated
c-di-AMP-binding constants <10 mM
(Figure S3), consistent with levels of
c-di-AMP reported in bacteria (Corrigan
et al., 2011). Specificity of the c-di-
AMP interaction was studied by com-
petitive binding with cold nucleotides.
For the proteins CbpA, CbpB, and
PstA, only excess c-di-AMP could abro-
gate binding when present at 400 mM
of unlabeled competing nucleotide (Fig-
ure S3). These observations support a specific interaction
with c-di-AMP.
C-di-AMP is an Allosteric Inhibitor of LmPC
Among those newly identified c-di-AMP-binding proteins, only
LmPC (120 kDa) has a known biological function. In fact,
LmPC is essential for L. monocytogenes growth (Schär et al.,
2010). Therefore, we focused our initial studies on the detailed
characterization of this molecular interaction and its biological
consequences. PC is a multidomain enzyme that catalyzes the
ATP-dependent carboxylation of pyruvate to oxaloacetate. Dur-
ing catalysis, the biotin carboxyl carrier protein (BCCP) domain is
carboxylated in an ATP-dependent manner by the biotin carbox-
ylase (BC) domain. Subsequently, the carboxyltransferase (CT)
domain mediates transfer of the carboxyl from biotin to the sub-
strate pyruvate. The PC tetramerization (PT) domain is important
for the quaternary structure of the enzyme (St Maurice et al.,
2007; Xiang and Tong, 2008) and together with the BC domain
defines the binding site of the allosteric activator acetyl-CoA
(St Maurice et al., 2007; Yu et al., 2009).
Binding studies indicated that LmPC interacts with c-di-AMP
with a Kd of 8 ± 0.2 mM (Figure 2A). We observed diminished
PC activity in the presence of increasing concentrations of c-
di-AMP (Ki 3 mM, Figure 2B). The inhibitory effect was at the
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level of the apparent kcat with slight lowering of the apparent Km
(Figure 2C), indicating that c-di-AMP does not compete with the
pyruvate substrate. We also found that the inhibition by c-di-
AMP could be overcome by high concentrations of acetyl-CoA
(Figure 2D). Finally, the inhibition was specific to c-di-AMP as
most of structurally related dinucleotides (Figure S4), includ-
ing c-di-GMP, bacterial cGAMP (cyclic[Gp(30,50)Ap(30,50)]), or
pApA, the breakdown product of c-di-AMP, showed no effect
on LmPC activity, while c-di-IMP did show weak inhibitory
activity (Figure 2E). Overall, these biochemical studies define
c-di-AMP as an allosteric inhibitor of LmPC.
Binding Mode of c-di-AMP in LmPC
To understand themolecular basis for the enzyme regulation, we
determined the structure of the LmPC-c-di-AMP complex at
2.5 Å resolution (Table S1). Clear electron density was observed
for the c-di-AMP ligand based on the crystallographic analysis
(Figure 3A). Unexpectedly, we observed another c-di-AMP that
bridges two c-di-AMP molecules bound to neighboring LmPC
in this crystal (Figure S5A). The bridging c-di-AMP inserts one
of its adenine bases between the two bases of the bound c-di-
AMP, forming p-stacking interactions, but it has no direct
contacts with the protein (Figure S5A). We observed a second
crystal form of the complex from the same crystallization condi-
tion, and determined its structure at 2.7 Å resolution (Table S1).
The bridging c-di-AMP molecule is absent in this crystal (Fig-
ure S5B), but the structure of the complex is essentially identical
to the other crystal form (Figure S5C). Therefore, the bridging
c-di-AMP is most likely an artifact in that crystal form and will
not be discussed further. A citrate molecule was found in the
acetyl-CoA-binding site, although our kinetic studies showed
that citrate had only small effects on the catalytic activity of
LmPC. Its presence in the structure was likely due to the high
concentration in the crystallization solution.
LmPC is a tetramer in the crystal structure (Figures 3B and
S5C), consistent with solution studies as well as earlier struc-
tures of R. etli PC (RePC), S. aureus (SaPC), and H. sapiens
(HsPC) (St Maurice et al., 2007; Xiang and Tong, 2008). The
tetramer is composed of two layers, with two monomers in
each layer. There are extensive interactions between the two
layers, mediated through the BC and CT domain dimers, which
are located at opposing corners of the diamond-shaped
tetramer. In contrast, there are few direct contacts between
the two monomers in the same layer. All four BCCP domains
are observed, but the linkers between the PT and the BCCP do-
mains (residues 1060–1066) are disordered. As a result, each
BCCP domain is assigned to a monomer based on the earlier
structure of SaPC (Figure 3B), although the actual PT-BCCP
Figure 3. Crystal Structure of LmPC in Complex with c-di-AMP
(A) Omit Fo–Fc electron density map for c-di-AMP at 2.5 Å resolution, contoured at 3s.
(B) Schematic drawing of the structure of LmPC tetramer in complexwith two c-di-AMPmolecules. The domains of monomer 1 are colored separately, according
to the diagram at the bottom of the panel. c-di-AMP is shown as a sphere model and labeled cdA (carbon atoms in black). Themetal ion in the active site of the CT
domain is shown as a gray sphere and labeled M2+. The distance from the CT active site and c-di-AMP-binding site is indicated with the dashed red line.
(C) Detailed interactions between c-di-AMP and LmPC. Hydrogen-bonding interactions are indicated with dashed lines (in red). Water molecules are shown as
red spheres. All structure figures were produced with PyMOL (www.pymol.org).
See also Table S1 and Figure S5.
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connectivity is ambiguous in LmPC. The overall position of
BCCP is similar to that in the exo site of the SaPC structure
(Xiang and Tong, 2008), but its orientation is very different (Fig-
ure S6A). Consequently, the biotin group in the current structure
is projected into the solvent and disordered. Besides the PT-
BCCP linker, the B domain of BC (residues 135–205) is also
disordered in the crystals.
The c-di-AMP nucleotide is bound at the dimer interface of two
CT domains (Figures 3B), with the 2-fold symmetry axis of the
compound aligned with that of the CT domains (Figure 3C).
Therefore, each LmPC tetramer binds only two c-di-AMP mole-
cules (Figure 3B). The binding site is formed by two helices in the
TIM barrel fold of the CT domain (Figure 3C), but it is located
25 Å away and on the opposite face from the CT active site
(Figures 3B). This region of PC has not been known previously
to have any regulatory or structural significance.
The c-di-AMP ligand adopts a U-shaped conformation (Fig-
ure 3A) and interacts with LmPC through hydrophobic and
hydrogen-bonding interactions (Figure 3C). The aromatic ring
of Tyr722 has a direct face-to-face p-stacking arrangement
with an adenine base. One of the terminal oxygen atoms of the
phosphate group of c-di-AMP forms a hydrogen bond with the
hydroxyl group of Tyr749, while the other terminal oxygen inter-
acts with the Ser756 side chain through a water molecule. The
ribose is located near Ala753, which together with Ala752 may
provide the space necessary for the ligand to bind.
The U-shaped conformation of c-di-AMP is similar to the bind-
ing mode of c-di-GMP in some proteins, such as the bacterial
PilZ domain (Benach et al., 2007) and the human STING protein
(Huang et al., 2012; Ouyang et al., 2012; Shang et al., 2012; Shu
et al., 2012; Yin et al., 2012). In addition, c-di-GMP is also aligned
with the 2-fold symmetry axis of a STING dimer, and the guanine
base isp-stackedwith a Tyr side chain. Together these observa-
tions identify a binding site of c-di-AMP to LmPC and confirm
kinetic studies that the site is unique from known substrates or
allosteric regulators of this family of enzymes.
The c-di-AMP-Binding Site Affects PC Catalytic Activity
To assess the functional importance of the binding site, we intro-
duced amino acid mutations into LmPC. We noted conservation
of ap-stacking aromatic amino acid amongmany cyclic dinucle-
otide-binding proteins, including STING, VpsT, and the EAL
domain protein YahA (Huang et al., 2012; Krasteva et al., 2010;
Ouyang et al., 2012; Shang et al., 2012; Sundriyal et al., 2014;
Yin et al., 2012), implicating Y722 as a critical residue for nucle-
otide recognition. Two amino acid substitutions (Y722F and
Y722T) were introduced into this site. The Y722F mutant was
chosen to assess the importance of the hydroxyl group interact-
ing with the N6 of the adenine base. The Y722T mutant was cho-
sen due to the presence of this amino acid in the corresponding
site of HsPC (Figure 4A). Comparison of the LmPC and SaPC
structures revealed that the analogous binding pocket does
not apparently exist within the latter enzyme (Figures 4B, 4C,
S6A, and S6B). This can be attributed to the presence of a Lys
and Gln substitution in SaPC corresponding to A752 and A753
of LmPC, respectively, which introduce significant steric bulk
into the pocket. Similarly, the Y749 residue required for hydrogen
bonding to the terminal oxygen of the phosphate at the bottom of
this pocket has been lost. These observations were used to
guide amino acid substitutions in the LmPC protein.
The mutants were expressed and purified following the same
protocol as was used for the wild-type protein. All amino acid
mutants, except Y749L, were catalytically active. However, the
Y722T, A752K, and A753Q variants lost sensitivity to inhibition
by c-di-AMP even at 100 mM concentration (Figure 4D). Interest-
ingly, the enzyme activity in the absence of c-di-AMP was sub-
stantially different from WT, with both increased and reduced
activity being observed for the mutants, suggesting that this re-
gion of the enzyme has a functionally relevant effect on PC catal-
ysis. The Y722F mutant behaved similar to the wild-type enzyme
in terms of its catalytic activity and responsiveness to c-di-AMP,
establishing that the hydroxyl group of Y722 is dispensable for
nucleotide recognition. In agreement with the kinetic data, bind-
ing to c-di-AMP was only observed for Y722F and none of the
other amino acid variants (Figure 4E).
We noted that although several of the residues required for
c-di-AMP binding by LmPC are absent in other bacterial en-
zymes, the required chemical features of the binding pocket
might be conserved. Specifically, when comparing LmPC to
PC from lactic acid bacteria (Figure 4A), such as PC from the
opportunistic pathogen Enterococcus faecalis (EfPC), structural
modeling predicted that the A752S and S756K variants could
establish favorable interactions with the c-di-AMP phosphate
group and compensate for the loss of the Y749 residue (Figures
4F–4G). Indeed, recombinant EfPC binds c-di-AMP and its cat-
alytic activity is inhibited by the nucleotide (Figures 4G and
4H). Consistent with a conserved binding site between the en-
zymes, mutation of the base stacking tyrosine results in loss of
c-di-AMP binding and regulation. Similarly, SaPC is insensitive
to c-di-AMP. Overall, the results from these studies confirm
the c-di-AMP-binding site identified by the structural analysis
and identify a previously unrecognized region important for PC
regulation in L. monocytogenes and other bacteria.
C-di-AMP Binding Induces Large Conformational
Changes in LmPC
We have also determined the structure of apo LmPC (Table S1),
in the absence of c-di-AMP. The best quality X-ray diffraction
data set we could collect after screening through a large number
of crystals was at 3.3 Å resolution. There are two tetramers in the
asymmetric unit that have essentially the same conformation,
with root mean square (rms) distance of 0.1 Å among their equiv-
alent Ca atoms (NCS restraints were applied throughout the
refinement and the crystal had pseudo C2 space-group symme-
try). Therefore, only one of these tetramerswill be used for further
analysis. All four BCCP domains and residues 850–950 in the CT
domain of one of the monomers had poor electron density and
were not modeled. The B domain of BC was partially ordered
in the four monomers and there was weak density for an ATP
molecule.
A comparison of the structure of apo LmPC and that bound to
c-di-AMP showed dramatic rearrangements in the tetramer
upon ligand binding (Figure 5A). Near the c-di-AMP-binding
site, there are significant changes in the orientation and position
of the two CT domains of the dimer, corresponding to a rotation
of 4.5 for each CT domain (Figure 5B). As a consequence, the
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Figure 4. Functional Analysis of the c-di-
AMP-Binding Site of PC
(A) Conservation of residues in the c-di-AMP-
binding site. The five residues in the binding site
are highlighted in red.
(B) Molecular surface of the LmPC-binding site for
c-di-AMP (labeled cdA), colored by the electro-
static potential (red: negative, blue: positive).
(C) Molecular surface of SaPC at the CT dimer
interface. The c-di-AMP molecule is shown as a
reference in stick models.
(D) Effects of c-di-AMP on the catalytic activity of
wild-type and mutant LmPC.
(E) C-di-AMP binding to WT and mutant LmPC
proteins measured by DRaCALA.
(F) LmPC c-di-AMP-binding pocket with corre-
sponding EfPC amino acid variations.
(G) Surface view of modeled EfPC.
(H) C-di-AMP binding to WT and Y718T EfPC.
(I) Activity of WT and Y718T EfPC in the presence
and absence of c-di-AMP.
Data are mean ± SEM (D, E, G, and H) and are
representative a multiple independent experi-
ments. See also Figure S6.
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side chains of both Tyr722 and Ser756 in the apo enzyme would
clash with the c-di-AMP molecule in the complex. These
changes greatly reduce the size of the pocket in this region,
such that it can no longer accommodate c-di-AMP (Figure 5C).
The BC dimer in apo LmPC has roughly the same structure as
that in the complex with c-di-AMP (Figure S5D). However, the
position and orientation of the BC domain relative to the CT
domain are different between the apo enzyme and the c-di-
AMP complex. In addition, the four LmPC monomers in the
c-di-AMP complex have essentially the same conformation,
while the monomers in the apo enzyme have large structural dif-
ferences. This is best visualized by overlaying the CT domains of
the four monomers in each structure. For the c-di-AMP complex,
overlaying the CT domains essentially brought the BC and PT
domains into overlay as well, with a difference of only1 in their
orientations (Figure 5D). In comparison, the four monomers differ
by 10 in the orientations of their BC domains after the CT
Figure 5. Large Conformational Differences
in the Structure of apo LmPC
(A) Overlay of the structure of LmPC in complex
with c-di-AMP (in color) with that of apo LmPC (in
gray). The superposition was based on monomer
1. Large differences in the positions of the other
monomers are visible.
(B) Conformational differences in the c-di-AMP-
binding site in the structure of apo LmPC.
(C)Molecular surface of apo LmPC at the CT dimer
interface. The c-di-AMP molecule would clash
with the enzyme in this conformation.
(D) Overlay of the four monomers of the LmPC
tetramer in the complex with c-di-AMP. The su-
perposition is based on the CT domain only. A
small conformational difference is seen for the BC
domain.
(E) Overlay of the four monomers of the apo LmPC
tetramer. Large differences are observed in the
positions and orientations of the BC domains.
domains are overlaid for the apo enzyme,
and the hinge rotation is located near the
boundary between the BC and PT do-
mains (Figure 5E). In comparison, the
overlay of the CT domains brought the
PT domains into superposition. The PT
domains of SaPC and HsPC have impor-
tant roles in mediating contacts in the
tetramer (Xiang and Tong, 2008). The PT
domains in the c-di-AMP complex of
LmPC and apo LmPC are positioned
further away from each other and do not
make direct contacts (Figure 5A).
Metabolic Balance Mediated by
c-di-AMP Affects Intracellular
Growth of L. monocytogenes
Structural and biochemical character-
ization of the interaction between
LmPC and c-di-AMP implicates the
nucleotide as a metabolic regulator in
L. monocytogenes. Listeria species have an incomplete citric
acid cycle, and the oxaloacetate (OA) generated by LmPC is
used as a precursor for aspartate and glutamate biosynthesis
(Figure 6A) (Kim et al., 2006). To study the effects of c-di-AMP
levels on metabolism in L. monocytogenes, we measured in-
corporation of isotope label from U-13C-glucose into amino
acids alanine (Ala), aspartate (Asp), and glutamate/glutamine
(Glx) in both WT and a conditional depletion strain of DacA
(cDdacA), which exhibits diminished levels of c-di-AMP (Witte
et al., 2013). Bacteria with depleted c-di-AMP exhibited substan-
tially increased 13C incorporation into Glx relative to bacteria with
normal levels of the nucleotide (Figure 6B). De novo synthesis of
Glx is entirely dependent on LmPC activity in L. monocytogenes
(Schär et al., 2010) and flux through the oxidative branch of the
citric acid cycle. To determine if these observations are a result
of PC activity directly, we generated a double conditional deple-
tion strain, cDdacA cDpycA, with IPTG inducible expression of
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DacA and theophylline inducible expression of PC (Figure S7A).
Indeed, increased levels of theophylline in the absence of IPTG
led to a direct increase in Glx synthesis (Figure 6B). Thus, c-di-
AMP, through its action on LmPC and possibly other down-
stream targets that affect flux through this pathway, negatively
affects de novo Glx biosynthesis. In comparison, reduced c-di-
AMP levels did not affect Asp synthesis, indicating that LmPC
is not the limiting activity for this pathway.
We hypothesized that this metabolic imbalance may be
responsible for the defects in bacterial growth and host coloniza-
tion associated with low levels of c-di-AMP. To test this possibil-
ity we infected macrophages with the cDdacA cDpycA strain
grown in the presence of varying concentrations of theophylline.
Increased cytosolic growth was observed as theophylline levels
were increased until a critical threshold was achieved, after
which the strain exhibited limited growth comparable to cDdacA
(Figure 6C). These observations are consistent with previous
reports where low PC activity results in diminished bacterial
growth in the cytosol. However, our findings also show that
enhanced PC activity is detrimental in the absence of c-di-
AMP and are consistent with the requirement for balancedmeta-
bolic activity to establish infection in the host.
It has not been established why PC is essential for
L. monocytogenes, though disruption of aspB resulted in dimin-
ished bacterial growth (data not shown), consistent with this
being the essential branch emanating from the precursor metab-
olite oxaloacetate. Based on these observations, we hypothe-
sized that the metabolic imbalance associated with diminished
c-di-AMP levels was a consequence of elevated flux to Glx. To
segregate the detrimental effects of hypo and hyperactive PC
we deleted citrate synthase (CitZ, Figure 6A), the first committed
step to Glx biosynthesis. Incorporation of 13C into Glx was abol-
ished in the WT and cDdacA strains containing the citZmutation
(Figure 6D), while levels of Asp and Ala incorporation remained
unchanged. Thus, disruption of citZ prevents unregulated gluta-
mate/glutamine biosynthesis from glucose under conditions of
low c-di-AMP.
Having corrected the elevated synthesis of Glx, we detailed
the effects of metabolic imbalance associated with altered
c-di-AMP signaling on L. monocytogenes growth and infection.
Although disruption of citZ had no discernable effect on broth
growth in the presence or absence of c-di-AMP production
(Figure S7B), a significant increase in intracellular growth in
the absence of c-di-AMP was observed within immortalized
bone-marrow-derived macrophages (iBMM) and mouse fi-
broblasts (Figures 6E and 6F). No change in growth was
observed for citZ disruption in the WT background (Figures
6F and S7C). Analysis of bacterial growth revealed that the
doubling time was not significantly altered by loss of citZ,
consistent with observations in rich media. However, the ability
of L. monocytogenes to maintain intracellular growth between 5
and 8 hr was rescued by disruption of citZ, resulting in nearly
WT levels of bacterial burden at later time points. Expression
of the citrate synthase gene in trans attenuated intracellular
growth of the cDdacA DcitZ strain back to cDdacA levels
(Figure 6E).
Figure 6. Metabolic Imbalance Specifically Alters L. monocytogenes Intracellular Growth
(A) De novo biosynthesis of amino acids and labeling patterns from 13C-glucose by L. monocytogenes. Dark spheres, 13C. Light spheres, natural abundance
carbon.
(B) 13C enrichment into Ala, Asp, and Glx from midexponential L. monocyotogenes strains.
(C) Magnitude of growth of L. monocytogenes strains in iBMMs. Data reported as the ratio of CFU recovered at 8 hpi relative to 0.5 hpi.
(D) 13C enrichment into Ala, Asp, and Glx from midexponential L. monocyotogenes strains.
(E) Immortalized murine bone-marrow-derived macrophages were infected with L. monocytogenes and CFU were enumerated at the indicated times.
(F) Plaque area from mouse fibroblasts (L2 cells) infected with indicated strains and normalized to WT.
(G) Bacterial burden in organs 48 hr postinfection with the median indicated by a horizontal bar.
(C–F) Data aremean ±SEM (B–G) Data are representative of at least two independent experiments. (D) *p < 0.001 (Students t test, two-tailed). See also Figure S7.
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To further characterize the effects of metabolic imbalance
associated with c-di-AMP deficiency, a murine model of acute
listeriosis was characterized. As previously reported (Witte
et al., 2013), the cDdacA strain exhibited 3.8- and 4.6-log defects
in both the spleen and liver, respectively (Figure 6G). When citZ
was disrupted in the cDdacA strain, 2.7- and 2.4-logs of growth
were rescued in the spleen and liver, respectively. Together
with ex vivo analysis of intracellular growth, these findings
support a model whereby metabolic imbalance associated
with altered c-di-AMP levels specifically affects the magnitude
of L. monocytogenes growth within the host cell cytosol with
significant consequences on bacterial virulence.
Metabolic Imbalance in L. monocytogenes Causes
Bacteriolysis within the Host Cytosol
To further elucidate the basis for the intracellular growth defect
resulting from altered bacterial metabolic activity, we charac-
terized the host response to infection. DNA released by
L. monocytogenes leads to activation of Caspase 1 through
the AIM2 inflammasome, resulting in pyroptosis during
L. monocytogenes infection (Sauer et al., 2010). We found that
bacteria with diminished levels of c-di-AMP production induce
increased cell death during infection (Witte et al., 2013), while
those with corrected metabolic activity through citZ disruption
exhibited significantly decreased levels of host cell death (Fig-
ure 7A). Consistent with these observations, bacteria deficient
in c-di-AMP production exhibit increased DNA delivery during
infection, while the metabolic correction of this strain results in
significantly reduced intracellular bacteriolysis (Figure 7B). Inter-
estingly, no significant change in bacteriolysis is observed during
growth in broth media (Figure 7C).
Pyroptosis is a protective host response to L. monocytogenes
infection (Sauer et al., 2011). As such, we predicted that removal
of this inflammatory response might rescue the growth of c-di-
AMP deficient bacteria that exhibit c-di-AMP-related metabolic
imbalance. Consistent with this hypothesis, intracellular growth
of bacteria deficient in c-di-AMP production significantly im-
proved in the absence of pyroptosis in primary bone-marrow-
derived macrophages (Figure 7D). These observations suggest
that the metabolic imbalance associated with diminished c-di-
AMP signaling leads in part to diminished bacterial growth as
a consequence of an enhanced restrictive host response.
Together with our biochemical studies we conclude that these
effects are most likely due to c-di-AMP-mediated regulation of
LmPC and perhaps other metabolic factors.
DISCUSSION
Chemical proteomics provides a powerful approach to interro-
gate small molecule-protein interactions (Rix and Superti-Furga,
2009). The nucleotide interactome revealed here substantially
broadens the known c-di-AMP protein-based signaling reper-
toire; identifying five previously unrecognized c-di-AMP-inter-
acting proteins in L. monocytogenes, in addition to LmPC.
The large number of effectors, their domain diversity, and seem-
ingly disparate functional roles (Grinberg et al., 2006; Leigh
and Dodsworth, 2007; Liu et al., 2006; Scott et al., 2004) are
consistent with the pleiotropic effects of the dacA gene in
L. monocytogenes.Our studies genetically segregate the effects
of c-di-AMP on the magnitude of intracellular growth and intra-
cellular bacterial lysis from other known phenotypes associated
with loss of c-di-AMP production. We anticipate that the identi-
fication of several other protein receptors for c-di-AMPwill guide
future studies to define the molecular details governing changes
in other c-di-AMP related phenotypes, including bacterial cell
stability in broth, susceptibility to cell-wall targeting antibiotics,
and bacterial growth rate in and out of the host.
Beyond broadening the known c-di-AMP effectors, our
studies provide a detailed molecular characterization of the ef-
fects of c-di-AMP on PC activity. Our structural studies of apo
and c-di-AMP-bound LmPC in comparison to known PC struc-
tures provide mechanistic insight into an unexpected mode
of enzyme regulation. The nearly identical structure of the
four LmPC monomers in the c-di-AMP complex is rather un-
usual among known PC structures. For SaPC, the differences
in the orientations of the BC domains vary between 6 and
18 after their CT domains are superimposed (Xiang and
Tong, 2008; Yu et al., 2009), and the differences are even larger
for RePC (St Maurice et al., 2007). The structural differences
among the four monomers in apo LmPC, as well as in SaPC
and RePC, indicate that domain movements are necessary dur-
ing PC catalysis, which is supported by recent EM studies on
SaPC (Lasso et al., 2014). Based on these observations, we
Figure 7. C-di-AMP-Induced Metabolic Imbalance Provokes Intra-
cellular Bacteriolysis and Host Cell Pyroptosis
(A) Cytotoxicity induced in iBMMs by the indicated strains following infection
was measured by LDH release.
(B) Intracellular lysis of bacterial strains in iBMMs as measured by reporter
plasmid delivery. Percent lysis was determined by normalizing to Holin-Lysin
and uninfected controls.
(C) Lysis of L. monocytogenes strains grown in BHI.
(D) Growth of cDdacA L. monocytogenes in WT (closed symbols) and Caspase
1/ (open symbols) BMMs.
Data are mean ± SEM and are representative of at least two independent
experiments. *p < 0.05 (Students t test, two-tailed); NS, not significant.
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favor a mechanism whereby c-di-AMP ‘‘freezes’’ the enzyme
into a single (symmetrical) conformation, which is incompatible
with catalysis.
Structure-function studies also clearly establish the location
and strict specificity of the c-di-AMP-binding pocket. However,
it is currently not clear how nucleotide specificity is achieved,
as there are no hydrogen-bonding interactions to the base. Mu-
tations of the sole base-interacting amino acid, Tyr722, do not
extend inhibition activity to related nucleotides, and therefore
other residues may contribute to this specificity. Beyond confer-
ring specificity, changes in this pocket have significant conse-
quences on enzyme function, even in the absence of ligand
binding. These observations may be indicative of a previously
unrecognized allosteric site for PC enzymes in response to
c-di-AMP and possibly other stimuli. Significant variability is
observed within the regulatory site identified by our studies.
The EfPC-c-di-AMP interaction illustrates this mechanism of
regulation extends beyond L. monocytogenes and that in the
absence of amino acid conservation, divergent amino acids
within the c-di-AMP-binding site can compensate to maintain
nucleotide-mediated enzyme regulation. Given the central func-
tion of PC, proper integration of this enzyme into existing meta-
bolic networks is required to maintain metabolic balance. As
such, we postulate that the diversity of the sequence at this novel
functional site may reflect divergent mechanisms of regulation,
either through allosteric ligands or altered enzyme dynamics,
which fine tune activity such that PC can properly integrate
into the unique metabolic capacity of the diverse organisms
that utilize this enzyme.
Bacteria have the capacity to thrive within a variety of environ-
mental and host niches. This adaptability is largely reliant on
the capacity to utilize diverse nutrients encountered in these
disparate environments. The phosphoenolpyruvate-pyruvate-
oxaloacetate node of central metabolism shapes the distribution
of carbon metabolites among anabolic, catabolic, and energy-
producing pathways (Jitrapakdee et al., 2008; Jitrapakdee and
Wallace, 1999; Sauer and Eikmanns, 2005; Schär et al., 2010).
Given this central function, aberrant metabolic activity as a
consequence of altered c-di-AMP signaling may disrupt any
one or a combination of the pathways required for bacterial
adaptation to accessible nutrients. During infection, intracellular
L. monocytogenes undergo a major metabolic transition from
utilization of glucose to alternative carbon sources (Joseph
et al., 2006), a process that affects activation of the master viru-
lence regulator PrfA (Joseph et al., 2008; Stoll et al., 2008).
Consequently, changes in PEP levels through increased pyru-
vate consumption may diminish PrfA activation and directly
link c-di-AMP-related metabolic activity to virulence capacity.
However, our observation that bacterial lysis is a downstream
consequence of altered c-di-AMP-dependent metabolism
suggests that the answer partially relates to the integrity of the
bacterial cell. The metabolic burden generated by unregulated
flux through the citric acid cycle may cause insufficiency in
cell wall biosynthesis intermediates, leading to bacteriolysis.
No apparent deficiency in de novo Asp, Ala, or Glx synthesis,
each of which contributes to biosynthesis of the glycan and pep-
tide components of the cell wall, suggests that limitations in
these metabolites are not responsible. As the critical compound
utilized by L. monocytogenes to combat acid stress and the pri-
mary counter ion to osmotic stabilizing potassium (Booth and
Higgins, 1990; Cotter et al., 2005; Yan et al., 1996), synthesis
of glutamate must be tightly regulated to appropriately respond
to changing conditions. As such, increased production of
glutamate and the precursor metabolites in its biosynthetic
pathway may have toxic effects on bacterial stability in the
cytosol. Finally, hyperactivity of LmPC and subsequent turn-
over of OA by CitZ could lead to defects in lipid synthesis
by consuming acetyl-CoA, a major precursor for the acyl-chain
required to generate branched chain fatty acids. It is not known
if L. monocytogenes strains deficient in these lipids exhibit
enhanced intracellular lysis; however, the synthesis of these
membrane components is required for L. monocytogenes sur-
vival within the cytosol of the host cell (Sun and O’Riordan,
2010). Clearly the effects of PC regulation extend beyond this
intracellular pathogen. The evidence supporting PC regulation
among lactic acid bacteria suggests that both extracellular path-
ogenic (i.e., E. faecalis) as well as nonpathogenic commensal
Lactobacilli spp. utilize a similar mechanism of metabolic regula-
tion, though the effects of this regulation remain an open
question. Future studies to detail the functional consequences
of c-di-AMP-mediated metabolic regulation through PC and
likely other protein receptors will provide important insight into
the physiology of these medically important host associated
organisms.
In summary, the c-di-AMP-binding proteins reported here are
widespread and conserved among environmental and patho-
genic microbes alike and broadly expand the protein targets of
c-di-AMP in bacteria. Furthermore, our biochemical and struc-
tural studies may provide important insight into a new molecular
mechanism of central metabolic regulation through the enzyme
PC. Finally, our studies demonstrate that c-di-AMP signaling
regulates bacterial central metabolism and survival within the
host environment. These findings lead us to propose that c-di-
AMP serves a conserved and central role in the regulation of
fundamental metabolic processes with important physiological
implications in the unique environments occupied by the bacte-
ria that utilize this secondary signaling molecule. A detailed un-
derstanding of bacterial signaling and metabolic regulation has
profound practical and therapeutic applications. As a central
element of these processes, the possibility of targeting c-di-
AMP signaling pathways in this regard is an attractive option
that remains to be explored.
EXPERIMENTAL PROCEDURES
C-di-AMP Pull-Downs
Soluble lysates from L. monocytogenes grown in 1.5 L BHI broth at 37C to
midexponential phase (OD600 = 0.8) were prepared in 30 ml of buffer (0.1 M
Tris-HCl [pH 7.5], 150 mM NaCl, 0.1% v/v Tween-20, 1 mM PMSF). Lysates
were incubated with rotation for 2 hr at 4C with 100 ml ethanoamine or c-di-
AMP conjugated beads. Beads were washed three times with 5 ml PBS,
mixed with 100 ml of SDS-PAGE sample loading buffer, incubated at 56C
for 10 min, and the soluble fraction removed. The elution was repeated
and each was pooled and processed for quantitative mass spectrometry
as detailed in the Supplemental Information. Pulldowns were performed
three independent times, one with the DpdeA strain and twice with WT
L. monocytogenes.
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Nucleotide-Binding Assays
The DRaCALA assays were performed with recombinant proteins or E. coli ly-
sates in binding buffer (40 mM Tris,100 mM NaCl, 20 mM MgCl2 [pH 7.5])
and analyzed as described previously (Roelofs et al., 2011). For competition
assays, 400 mM unlabeled nucleotide (ATP, GTP, cAMP, cGMP, NAD,
NADH, c-di-AMP, c-di-GMP, pApA) was added prior to the addition of
32P-c-di-AMP.
Protein Crystallization
LmPC crystals were grown by the sitting-drop vapor diffusion method at 20C.
For the c-di-AMP complex, the protein was incubated with 2.5 mM c-di-AMP
and 2.5 mM ATP for 30 min at 4C before setup. The reservoir solution con-
tained 19% (w/v) PEG3350 and 0.2 M ammonium citrate (pH 7.0). The crystals
appeared within 1–2 weeks and grew to full size after a few additional days.
The crystals were cryoprotected in the reservoir solution supplemented with
10% (v/v) PEG200 and were flash-frozen in liquid nitrogen for data collection
at 100 K. For the apo structure, the protein at 5 mg/ml was incubated with
2.5mMATP and 2.5mMpyruvate for 30min at 4Cbefore setup. The reservoir
solution contained 16% (w/v) PEG3350, 0.1 M Bis-Tris (pH 6.5), and 1% (w/v)
tacsimate (pH 7.0, Hampton). The crystals appeared within 1week and grew to
full size within a few more days. They were cryoprotected in the reservoir so-
lution supplemented with 15% (v/v) ethylene glycol and flash frozen in liquid
nitrogen. Data collection and structure determination were as detailed in the
Extended Experimental Procedures.
13C Incorporation Studies
Bacterial strains were grown overnight in BHI at 37C. The cells were sedi-
mented and washed with PBS. BHI was supplemented with 2.5 mg/ml
[U-13C6] glucose and were subsequently inoculated with an aliquot of the
cell suspensions to an OD600 of 0.1. The cultures were grown at 37
C until
OD600 = 1.0. Sodium azide was then added to a final concentration of
10 mM. The cells were centrifuged and washed three times with water. Bacte-
rial cells (approximately 20 mgwashed wet pellet) were suspended in 0.5 ml of
6 M hydrochloric acid. The mixture was heated at 105C for 24 hr. The hydro-
lysate was placed on a column of Dowex 50W3 8 (H+form; 200 to 400mesh; 5
by 10 mm) previously washed with 4 ml of 7% formic acid and water. After
loading the acid hydrolysate the column was washed with 4 ml of water. Sam-
ple was then eluted with 4 ml of 1 N ammonium hydroxide. The samples were
air-dried under vacuum, and the residue was dissolved in 30 ml of pyridine. A
total of 30 ml of-(tert-butyldimethyl-silyl)-methyl-trifluoroacetamide containing
1% tert-butyl-dimethyl-silylchloride (Sigma) was added. The mixture was kept
at 90C for 60 min. Derivatized amino acids were analyzed by GC/MS as
detailed in the Extended Experimental Procedures.
Tissue Culture and Infection Assays
Primary bone-marrow-derived macrophages were generated as previously
described (Jones and Portnoy, 1994). Macrophage growth curves, LDH, and
DNA release assays were performed in primary or J2 immortalized BMMs
(Sauer et al., 2010), as indicated. Plaque assays we conducted in L2 mouse
fibroblasts (Sun et al., 1990). Murine infections were performed as described
previously (Witte et al., 2013). All protocols were reviewed and approved by
the Institutional Animal Care and Use Committee at the University of Wiscon-
sin, Madison and the University of Washington.
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Cyclic-di-AMP (c-di-AMP) is a broadly conserved bacterial second messenger
that is of importance in bacterial physiology. The molecular receptors mediat-
ing the cellular responses to the c-di-AMP signal are just beginning to be dis-
covered. PstA is a previously uncharacterized PII-like protein which has been
identified as a c-di-AMP receptor. PstA is widely distributed and conserved
among Gram-positive bacteria in the phylum Firmicutes. Here, we report the
biochemical, structural, and functional characterization of PstA from Listeria
monocytogenes. We have determined the crystal structures of PstA in the c-di-
AMP-bound and apo forms at 1.6 and 2.9 A resolution, respectively, which
provide the molecular basis for its specific recognition of c-di-AMP. PstA forms
a homotrimer structure that has overall similarity to the PII protein family
which binds ATP. However, PstA is markedly different from PII proteins in the
loop regions, and these structural differences mediate the specific recognition of
their respective nucleotide ligand. The residues composing the c-di-AMP bind-
ing pocket are conserved, suggesting that c-di-AMP recognition by PstA is of
functional importance. Disruption of pstA in L. monocytogenes affected c-di-
AMP-mediated alterations in bacterial growth and lysis. Overall, we have
defined the PstA family as a conserved and specific c-di-AMP receptor in
bacteria.
Introduction
Bacteria utilize a wide array of nucleotide-based signaling
molecules. Cyclic-di-AMP (c-di-AMP) is a broadly con-
served and functionally diverse cyclic-dinucleotide second
messenger that is found in many bacterial species. The
levels of c-di-AMP in the cell are controlled through the
opposing activities of diadenylate cyclases (DACs) which
synthesize c-di-AMP from two molecules of ATP or
ADP (Witte et al. 2008; Bai et al. 2012) and DHH/
DHHA1 or HD domain containing phosphodiesterases
which degrade c-di-AMP to pApA or AMP (Rao et al.
2010; Bai et al. 2013; Huynh et al. 2015). Cyclic-di-AMP
is of fundamental importance for microbial physiology
ª 2015 The Authors. MicrobiologyOpen published by John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use,
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including bacterial growth and metabolism, cell morphol-
ogy, potassium homeostasis, stress responses, antibiotic
resistance, and virulence (Corrigan et al. 2011; Oppenhei-
mer-Shaanan et al. 2011; Luo and Helmann 2012; Pozzi
et al. 2012; Smith et al. 2012; Corrigan and Grundling
2013; Mehne et al. 2013; Campos et al. 2014; Sureka et al.
2014).
Several macromolecules such as the metabolic enzyme
pyruvate carboxylase (Sureka et al. 2014), the ydaO
riboswitch family (Nelson et al. 2013), the transcription
factor DarR (Zhang et al. 2013), and proteins involved in
potassium uptake (Corrigan et al. 2013; Bai et al. 2014)
have been identified as c-di-AMP receptors in bacteria. In
addition, the innate immune system in humans can detect
secreted c-di-AMP during bacterial infection through the
cytosolic surveillance protein STING (stimulator of inter-
feron genes), leading to a host type I interferon response
(Woodward et al. 2010; Burdette and Vance 2013). Recent
studies on c-di-AMP signaling have begun to unravel some
of the molecular mechanisms through which c-di-AMP
exerts its physiological effects in bacteria. Crystal structures
of c-di-AMP bound to the metabolic enzyme pyruvate car-
boxylase (Sureka et al. 2014) and the ydaO riboswitch
(Gao and Serganov 2014; Jones and Ferre-D’Amare 2014;
Ren and Patel 2014) have provided insights into the mech-
anism by which c-di-AMP is recognized by its receptors.
PstA (PII-like signal transduction protein A) is a previ-
ously uncharacterized protein that has been reported to
bind c-di-AMP in Staphylococcus aureus (Corrigan et al.
2013) and Listeria monocytogenes (Sureka et al. 2014), and
its sequence is highly conserved among the collection of
bacterial species (Fig. 1A). PstA contains a DUF970
domain which is predicted to be structurally homologous
to the nitrogen regulatory PII proteins (Corrigan et al.
2013). PII proteins are able to sense ATP, ADP, and 2-oxo-
glutarate levels in the cell (Corrigan et al. 2013; Huergo
et al. 2013), and these various ligands modify the PII struc-
ture promoting its binding and regulation of protein tar-
gets such as the ammonium channel AmtB (Conroy et al.
2007; Gruswitz et al. 2007). There have been many
reported crystal structures of PII proteins bound to its
ligands, and the binding pocket for ATP has been particu-
larly well characterized (Xu et al. 1998; Sakai et al. 2005;
Shetty et al. 2010). In contrast, PstA was found to bind
specifically to c-di-AMP but not ATP (Sureka et al. 2014),
although the structural basis for this selectivity was not
known. Here, we report the crystal structures of PstA from
L. monocytogenes (LmPstA) bound to c-di-AMP and in the
apo form. A comparison of these structures to the ATP-
bound PII proteins reveals significant differences in the
architecture of the binding pocket for each ligand, provid-
ing a structural basis for the specific binding of c-di-AMP
to PstA. We also find that the c-di-AMP binding pocket in
PstA is highly conserved (Fig. 1A), suggesting that this
interaction is of importance in bacterial physiology.
Experimental Procedures
Protein expression and purification
L. monocytogenes pstA (lmo2692) was subcloned into a
pET20b vector with a C-terminal His-tag. This construct
was transformed into BL21(DE3) Rosetta cells. The cells
were cultured in LB (Luria–Bertani) medium with 35 mg/
L kanamycin and 35 mg/L chloramphenicol and were
induced for 14 h with 1 mmol/L Isopropyl b-D-1-thioga-
lactopyranoside at 20°C. The protein was purified through
nickel-agarose affinity chromatography followed by gel fil-
tration chromatography (S-300, GE Healthcare, Piscat-
away, New Jersey, USA). The purified protein was
concentrated to 20 mg/mL in a buffer containing
20 mmol/L Tris (pH 8.0), 150 mmol/L NaCl, 5% (v/v)
glycerol, and 5 mmol/L dithiothreitol, flash-frozen in
liquid nitrogen and stored at 80°C. The C-terminal
hexa-histidine tag was not removed for crystallization.
Crystallization
LmPstA crystals were grown by the sitting-drop vapor dif-
fusion method at 20°C. For the c-di-AMP complex, the
protein at 20 mg/mL was incubated with 2.5 mmol/L c-
di-AMP for 30 min at 4°C before setup. The reservoir
solution contained 12% (w/v) PEG3350 and 0.1 mol/L
sodium malonate (pH 4.0). The crystals appeared within
1–2 weeks. The crystals were cryoprotected in the reser-
voir solution supplemented with 15% (v/v) glycerol and
were flash-frozen in liquid nitrogen for data collection at
100 K. For the apo LmPstA structure, the protein at
10 mg/mL was mixed with a reservoir solution contained
20% (w/v) PEG3350, 0.1 mol/L bis-Tris (pH 5.5), and
0.1 mol/L ammonium acetate. The crystals appeared
within 1 week and grew to full size within a few more
days. They were cryoprotected in the reservoir solution
supplemented with 10% (v/v) glycerol and flash-frozen in
liquid nitrogen.
Data collection and structure determination
All X-ray diffraction data were collected at the X29 beam-
line at the National Synchrotron Light Source (NSLS) at
Brookhaven National Laboratory. The diffraction images
were processed using HKL3000 (Minor et al. 2006). The
structures were solved using the molecular replacement
method with the program Phaser (McCoy et al. 2008),
using a PstA homolog from Pediococcus pentosaceus (PDB
code 3M05) as the search model. Manual rebuilding was
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carried out in Coot (Emsley and Cowtan 2004) and
refinement was done with the program Refmac (Murs-
hudov et al. 1997). Coordinates and structure factors have
been deposited in the Protein Data Bank with accession
codes 4RWW and 4RWX.
Site-directed mutagenesis
Mutants were made using the QuikChange kit (Agilent
Technologies, Santa Clara, California, United States) and
confirmed by sequencing. The primers used for generation
of amino acid variants are listed in Table 1. PstA contain-
ing point mutants were expressed and purified using the
same protocol as the wild-type (WT) protein.
Construction of ΔpstA strain
Deletion of the chromosomal copy of pstA was accom-
plished using the pKSV7-oriT plasmid. Briefly, 1000 base
pairs flanking the 50 and 30 ends of the pstA gene were
amplified and subsequently combined by splicing by over-
lap extension (SOE) PCR using the primers described in
Table 1. A total of six amino acids from the original open
reading frame were retained to limit disruption of down-
stream genes. The SOE amplified product was digested
with SacI and PstI and ligated into similarly digested
pKSV7-oriT. The plasmid was then conjugated into L.
monocytogenes WT or cΔdacA strains through the donor
strain E. coli SM10. Subsequent selection for integration,
(A)
(B)
Figure 1. Crystal structure of Listeria
monocytogenes PstA in complex with cyclic-di-
AMP (c-di-AMP). (A) Sequence alignment of
PstA from L. monocytogenes (Lm),
Staphylococcus aureus (Sa), Halobacillus
halophilus (Hh), Bacillus subtilis (Bs),
Enterococcus faecalis (Ef), Lactobacillus brevis
(Lb), Clostridium botulinum (Cb), and
Thermoanaerobacterium
thermosaccharolyticum (Tt). The secondary
structure elements are indicated at the top of
the alignment. Conserved residues are
indicated in red. Residues that interact with c-
di-AMP are colored cyan (monomer 1) or
yellow (monomer 2). The T-loop is indicated by
the orange bar. The B-loop is indicated by the
green bar. Produced with Espript (Gouet et al.
1999). (B) Schematic drawing of the LmPstA
homotrimer in complex with three c-di-AMP
molecules. The three monomers are colored
separately and the c-di-AMP molecules are
labeled. The structure figures were produced in
PyMOL (http://www.pymol.org).
ª 2015 The Authors. MicrobiologyOpen published by John Wiley & Sons Ltd. 363
P. H. Choi et al. Structure of PstA in complex with c-di-AMP
 167
plasmid excision, and plasmid curing were as described
previously (Camilli et al. 1993).
Complementation of ΔpstA strain
For complementation, pstA was expressed under the con-
stitutive hyper-Pspac promoter. The pstA gene was ampli-
fied using the primers GTG GTG GTA CCT TTT AGG
AAG GGT TGA TTT CTT TG and GAT TGC TGC AGC
TAG TGA TGA TGA TGA TGA TGA AAA TGA TGG
AAA CTC TCA A and the PCR product was digested
with KpnI and PstI restriction enzymes and ligated into
the plasmid pJW361 (Sureka et al. 2014) digested with
the same enzymes. The resulting plasmid was then elec-
troporated into different ΔpstA strains.
Tissue culture and infection assays
Macrophage growth curves, DNA release, and plaque
assays were performed in J2 immortalized marrow-
derived macrophages (BMMs) (Sauer et al. 2010) or L2
mouse fibroblasts as indicated and described previously
(Sun et al. 1990).
Bacteriolysis and antibiotic susceptibility
Bacteriolysis as measured by b-galactosidase release and
sensitivity to cefuroxime determined by the zone of inhi-
bition in a disk diffusion assay were performed as
described previously (Witte et al. 2013).
Results
Biochemical and genetic characterization of
PstA
We previously identified LmPstA as a c-di-AMP binding
protein utilizing a chemical proteomics approach (Sureka
et al. 2014). It binds c-di-AMP specifically with a Kd of
1.4 lmol/L, determined with DRaCALA (differential
radial capillary action of ligand assay), which is consistent
with the levels of c-di-AMP in bacterial cells (Corrigan
et al. 2013). We analyzed the sequence database to assess
the conservation of PstA in bacteria, and found that it is
widely distributed in Firmicutes (low GC content Gram-
positive bacteria), but is completely absent in Actinobac-
teria (high GC content Gram-positive bacteria) and
Gram-negative bacterial species. The sequence of PstA
consists of 109 residues and is generally well conserved
between species (Fig. 1A). LmPstA has 16% and 20%
sequence identity with the Escherichia coli PII proteins
GlnK and GlnB, respectively.
We also analyzed the genomic context of the pstA gene
in the bacterial species L. monocytogenes, S. aureus, Bacil-
lus subtilis, Enterococcus faecalis, Clostridium botulinum,
and Lactobacillus brevis. In all of these species, pstA is
invariably found in an operon with the gene encoding
thymidylate kinase, an enzyme involved in the purine sal-
vage pathway. In several of these bacteria, a gene encod-
ing an ornithine–arginine–lysine decarboxylase is also part
of this operon.
Table 1. Primers used in this study.
Primer name Sequence Description
ΔpstA A
SacI fwd
GAGGAGGAGCTCGCGACCGAATTCGCATTAC Primer for amplifying 1000 bp upstream
of pstA. The SacI cut site is underlined
ΔpstA B rev TCCCACTATCTGTTCTAAAAATGATGGAGTTTCAAAGAAATCAACCCTTCC Primer for amplifying 1000 bp upstream of pstA
ΔpstA C
fwd




GAGGAGCTGCAGGGACTCACTTTGGAGAATCGC Primer for amplifying 1000 bp downstream
of pstA. The PstI cut site is underlined
pstA KpnI
fwd
GTGGTGGTACCTTTTAGGAAGGGTTGATTTCTTTG Primer for amplifying pstA into pJW282.
The KpnI cut site is underlined
pstA PstI rev GATTGCTGCAGCTAGTGATGATGATGATGATGAAAATGATGGAAACTCTCAA Primer for amplifying pstA into pJW282.
The PstI cut site is underlined
pstA F36A S GTTTCCTGCTTTTAAAGCTCCACCCGTTGTAGC Sense primer for quick change mutagenesis
of PstA
pstA F36A AS GCTACAACGGGTGGAGCTTTAAAAGCAGGAAAC Antisense primer for quick change mutagenesis
of PstA




TTTTTAAAAGCAGGAGCCACCACGTTTATCATC Antisense primer for quick change mutagenesis
of PstA
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Overall structure of PstA and comparison
with PII proteins
We cocrystallized LmPstA with c-di-AMP and determined
the structure of the complex at 1.6 A resolution by the
molecular replacement method (Fig. 1B). A homolog of
PstA from P. pentosaceus (PDB code 3M05), which shares
56% sequence identity with LmPstA, was used as the
search model. We also determined the apo structure of
LmPstA at 2.9 A resolution. There is a trimer of LmPstA
in the asymmetric unit for both crystals, and LmPstA
migrated as a trimer on a gel filtration column. The final
atomic models have good agreement with the X-ray dif-
fraction data and the expected geometric parameters
(Table 2). All of the residues in both structures are in the
favored region of the Ramachandran plot.
The structure of each LmPstA monomer is composed
of a four-stranded antiparallel b-sheet packed against two
a-helices on one face (Fig. 2A). A fifth b-strand from a
neighboring monomer of the trimer joins the b-sheet. We
compared LmPstA to the crystal structure of a GlnK PII
protein bound to ATP from Mycobacterium tuberculosis
(Mtb PII, PDB code 3LF0), which is structurally represen-
tative of the larger PII family of proteins. The architecture
of the LmPstA monomer is largely similar to the Mtb PII
monomer (Shetty et al. 2010) with a r.m.s. (root mean
square) distance of 1.0 A for their Ca atoms when the
monomers are overlaid without the loop regions (Fig. 2B
and C). However, several of the loops that connect the
various b-strands and a-helices have notable differences.
For consistency, the naming convention for the PII pro-
tein loops will be used for the description of PstA. In
Mtb PII, the T-loop (residues 36–55) is a 20-residue flexi-
ble extension located in the loop connecting strands b2
and b3. The B-loop (residues 82–87) is a smaller loop
connecting a2 and b4 (Fig. 2B). There is also a C-loop at
the C-terminus of the protein. In PstA, however, the B-
loop (residues 65–94) has a 30-residue extension while
the T-loop (residues 35–38) is much shorter and LmPstA
does not contain a C-loop (Figs. 1A and 2A). The B-loop
forms a twisted two-stranded b-sheet (residues 67–71 and
89–93) connected by a long looping turn (residues 72–
88). The two-stranded b-sheet structure of the B-loop of
LmPstA is similar to the T-loop of Mtb PII. However, the
length of the turn connecting the two b-strands is much
shorter in the Mtb PII T-loop.
The three LmPstA monomers are almost identical in
structure with an r.m.s. distance of 0.3 A for their Ca
atoms, with the exception of the B-loop which shows
variations among the three monomers, reflecting its flexi-
bility (Fig. 2A). Similarly, crystal structures of PII pro-
teins also show T-loops adopting various conformations
(Sakai et al. 2005). However, the overall orientation of
the LmPstA B-loop in relation to the core trimer struc-
ture is comparable between the three monomers
(Fig. 1B). The B-loop has several intermolecular inter-
actions with the B-loops from neighboring trimers, so
crystal contacts likely contribute to some degree to the
observed conformations of this loop. A part of the B-loop
in two of the monomers is disordered. In the apo LmPstA
structure, all of the T-loops and B-loops have disordered
regions.
Table 2. Summary of crystallographic data.
c-di-AMP complex apo
Space group P1 P212121
Cell dimensions
a, b, c (A) 51.2, 51.8, 53.0 55.9, 61.6, 83.5
a, b, c (°) 110.8, 105.6, 109.8 90, 90, 90
Resolution 40–1.6 (1.66–1.60) 40–2.9 (3.0–2.9)
Rmerge (%) 9.0 (41.6) 6.1 (51.3)
I/rI 15.8 (3.1) 22.4 (3.3)
Redundancy 3.9 (3.8) 4.7 (4.8)
Completeness 96.6 (94.6) 99.3 (100)
Rwork (%) 15.7 (24.6) 22.4 (33.1)





R.m.s. deviation bond lengths (A) 0.015 0.011
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In the LmPstA trimer, the b-sheet of the three mono-
mers form the core, and the a-helices are on the periph-
ery (Fig. 1B). The overall organization of this trimer is
similar to that of Mtb PII and the r.m.s. distance is 0.9 A
for their Ca atoms when the trimers are overlaid without
the loop regions.
The c-di-AMP binding mode in PstA
Three c-di-AMP molecules are bound to symmetrically
equivalent locations on the LmPstA homotrimer
(Fig. 1B), located in the inter-subunit cleft between b1
and b4, and the T/B-loops of one monomer and a1, b2–
b3, and b5 of a neighboring monomer (Fig. 3A). A
fourth c-di-AMP molecule mediates contacts between
LmPstA trimers in the crystal, which is likely a crystal-
packing artifact and will not be discussed further.
The adenine base of the first nucleotide of c-di-AMP is
recognized specifically by LmPstA, through hydrogen-
bonds between its N1 and N6 atoms with the main chain
amide and carbonyl of Gly47 (at the end of b3), respec-
tively (Fig. 3B). One face of this adenine is packed against
the Gly26–Ala27 amide bond (near the beginning of b2),
while the other face is in contact with the side chains of
Thr97 and Phe99 (in b4) from the neighboring monomer.
The 20 OH of the ribose has hydrogen-bonding interac-
tions with the side chains of Asn41 (b3 of neighboring
monomer) and Thr28 (b2), with the latter also hydrogen-
bonded to N3 of adenine. The phosphate group is hydro-
gen-bonded to the side chain His108 (b5) and the main
chain amide of Gly94 (B-loop of neighboring molecule).
The binding site for this nucleotide of c-di-AMP in
LmPstA is equivalent to that for ATP in Mtb PII (Fig. 3C).
In contrast the recognition of the second nucleotide of the
c-di-AMP molecule is mediated by unique structural fea-
tures in PstA, due primarily to the significant structural
differences in the T-loop which forms a part of the inter-
subunit cleft where the ligand binds. The extended T-loop
of Mtb PII would clash with the adenine of the second
nucleotide of c-di-AMP (Fig. 3C). Instead, the T-loop in
PstA forms a shorter, more structured loop with a con-
served 34-GGFL-37 sequence in the turn. The main chain
amides of Gly35, Phe36, and Leu37 have hydrogen-bond-
ing interactions with the phosphate group of this nucleo-
tide. The side chain of Phe36 is p-stacked against one face
of the adenine, while its other face is exposed to the
solvent.
In Mtb PII structure, the B-loop and C-loop are impor-
tant for anchoring the triphosphate moiety of ATP
(Fig. 3C). The B-loop has a highly conserved Walker A-
like sequence motif (TGxxGDGKI) (Huergo et al. 2013)
which interacts with the ATP triphosphate, and the C-
loop also interacts with the ATP triphosphate through
several arginine residues. In sharp contrast, PstA lacks the
C-loop entirely, and the B-loop has a 30-residue flexible
extension instead of the shorter, more structured B-loop
found in PII proteins. In addition, the B-loop of PstA
does not contain a Walker A-like motif. As a result, the
b- and c-phosphates of ATP are unlikely to have strong
interactions with PstA, which may explain why the pro-
tein does not bind this nucleotide.
To better characterize the c-di-AMP binding site in
PstA, residues that were found to interact with c-di-AMP
were substituted to alanine (Fig. 3D). In particular, we
mutated several conserved residues on the T-loop includ-
ing Phe36 and Asn41. The F36A mutant exhibited
reduced binding to c-di-AMP with a Kd of 7 lmol/L. The
N41A mutant had even weaker binding to c-di-AMP with
a Kd of ~140 lmol/L, though saturation was not achieved
in this binding titration, precluding an accurate measure
of the affinity. These results confirm that the c-di-AMP
binding site identified by structural analysis is the true




Figure 2. Structure of a PstA monomer and comparison with a PII
monomer. (A) Structure of a LmPstA monomer (cyan) in complex with
cyclic-di-AMP (c-di-AMP) (black). The secondary structure elements
and loops are labeled. The B-loops from the two other monomers are
shown in yellow and pink. (B) Structure of a PII monomer from
Mycobacterium tuberculosis (green) in complex with ATP (black). (C)
Overlay of the LmPstA monomer (cyan) with the PII monomer (gray).
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Conformations of the c-di-AMP molecules
The adenine base of the first nucleotide in all three c-di-
AMP molecules is in the anti conformation (Fig. 3B), as
is the case with ATP bound to PII. This is consistent with
the several specific interactions the adenine has with PstA.
In comparison, the adenine base for the second nucleo-
tide in two of the c-di-AMPs assumes a syn conformation
while the third one has an anti conformation (Fig. 4A
and B). In both conformations, the adenine base is p-
stacked against the Phe36 side chain. The ability of this
adenine to adopt syn and anti conformations is consistent
with the relative weak interactions it has with PstA. It is
unclear if this conformational flexibility has any func-
tional relevance.
In the structure of the ydaO riboswitch in complex
with c-di-AMP, the c-di-AMP molecules also have one
adenine in syn and one in anti (Gao and Serganov 2014;
Jones and Ferre-D’Amare 2014; Ren and Patel 2014). All
the adenines in the anti conformation have the C30 endo
pucker for its associated ribose, while those in the syn
conformation have a C20 endo ribose pucker (Fig. 4C).
Structural changes in PstA upon c-di-AMP
binding
The overall structure of the c-di-AMP-bound form of the
LmPstA trimer is almost identical to the apo structure
with an r.m.s. distance of 0.6 A for their Ca atoms when
they are overlaid (Fig. 5A). However, there are significant
differences in the conformations of the T-loop and B-
loop between the apo and c-di-AMP-bound structures. In
the apo LmPstA structure, the T-loop from residues 33–
39 are largely disordered, indicating that this loop is flexi-
ble in the absence of c-di-AMP binding. In addition, the
B-loop kinks at a conserved 94-GGA-96 motif upon c-di-
AMP binding significantly change the location and orien-
tation of the loop (Fig. 5B, Video S1). Several interactions
between LmPstA and c-di-AMP mediate the movement of
the B-loop upon ligand binding. The main chain nitrogen
of Gly94 interacts with the phosphate of the first nucleo-
tide of c-di-AMP, and the main chain carbonyl of Gln92
interacts with the 20 OH of the second nucleotide.
The C-terminal His-tag of the apo LmPstA structure




Figure 3. The PstA cyclic-di-AMP (c-di-AMP)
binding pocket. (A) The overall organization of
the LmPstA c-di-AMP binding pocket. The first
and second nucleotide are labeled for c-di-
AMP. (B) Detailed interactions between LmPstA
and c-di-AMP. Hydrogen-bonding interactions
are indicated with dashed lines (in black).
Water molecules are shown as red spheres. (C)
The overall organization of the Mtb PII ATP
binding pocket. (D) DRaCALA (differential
radial capillary action of ligand assay) binding
titration of c-di-AMP and LmPstA mutants
using 32P-c-di-AMP.
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affecting its conformation. Thus, we also compared the c-
di-AMP-bound LmPstA with the apo form of a PstA
homolog from P. pentosaceus which was crystallized with
an N-terminal His-tag (Fig. 5C). The same differences in
the B-loop are also seen in this comparison, and because
the B-loops are more ordered in the P. pentosaceus struc-
ture, the conformational changes that occur upon c-di-
AMP binding are even more apparent.
While our article was under preparation and review,
the structures of PstA from S. aureus (SaPstA) (Campeot-
to et al. 2015; Muller et al. 2015) and a PstA homolog
DarA from Bacillus subtilis (Gundlach et al. 2015) bound
to c-di-AMP were reported. The detailed interactions with
c-di-AMP for SaPstA and DarA are largely identical to
what we observed for LmPstA. The main difference in the
ligand binding mode between these structures and LmP-
stA is that the second adenine of c-di-AMP bound to
SaPstA and DarA is sandwiched between the side chains
of Phe36 and Arg26, forming p-stacking and cation–p
interactions. This Arg26 residue is present in most PstA
proteins (Fig. 1A), but in LmPstA this residue is instead a




Figure 4. Conformations of the cyclic-di-AMP
(c-di-AMP) molecules. (A) Omit Fo–Fc electron
density for c-di-AMP with the second
nucleotide in the syn conformation at 1.6 A
resolution, contoured at 3r. The first and
second nucleotides are labeled. (B) Omit Fo–Fc
electron density for c-di-AMP with the second
nucleotide in the anti conformation at 1.6 A
resolution, contoured at 3r. (C) Overlay of two
c-di-AMP molecules, with the second
nucleotide in syn or anti conformation.
(A)
(B)
(C) Figure 5. Comparisons between c-di-AMP
bound and apo forms of LmPstA. (A) Overlay
of cyclic-di-AMP (c-di-AMP) bound and apo
forms of the LmPstA trimer. (B) Overlay of an
LmPstA monomer with c-di-AMP bound (cyan)
and in the apo (gray) form. The red arrow
highlights the conformational changes of the
B-loop upon c-di-AMP binding. (C) Overlay of
an LmPstA monomer with c-di-AMP bound
(cyan) and a monomer of the apo form of
Pediococcus pentosaceus PstA (gray).
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indicates that the arginine side chain is dispensable for c-
di-AMP binding. In addition, the c-di-AMP molecules in
the SaPstA and DarA structures all adopt an anti confor-
mation, in contrast to the LmPstA structure. The presence
of the Arg26 residue may promote the anti conformation
of the adenine base.
The conformational change of the B-loop upon c-di-
AMP binding that was observed for LmPstA is also present
in DarA, but is absent in the Muller et al. (2015) SaPstA
structure. The Campeotto et al. (2015) SaPstA structure
shows one B-loop with a conformational change, while
this change is absent in the other two B-loops. These dif-
ferences in the B-loop conformations may be due to crys-
tal-packing influence in the SaPstA structures, in which
the N-terminal His-tag of an adjacent SaPstA trimer
makes several interactions with the c-di-AMP molecule in
place of the B-loop.
Functional studies of PstA
To interrogate the role of PstA-mediated c-di-AMP signal-
ing in L. monocytogenes, we generated ΔpstA clean dele-
tions in both WT and a conditional depletion strain of the
sole diadenylate cyclase dacA (cΔdacA) (Witte et al. 2013)
(Tables 3 and 4). Previous studies have shown that lower-
ing the c-di-AMP level in L. monocytogenes causes a severe
growth defect in nutritive media, defects in intracellular
growth, and enhanced bacteriolysis in these environments.
The absence of pstA in the cΔdacA strain resulted in a
slightly improved growth rate, with the cΔdacA ΔpstA
mutant exhibiting a 70-min doubling time, while cΔdacA
exhibited an 80-min doubling time. The ΔpstA mutant
had no effect in the WT parental background (Fig. 6A).
Bacteriolysis measured as b-Gal release into the culture
supernatant also revealed a partial rescue of the cell lysis
defect in the cΔdacA strain, with the double cΔdacA-ΔpstA
mutant exhibiting a twofold reduction relative to the
parental strain alone (Fig. 6B). Introduction of pstA on a
plasmid with a constitutively active promoter (PSPAC)
resulted in enhanced broth lysis beyond levels observed in
the cΔdacA strain, likely as a result of over complementa-
tion of PstA levels in this strain. In contrast to our expec-
tation, there was no change in cefuroxime sensitivity for
cΔdacA strain after deletion of pstA (Fig. 6C), suggesting
that the stabilization of bacterial cell after pstA deletion in
the cΔdacA strain may not be directly linked to a weak-
ened cell wall.
We next assessed the effect of PstA on intracellular
growth in macrophages and fibroblasts. In accordance
with the broth growth, deletion of pstA had no effect on
the growth of the WT strain but resulted in a small but
reproducible effect on the growth defect exerted by loss
of c-di-AMP production. Specifically, the double cΔdacA-
ΔpstA mutant was observed to reach slightly higher levels
of intracellular growth after 8 hours of BMM infection
(Fig. 6D). To examine the effect of PstA over an extended
infection period, fibroblast plaque assays were performed
for 3 days. In accordance with macrophage growth, the
plaques formed by the double cΔdacA-ΔpstA exhibited a
twofold increase in area relative to the cΔdacA strain
(Fig. 6E). We previously showed that the cΔdacA mutant
undergoes enhanced lysis in macrophages (Witte et al.
2013; Sureka et al. 2014). Therefore, we tested the intra-
cellular lysis of pstA mutants by a DNA delivery assay
(Sauer et al. 2010). The results showed a twofold reduc-
tion in cell lysis in the cΔdacA-ΔpstA double mutant
compared to cΔdacA, whereas the ΔpstA remained unaf-
fected (Fig. 6F). Together these studies suggest that in the
absence of c-di-AMP production, PstA has a negative
impact on bacterial growth and survival both in and out
of the host and that these are likely due to effects on
bacterial cell stability.
Table 3. Strains used in this study.
Strain Strain number Description Reference
WT Lm JW6 Listeria monocytogenes 10403s
cΔdacA JW102 Conditional depletion strain of dacA Witte et al. (2013)
ΔpstA JW264 pstA deletion mutant This study
cΔdacA-ΔpstA JW282 Strain 102 with deletion in pstA This study
cΔdacA-ΔpstA
pBAV1K-Pspac-hy-pstA
JW457 Complementation of pstA disruption in strain 282 This study
Holin–Lysin JW128 Strain expressing phage holin and lysin
driven by the cytosol-specific actA promoter
Sauer et al. (2010)
Table 4. Plasmids used in this study.
Strain number Description Reference
JW219 pstA in pET20b This study
JW458 pstA F36A in pET20b This study
JW459 pstA N41A in pET20b This study
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Sequence conservation analysis of the PstA protein family
shows that the residues identified in the structure as being
important for c-di-AMP recognition are highly conserved
(Fig. 7A). These include the 34-GGFL-37 residues on the
T-loop which interact with the second nucleotide of c-di-
AMP. In addition, the 94-GGA-96 sequence at the B-loop
kink which allows for the loop to move toward c-di-AMP
is also universally conserved. The surface of the rest of
the PstA trimer is less conserved with the exception of
several residues on the bottom of the trimer which are
likely important for the structural integrity of the trimer
(Fig. 7B and C). Unlike PII proteins where the extended
T-loop is highly conserved (Huergo et al. 2013), the
extended B-loop in PstA has only weak sequence conser-
vation (Fig. 7B and C). Notably, Tyr51 on the T-loop of
PII proteins is strictly conserved and can be modified by
reversible uridylylation or adenylation in some bacterial
species (Huergo et al. 2013). PII proteins interact with
their protein targets primarily through T-loop-mediated
interactions, and the uridyl-modification of Tyr51 has
been shown to disrupt the interaction of the PII protein
GlnK with the ammonium channel AmtB (Conroy et al.
2007). The two tyrosine residues on the B-loop of PstA
have only ~70% sequence conservation (Fig. 1A). Further-
more, L. monocytogenes does not contain a homolog of
the E. coli uridylyl-transferase GlnD. However, we did
note that within the shotgun sequencing that previously
identified LmPstA as a c-di-AMP binding protein (Sureka
et al. 2014), the peptides mapping to the B-loop of
LmPstA were notably absent (Fig. 7D), consistent with a
modification to this region of the protein that precluded
its identification. Together these observations provide
intriguing albeit speculative evidence of a modification to
this site. However, given the absence of GlnD homologs
in the Firmicutes (Huergo et al. 2013), it is unlikely that





Figure 6. PstA functional studies in Listeria
monocytogenes. (A) Growth of L.
monocytogenes strains in Brain-heart infusion
(BHI) media. (B) b-galactosidase release assay
during mid-exponential growth of indicated L.
monocytogenes strains. Percent bacteriolysis is
normalized with respect to the cΔdacA strain.
(C) Kirby–Bauer disk diffusion assay measuring
the zone of inhibition around a filter disk
impregnated with 20 lg of cefuroxime
antibiotic. Values are reported as the diameter
of the zones of inhibition. (D) Immortalized
bone marrow-derived macrophages (iBMMs)
were infected with indicated L.
monocytogenes strains and CFU (colony
forming units) were enumerated at various
times post infection. (E) Plaque area from
mouse fibroblasts (L2 cells) infected with
indicated strains for three days and normalized
to wild type (WT). (F) Intracellular lysis of
bacterial strains in iBMMs as measured by
reporter plasmid delivery. Percent lysis was
determined by normalizing to Holin–Lysin and
uninfected controls. For all panels, the data are
the mean  SEM of at least three measures
and are representative of multiple independent
experiments (n ≥ 2). *P ≤ 0.01 by two-tailed
t-test.
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of the B-loop tyrosine residues common to GlnD-medi-
ated PII modification and may be due to phosphorylation,
as has been described in cyanobacteria (Forchhammer
and Tandeau de Marsac 1995).
The core structure of PII and PstA are remarkably simi-
lar (r.m.s. distance 0.9 A for the Ca atoms) despite only
~15–20% sequence identity. In addition, the recognition
of the equivalent adenine of c-di-AMP and ATP are
almost identical in PstA and PII proteins. The structures
differ in the loop regions which are less important for the
overall structural integrity of the trimer but are critical
for defining the ligand binding site. Thus, it is likely that
PstA and PII arose from a common protein ancestor, and
diverged through evolutionary changes in these loop
regions. On the basis of these observations, we conclude
that PstA is related to the larger PII protein superfamily,
but has diverged through evolution to specifically recog-
nize the bacterial second messenger c-di-AMP and thus is
structurally and functionally distinct from the canonical
PII proteins.
Possible functions of PstA
PstA currently has no known function. Based on its struc-
tural similarity to PII proteins, it is likely that PstA func-
tions through a PII-like mechanism of binding and
modifying the activities of its protein targets. There have
been several reports of PII proteins bound to various mac-
romolecules. The stoichiometry of these complexes are
either one PII trimer bound to a trimeric protein in the
case of AmtB and N-acetylglutamate kinase (Conroy et al.
2007; Gruswitz et al. 2007; Llacer et al. 2007; Mizuno
et al. 2007), or to three separate monomers in the case of
PipX and DraG (Llacer et al. 2010; Rajendran et al.
2011). In almost all of these complexes, the T-loop plays
a critical role in complex formation, and is found in a
different conformation in each complex. A notable excep-
tion is the PII–DraG complex where the T-loop is not
involved in binding DraG, which instead binds to the lat-
eral face of the PII trimer close to the ADP binding site.
In the case of AmtB and N-acetylglutamate kinase, ATP
binding to PII promotes complex formation through a
mechanism involving changes in the T-loop conformation
(Durand and Merrick 2006; Llacer et al. 2007). In Mtb
PII, the T-loop makes several contacts with ATP, support-
ing such a mechanism (Shetty et al. 2010). Thus, ligand
binding induces a particular shape and orientation of the
T-loop in PII which plays a key role in complex formation
with its protein target.
Although we provide indications that PstA contributes
to bacterial cell stability in the absence of c-di-AMP pro-
duction, the identity of protein regulatory targets, which
(A) (B)
(D) (C)
Figure 7. Sequence conservation of PstA. (A)
Sequence conservation of residues in the
cyclic-di-AMP (c-di-AMP) binding site,
generated based on an alignment of 150
sequences by the program ConSurf (Armon
et al. 2001). Purple indicates conserved
residues, cyan indicates variable residues, and
white indicates average conservation. The c-di-
AMP molecule is labeled. (B) Top view of the
LmPstA trimer showing sequence conservation.
(C) Bottom view of the LmPstA trimer showing
sequence conservation. (D) Mapping of LmPstA
peptides identified by Sureka et al. (2014) to
the structure. Peptides identified by
quantitative shotgun sequencing are
highlighted in red and those absent are in
green.
ª 2015 The Authors. MicrobiologyOpen published by John Wiley & Sons Ltd. 371
P. H. Choi et al. Structure of PstA in complex with c-di-AMP
 175
parts of the PstA trimer are involved in target recognition,
and the cellular consequences of target recognition remain
to be discovered. The genetic context of c-di-AMP ribos-
witches and the posttranslational effects on protein targets
support a general role for c-di-AMP in osmotic stress
responses in Firmicutes, within which PstA homologs are
conserved (Corrigan et al. 2013; Nelson et al. 2013; Sureka
et al. 2014). Consistent with these observations, our find-
ings link PstA-mediated c-di-AMP signaling to bacterioly-
sis. If canonical PII protein regulatory mechanisms provide
any insight into the biological role of PstA, it is feasible
that PstA may regulate membrane transporter function
analogous to GlnK regulation of the ammonium trans-
porter. Such transporters may be linked to ion or osmolyte
levels that help to stabilize the cell. Conversely, metabolic
effects reminiscent of PII regulation of glutamine synthe-
tase may impose changes in cell wall synthesizing capacity
or osmolyte synthesis to affect cell stability.
Based on the large movement of the B-loop upon c-di-
AMP binding, which dramatically changes the overall
shape of the PstA trimer, it is likely that c-di-AMP bind-
ing can modulate the binding of PstA to its target pro-
teins. However, the B-loop is significantly longer and less
conserved than the PII T-loop, so any protein–protein
interactions mediated by the B-loop are likely to be dif-
ferent than what has been observed for PII proteins.
Clearly, identification and characterization of the binding
partners of PstA will reveal significant insight into the
mechanism by which PstA-mediated c-di-AMP signaling
affects the physiology and cellular stability within the Fir-
micutes.
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Summary
Cellular turgor is of fundamental importance to bac-
terial growth and survival. Changes in external osmo-
larity as a consequence of fluctuating environmental
conditions and colonization of diverse environments
can significantly impact cytoplasmic water content,
resulting in cellular lysis or plasmolysis. To ensure
maintenance of appropriate cellular turgor, bacteria
import ions and small organic osmolytes, deemed
compatible solutes, to equilibrate cytoplasmic osmo-
larity with the extracellular environment. Here, we
show that elevated levels of c-di-AMP, a ubiquitous
second messenger among bacteria, result in signifi-
cant susceptibility to elevated osmotic stress in the
bacterial pathogen Listeria monocytogenes. We
found that levels of import of the compatible solute
carnitine show an inverse correlation with intracellu-
lar c-di-AMP content and that c-di-AMP directly binds
to the CBS domain of the ATPase subunit of the car-
nitine importer OpuC. Biochemical and structural
studies identify conserved residues required for this
interaction and transport activity in bacterial cells.
Overall, these studies reveal a role for c-di-AMP medi-
ated regulation of compatible solute import and pro-
vide new insight into the molecular mechanisms by
which this essential second messenger impacts bac-
terial physiology and adaptation to changing environ-
mental conditions.
Introduction
Bacterial signal transduction employs various proteins
and small molecule second messengers to regulate mul-
tiple cellular processes. Among these signals, the nucle-
otide cyclic di-3’,5’- adenosine monophosphate (c-di-
AMP) has recently emerged as a near ubiquitous sec-
ond messenger among bacteria, with essential roles in
both bacterial physiology and host–pathogen interac-
tions. Studies in different bacterial species revealed that
this nucleotide is involved in broad cellular processes,
such as DNA damage responses, central metabolism,
cell wall homeostasis, stress responses, potassium
transport, and virulence (Corrigan and Grundling, 2013;
Commichau et al., 2015). Intriguingly, although mecha-
nisms of c-di-AMP synthesis and hydrolysis are seem-
ingly conserved in bacteria, many molecular targets
appear unique to certain species. This suggests both
the conservation and divergence of c-di-AMP signaling
networks for different bacterial lifestyles.
Within bacterial cells, c-di-AMP is synthesized by the
diadenylate cyclase (Dac) activity of DisA_N domain–
containing proteins. Hydrolysis occurs through enzy-
matic activities of phosphodiesterase (Pde) proteins with
a catalytic DHH-DHHA1 domain or HD domain. For bac-
teria that produce c-di-AMP, a defect in c-di-AMP syn-
thesis confers aberrant physiology and even lethality in
several species. Conversely, the accumulation of this
nucleotide also diminishes growth and virulence (Huynh
and Woodward, 2016).
The intracellular pathogen Listeria monocytogenes
synthesizes and secretes c-di-AMP during growth in
broth culture and in host cells. Deletion of dacA, which
encodes a diadenylate cyclase for c-di-AMP synthesis,
is detrimental to Listeria growth. For c-di-AMP degrada-
tion, L. monocytogenes encodes PdeA and PgpH, which
act cooperatively to hydrolyze c-di-AMP. The DpdeA
DpgpH mutant, which accumulates approximately four
times more c-di-AMP than the wild-type strain, is defec-
tive for growth in broth and macrophages. As shown for
several other pathogens, the DpdeA DpgpH mutant is
also severely attenuated in a murine infection model,
again highlighting the toxicity of elevated c-di-AMP levels
(Huynh et al., 2015).
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Phosphodiesterase mutants in various bacteria exhibit
aberrant phenotypes, such as altered cell wall metabo-
lism, cell division, impaired potassium transport, defec-
tive stress responses, and diminished virulence (Bai
et al., 2013; Cho and Kang, 2013; Mehne et al., 2013;
Yang et al., 2014; Ye et al., 2014; Dey et al., 2015).
Nevertheless, there has been no systematic examina-
tion of the physiological effects of c-di-AMP accumula-
tion. In an attempt to investigate the mechanism of
c-di-AMP toxicity, we performed a phenotypic microarray
screen on the pdeA pgpH mutant. Among the observed
phenotypes, this mutant was highly sensitive to osmotic
stress. As such, we interrogated the interaction of c-di-
AMP with several membrane transporters involved in
osmotic stress responses. We found that c-di-AMP inter-
acts specifically with the ATPase component of the
OpuC carnitine transporter, likely inhibiting carnitine
uptake upon osmotic upshift. Thus, our studies expand
the known targets of c-di-AMP, and generalize the role
of c-di-AMP in osmotic regulation, a universal aspect of
bacterial physiology.
Results
C-di-AMP accumulation diminishes compatible solute
uptake
The Biolog phenotype microarray (Biolog Inc.) provides
a platform for high-throughput screening of bacterial
responses to >1000 distinct growth conditions. In this
technology, bacterial strains are cultivated in 96-well
microplates, with each well presenting a different culture
condition. Metabolic activity is measured through cellular
respiration, which reduces a tetrazolium dye and pro-
duces a purple color. The color intensity reflects altered
levels of metabolism, and can be easily monitored and
quantitated (Bochner et al., 2001). We subjected the L.
monocytogenes WT and DpdeA DpgpH strains to plates
PM 1 210, which test metabolic activity under various
carbon, phosphorous and sulfur sources, amino acid
and vitamin supplements, peptide nitrogen sources, and
pH and osmotic stresses. These two strains showed
consistent metabolic differences in PM 9, with increas-
ing osmolyte concentrations in the presence or absence
of compatible solutes (Fig. 1A, for all plate images see
Supporting Information Fig. S1).
To validate this observation, we examined L. monocy-
togenes strains for growth under osmotic stress. Since
dacA is an essential gene, it was deleted in the presence
of an IPTG-inducible allele, creating a conditionally null
mutant (cDdacA) (Woodward et al. 2010). In BHI broth
with increasing concentrations of NaCl, the cDdacA
strain, which has the lowest level of c-di-AMP, was the
most resistant to osmotic stress (Fig. 1B). The DpdeA
strain which has WT levels of c-di-AMP in broth (Witte et
al. 2013) showed transport similar to WT bacteria. con-
trast, the DpdeA DpgpH strain, which has the highest
level of c-di-AMP, was the most sensitive. Similar obser-
vations were made with the non-ionic osmolyte sorbitol
(Fig. 1C). Additionally, whereas the WT and cDdacA
strains also exhibited growth defects in defined minimal
medium supplemented with 2% NaCl (MMS), the DpdeA
DpgpH strain was completely inhibited (Fig. 1D).
L. monocytogenes is well adapted to high-salt environ-
ments and accumulates various solutes to cope with
osmotic stress, with the best studied examples of potas-
sium, betaine, and carnitine (Sleator et al., 2003). In the
presence of salt stress, the WT and cDdacA growth
defects were rescued by betaine and carnitine, but not by
KCl, suggesting that potassium alone is insufficient for
long-term adaptation to osmotic stress. Additionally, the
DpdeA DpgpH growth defect was not rescued by any sol-
ute, indicating a defect for solute transport (Fig. 1D).
We selected carnitine as a representative compatible
solute to test for transport activities by the WT and
mutant strains. In these transport assays, exponential
phase cultures in BHI broth were subjected to BHI 1 4%
NaCl 1 14C-labeled carnitine and radioactivity was
measured to evaluate intracellular carnitine accumula-
tion. Compared to the WT strain, the cDdacA mutant
exhibited slightly higher transport activity (Fig. 2A).
Among the phosphodiesterase mutants, the DpdeA
strain has wild-type c-di-AMP level (Witte et al. 2013),
whereas the DpgpH mutant exhibits a two-fold increase,
and the DpdeA DpgpH mutant has four-fold more c-di-
AMP than WT (Fig. 2B). For carnitine transport, DpdeA
was indistinguishable from the WT strain, and DpgpH
exhibited a small but consistent decrease in transport
activity. Finally, the DpdeA DpgpH mutant was highly
impaired for carnitine transport (Fig. 2A). When the car-
nitine transported by these strains was compared to
their relative intracellular c-di-AMP levels, a clear inverse
correlation was observed (Fig. 2B). Together with the hyper-
sensitivity of the DpdeA DpgpH strain to osmotic stress, its
defect for compatible solute uptake indicates that c-di-AMP
has an inhibitory effect on transport activity.
C-di-AMP interacts specifically with the carnitine
transporter component OpuCA
Given the assumption that c-di-AMP antagonizes com-
patible solute transport, we wished to examine specific
transporters for interactions with c-di-AMP. L. monocyto-
genes encodes various transport systems for solute
uptake and efflux, including KdpABC and Ktr-type trans-
porters for potassium uptake, BetL and GbuABC for
betaine uptake, OpuC for carnitine uptake, various
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peptide transporters, aquaporins and mechanosensitive
channels (Sleator et al., 2003).
Consistent with previous studies in Staphylococcus
aureus, we observed that the histidine kinase sensor
KdpD bound c-di-AMP via the USP domain (data not
shown) (Moscoso et al., 2016). However, as potassium
did not rescue long-term growth by L. monocytogenes
under osmotic stress, we also investigated the carnitine
and betaine transporters.
OpuC is a high affinity uptake system for carnitine
and comprised of four proteins: OpuCA, OpuCB,
OpuCC, and OpuCD. OpuCC is an extracellular sub-
strate binding protein that is tethered to the cell mem-
brane via a lipid modification. OpuCB and OpuCD form
transmembrane permease subunits. OpuCA is a cyto-
plasmic protein with an ATP-binding cassette (ABC) and
tandem cystathionine-b-synthase (CBS) domains (Fig.
3A). The ATPase activity of OpuCA is required for trans-
port activity of the OpuC system. It has been shown
that the uptake rate is stimulated by increased osmolal-
ity, and might be inhibited by intracellular metabolites
(Fraser et al., 2000). The glycine betaine transporter
GbuABC has a similar architecture to OpuC (Fig. 3A), in
which GbuA is a cytoplasmic ATPase protein with tan-
dem CBS domains. Interestingly, mutations in GbuABC
transporter were recently reported in strains of L. mono-
cytogenes suppressed for c-di-AMP essentiality (White-
ley et al., 2015). The BilE transport system is very
closely related to OpuC, but has been implicated in bile
acid resistance rather than osmolyte import (Sleator
et al., 2005). Furthermore, the ATPase subunit of BilE
and OpuCA share 60% amino acid identity but differs
markedly in the C-terminus, where the CBS domain of
the ATPase subunit of the BilE transporter is signifi-
cantly truncated (Fig. 3A). As previous work in L. mono-
cytogenes reported the interaction of c-di-AMP with two
CBS domain-containing proteins, Lmo0553 and
Lmo1009 (Sureka et al., 2014), we hypothesized that c-
di-AMP may also bind the CBS domains of osmolyte
importers. Thus, we examined GbuA, OpuCA, and BilE,
and observed c-di-AMP binding only for OpuCA
(Fig. 3B). Furthermore, the CBS domain alone was able
Fig. 1. Inverse correlation
between c-di-AMP levels and
osmotic stress tolerance.
A. Phenotype microarray
results of WT vs. DpdeA
DpgpH on PM9 wells A1-A9
with increasing NaCl
concentrations.
B. The L. monocytogenes
cDdacA, wild-type (WT), and
DpdeA DpgpH strains were
tested for growth in BHI broth
with increasing NaCl
concentrations. One-hundred
percent indicates growth rate
for each strain in the absence
of NaCl.
C. Similar to (B) but growth
rates were examined in
increasing sorbitol
concentrations.
D. Growth yields in minimal
medium with no salt, or
minimal medium 1 2% NaCl
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to directly interact with c-di-AMP but not the isolated
ATP-binding domain (Fig. 3B). Together these observa-
tions suggested that c-di-AMP interacts with the CBS
domain of the ATPase subunit of the solute transporter
OpuC.
To further characterize OpuCA, we purified both the full-
length protein fusion with maltose binding protein (MBP-
OpuCA) and the 6xHis-tagged CBS domain (CBS). The full-
length protein bound c-di-AMP at a high affinity (Fig. 3C),
while the isolated CBS domain showed decreased affinity
comparable to the full-length protein (Fig. 3D). CBS domains
associated with several proteins have been shown to be
regulated by adenosine nucleotides, such as ATP and AMP.
In a competition-binding assay, we tested these and other
related nucleotides in excessive concentrations (at least
1000-fold) relative to radio-labeled c-di-AMP, and found that
CBS protein interacted with c-di-AMP specifically (Fig. 3E).
To determine if this observation was unique to L. monocyto-
genes, we also tested the binding of an OpuCA homolog
from Enterococcus faecalis and found a similar low
Fig. 2. Carnitine transport under salt stress in the presence of different c-di-AMP levels.
A. Mid-exponential phase cultures grown in BHI broth were shifted to BHI 1 4% NaCl 1 85 lM 14C- carnitine. Imported carnitine was evaluated
by radioactivity retained by bacterial cells, and normalized to optical density at each time point.
B. Plot comparing the intracellular c-di-AMP levels of various L. monocytogenes strains versus the amount of carnitine transported at 20
minutes in panel A. The WT c-di-AMP level is typically 4 lM. Data represents at least two independent experiments.
Fig. 3. C-di-AMP interacts specifically with the CBS domain of the carnitine transporter component OpuCA.
A. Domain organization of OpuCA (Lmo1428), GbuA (Lmo1014), and BilE (Lmo1421).
B. Binding of OpuCA, GbuA, and BilE to c-di-AMP as measured by DRaCALA to full-length (FL), ATP-binding (ATP), or CBS domains.
C. Binding titration for the OpuCA full-length OpuCA protein and
D. the isolated CBS domain.
E. Competition binding assay for 1.5 nM radiolabeled c-di-AMP, in the presence of 200 lM unlabeled nucleotides. (C) Binding titration for the
E. faecalis full-length OpuCA homolog.
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micromolar affinity for the EfOpuCA protein (Fig. 3F).
Together, these findings show that the CBS domain within
the ATPase subunit of the osmolyte transporter OpuC spe-
cifically binds to c-di-AMP at physiologically relevant concen-
trations, and that this may be a widespread interaction
among bacteria.
Structural studies reveal the mode of c-di-AMP binding
We solved the structure of L. monocytogenes OpuCA
(LmOpuCA) tandem CBS domains (residues 247-371,
Fig. 3A) at 2.9 Å resolution (PDB entry code: 5KS7) using
the molecular replacement method with the CBSX1
protein structure from Arabidopsis thaliana as the search
model (Jeong et al., 2013) (PDB entry code: 4GQV,
sequence identity 27%). There is a dimer of LmOpuCA in
the asymmetric unit. The crystallographic statistics are
summarized in Table S1. The crystal was found to have sig-
nificant pseudo-translational symmetry (with a peak height
of 64% relative to the Patterson origin peak), which is likely
part of the reason for the somewhat higher R values for this
structure. The data set used for refinement was the best one
among the many that we collected on these crystals.
The structure of each CBS domain of LmOpuCA has a
three-stranded anti-parallel b-sheet packed against two a-
helices (Fig. 4A). The b-sheets of the two tandem CBS
Fig. 4. Crystal structure of LmOpuCA tandem CBS domains in complex with c-di-AMP.
A. Schematic drawing of the dimer of LmOpuCA tandem CBS domains (monomer 1 in cyan, monomer 2 in yellow) in complex with c-di-AMP
(labeled cdA, carbon atoms colored black). The two CBS domains in each monomer are labeled CBS1 and CBS2.
B. Omit Fo–Fc electron density for c-di-AMP at 2.9 Å resolution, contoured at 2.5r.
C. Molecular surface of the LmOpuCA binding sites for c-di-AMP, colored according to the electrostatic potential (blue: positive, red: negative).
D. Detailed interactions between LmOpuCA and c-di-AMP. Hydrogen bonds are shown with dashed lines (red).
E. Sequence conservation of residues in the LmOpuCA c-di-AMP binding site, generated based on an alignment of 150 sequences by the
program Consurf (Armon et al., 2001). Purple indicates conserved residues, cyan indicates variable residues, and white indicates average
conservation. All structure figures were produced with PyMOL (www.pymol.org).
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domains within the monomer are packed against each other,
forming a Bateman domain. Two LmOpuCA Bateman
domains then dimerize head-to-tail, mediated primarily by
interactions between the a-helices, forming a disk-like
assembly with a central cavity (Fig. 4A). Both head-to-head
and head-to-tail dimeric associations have been commonly
observed for Bateman domains (Baykov et al., 2011).
The diffraction quality of the free OpuCA CBS domain
crystals was very poor, and we were not able to deter-
mine the structure of the free protein. However, soaking
of these crystals with c-di-AMP overnight greatly
improved their diffraction, which allowed us to determine
the structure of the complex. This could indicate that c-
di-AMP might induce some conformational rearrange-
ment in the OpuCA CBS domain.
We observed clear electron density for one c-di-AMP mol-
ecule bound to the OpuCA dimer (Fig. 4B), with the two-fold
symmetry axis of the compound aligned with that of the
dimer (Fig. 4A). This is similar to the binding mode of c-di-
AMP to the CT dimer of LmPC (pyruvate carboxylase), in
which the ligand is also aligned with the two-fold symmetry
axis of that dimer (Sureka et al., 2014). In LmOpuCA, the c-
di-AMP is located in a solvent-exposed, electropositive
pocket in the center of the dimer (Fig. 4C). The c-di-AMP
adopts a flat, nearly fully extended conformation, which
appears to be unique among known c-di-AMP complexes.
For example, c-di-AMP assumes a mostly folded conforma-
tion in the complex with LmPC.
The c-di-AMP compound bridges the two OpuCA mono-
mers, and makes identical interactions with each (Fig. 4D).
The adenine bases are buried deep into the binding pocket,
packed between the side chains of Tyr342 and Ile355 on
one face, and Val260 and Val280 on the other. The adenines
are specifically recognized by the protein through hydrogen
bonds between its N1 and N6 atoms to the main chain
amide and carbonyl of Val280. In addition, the N7 atom of
adenine makes a hydrogen bond with the side chain
hydroxyl of Thr282. The phosphate group of c-di-AMP
makes two hydrogen bonds to the main chain amide of
Arg358 and Ala359, which are located at the N-terminal end
of the last helix of the CBS domain, suggesting that the
phosphate also has favorable interactions with the dipole of
this helix. The residues in the c-di-AMP binding pocket are
well conserved among OpuCA homologues (Fig. 4E), sug-
gesting that c-di-AMP binding to OpuCA is of functional
importance in many bacteria.
C-di-AMP binding mutants exhibit altered carnitine
transport activities
Since c-di-AMP appeared to inhibit carnitine transport in
bacterial cultures, we attempted to characterize this inhi-
bition on the ATPase activity of OpuCA. However, for
both the L. monocytogenes and E. faecalis homologs,
the protein activity was rapidly lost, likely due to the
requirement to associate with other components of the
transport complex to perform repeated turnover. Thus,
we performed a mutational analysis of OpuCA to exam-
ine the relationship between c-di-AMP binding and car-
nitine transport.
Based on the crystal structure of the OpuCA CBS
domains, we generated several amino acid mutations in
sites highly conserved among OpuCA homologs. Muta-
tions of the conserved R279, V280 and D281 residues
resulted in very weak to no observable binding to c-di-
AMP (Fig. 5A). By contrast, mutations of the K341 and
Fig. 5. C-di-AMP binding mutants exhibit altered carnitine transport
activities.
A. Binding curves of OpuCA CBS point mutants with radiolabeled c-di-
AMP
B. Effects of opuCA mutant alleles in the DpdeA DpgpH background on
carnitine transport.
C. Plot comparing the amount of 14C-carnitine transported in panel B at
30 minutes versus the observed binding constant for c-di-AMP. V280A
and D281A Kd values were above the limit of detection of the binding
assay. Data represents at least two independent experiments.
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Y342 residues resulted in a slight increase and
decrease in c-di-AMP binding affinity, respectively.
Together, these data confirmed that conserved amino
acids in the c-di-AMP binding pocket of OpuCA affected
the affinity of the protein for this nucleotide.
To interrogate the effects of these amino acids on protein
activity, we next performed allelic exchange to replace the
opuCA1 allele with these point mutant alleles in the WT,
DpgpH, and DpgpH pde::Tn917 backgrounds (please see
Experimental Procedures for an explanation). We reasoned
that if c-di-AMP is an allosteric regulator of the ATPase activ-
ity of OpuCA, then c-di-AMP-binding site mutants could alter
the transport of this osmolyte in L. monocytogenes. The
V280 and K341 mutations completely abolished carnitine
transport activity in all strains, irrespective of c-di-AMP levels
(Fig. 5B and Supporting Information Fig. S2). In the wild-
type and DpgpH backgrounds, which have normal and inter-
mediate c-di-AMP levels, no significant change in transport
was observed for the other point mutations (Supporting
Information Fig. S2). In the DpgpH pde::Tn917 background
with elevated c-di-AMP activity, we found that relative to WT,
the R279A mutant exhibited increased transport activity and
the D281A and Y342A mutations resulted in lower transport
activity (Fig. 5B). Together, these studies show that mutation
of the conserved RVD and KY amino acids lining the c-di-
AMP binding pocket drastically affect transport activity of
OpuC, although only the RVD sequence is indispensable for
high-affinity binding to c-di-AMP by OpuCA. No obvious cor-
relation between c-di-AMP affinity and transport activity was
revealed by these studies (Fig. 5C), suggesting a complex
interplay between the role of these conserved amino acids
in mediating c-di-AMP nucleotide recognition and osmolyte
transport.
Discussion
Regulation of CBS domains by c-di-AMP
CBS domains (Pfam PF00571) are widespread in all
three domains of life, currently identifiable in more than
35,000 protein sequences, and assumed to regulate the
catalytic activity of associated enzymatic or signal trans-
duction domains. The regulatory function of many CBS
domains has been shown to be dependent on adenine
nucleotide ligands, such as S-adenosyl methionine,
AMP, ATP, and diadenosine polyphosphates (Baykov
et al., 2011; Anashkin et al., 2015). Through biochemi-
cal, structural, and genetic analyses, we examined the
OpuCA CBS domain as another molecular target of c-
di-AMP in bacteria.
A previous study in L. monocytogenes revealed that
c-di-AMP binds two CBS-domain containing proteins,
Lmo1009 and Lmo0553 (Sureka et al., 2014). Addition-
ally, as documented for S. aureus and L. lactis (Smith
et al., 2012; Corrigan et al., 2013), we observed a nega-
tive regulatory effect of c-di-AMP in osmotic stress
response. These findings prompted us to examine three
ABC-type solute transporters, OpuC, GbuABC, and
BilE, which all harbor CBS domains. Among these pro-
teins, we found that c-di-AMP binds to the CBS domain
of OpuCA, the ATPase subunit of OpuC, but did not
interact with GbuA, although it is highly similar to
OpuCA in architecture and function. CBS domain
sequences are highly divergent, despite their structural
conservation (Baykov et al., 2011). Consistent with this
notion, we observed low sequence conservation among
these five bacterial CBS domains. Among c-di-AMP
binding proteins, OpuCA exhibits the conserved RVD
residues that are required for interaction, but the corre-
sponding amino acids are different (GYS/R) for
Lmo1009 and Lmo0553. Interestingly, GbuA exhibits the
GTS residues at these positions, reminiscent of
Lmo1009, although it did not interact with c-di-AMP
(Supporting Information Fig. S3). Thus, systematic anal-
yses of more CBS domains are required to elucidate
conserved structural elements of c-di-AMP interaction.
CBS domains are widespread among bacterial ABC
transporters involved in compatible solute uptake, which
presumably are important in regulating transport activity
under osmotic stress. For instance, in Pseudomonas
sp., opuC mutants with CBS-domain deletions were
defective for growth under hyperosmotic conditions,
reflecting the requirement of this element in OpuC func-
tion (Chen and Beattie, 2007). For the well-studied gly-
cine and betaine transporter OpuA of Bacillus subtilis
and Lactococcus lactis, the CBS domain has also been
extensively characterized with a role for sensing ionic
strength within the cytoplasm, and possibly in a confor-
mational change that is required for catalytic activity
(Horn et al., 2003; Biemans-Oldehinkel et al., 2006;
Mahmood et al., 2006; Horn et al., 2008). However, no
allosteric regulators have been reported for compatible
solute transporters.
Our analyses indicated that c-di-AMP inhibits OpuC
function, as c-di-AMP levels were inversely correlated to
carnitine transport in L. monocytogenes. Since the
OpuCA CBS domain interacted specifically with c-di-
AMP at high affinity, we hypothesize that c-di-AMP is an
allosteric regulator of OpuC transport function. Several
mutations of the c-di-AMP binding site altered transport
activity. In the pdeA pgpH background with a high c-di-
AMP level, the weak-binding mutant R279A recovered
carnitine transport, whereas the strong-binding mutant
K341A abolished transport. These mutant phenotypes
are consistent with a negative regulation of OpuCA by
c-di-AMP, but further biochemical studies are required to
establish a direct link between ligand binding and pro-
tein function. Indeed, the V280A and V280W mutations
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abolished both c-di-AMP binding and transport activity.
Interestingly, the D281A mutation severely impaired c-di-
AMP binding but inhibited activity only in the pdeA pgpH
background. It is possible that this strain is altered for
ionic contents which also affect OpuCA activity as dis-
cussed below. Together, the mutant phenotypes reflect
the complexity in OpuCA regulation and c-di-AMP is
perhaps another allosteric factor though the mechanism
for this regulation is not yet elucidated in this study.
Interaction of c-di-AMP with the OpuCA CBS domains
may cause conformational changes that affect protein
function. In transport cycles of bacterial ABC transport-
ers, including OpuA, the nucleotide-binding ATPase
domain typically undergoes a dynamic interconversion
between the dimer and monomer conformations, and
the ATP-dependent closed dimer conformation allows
ATP hydrolysis (Higgins and Linton, 2004). It is conceiv-
able that c-di-AMP binding traps the nucleotide-binding
domain in the open conformation, thereby inhibiting
transport. Indeed, substrate binding to the CBS domains
has been shown to induce large conformational changes
in the associated domains, as shown for the magnesium
transporter MgtE (Takeda et al., 2014). As the c-di-AMP
binding pocket is formed at the dimer interface of
OpuCA CBS domain, it is likely that binding alters pro-
tein dimerization. Additionally, the CBS domain of
OpuAA interacts with the negatively charged membrane
surface and blocks transport function. Above a threshold
ionic strength, Na1 and K1 ions relieve this inhibition
and activate the transporter (Biemans-Oldehinkel et al.,
2006; Mahmood et al., 2006; Mahmood et al., 2009;
Karasawa et al., 2011). If this phenomenon also occurs
for OpuCA, c-di-AMP binding may result in a conforma-
tional change within the CBS domain that reduces ion
sensing, for instance, by preventing the exposure of
charged residues that interact with Na1 and K1 ions.
The global regulatory role of c-di-AMP in osmotic stress
response is a conserved aspect of c-di-AMP signaling
The ability to cope with osmotic stress is a universal
aspect of bacterial physiology, and is a major determin-
ing factor for growth and virulence (Poolman and
Glaasker, 1998). The majority of bacterial species
encode various strategies to cope with osmotic stress.
The initial response is typically potassium uptake via
Trk/Ktr and Kdp systems. C-di-AMP has been shown to
interact with protein components of both systems, and
possibly with riboswitches preceding certain genes
(Corrigan et al., 2013; Nelson et al., 2013; Bai et al.,
2014; Kim et al., 2015; Moscoso et al., 2016). Similar to
findings in S. aureus, we also observed an interaction of
c-di-AMP with the KdpD USP domain in L.
monocytogenes, confirming a role for c-di-AMP in regu-
lating potassium transport. However, potassium supple-
mentation did not rescue L. monocytogenes growth
under long-term osmotic stress. Indeed, the role of the
kdp system in L. monocytogenes osmotic tolerance has
been shown to be strain dependent, as the EGD kdpE
mutant exhibited no defect for growth under high salt
(Brondsted et al., 2003).
The regulatory effect of c-di-AMP in carnitine trans-
port may partially explain the pleiotropic phenotypes
conferred by elevated c-di-AMP levels. For L. monocyto-
genes, in addition to transporting carnitine under salt
stress, OpuC is also important for bile resistance, and
required for survival in the GI tract as well as systemic
invasion (Wemekamp-Kamphuis et al., 2002; Watson
et al., 2009). The human small intestine has an osmo-
larity equivalent to 0.3 M NaCl, requiring gastrointestinal
pathogens to be highly tolerant to salt stress in order to
persist in this environment and to further invade other
tissues (Sleator et al., 2009). Exposure to elevated
osmolarity induces the expression of the rB regulon for
general stress responses and GI epithelial cell invasion
(Abram et al., 2008; Bae et al., 2012; Walecka-
Zacharska et al., 2013). Furthermore, rB also controls
the transcription of PrfA, the master virulence regulator,
and the rB and PrfA regulons significantly overlap, fur-
ther emphasizing the role of osmotic stress as a primary
stress and virulence signal (Ollinger et al., 2009;
Chaturongakul et al., 2011). Thus, an impaired OpuC
transport activity in the DpdeA DpgpH mutant may have
adverse consequences in physiology and virulence.
Indeed, this strain is also highly sensitive to bile stress
(unpublished data) and future studies to interrogate the
effects of c-di-AMP and OpuCA on virulence are
warranted.
In summary, we report c-di-AMP as the first second
messenger that targets the CBS domain of a bacterial
membrane transporter and provide an atomic level
description of this protein-nucleotide interaction. Alloste-
ric regulation of solute transporters is a rapid strategy in
coping with osmolarity fluctuations encountered by bac-
teria. The widespread presence of CBS domains among
osmolyte transporters in bacteria suggests that this
likely represents the first example of a conserved regu-
latory target of c-di-AMP. Despite the potentially con-
served role of c-di-AMP in this context, why c-di-AMP is
integrated in the pathway of osmolyte accumulation
remains unresolved. Interestingly, CBS domain
containing membrane transporters are broadly con-
served among living organisms, many of which have not
been described to produce c-di-AMP, opening the possi-
bility that other second messenger mediators of osmo-
lyte import may await discovery.
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Experimental procedures
Bacterial strains and culture conditions
L. monocytogenes strains used in this study are listed in
Supporting Information Table S2. Deletion of opuCA (amino
acid residues 4-395) was achieved by allelic exchange as
previously described (Camilli et al., 1993). Briefly, a trun-
cated opuCA DNA fragment (deleted for amino acids 4-
395), with upstream and downstream flanking regions, was
cloned into a pKSV7 vector, to create a pKSV7-DopuCA
plasmid. This plasmid was transformed into E. coli SM10
strain, and conjugated into L. monocytogenes. Since
pKSV7 is temperature sensitive, trans-conjugants were
grown at 428C to allow chromosomal integration of the plas-
mid, and plasmid curing was obtained by several passages
at 308C in the absence of selective antibiotics. Site-specific
mutagenesis of opuCA was first obtained by Quick Change
PCR on a pET20b-opuCA plasmid, and the mutated opuCA
fragments were cloned into pKSV7 with 500 base pairs of
upstream and downstream flanking fragments. Mutant
alleles of opuCA were then introduced into DopuCA or
DopuCA DpgpH by the same allelic exchange method. We
found that if allelic exchange was performed in the DpdeA
DpgpH background, growth at 428C selected for suppressor
mutations that grew equivalent to WT L. monocytogenes
and had diminished levels of c-di-AMP (data not shown).
As such, the knock-in strains in the DpgpH background
were subsequently transduced with U153 phage lysate gen-
erated from a pdeA::Tn917 strain, to create the knock-in
point mutants in the double phosphodiesterase mutant
background. Broth growth curves were assessed in Brain
Heart Infusion (BHI) broth at 378C.
Protein expression, purification, and nucleotide binding
The DNA fragment encoding the OpuCA protein was PCR-
amplified and cloned into the pMAL-c23 vector with the
XbaI and HindIII restriction sites, generating an amino-
terminal fusion of maltose binding protein (MBP-OpuCA).
The CBS domain (aa 251-397) was cloned into a pET20b
vector with the NdeI and XhoI restriction sites, generating a
carboxy-terminal 63 Histidine tag (CBS protein). The result-
ing plasmids were transformed into Escherichia coli BL21
(DE3) strain for expression. Site directed mutagenesis was
performed using QuikChange Site- Directed Mutagenesis
(Agilent).
For MBP-OpuCA expression, an overnight E. coli culture
were used to inoculate 1.5 L of LB medium containing
0.2% glucose and 100 lg mL21 Ampicillin, and grown at
378C, 200 rpm until late-exponential phase (OD600 0.8).
At this stage, the culture was supplemented with 0.8 mM
IPTG and shaken at 168C, 200 rpm for approximately 14
hours. Cell pellets were collected by centrifugation and
lyzed by sonication in lysis buffer (20 mM Tris, pH 7.5,
500 mM NaCl, 5% glycerol, 1 mM phenylmethylsulfonyl flu-
oride, 0.1% b-mercaptoethanol). Cell lysate containing solu-
ble proteins were run through 2.5 mL of amylose resin
(New England Biolabs), washed with column buffer (20 mM
Tris, pH 7.5, 500 mM NaCl, 5% glycerol) and protein was
eluted with elution buffer (column buffer supplemented with
10 mM maltose monohydrate). For CBS protein, the E. coli
expression culture was induced with 0.5 mM IPTG for 3
hours at 378C. Cell pellets were re-suspended in phosphate
buffer (30 mM K2HPO4 pH 8.0, 300 mM NaCl) and purified
with a HisPur NiNTA resin (ThermoFisher Scientific). After
SDS-PAGE analysis, protein fractions were pooled, concen-
trated with 5 kDa MWCO spin column concentrators (GE
Healthcare). The concentrated proteins were desalted with
PD-10 columns (GE Healthcare) and exchanged into bind-
ing buffer (40 mM Tris pH 7.5, 100 mM NaCl, 20 mM
MgCl2). Nucleotide binding assays were performed using
DRaCALA as previously described (Roelofs et al., 2011).
Solute transport assay
Bacterial cultures were grown in BHI broth until mid-
exponential phase (OD  0.7) and diluted 1:1 (v/v) with
BHI 1 8% NaCl with 14C-labeled carnitine (final concentra-
tion 85 lM). At indicated time points, samples were taken,
applied on a 0.45 lm filter, and washed with phosphate buf-
fered saline containing 4.5% NaCl. The filters were dried
and immersed in scintillation liquid for radioactivity count.
Concurrently, a duplicate culture containing cold carnitine
was assessed for bacterial growth density.
Protein expression and purification for crystallization. L.
monocytogenes OpuCA (lmo1428) residues 247-371 were
subcloned into a pET28a vector with an N-terminal His-tag.
This construct was then transformed into BL21 Star (DE3)
cells. The cells were cultured in LB (Luria–Bertani) medium
with 35 mg L21 kanamycin and were induced for 14 h at
208C with 1 mM isopropyl b-D-1-thiogalactopyranoside. The
protein was purified through nickel-agarose affinity chroma-
tography followed by gel filtration chromatography (S-300,
GE Healthcare, Piscataway, New Jersey, USA). The purified
protein was concentrated to 30 mg mL21 in a buffer con-
taining 20 mM Tris (pH 8.0), 250 mM NaCl, 5% (v/v) glyc-
erol, and 5 mM dithiothreitol, flash-frozen in liquid nitrogen
and stored at 2808C. The N-terminal hexa-histidine tag
was not removed for crystallization.
Crystallization. LmOpuCA (residues 247-371) crystals
were grown by the sitting-drop vapor diffusion method at
208C. The protein at 3 mg/mL was mixed with reservoir
solution containing 0.1 M bicine (pH 9.0), 3% (w/v) PEG
20,000, and 2% (v/v) 1,4-dioxane. The crystals appeared
within a few days. The crystals were then soaked overnight
in the reservoir solution supplemented with 4 mM of c-di-
AMP and 25% (v/v) ethylene glycol. The crystals were then
flash-frozen in liquid nitrogen for data collection at 100 K.
Data collection and structure determination. The X-ray
diffraction data set was collected using Saturn944HG CCD
mounted on a Rigaku Micromax-003 X-ray generator. The
diffraction images were processed using HKL-3000 (Minor
et al., 2006). Pseudo-translational symmetry (peak height
64% of Patterson origin) was identified in the crystal using
the program Phenix.Xtriage (Adams et al., 2010). The
structure was solved using the molecular replacement
method with the program Phaser (McCoy et al., 2007),
Cystathionine beta-synthase domain 241
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using the CBSX1 protein structure from Arabidopsis thali-
ana (PDB code 4GQV) as the search model. Manual
rebuilding was carried out in Coot (Emsley and Cowtan,
2004) and refinement was done with the program Refmac
(Murshudov et al., 2011). Atomic coordinates and structure
factors have been deposited in the Protein Data Bank with
accession code 5KS7
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A distinct holoenzyme organization for two-subunit
pyruvate carboxylase
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Pyruvate carboxylase (PC) has important roles in metabolism and is crucial for virulence for
some pathogenic bacteria. PC contains biotin carboxylase (BC), carboxyltransferase (CT) and
biotin carboxyl carrier protein (BCCP) components. It is a single-chain enzyme in eukaryotes
and most bacteria, and functions as a 500 kD homo-tetramer. In contrast, PC is a two-subunit
enzyme in a collection of Gram-negative bacteria, with the a subunit containing the BC and
the b subunit the CT and BCCP domains, and it is believed that the holoenzyme has a4b4
stoichiometry. We report here the crystal structures of a two-subunit PC from Methylobacillus
flagellatus. Surprisingly, our structures reveal an a2b4 stoichiometry, and the overall
architecture of the holoenzyme is strikingly different from that of the homo-tetrameric PCs.
Biochemical and mutagenesis studies confirm the stoichiometry and other structural
observations. Our functional studies in Pseudomonas aeruginosa show that its two-subunit PC
is important for colony morphogenesis.
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P
yruvate carboxylase (PC) catalyses the MgATP-dependent
conversion of pyruvate to oxaloacetate1,2. It has important
functions in gluconeogenesis, glyceroneogenesis, lipogenesis,
neurotransmitter release, as well as anaplerosis to replenish the
intermediates of the tricarboxylic acid (TCA) cycle. PC deficiency in
humans is linked to various clinical symptoms such as lactic
acidaemia and psychomotor retardation, while PC over-expression
has been observed in several types of cancers3,4. The PC of the
intracellular pathogen Listeria monocytogenes (LmPC) is important
for growth and virulence in the host cell5,6.
PC is a member of the biotin-dependent carboxylase family
and contains biotin carboxylase (BC), carboxyltransferase (CT)
and biotin carboxyl carrier protein (BCCP) components. In
mammals and most bacteria, these domains reside in a single
polypeptide chain (Fig. 1a). These single-chain PC enzymes
function as 500 kD homo-tetramers and are stimulated by acetyl-
CoA. In mammals, insulin suppresses hepatic gluconeogenesis by
reducing acetyl-CoA levels and thereby PC activity, suggesting an
important role for PC in type 2 diabetes7. The crystal structures of
several single-chain PCs have defined their overall holoenzyme
architecture6,8,9. The four PC molecules are arranged in two
layers, in the overall shape of a diamond (Fig. 1b). The two
molecules in each layer of the structure have few interactions with
each other. The holoenzyme is primarily formed through BC
(Fig. 1c) and CT domain dimers between the layers, which are
located at alternate corners of the diamond. The structures also
reveal a new domain, named the PC tetramerization (PT)
domain9 or allosteric domain8 that is important for tetramer
formation by Staphylococcus aureus and human PCs (SaPC and
HsPC) and for interaction with acetyl-CoA8–10. This domain is
formed by two discontinuous segments of the protein—the linker
between BC and CT and that between CT and BCCP (Fig. 1a).
On the other hand, in a diverse array of Gram-negative
bacteria among the phyla Proteobacteria and Aquificae
(Supplementary Fig. 1), the PC enzyme is encoded by two
separate genes, with the BC domain residing in a 52 kD a subunit
and the CT and BCCP domains in a 67 kD b subunit (Fig. 1a)11.
The BC, CT and BCCP domains of these two-subunit PCs share
high sequence identity with those of the single-chain PCs (B50%
for BC and B40% for CT and BCCP), but the sequence identity is
o10% in the regions corresponding to the PT domain
(Supplementary Figs 2 and 3). It is generally accepted that
these two-subunit PCs form an a4b4 complex12, which would be
equivalent to the homo-tetrameric single-chain PCs. In contrast
to the single-chain PCs, however, the two-subunit enzymes are
not stimulated by acetyl-CoA13.
The two-subunit PC from Pseudomonas aeruginosa (PaPC) is
necessary for growth on C3 and C6 compounds14. In addition,
transcriptional upregulation of PaPC and other genes by PycR,
which is encoded immediately downstream of the PC operon in
the genome, is important for maintaining P. aeruginosa lung
infection in a rat model, and PycR has been proposed as a
potential target for antimicrobial therapy15. The PC from
Pseudomonas fluorescens is important for the expression of
small RNAs that mediate secondary metabolism and the
biosynthesis of antibiotic compounds16. The two-subunit PC
from Azotobacter vinelandii is necessary for growth on minimal
media with glucose or sucrose as the sole carbon source,
and a deletion mutant accumulates the compound poly-b-
hydroxybutyrate due to a slowdown of the TCA cycle17,18.
The crystal structure of the BC subunit of Aquifex aeolicus PC
has been reported19, although currently there is no structure of
the holoenzyme of a two-subunit PC. We report here the
structures of the two-subunit PC from Methylobacillus flagellatus
(MfPC). Surprisingly, our structures reveal an a2b4 stoichiometry
for the holoenzyme, with one BC dimer and two CT dimers, and
the overall architecture of the holoenzyme is strikingly different
from that of the homo-tetrameric PCs. An a helix at the C
terminus of the a subunit is surrounded by two four-stranded
b-sheets from two b subunits, forming a domain that is
SaPC




















































Figure 1 | Domain organization of PC. (a) Domain organization of single-chain SaPC and two-subunit MfPC. The domains are labelled and given different
colours. (b) Schematic drawing of the structure of the single-chain SaPC holoenzyme9. The domains in the four monomers are coloured according to a and
labelled. (c) Structure of SaPC viewed down the two-fold axis of the BC dimer, along the arrow of b. The structure figures were produced with PyMOL
(www.pymol.org).
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remarkably similar to the BT (BC–CT interaction) domain found
in propionyl-CoA carboxylase20, 3-methylcrotonyl-CoA carbo-
xylase21 and acetyl-CoA carboxylase (ACC)22. Biochemical and
mutagenesis studies confirm the stoichiometry, as well as other
observations from the structure. Our functional studies in
P. aeruginosa PA14 show that PC is important for colony
morphogenesis and for growth on pyruvate and glucose as carbon
sources.
Results
Structure determination. We screened through a collection of
two-subunit PCs for their expression and crystallization beha-
viour, and produced crystals of MfPC23. MfPC has 65% amino-
acid sequence identity with PaPC (Supplementary Figs 2 and 3).
The a and b subunits were over-expressed in Escherichia coli
using a bicistronic plasmid, with an N-terminal hexa-histidine tag
on the a subunit. The two subunits readily formed a stable
complex, which was then purified to homogeneity. Purified MfPC
was confirmed to be fully biotinylated by streptavidin gel shift
assay, and had robust PC enzymatic activity (Supplementary
Fig. 4). We compared the catalytic activities of MfPC and PaPC
with those of the single-chain PCs LmPC and SaPC. In contrast to
the single-chain PCs and consistent with previous reports, MfPC
and PaPC are not sensitive to activation by acetyl-CoA
(Supplementary Fig. 4). However, MfPC and PaPC have B10-
fold higher specific activity than LmPC and SaPC in the absence
of acetyl-CoA. When acetyl-CoA is present, SaPC activity
becomes comparable to those of the two-subunit PCs, while
LmPC activity is still B5-fold lower.
The MfPC crystals diffracted only to 6.6 Å resolution even after
extensive optimization. To improve the diffraction quality, we
introduced three single-site mutations (K419A, E421A and
E422A) in the b subunit designed to reduce the surface entropy24.
These residues are located in a solvent-exposed region of the CT
domain and are not strictly conserved among PC homologues
(Supplementary Fig. 3). The mutations had no effect on the
catalytic activity of the enzyme, but they only slightly improved
the diffraction quality of the crystals.
We then removed the flexible B sub-domain (residues
131–201) of the BC domain and replaced it with a Gly–Ser–
Ser–Gly linker. The B domain closes down over the BC active
site during catalysis but is often disordered or has high
temperature factors in PC crystal structures. This deletion
mutant behaved identically to the wild-type enzyme during
purification, and expectedly was inactive catalytically. A mutant
protein having this deletion and the three single-site changes
produced a different crystal form with better diffraction,
allowing us to determine the crystal structure of the MfPC
holoenzyme at 3.0 Å resolution (Supplementary Fig. 5) using
the molecular replacement method with the SaPC structure9 as
the search model. Several segments of the protein had poor
electron density and were not modelled in the final structure,
including the linker between the PT and BCCP domains and
the linker between the CT and PT domains for one b dimer.
Only three of the four BCCP domains were observed. The
crystallographic statistics are summarized in Table 1.
Using the structure of this mutant as the search model, we also
determined the structure of the MfPC with only the three single-
site mutations (referred to hereafter as wild-type since the
mutations did not affect the catalytic activity) at 6.6 Å resolution.
The BC and CT domains were located individually with the
molecular replacement method. After one round of refinement,
there was electron density indicating the position of the PT
domain, the B domain of BC and a BCCP domain in one of the
CT active sites. Inclusion of these additional domains reduced the
R factors of the model (Table 1). Because of the low-resolution
nature of the data set, this structure was not refined further.
Overall structure of two-subunit PC deletion mutant. Contrary
to the expectations of an a4b4 holoenzyme, the structure revealed
a 370 kD a2b4 oligomer for the MfPC mutant, with one BC dimer
and two CT dimers (Fig. 2a). The mutant holoenzyme has overall
dimensions of 140 130 70 Å and adopts a shape similar to the
letter U, strikingly different from the holoenzyme architecture of
single-chain PCs (Fig. 1b). The BC dimer (Fig. 2b) forms the
bottom and a CT dimer is on each arm of the U shape, leaving a
large cavity in the middle (Fig. 2a).
The BC dimer possesses a two-fold axis of symmetry, with root
mean square (r.m.s.) distance of 0.1 Å for the equivalent Ca
atoms of the two domains. However, the two CT dimers do not
follow this symmetry, and have different orientation and position
relative to the BC domains (Supplementary Fig. 6). This
asymmetry would disfavour the binding of a second BC dimer
at the top of the U-shaped structure, which partly explains the
a2b4 stoichiometry observed in the structure. In addition, one of
the CT dimers (b3 and b4) has relatively poor electron density
and high temperature factors.
Of the three BCCP domains that are observed in this mutant
holoenzyme, two are situated between the BC and CT domains,
near the bottom of the U-shaped structure (Fig. 2a). These two
BCCP domains likely come from the two b subunits (b2 and b4)
that are distal from the BC dimer, and may help stabilize the
overall structure of the mutant holoenzyme. The third BCCP
Table 1 | Data collection and refinement statistics.








Space group R32 P3121
Cell dimensions
a, b, c (Å) 285.8, 285.8, 274.9 160.8, 160.8,
227.7
a, b, g () 90, 90, 120 90, 90, 120
Resolution (Å) 50–3.0 (3.1–3.0)* 50–6.6
(6.83–6.6)
Rmerge 8.2 (60.8) 8.8 (4100)
CC1/2 (0.67) (0.64)
I/sI 11.0 (1.8) 14.9 (1.3)
Completeness (%) 96 (96) 95 (96)
Redundancy 2.8 (2.7) 6.4 (6.3)
Refinement
Resolution (Å) 50–3.0 50–6.6











Bond lengths (Å) 0.010 0.010
Bond angles () 1.5 1.3
Three crystals were used for data collection for mutant MfPC, and one crystal for wild-type
MfPC.
*Highest-resolution shell is shown in parenthesis.
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domain is located in the active site of the distal b subunit with
good electron density (b2), and its biotin is well ordered
(Supplementary Fig. 5), but it comes from a proximal b subunit
(likely b1). Therefore, the BCCP domains are extensively
swapped in the holoenzyme.
We assigned the BCCP in the CT active site as coming from
the other proximal b subunit based on considering the
distances of the gaps. To provide evidence for this assignment,
we separately purified wild-type a and b subunits, along with
A49T and K581A mutant b subunits, which would inactivate
the CT and BCCP domains, respectively (please see section
below on structure-based mutations). The wild-type a subunit
was then mixed separately with the three b subunits to form the
holoenzyme. As expected, the wild-type holoenzyme was fully
active, while the holoenzymes containing the A49T or K581A
mutant b subunit had 1 and 2% of wild-type activity,
respectively. We then diluted and mixed the two b subunit
mutants together in a 1:1 ratio, allowing the formation of
homo and hetero mutant b subunit dimers, before adding the
a subunit to form a mixed population of hybrid mutant
holoenzymes. If a BCCP domain can only visit the CT active
site in the same b subunit during catalysis, we would expect no
recovery of activity. However, if a BCCP domain visits the
active site in the other b subunit during catalysis, about B25%
of wild-type activity should be recovered. In support of the
latter model and the assignments of BCCP in the structure, 29%
of wild-type activity was recovered when the b subunit mutants
were combined.
Overall structure of wild-type two-subunit PC. The structure of
the wild-type MfPC confirmed that the two-subunit PC holoen-
zyme has a2b4 stoichiometry (Fig. 2c). However, the CT dimers
moved closer to the BC dimer and the two proximal b subunits
moved close to each other as well, indicating that the contact
between the BC and CT domains is flexible. Consequently, there
is no space between the BC and CT domains to accommodate a
BCCP domain and the large cavity in the centre of the mutant
holoenzyme is absent as well. The wild-type holoenzyme instead
has an overall shape of a butterfly, with overall dimensions of
160 110 120 Å (Fig. 2c). The two distal b subunits are splayed
away from each other (Fig. 2d), which would further disfavour
the binding of a second BC dimer.
Compared with the single-chain PCs, the CT dimers in MfPC
(Fig. 2d) are rotated by almost 90 relative to those in SaPC
(Fig. 1c and Supplementary Fig. 6). Therefore, the difference in
the architecture of the two-subunit PC holoenzyme is not due
simply to the removal of a BC dimer from one corner of the
single-chain PC tetramer.
On the basis of the single-chain PC structures, we expected that
the B domain of BC would not have interactions with other
regions of the protein. However, the B domain in the wild-type
MfPC structure has some contact with the proximal b subunit
(Fig. 2c), due to the large differences in the orientation of the
CT dimer compared with the single-chain PCs. The loss of this
BC–CT interaction in the mutant protein may explain why the
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Figure 2 | Structures of MfPC holoenzyme. (a) Schematic drawing of the mutant MfPC a2b4 holoenzyme structure, having the shape of the letter U in this
view. The domains are coloured according to Fig. 1a, except the BC domain of the second a subunit is coloured in pink. BT-L, BT-like domain. (b) Structure of
the mutant MfPC holoenzyme viewed down the BC domain dimer, along the arrow of a. (c) Structure of wild-type MfPC holoenzyme, having the shape of a
butterfly in this view. (d) Structure of the wild-type MfPC holoenzyme viewed down the BC domain dimer, along the arrow of c. The two distal b subunits
(b2 and b4) are splayed away from each other, and other differences to the mutant MfPC holoenzyme are also clearly visible by comparing with b.
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The structures of the individual BC and CT dimers of
MfPC are largely similar to those of the single-chain PCs
(Supplementary Fig. 7). The structure of the BC dimer is actually
more similar to that of SaPC in complex with CoA10. The
C-terminal helix is disordered in the structure of the BC subunit
of A. aeolicus PC19.
A BT-like structure in two-subunit PC. As in the single-chain
PCs, there are few direct contacts between the BC and CT dimers
in MfPC. Instead, interactions between the a and b subunits are
mediated primarily through a helix at the C-terminal end of an
a subunit (residues 454–472, outside of the BC domain) and a
four-stranded anti-parallel b-sheet (residues 470–512) in the
CT–BCCP linker of a b subunit, equivalent to the PT domain in
the single-chain PCs (Fig. 1a), with r.m.s. distance of 3.7 Å for 56
equivalent Ca atoms between the MfPC and SaPC structures
(Supplementary Fig. 7).
Surprisingly, the structure shows that the b-sheet from the
second subunit of the CT dimer wraps around the other face of
the helix (Fig. 2a), giving rise to a domain with a central a-helix
surrounded by an eight-stranded up-down b-barrel (Fig. 3a and
Supplementary Fig. 5). The overall structure of this domain is
therefore remarkably similar to that of the BT (BC–CT
interaction) domain found in the structures of propionyl-CoA
carboxylase (PCC)20, 3-methylcrotonyl-CoA carboxylase21 and
ACC22. The r.m.s. distance is 3.2 Å for 88 equivalent Ca atoms
between MfPC and the PCC BT domain (Fig. 3b), even though
the latter has a longer central helix and a ‘hook’ linking the helix
and the first strand of the barrel that is important for interactions
in the PCC holoenzyme. The stoichiometry of this BT-like
domain is a1b2, and the formation of this domain is likely the
primary determinant for the a2b4 stoichiometry of the MfPC
holoenzyme. While the BT-like domain has essentially no
sequence identity with the PT domain of single-chain PCs,
there is a high degree of sequence conservation of the BT-like
domain among all bacterial two-subunit PCs (Supplementary
Figs 2 and 3), strongly suggesting that these enzymes share a
common a2b4 subunit composition.
An important difference between the two-subunit and single-
chain PCs is that the helix in the PT domain of single-chain PCs
is amphipathic, with the hydrophilic side exposed to the solvent
in the holoenzyme (Fig. 3c,d). In contrast, the central helix of the
BT-like domain in two-subunit PCs is entirely hydrophobic,
consisting primarily of alanine residues (Fig. 3e), and is
completely shielded from solvent by the b-barrel structure
(Fig. 3f). This is similar to the BT domain in PCC and
3-methylcrotonyl-CoA carboxylase.
A highly conserved 476-HGE-478 motif in a b-hairpin of the
BT-like domain interacts with residues at the BC dimer interface
(Fig. 4a). Additional conserved residues at this interface include
Asp502 and Glu507 in the BT-like domain. However, these
residues are not conserved in single-chain PCs (Supplementary
Fig. 3). Instead, this region is equivalent to the binding site for the
adenine diphosphate portion of acetyl-CoA in single-chain PCs
(Fig. 4b)8–10. Especially, the side chain of His476 occupies the
same position as the adenine base of acetyl-CoA, and forms an
equivalent hydrogen bond with the carbonyl of Ala45 (Ala47 in
SaPC). The Glu478 side chain is located near the 30 phosphate of
acetyl-CoA, and they both interact with residues in the opposite
BC monomer. This is consistent with the fact that the BC
dimer in MfPC is more similar to the CoA complex of SaPC
(Supplementary Fig. 7), even though there is a significant
difference in the position of the BT-like domain relative to the
PT domain of single-chain PCs (Fig. 4b). This may also explain
why two-subunit PCs are not sensitive to acetyl-CoA, as the
binding site is occupied by a protein segment from the b subunit.
The conformational change in the SaPC BC dimer induced by
acetyl-CoA binding has also been linked to the activation of the
enzyme10. Thus, the conformation of MfPC BC dimer induced by
the 476-HGE-478 motif may be responsible for the high kcat value
observed for this enzyme (Supplementary Fig. 4).
Further evidence for the a2b4 stoichiometry. The a2b4 stoi-
chiometry of two-subunit PCs is unusual in light of the structures
of the single-chain PCs along with the fact that all other
biotin-dependent carboxylases studied to date have a 1:1 ratio
between their BC and CT domains. Therefore, we sought further
evidence in support of this stoichiometry.
We confirmed that the a2b4 complex is not limited just to
MfPC, as all the bacterial two-subunit PCs that we were able to
express and purify from E. coli migrated at nearly the same
position as MfPC on a gel filtration column, substantially
later than that for the single-chain SaPC (Fig. 5a), and an
SDS–polyacrylamide gel electrophoresis (SDS–PAGE) gel showed
that the two-subunit PCs have the same ratio of a to b subunits
(Fig. 5b). The 1:2 stoichiometry of the subunits is further
confirmed by running known amounts of the individual subunits
in an SDS–PAGE gel (Fig. 5c). To address the possibility that
expression of the b subunit was somehow favoured over the
a subunit in E. coli, we introduced a separate plasmid expressing
only the a subunit along with the bicistronic plasmid expressing
both a and b subunits. After purification, the complex was
identical to that obtained from the bicistronic plasmid only,
migrating at the same position on the gel filtration column and
showing excess b by SDS–PAGE.
As further evidence in support of the a2b4 stoichiometry of
two-subunit PCs, we carried out analytical ultracentrifugation
experiments with MfPC (wild-type and the deletion mutant) and
PaPC, and we used single-chain SaPC as a control. All three
two-subunit PC samples gave molecular masses of B340 kD
(B11.5S), consistent with the a2b4 stoichiometry (Fig. 5d and
Supplementary Fig. 8). In comparison, SaPC gave a molecular
mass of B570 kD (14.8S), consistent with a homo-tetramer as we
found earlier25.
We then purified the a and b subunits of MfPC separately and
mixed them together in different molar ratios, followed by
analytical gel filtration. Mixing of a and b in 1:2, 1:1 or 2:1 molar
ratios did not change the composition of the complex as they all
migrated similarly on the gel filtration column (Fig. 5e) and
showed excess b over a by SDS–PAGE (Fig. 5f). Moreover, when
a and b subunits were mixed in a 1:1 molar ratio, only half of the
total a formed the complex and the rest migrated as free a on the
gel filtration column. Only when a and b were mixed in a 1:2
molar ratio was all of the a subunit absorbed into the complex.
While it has been generally accepted that the bacterial
two-subunit PCs form an a4b4 complex12, earlier biochemical
characterizations of these enzymes from several species actually
produced a range of estimates for the molecular weight and
subunit composition17,26,27. Studies of the two-subunit PC from
A. vinelandii, Pseudomonas citronellolis and P. fluorescens
reported a molecular weight of B300 kD based on gel filtration
and sedimentation experiments, and these groups proposed an
a2b2 subunit stoichiometry17,26,27. On the other hand, another
study on the PC enzyme from P. citronellolis reported a molecular
weight of B500 kD based primarily on gel filtration analysis, and
this group proposed an a4b4 subunit composition12. However,
a4b4 subunit ratios of 1:1.7 and 1:1.18 were found based on two
different protocols for Coomassie blue staining of SDS gels, which
is inconclusive between 1:1 and 1:2 ratios of subunits. On the
basis of SDS–PAGE gels, PaPC appears to have an excess of
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b subunit when it is expressed aerobically in Pseudomonas11. The
wide range of these estimates is likely due to the limitations of
using gel filtration to determine molecular weights, particularly
for large proteins with extended shapes.
BCCP movement during catalysis. The two-subunit PCs are
unique among the biotin-dependent carboxylases in that they
have a 1:2 ratio of BC:CT active sites. In both the wild-type and
mutant structures, a BCCP domain is found only in the active site
of the distal CT domain (Fig. 2a,c). This distal CT active site is
located 70 Å away from the nearest BC active site (Supplementary
Fig. 9), a distance which is within the range found in other biotin-
dependent carboxylases, and which supports a swinging-domain
model for catalysis2. The proximal CT domain active site is
accessible to BCCP in the mutant structure, but inaccessible in the
wild-type structure due to clashes with the BC dimer
(Supplementary Fig. 9). This suggests the possibility that only
the distal CT domain is catalytically active. In this model, one
b subunit would provide the active CT domain, while the other
b subunit provides the active BCCP domain.
We cannot rule out an alternative model in which conforma-
tional changes in the wild-type enzyme allow both CT domains to
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Figure 3 | A BT-like domain in the structure of two-subunit PC. (a) Schematic drawing of the BT-like domain in MfPC. The helix comes from the a subunit
(red), and the two four-stranded b-sheets come from two separate b subunits (green and yellow). Each subunit is given a different colour to highlight the
origins of the protein segments in the BT-like domain. (b) Overlay of the structures of the BT-like domain of MfPC (orange) and the BT domain of PCC
(grey)20. (c) Sequence alignment of the residues in the a helix of the PT domain in single-chain PCs. Hydrophobic residues are coloured purple, and
hydrophilic ones in cyan. (d) The a helix of the PT domain in SaPC is amphipathic, with half of its surface having hydrophilic residues and exposed to the
solvent. Hydrophobic side chains are coloured in purple, and hydrophilic ones in cyan. (e) Sequence alignment of the residues in the a helix of the BT-like
domain in two-subunit PCs, at the C-terminal end of the a subunit. (f) The a helix of the BT-like domain in MfPC is hydrophobic, completely surrounded by
the b-barrel and having mostly small side chains.
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subunit is likely B40 Å away from the same BC active site that
will be accessed by the distal b subunit (Supplementary Fig. 9),
and therefore both BCCP domains of a b dimer likely visit the
same BC active site during catalysis. It is not clear from the
structures whether there would be coordination between the two
BCCP domains in their access to this active site. It could be
possible that while one BCCP domain is in the BC active site, the
other BCCP domain is in the CT active site.
Structure-based mutations block holoenzyme formation. We
introduced mutations in MfPC based on the structural observa-
tions, and tested their effects on catalysis (Fig. 4c) and/or
holoenzyme formation. As expected, deleting the last helix of the
a subunit with the Q452stop mutant, in the centre of the BT-like
domain, abolished the formation of the holoenzyme (Fig. 4d). In
addition, mutating one of the alanine residues in this helix to
arginine (A465R) also abrogated the formation of the holoen-
zyme, confirming that it is necessary for the helix to have small
hydrophobic residues to form the intact BT-like domain (Fig. 4e).
Both mutants are catalytically inactive as well (Fig. 4c). We then
assessed the function of the conserved residues at the interface
between the BC- and BT-like domains (Fig. 4a) by generating the
double mutants H476A/E478A and D502A/E507A. Both of
these double mutants still formed a stable holoenzyme, and the
H476A/E478A mutant was fully active while the D502A/E507A
double mutant retained 40% of wild-type activity (Fig. 4c).
However, the H476A/E478A/D502A/E507A quadruple mutation
completely abolished holoenzyme formation (Fig. 4f) and cata-
lytic activity (Fig. 4c), consistent with the structural observations
and implicating this interface as a key region for stabilizing the
holoenzyme.
The BC dimer interface is similar to that observed in SaPC
(Supplementary Fig. 7), as well as the BC subunit of E. coli
ACC28,29. Mutational studies of SaPC demonstrated that a single
point mutation (K442E) at the BC dimer interface is sufficient to
disrupt tetramerization of the enzyme and abolish catalytic
activity25. We introduced the equivalent mutation (R401E)
in the a subunit of MfPC, but found that it still formed the
a2b4 complex and had only a B50% reduction in catalytic
activity compared with wild-type MfPC (Fig. 4c). We tested two
additional BC dimer interface mutants, R19E and E23R. In SaPC,
the R19E mutant forms a tetramer but does not have catalytic





































































































Figure 4 | Mutagenesis studies to assess the structural observations. (a) Interactions between the BT-like domain and the BC dimer at the holoenzyme
interface. (b) Overlay of the structure of MfPC (in colour) and SaPC (in grey) in complex with CoA (grey for carbon atoms)10. The red arrow indicates the
difference in position of the BT-like domain in MfPC and the PT domain in SaPC. (c) Catalytic activities of wild-type and mutant MfPCs. The pyruvate
concentration is at 20 mM. The error bars represent the s.d. from three independent measurements. NA, no activity observed under the condition tested.
(d) Deletion of the a helix of the BT-like domain, or mutation of one of its Ala residues (A465R), abolished the formation of the MfPC holoenzyme. The two
subunits were co-expressed in E. coli, with the a subunit carrying a His-tag. E, eluate from the Nickel column; F, flow-through of the Nickel column; P, pellet;
S, soluble fraction. (e) Mutation of an Ala residue (A465R) in the helix of the BT-like domain abolished the formation of the MfPC holoenzyme. (f) A
quadruple mutation in the interface between the BT-like domain and BC blocked holoenzyme formation.
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MfPC mutants were also able to form the holoenzyme and did
not differ markedly from the wild-type enzyme in catalytic
activity (Fig. 4c). Overall, these results indicate that the MfPC
complex is more robust to mutations at the BC dimer interface
compared with SaPC. The single-chain PC monomers are held
together in the tetramer primarily by the BC and CT dimer
interfaces (Fig. 1b). The additional inter-subunit interactions
mediated by the BT-like domain in MfPC may allow for the
complex to better tolerate these BC interface mutations and retain
catalytic activity. The a subunit of MfPC alone is a monomer in
solution (Fig. 5e), and the BC domain from SaPC alone is also a
monomer and catalytically inactive25, indicating that additional
interactions within the holoenzyme are necessary to form a stable
BC dimer in these PC enzymes.
We also created the A49T mutant of MfPC, equivalent to the
disease-causing A610T mutant of HsPC. This residue is located in
the CT active site (Supplementary Fig. 9), and the bulkier Thr side














1 α : 0.5 β
1α 1β
1 α : 0.5 β 1 α : 2 β
1 α : 1 β






























































































Figure 5 | Experiments to confirm a2b4 stoichiometry of two-subunit PCs. (a) Gel filtration profiles for two-subunit PCs (Mf, M. flagellates; Pa,
P. aeruginosa; Pf, P. fluorescens; Td, T. denitrificans) and the single-chain SaPC. (b) Coomassie-stained SDS–PAGE gel with purified two-subunit PCs from
different species. Two lanes were run for each protein, with twice as much protein loaded in the first lane. The band for the a subunit in this lane is roughly
the same as that for the b subunit in the second lane, consistent with the 1:2 stoichiometry. (c) SDS–PAGE gel with known amounts of a and b subunits and
their mixtures, indicating that the purified holoenzyme has 1:2 stoichiometry. The b subunit in the MfPC holoenzyme sample is slightly smaller than the b
subunit sample alone as it does contain a His tag. (d) Size distribution of PCs in solution at a concentration of 0.5 mg ml 1, based on the best-fit results by
the continuous size distribution analysis. Two-subunit PCs (MfPC wild-type and deletion mutant, and PaPC) showed a similar major species of S¼ 11.5,
while single-chain SaPC showed a tetrameric species of S¼ 14.8. (e) Gel filtration profiles from mixing experiments of different ratios of MfPC a and b
subunits. The vertical dashed line indicates the elution volume of the complex that is formed on mixing. (f) Coomassie-stained SDS–PAGE gels of peak
fractions collected from two different mixing experiments (F5 and F6 indicates collected fractions 5 and 6, respectively, indicated in e).
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12713
8 NATURE COMMUNICATIONS | 7:12713 | DOI: 10.1038/ncomms12713 | www.nature.com/naturecommunications
 199
mutant had essentially no catalytic activity (Fig. 4c). In addition,
blocking biotinylation of the enzyme by mutating the Lys581
residue in BCCP to Ala also abolished catalysis, as expected
(Fig. 4c).
Colony morphogenesis of P. aeruginosa PC mutant strains. We
then assessed the functional importance of the two-subunit PC in
the human pathogen P. aeruginosa (PaPC). PaPC has high
sequence identity with MfPC (67% identity overall, 74% BC, 72%
CT, 53% BT-like and 62% BCCP), and is likely to have the same
a2b4 stoichiometry and architecture based on our gel filtration
and sedimentation analysis (Fig. 5a,d). We created a markerless
deletion of the PC operon, DPC (DPA14_71720-PA14_71740),
and a series of point mutants that would allow us to assess the
functional importance of key residues identified in the structure
and that are conserved between M. flagellatus and P. aeruginosa.
The growth profiles of these strains were analysed in a defined
medium containing either succinate (a C4 compound), pyruvate
(C3) or glucose (C6) as the sole carbon source. We did not
observe any major effects when growth of the mutant strains was
compared with that of the wild type on succinate (Fig. 6a). While
all strains showed overall decreased growth on pyruvate, a subset
of the strains, including DPC, exhibited severe growth defects
relative to the wild type (Fig. 6b). The K451stop mutation in the a
subunit (equivalent to Q452 in MfPC), which would delete the
helix of the BT-like domain and disrupt holoenzyme formation,
and the K572A mutation in the b subunit (equivalent to K581 in
MfPC), which would abolish biotinylation, led to growth defects
in pyruvate that were similar to that of the DPC deletion mutant.
The A55T mutation in the b subunit (equivalent to A49 in
MfPC), which reduces PC activity by 50-fold and would interfere
with biotin binding to the CT active site, exhibited growth on
pyruvate that was similar to the wild type. Finally, the growth
defect of DPC was rescued when the PC operon was placed back
into the endogenous locus (Fig. 6a). These phenotypes were
recapitulated on glucose, though all strains showed better growth
overall on this carbon source. Defective growth of mutants with
impaired PC activity on C3 and C6 (but not C4) carbon sources
confirms earlier findings14.
While culturing in well-aerated, homogenous liquid medium
has been a traditional system for assessing microbial growth
phenotypes, it does not represent the primary mode of growth
outside the laboratory for most microbes. In non-laboratory
habitats, microbes typically grow as communities of densely
packed cells held together by a self-produced matrix. Cells in
matrix-encased assemblages often exhibit unique metabolisms
due to resource limitation. To examine a possible role for PC in
P. aeruginosa growth under such conditions, we adapted defined
media for use in two additional models that assess the production
of extracellular matrix: (i) a pellicle assay, in which liquid cultures
are incubated without shaking and biofilms develop at the
air–liquid interface; and (ii) a colony morphology assay, in which
cell suspensions are spotted on agar-solidified media containing
the dyes Congo red and Coomassie blue and matrix production is
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Figure 6 | The two-subunit PaPC is required for growth on selected carbon sources. (a) Shaken liquid-culture growth of wild-type P. aeruginosa PA14,
DPC, the PC-complemented strain and various site-specific mutants in a defined medium containing 20 mM succinate, pyruvate or glucose as the sole
carbon source. Each growth curve represents the average of three biological replicates. Error bars denote s.d. (b) Pellicles formed by P. aeruginosa PA14,
DPC, and the PC-complemented strain on a defined medium containing succinate, pyruvate, or glucose as the sole carbon source. (c) Colony morphology of
P. aeruginosa PA14, DPC and the PC-complemented strain on a defined medium (supplemented with 1% agar, Congo red and Coomassie blue) containing
succinate, pyruvate or glucose as the sole carbon source. Images depict day 3 of colony development.
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surface30,31. All strains formed robust pellicles and colony
structures when succinate was supplied as the carbon source,
with the DPC showing similar morphologies to those of the wild
type. However, when glucose or pyruvate was provided as the
carbon source, the DPC mutation prevented growth (Fig. 6b,c).
The growth phenotypes we observed in the pellicle and colony
morphology assays recapitulated the results for growth in aerated
liquid cultures. However, utilization of complex medium
(1% tryptone) revealed a PC-dependent phenotype specific to
matrix production in colonies (Fig. 7a,b) (since we did not
observe robust pellicle formation for wild-type PA14 in standing
cultures of 1% tryptone medium, we could not test for altered
pellicle formation under these conditions). In the colony
morphology assay, the wild type initially produces a smooth
colony, which forms wrinkle structures in the centre starting on
day 3 (Fig. 7a). By day 5, the wrinkles have spread over the
colony, but a region of smooth morphology remains at the colony
edge. We found that, in contrast, DPC and K572A colonies begin
to wrinkle on day 2 and exhibit a flatter morphology with several
exaggerated wrinkles in a ‘spoke’ formation, which is reminiscent
of morphologies that arise during electron acceptor-limited
conditions32. Colonies formed by all other mutants exhibited
morphologies that were similar to the wild type. Quantification of
the cationic exopolysaccharide Pel, a major component of the
PA14 biofilm matrix33, showed that, indeed, increased matrix
production is associated with enhanced colony wrinkling
(Fig. 7a,b). Wild-type colony morphology and matrix
production were restored in the DPC complementation strain
(Fig. 7a). Interestingly, colony morphology and liquid-culture
growth phenotypes did not correlate. Though the DPC and
K572A mutants showed altered colony morphogenesis on
agar-solidified 1% tryptone, they were unaffected in shaken
liquid-culture growth on this medium. Further, while both the
K572A and K451stop mutants exhibit defects when grown on
defined media containing pyruvate or glucose as the sole carbon
source, only K572A shows altered development in the colony
morphology assay on tryptone. The colony morphology assay
therefore reveals PC-dependent metabolic disruptions that
specifically affect a matrix-encased, structured community.
Discussion
The central helix at the C-terminal end of the a subunit is not
present in the BC subunit of bacterial multi-subunit ACC34. In
fact, many of the PC a subunits are mis-annotated as BC subunits
of ACC in the sequence database, and the presence of this
C-terminal helix can be used to readily distinguish between them.
In addition, the multi-subunit ACC and the two-subunit PC are
both present in several bacterial species, including P. aeruginosa2,
and this C-terminal helix may ensure that the correct a subunit is
incorporated into the complex in vivo.
The PC enzymes from archaea are also separated into a and b
subunits35,36, but they have several major differences from
bacterial two-subunit PCs. The b subunit of archaeal PCs is
B570 residues, significantly shorter than the 600–620 residues of
bacterial two-subunit PCs. This is due to a large deletion in the
region corresponding to the putative PT-/BT-like domain, such
that only two b strands are predicted. The a subunit of bacterial
two-subunit PCs is generally B471 residues and terminates
precisely at the end of the BT-like domain a helix (Supplementary
Fig. 2). In comparison, the a subunit of archaeal PCs has B500
residues due to a much longer C-terminal extension. In addition,
while a stretch of small hydrophobic residues is present in the


























































Figure 7 | PaPC dysfunction leads to increased matrix production and altered colony morphology. (a) Colony morphology of wild-type P. aeruginosa
PA14, DPC, the PC-complemented strain and the K572A mutant on 1% tryptone, 1% agar (supplemented with Congo red and Coomassie blue).
(b) Quantification of Congo red binding, a proxy for matrix production, for P. aeruginosa PA14, DPC, the PC-complemented strain and various site-specific
mutants grown on 1% tryptone, 1% agar with no added dyes. Colonies were grown for 3 days before they were collected for the Congo red binding assay.
(c) Shaken liquid-culture growth of P. aeruginosa PA14, DPC, the PC-complemented strain and various site-specific mutants in 1% tryptone. Each growth
curve represents the average of three biological replicates. Error bars denote s.d.
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bacterial two-subunit PCs. Because of these significant
differences, it is unclear if archaeal two-subunit PCs share the
subunit stoichiometry and holoenzyme architecture of bacterial
two-subunit PCs. Thus, it may be better to classify the bacterial
and archaeal two-subunit PCs into two distinct categories.
The multifunctional biotin-dependent carboxylases likely arose
through gene fusion of smaller mono-functional precursors. The
structures of the homo-tetrameric and the two-subunit PCs give
general insights into the mechanisms by which a protein can
adapt to the gene fusion event, with the newly formed multi-
domain protein preserving essential functions while gaining new
features. An important consequence of this gene fusion event in
the case of PC would be the disruption of the a1b2 stoichiometry
of the BT-like domain, likely precipitating the drastic differences
observed in holoenzyme architectures. However, the structures of
the individual domains and the catalytic mechanism appear to be
conserved between homo-tetrameric and two-subunit PCs. With
the disruption of the BT-like domain, the new PT domain
acquired additional functions, including tetramer stabilization
and recognition of the allosteric activator acetyl-CoA. Intrigu-
ingly, acetyl-CoA binds to single-chain PCs in a conformation
that mimics an important structural motif in the two-subunit
PCs, suggesting that the development of acetyl-CoA regulation of
PC might be linked to the structural rearrangements induced by
the fusion. The various structures of biotin-dependent carbox-
ylases have demonstrated that homologous domains can be
arranged into remarkably different holoenzyme architectures, and
that these distinct architectures have been tuned by evolutionary
processes to perform distinct functions in cells.
Our in vivo results obtained with P. aeruginosa PA14 PC
mutants confirm the role of PaPC during growth on pyruvate, a
C3 compound, and support the model that this enzyme functions
to replenish C4 intermediates thereby enabling TCA cycle
function14. We also observed that impaired PC function led to
increased matrix production and the development of flat colonies
with pronounced wrinkle features on a medium containing
tryptone as the carbon source. We have previously observed this
phenotype under electron acceptor limitation32 and hypothesize
that it is an adaptive community response to cellular redox
imbalance. This suggests that the anaplerotic role of PC supports
TCA cycle function and redox homeostasis during multicellular
growth on complex carbon sources and may contribute to
P. aeruginosa pathogenicity via this mechanism15.
Methods
Protein expression and purification. The a and b subunits for PC from
several bacterial species, including M. flagellatus, P. aeruginosa, P. fluorescens and
Thiobacillus denitrificans were amplified from genomic DNA (American Type
Culture Collection) and sub-cloned into the pCDFduet vector (Novagen). The
a subunit was sub-cloned into MCS1 with an N-terminal hexa-histidine tag, and
the b subunit was sub-cloned into MCS2 with no tag. The internal B-domain
deletion was made using overlapping PCR. Surface entropy reduction mutations
were chosen based on the UCLA SerP server24. The individual a and b subunits for
MfPC were sub-cloned into pET28a with an N-terminal hexa-histidine tag. All
expression constructs were co-transformed into BL21 Star (DE3) cells along with a
plasmid encoding the E. coli biotin ligase (BirA) gene.
The cells were cultured in Luria–Bertani (LB) medium with 50 mg ml–1
streptomycin and 35 mg ml–1 chloramphenicol, and were induced for 14 h with
1 mM isopropyl-b-D-thiogalactosideat 20 C. Before induction, 20 mg l–1 biotin and
10 mM MnCl2 were added to the growth medium. The protein was purified
through nickel-agarose affinity chromatography (Qiagen) followed by gel filtration
chromatography (Sephacryl S-300, GE Healthcare). The purified protein was
concentrated to 15 mg ml–1 in a buffer containing 20 mM Tris (pH 8.0), 150 mM
NaCl, 5% (v/v) glycerol and 5 mM dithiothreitol, flash-frozen in liquid nitrogen
and stored at –80 C. The protein was confirmed to be fully biotinylated by a
streptavidin gel-shift assay. The N-terminal hexa-histidine tag was not removed for
crystallization.
Protein crystallization. Crystals were grown by the sitting-drop vapour diffusion
method at 20 C. For MfPC with B-domain deletion, the protein was incubated
with 2.5 mM pyruvate for 30 min at 4 C before crystallization set-up. The reservoir
solution contained 19% (w/v) PEG3350, 2% tacsimate (pH 6.0) (Hampton) and 3%
(v/v) ethanol. The crystals appeared within 1 week and grew to full size after an
additional week. The crystals were cryo-protected in the reservoir solution
supplemented with 10% (v/v) ethylene glycol and 5% (w/v) sucrose and were
flash-frozen in liquid nitrogen for data collection at 100 K.
For wild-type MfPC, the protein at 15 mg ml–1 was incubated with 2.5 mM ATP
and 2.5 mM pyruvate for 30 min at 4 C before crystallization set-up. The reservoir
solution contained 1.3 M ammonium sulfate and 0.1 M sodium citrate (pH 6.0).
The crystals appeared after 1 day and grew to full size within a week. They were
cryo-protected in the reservoir solution supplemented with 15% (v/v) ethylene
glycol and flash-frozen in liquid nitrogen for data collection at 100 K
Data collection and structure determination. X-ray diffraction data were
collected at the Advanced Photon Source beamline NE-CAT 24-ID-E using an
ADSC Q315r detector and at the X25 beamline at the National Synchrotron Light
Source at Brookhaven National Laboratory using a Pilatus 6M detector. The
diffraction images were processed using HKL2000 (ref. 37).
Crystals of the mutant MfPC belong to space group R32 with unit cell
parameters of a¼ b¼ 285.8 Å and c¼ 274.9 Å. With an a2b4 oligomer in the
asymmetric unit, the Vm is 2.9 Å3 Da–1 and the solvent content is 58%. The
structure was solved by the molecular replacement method with the programme
Phaser38, using the BC, CT and BCCP domains of the S. aureus PC structure9 as
the search models. Manual rebuilding was carried out with Coot39 and refinement
with the programme Refmac40.
Crystals of wild-type MfPC belong to space group P3121 with unit cell
parameters of a¼ b¼ 160.8 Å and c¼ 227.7 Å. A molecular replacement solution
for this structure was found with the programme Phaser using the individual BC
and CT domains of the refined mutant MfPC structure as the search models. There
is one a subunit and two b subunits in the asymmetric unit, and the full a2b4
complex can be generated by a crystallographic two-fold axis. On the basis of this
molecular replacement solution, the solvent content of the crystal is 73% and the
Matthews coefficient is 4.6 Å3 Da–1. After one round of refinement, electron density
was observed indicating the positions of the B domain of BC and the BT-like
domain. There was also density indicating a BCCP domain in the active site of the
distal CT domain, which itself adopts a conformation that is consistent with an
interaction with BCCP. In addition, the MfPC molecules in the crystal do not have
direct contacts without this BCCP domain, further supporting its placement in the
model. After inclusion of these additional domains, we observed a decrease in the
R values and clear density for these domains on refinement.
Analytical ultracentrifugation. Analytical ultracentrifugation was performed on
an XL-A analytical ultracentrifuge (Beckman Coulter) using an An-50 Ti rotor.
The sedimentation velocity experiments were carried out using a double-sector
epon charcoal-filled centrepiece at 20 C with a rotor speed of 42,000 r.p.m. Protein
solutions of 0.5 mg ml–1 (330 ml) and reference (370 ml) solutions, both containing
20 mM Tris (pH 8.0) and 150 mM NaCl, were loaded into the centrepiece. The
absorbance at 280 nm was monitored in a continuous mode with a time interval of
360 s and a step size of 0.003 cm. Multiple scans at different time intervals were
then fitted to a continuous c(s) distribution model using the SEDFIT programme41.
Mutagenesis and kinetic studies. Mutants were made using the QuikChange kit
(Stratagene) and confirmed by sequencing. They were expressed and purified using
the same protocol as described for the wild-type enzyme. The catalytic activity was
determined based on a published protocol42, which couples oxaloacetate
production to the oxidation of NADH by malate dehydrogenase, followed
spectrophotometrically by the decrease in absorbance at 340 nm. The activity was
measured at room temperature in a reaction mixture containing 20 mM Tris
(pH 7.5), 200 mM NaCl, 5 mM MgCl2, 50 mM sodium bicarbonate, 50 mM
ammonium sulfate, 5 units of malate dehydrogenase (Sigma), 2 mM ATP, 108 nM
MfPC (based on the a subunit) and varying concentrations of pyruvate. The
Michaelis–Menten curve was fitted using the programme Origin.
Construction of PC mutant and complementation strains. PC mutant and
complementation strains were made for the two-gene operon encoding PC
(PA14_71720-PA14_71740) in P. aeruginosa PA14 as follows. Relevant genomic
sequences were amplified, with point mutations introduced where noted in
Supplementary Table 1, and recombined into the allelic replacement vector pMQ30
through gap repair cloning in the Saccharomyces cerevisiae strain InvSc1. The
deletion construct contained two fused B1-kb sequences representing regions
upstream and downstream of the PA14_71720-PA14_71740 operon. Point-mutant
and complementation constructs contained the full operon sequence, with muta-
tions where appropriate, plus these two flanking regions. Each plasmid was
transformed into E. coli strain DH5a, verified by sequencing, and put into P.
aeruginosa using biparental conjugation. PA14 single recombinants were selected
on LB plates containing 100 mg ml–1 gentamicin. Double recombinants (with the
final genotype of interest) were selected on agar plates containing 10% (w/v)
sucrose, and their genotypes were confirmed by PCR. For point mutant strains,
genotypes were confirmed by sequencing.
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P. aeruginosa PA14 growth conditions. For genetic manipulation and pre-cul-
turing, PA14 was routinely grown in LB (unless otherwise noted) at 37 C with
shaking at 250 r.p.m. For growth curve analysis, overnight pre-cultures of PA14
strains were diluted 100-fold in either 1% tryptone or a defined medium
(50 mM MOPS (4-morpholinepropanesulfonic acid), 43 mM NaCl, 93.5 mM
NH4Cl, 2.2 mM KH2PO4, 1 mM MgSO4 and 1 mg ml–1 FeSO4) amended with
20 mM sodium succinate, sodium pyruvate or glucose as the carbon source and
grown to the following approximate OD500nm values: 0.6 for succinate; 0.1 for
pyruvate; and 0.1 for glucose. These cultures were diluted to OD500nmE0.01 and
dispensed into 96-well plates, then incubated at 37 C with continuous shaking on
the medium setting in a Biotek Synergy 4 plate reader.
P. aeruginosa PA14 colony morphology assay. For the standard assay, PA14 was
grown overnight in LB and diluted to OD500nm¼ 0.5. A volume of 10ml of these
normalized cell suspensions were spotted on colony morphology assay medium
(1% tryptone, 1% agar, 40mg ml–1 Congo red and 20mg ml–1 Coomassie blue; 60 ml
in each 9 cm 9 cm square plate) and incubated in a humidified chamber at 25 C
for up to 5 days. When defined media were used for the colony morphology assay,
PA14 pre-cultures were grown overnight in MOPS liquid medium (50 mM MOPS,
43 mM NaCl, 93.5 mM NH4Cl, 2.2 mM KH2PO4, 1 mM MgSO4 and 1 mg ml–1
FeSO4 with 20 mM succinate). Pre-cultures were centrifuged for 1 min at
12,396 g and resuspended in defined medium without a carbon source to
OD500nm¼ 0.25. A volume of 10 ml of washed and resuspended cells were spotted
onto solidified defined medium (25 mM HEPES (4-(2-hydroxyethyl)-1-piper-
azineethanesulfonic acid), 7.6 mM (NH4)2SO4, 0.8 mM MgSO4  7H2O, 10 mM
K2HPO4, 20 mM of carbon source (succinate, pyruvate or glucose), 40 mg ml–1
Congo red, 20mg ml–1 Coomassie blue and 1% agar; 60 ml in each 9 cm 9 cm
square plate) and incubated in a humidified chamber at 25 C for up to 5 days.
Images were taken with a CanoScan 5600F scanner (Canon).
P. aeruginosa PA14 Congo red binding assay. PA14 colonies were grown for 3
days (76 h) in the standard colony morphology assay, with the modification that
dyes were omitted from the 1% tryptone, 1% agar medium. Each colony was
scraped from the agar using a 1,000 ml pipette tip and resuspended in 1.5 ml
phosphate-buffered saline (136 mM NaCl, 2.68 mM KCl, 10.1 mM Na2HPO4 and
1.76 mM KH2PO4, at pH 7.4) supplemented with 60 mg of Congo red. Each colony
suspension was briefly vortexed and shaken at 250 r.p.m. at 37 C for 1 h to allow
the matrix to bind the Congo red dye. The colony biomass was then pelleted by
centrifugation at 16,873 g for 2 min. A volume of 200ml of supernatant were
dispensed into 96-well plates and the absorbance at 490 nm, representing unbound
Congo red, was measured using a Biotek Synergy 4 plate reader. Bound Congo red
was calculated by subtracting the absorbance of the unbound Congo red from that
of the control solution containing 60 mg Congo red per 1.5 ml PBS.
P. aeruginosa PA14 pellicle assay. Overnight LB pre-cultures of PA14 strains
were diluted 100-fold in MOPS liquid medium (50 mM MOPS, 43 mM NaCl,
93.5 mM NH4Cl, 2.2 mM KH2PO4, 1 mM MgSO4 and 1 mg ml–1 FeSO4) amended
with 20 mM sodium succinate as the carbon source and grown to OD500nmE0.7
A sample (4.6 ml) of each subculture was centrifuged at 10,000 g for 1 min, and
the pellet was resuspended in 23 ml of the defined medium amended with 20 mM
sodium succinate, D-glucose or sodium pyruvate in a scintillation vial, with a
starting OD500nm at 0.14 for pellicle growth. Scintillation vials were incubated
without shaking or disturbance at 37 C for up to 4 days and photographed under
side illumination using an iPhone 5S.
Data availability. Atomic coordinates and structure factors for the two reported
structures of M. flagellatus PC have been deposited in the Protein Data Bank under
the primary accession code 5KS8. The authors declare that all other relevant data
supporting the findings of this study are available on request.
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